Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003396	ab-be	mmol/l (mmol/l)	34370	263110	0.00%
3003396	ab-be	— (—)	17617	58312	100.00%	Distribution not available
3003396	ab-emäsylimäärä	mmol/l (—)	690	1842	100.00%	Distribution not available
3003396	emäsylimäärä,valtimoveri	mmol/l (—)	83	151	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Colorectal cancer, excluding all cancers (controls excluding all cancers)

2545

11296

2.49

323.31

7.7

6.8

0.57

1.30

mmol/l

17.53

2135

8751

Obesity due to excess calories

3495

17904

2.12

323.31

8.6

7.3

1.35

0.89

mmol/l

8.21

2833

13981

Focal epilepsy

1998

8263

2.79

323.01

7.5

7.3

1.11

0.99

mmol/l

0.75

1540

6372

Cardiomyopathy

1631

6105

3.11

322.35

12.0

6.4

0.66

0.91

mmol/l

1.28

1310

4700

Insulin, fast-acting

3118

15443

2.23

320.82

9.6

7.1

0.85

0.99

mmol/l

0.84

2410

12126

Stroke, excluding SAH

5227

22458

1.88

319.49

8.0

6.9

1.15

1.09

mmol/l

0.42

4152

17729

Coronary artery bypass grafting

2730

9717

2.45

317.89

10.8

6.6

0.98

mmol/l

0.03

2200

7669

Biguanides

7519

29051

1.69

317.56

8.0

7.1

1.08

1.07

mmol/l

0.05

5841

23088

ILD, hospital admissions

1636

6309

3.22

316.65

9.2

6.8

1.42

1.06

mmol/l

2.72

1357

4852

Other interstitial pulmonary diseases

1651

6419

3.18

314.06

9.2

6.8

1.42

1.06

mmol/l

2.76

1370

4940

Other dorsopathies, not elsewhere classified

7790

25767

1.67

313.90

6.8

7.7

1.19

0.89

mmol/l

8.49

6066

20172

Diseases of the digestive system

3938

21260

2.02

313.42

9.1

6.7

1.06

1.03

mmol/l

0.19

3096

16573

Lung cancer and mesothelioma

1759

5831

2.97

313.11

7.2

6.0

1.59

0.45

mmol/l

30.13

1492

4490

Interstitial lung disease endpoints

1651

6431

3.17

312.92

9.2

6.8

1.42

1.06

mmol/l

2.72

1370

4942

Interstitial lung disease

1651

6431

3.17

312.92

9.2

6.8

1.42

1.06

mmol/l

2.72

1370

4942

Abdominal and pelvic pain

8039

25512

1.66

311.71

7.8

7.3

1.00

0.99

mmol/l

0.10

6354

19848

Peripheral arterial reconstruction

1868

7740

2.94

311.10

9.9

6.3

0.92

1.02

mmol/l

0.45

1457

5930

Other special examinations and investigations of persons without complaint or reported diagnosis

5483

15840

1.85

308.99

7.7

7.1

1.24

0.88

mmol/l

8.20

4135

12545

Alcohol abuse, main dg, excluding more controls

1409

4984

3.30

308.85

8.5

7.9

1.27

0.84

mmol/l

2.68

1097

3869

Diverticular disease of intestine

5891

23363

1.79

308.57

7.2

7.1

0.97

1.11

mmol/l

1.65

4690

18379

Aneurysms, operations, SAH

1664

6491

3.05

307.95

8.4

7.0

1.13

1.10

mmol/l

0.08

1295

5039

Cerebrovascular diseases (FINNGEN)

3647

5485

5.73

307.65

9.6

5.9

1.09

0.93

mmol/l

1.25

2915

4291

Lower back pain or/and sciatica

7991

34981

1.67

307.65

6.7

7.5

1.28

0.97

mmol/l

10.19

6316

27395

Other anaemias

3781

19040

2.13

307.65

8.3

6.5

0.84

1.11

mmol/l

2.68

2972

14802

Implicit bacterial Sepsis

5379

15317

4.11

307.65

12.0

5.9

1.37

0.97

mmol/l

6.98

4301

11891

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2314

9496

2.70

307.65

8.1

7.5

1.14

0.87

mmol/l

2.21

1811

7299

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

10873

29347

2.97

307.65

9.5

6.8

1.59

0.75

mmol/l

69.45

8771

22919

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3261

7059

3.18

307.65

8.6

5.8

1.03

0.91

mmol/l

0.87

2580

5451

Other respiratory diseases principally affecting the interstitium

1952

7716

3.09

307.65

10.0

6.7

1.56

1.09

mmol/l

4.77

1602

5939

Syncope and collapse

3660

16537

2.13

307.65

7.2

6.9

1.06

0.99

mmol/l

0.50

2871

12927

Viral Sepsis

2308

6902

4.22

307.65

11.7

5.9

1.47

1.01

mmol/l

4.75

1855

5312

5351

24946

2.17

307.65

9.6

7.4

0.97

0.94

mmol/l

0.17

4228

19535

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8105

27717

1.91

307.65

8.7

6.8

0.94

1.10

mmol/l

2.27

6315

22007

ILD differential diagnosis

6741

16002

2.26

307.65

8.3

6.5

1.31

0.51

mmol/l

43.40

5326

12363

Explicit Sepsis

5068

16715

3.50

307.65

11.3

6.0

1.07

0.94

mmol/l

1.05

4013

12967

Stroke, including SAH

5706

23497

1.97

307.65

8.3

7.0

1.15

1.08

mmol/l

0.62

4541

18551

First line medication for Crohn's disease

10014

27962

2.10

307.65

8.0

7.2

1.15

0.89

mmol/l

7.27

7952

21670

Mental and behavioural disorders due to alcohol

4696

22833

2.21

307.65

9.2

7.6

1.12

0.91

mmol/l

2.24

3701

17861

Major coronary heart disease event

6882

23537

2.17

307.65

8.8

6.9

1.06

1.10

mmol/l

0.34

5422

18772

Bacterial Sepsis

5960

17017

3.90

307.65

11.7

5.9

1.34

0.97

mmol/l

6.70

4761

13259

8941

29593

1.68

307.65

7.4

7.0

1.35

0.85

mmol/l

24.35

7121

23029

Ischemic heart diseases

7527

22710

2.31

307.65

8.8

7.0

1.13

1.07

mmol/l

0.60

5979

18197

Codeine or tramadol medication

9833

31077

1.87

307.65

7.2

7.3

1.02

1.03

mmol/l

0.12

7753

24276

Calcific aortic valvular stenosis, operated

3007

13970

2.45

307.65

8.1

6.3

1.06

1.11

mmol/l

0.26

2423

10736

Benign neoplasm: Colon

4146

15567

2.26

307.65

7.2

0.93

1.25

mmol/l

5.11

3285

12177

DVT of lower extremities and pulmonary embolism

4035

19289

2.36

307.65

8.0

6.7

1.27

1.06

mmol/l

2.63

3223

15078

Hypertensive heart and/or renal disease

2503

7671

2.91

307.65

7.9

6.2

1.10

1.08

mmol/l

0.05

2044

5997

Mental and behavioural disorders due to alcohol, excluding acute intoxication

4183

20462

2.27

307.65

9.4

7.7

1.13

0.93

mmol/l

1.90

3312

16069

5565

25475

2.15

307.65

9.6

7.4

0.99

0.95

mmol/l

0.23

4406

19945

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5257

26000

2.25

307.65

9.9

6.7

1.17

1.03

mmol/l

1.77

4217

20404

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6069

28249

2.22

307.65

8.0

6.9

1.44

1.00

mmol/l

14.02

4982

22148

Septicaemia

4955

16604

3.48

307.65

11.2

6.4

1.07

1.03

mmol/l

0.23

3920

12926

Benign neoplasms

5493

17011

1.92

307.65

7.4

8.0

0.81

1.07

mmol/l

4.89

4249

13012

Type 2 diabetes, strict (exclude DM1)

7586

27230

1.76

307.65

8.4

6.8

1.03

1.09

mmol/l

0.59

5943

21626

Implicit viral Sepsis

2305

6889

4.22

307.65

11.8

5.9

1.47

1.01

mmol/l

4.73

1852

5301

Symptoms and signs involving cognition, perception, emotional state and behaviour

8108

32471

1.87

307.65

6.9

7.5

1.20

0.99

mmol/l

4.71

6353

25561

Malignant neoplasm, wide definition for exclusion

7995

23213

2.22

307.65

7.7

7.6

0.82

1.17

mmol/l

12.41

6505

18033

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5792

27324

2.36

307.65

9.9

6.6

1.17

1.02

mmol/l

2.20

4654

21440

Hypertensive diseases (excluding secondary)

4789

7596

4.11

307.65

9.6

6.1

0.97

0.92

mmol/l

0.27

3827

5880

Asthma, hospital admission 2, infections

5730

24241

2.61

307.65

8.1

7.0

1.72

0.89

mmol/l

40.25

4624

18812

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

10256

23076

3.18

307.65

9.6

6.6

1.56

0.70

mmol/l

65.97

8277

17970

Respiratory insufficiency

1448

2424

9.65

307.65

10.9

5.9

3.69

0.46

mmol/l

109.68

1292

1846

Other respiratory disorders and diseases

2698

8751

4.00

307.65

11.4

6.5

3.02

0.95

mmol/l

97.47

2331

6656

Asthma, hospital admissions , main diagnosis only

6570

34026

1.84

307.65

7.1

7.3

1.47

0.94

mmol/l

21.81

5276

26545

Pneumonias (Asthma/COPD co-morbidities)

11172

29137

3.03

307.65

9.8

6.6

1.57

0.75

mmol/l

68.43

9031

22718

Excluding asthma or asthma-COPD overlap

6802

16005

2.28

307.65

8.3

6.5

1.31

0.50

mmol/l

44.27

5382

12367

Asthma, hospital admissions 3, pneumonia

4170

15015

3.32

307.65

8.7

6.6

1.95

0.94

mmol/l

39.64

3408

11577

Asthma (mode)

6717

16002

2.50

307.65

7.4

6.5

1.32

0.51

mmol/l

45.87

5348

12363

Any event in cancer register

7858

24969

2.01

307.65

7.4

7.5

0.87

1.11

mmol/l

5.99

6201

19580

Any reimbursement code in KELA

4283

7493

3.07

307.65

8.6

6.6

0.88

0.75

mmol/l

1.12

3314

5691

Asthma-related pneumonia or sepsis

4170

15015

3.32

307.65

8.7

6.6

1.95

0.94

mmol/l

39.64

3408

11577

Other chronic obstructive pulmonary disease

5194

16711

3.11

307.65

7.9

7.0

2.05

0.81

mmol/l

72.72

4295

13057

Complications of medical and surgical care

7221

31373

2.45

307.65

9.5

6.7

1.17

1.02

mmol/l

2.31

5797

24609

Pain in limb

6428

25725

1.94

307.65

7.2

7.5

1.09

0.97

mmol/l

1.33

5199

20073

Care involving use of rehabilitation procedures

5721

26769

2.23

307.65

9.0

6.9

1.44

1.03

mmol/l

11.90

4413

21053

Continuous positive airway pressure

1540

3756

4.02

307.65

9.9

6.0

1.11

0.69

mmol/l

2.82

1287

3015

Fall on same level

9132

31491

1.70

307.65

8.1

7.3

1.11

0.95

mmol/l

2.90

7303

24508

Cerebrovascular diseases

7202

26391

2.18

307.65

8.0

7.0

1.11

1.07

mmol/l

0.40

5730

20839

Atherosclerosis, excluding cerebral and coronary sclerosis

4046

16409

2.22

307.65

8.4

6.2

0.90

1.11

mmol/l

2.20

3150

12740

COPD, hospital admissions

5221

18550

2.83

307.65

7.9

6.9

2.05

0.89

mmol/l

65.62

4310

14432

Other nutritional deficiencies

5159

25749

2.13

307.65

8.7

7.4

1.37

0.91

mmol/l

11.54

4188

20148

Hypertensive diseases

7069

17380

2.52

307.65

9.1

6.9

1.03

1.01

mmol/l

0.09

5621

13634

Other and unspecified anaemias

3752

18897

2.14

307.65

8.3

6.5

0.83

1.11

mmol/l

2.83

2949

14689

Bacterial infection, other or unspecified

5845

20464

3.02

307.65

9.2

6.4

1.06

1.03

mmol/l

0.23

4666

16047

Other arrhythmias

4679

18731

2.05

307.65

7.1

6.4

1.12

0.91

mmol/l

3.28

3683

14620

Malignant neoplasm

7773

24669

2.02

307.65

7.7

7.5

0.89

1.13

mmol/l

6.21

6287

19299

Hypertension

7055

17374

2.51

307.65

9.1

6.9

1.02

1.01

mmol/l

0.09

5614

13629

Early onset COPD, excluding more controls

2515

6926

4.54

307.65

9.2

6.7

2.12

0.43

mmol/l

64.81

2123

5394

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

8386

29917

2.06

307.65

10.3

6.7

0.87

1.05

mmol/l

3.32

6680

23449

Type 2 diabetes

8190

27684

1.87

307.65

8.8

6.7

1.01

1.09

mmol/l

0.89

6409

21932

Mood disorders, excluding more controls

7225

26719

1.73

307.65

7.7

7.3

1.16

0.94

mmol/l

4.32

5733

21006

ILD, hospital admissions 3, with pneumonia sepsis

1050

2864

5.01

307.65

10.1

6.3

1.68

0.72

mmol/l

9.57

881

2180

Hypothyroidism and >3 levothyroxin purchases

1576

1897

5.13

307.65

8.8

5.3

0.83

0.77

mmol/l

0.19

1207

1373

Asthma (only as main-diagnosis)

6325

15871

2.62

307.65

7.2

6.5

1.46

0.50

mmol/l

58.56

5079

12270

Pneumonia, organism unspecified

9958

27323

3.01

307.65

9.2

6.7

1.59

0.75

mmol/l

64.46

8077

21367

Later onset COPD, excluding more controls

2486

6048

4.03

307.65

6.9

5.6

1.97

0.50

mmol/l

44.55

2034

4631

Malaise and fatigue

4920

16655

2.79

307.65

7.4

6.8

1.30

0.97

mmol/l

5.59

3950

12987

ILD, hospital admission 2, with pulmonary infections

1200

3296

4.88

307.65

10.0

6.3

1.56

0.69

mmol/l

9.33

1010

2494

Diseases of arteries, arterioles and capillaries

6750

24543

2.31

307.65

9.6

6.6

0.94

1.10

mmol/l

2.10

5434

19286

COPD, early/later onset

5248

18645

2.83

307.65

7.9

6.9

2.05

0.89

mmol/l

65.48

4334

14517

Certain infectious and parasitic diseases

8377

22645

1.97

307.65

8.4

6.6

1.01

0.96

mmol/l

0.56

6578

17606

Condition for Implicit Sepsis (Organ dysfunction codes)

9590

26434

3.03

307.65

10.7

6.2

1.20

0.95

mmol/l

5.50

7674

20737

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

4214

15231

2.45

307.65

8.5

7.2

0.69

1.27

mmol/l

17.33

3550

11890

Peripheral artery disease

4359

17477

2.27

307.65

8.6

6.3

0.94

1.10

mmol/l

1.37

3415

13590

Benign neoplasm of colon, rectum, anus and anal canal

4686

16443

2.24

307.65

7.2

7.3

0.95

1.24

mmol/l

4.70

3720

12842

Asthma

7367

15871

2.73

307.65

7.5

6.5

1.45

0.50

mmol/l

64.44

5896

12270

Depression medications

1956

2033

5.19

307.65

8.5

5.2

1.00

0.83

mmol/l

0.81

1537

1480

Implicit Sepsis

8873

24700

3.30

307.65

10.8

6.1

1.29

0.95

mmol/l

8.84

7114

19380

COPD-related respiratory insufficiency

1828

4807

5.61

307.65

10.4

6.6

2.77

0.82

mmol/l

57.97

1578

3674

Venous thromboembolism

4991

25044

2.15

307.65

7.9

6.7

1.22

1.05

mmol/l

2.32

4002

19644

Persons encountering health services for specific procedures and health care

10337

30434

2.30

307.65

9.1

6.9

1.01

0.99

mmol/l

0.17

8221

23791

COPD (mode)

4150

9208

4.53

307.65

8.1

6.3

2.10

0.54

mmol/l

83.29

3438

7167

Viral pneumonia

1426

4058

4.41

307.65

13.4

6.6

1.52

0.67

mmol/l

9.83

1166

3085

Presence of cardiac and vascular implants and grafts

4828

17473

2.39

307.65

9.9

6.5

0.96

1.10

mmol/l

1.51

3849

13747

Other medical care

3858

17616

2.41

307.65

6.9

6.4

1.47

1.04

mmol/l

8.23

3087

13746

Non-rheumatic valve diseases

4846

13467

3.03

307.65

9.6

6.4

1.15

0.91

mmol/l

3.61

3964

10585

Sequelae of external causes of morbidity and mortality

2359

10382

2.62

307.65

9.8

6.9

1.21

1.04

mmol/l

1.26

1956

8082

3774

16836

2.46

307.65

7.8

7.3

1.61

0.87

mmol/l

23.00

3053

13073

10256

23076

3.18

307.65

9.6

6.6

1.56

0.70

mmol/l

65.97

8277

17970

Hernia of abdominal wall, postoperative

1637

5515

3.44

307.65

9.8

6.0

0.97

1.14

mmol/l

0.83

1340

4274

COPD differential diagnosis

6747

16006

2.26

307.65

8.3

6.5

1.31

0.51

mmol/l

43.67

5332

12365

Examination and observation for other reasons

5387

15599

2.28

307.65

8.2

7.2

0.96

0.89

mmol/l

0.68

4302

12378

Diseases of arteries, arterioles and capillaries (FINNGEN)

2958

4159

6.17

307.65

11.1

6.1

0.83

0.90

mmol/l

0.34

2434

3281

Asthma (only as main-diagnosis), excluding more controls

6133

14114

2.84

307.65

7.3

6.2

1.44

0.50

mmol/l

54.84

4927

10914

Alcohol use disorder, Swedish definition

5161

24078

2.20

307.65

9.7

7.5

0.99

0.95

mmol/l

0.27

4102

18868

Type 2 diabetes, definitions combined

7567

27035

1.77

307.65

8.4

6.7

1.04

1.10

mmol/l

0.58

5931

21464

Bronchitis

8243

34383

1.65

307.65

7.5

7.2

1.35

0.93

mmol/l

16.39

6553

26800

Coronary atherosclerosis

6679

20455

2.37

307.65

8.7

7.0

1.02

1.06

mmol/l

0.23

5294

16378

Asthma, unspecified (mode)

5252

14566

3.23

307.65

7.4

6.4

1.55

0.52

mmol/l

54.51

4233

11278

Other diseases of intestines

8472

29011

1.79

307.65

8.2

7.3

0.96

1.01

mmol/l

0.44

6735

22544

Cardiovascular diseases (excluding rheumatic etc)

5448

9137

3.79

307.65

9.5

6.1

0.83

0.77

mmol/l

0.39

4286

6919

Personality disorders, excluding more controls

1915

7468

2.82

307.65

7.8

7.5

1.35

0.82

mmol/l

6.10

1526

5755

Other diseases of pleura

5221

19049

2.89

307.65

9.7

6.7

2.20

0.85

mmol/l

86.42

4387

14712

All pneumoniae

11226

29152

3.03

307.65

9.8

6.7

1.57

0.74

mmol/l

69.52

9065

22738

Spinal stenosis

4562

19458

2.01

307.65

6.3

7.4

1.23

0.99

mmol/l

3.35

3556

15404

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

3617

15527

2.28

307.65

6.8

7.1

1.29

1.27

mmol/l

0.14

2922

12098

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1491

5017

3.44

307.65

8.7

7.9

1.06

0.83

mmol/l

1.18

1183

3894

Atrial fibrillation and flutter

3334

5260

4.85

307.65

10.8

5.9

1.11

0.95

mmol/l

1.23

2717

4138

Codes for special purposes

3982

17568

2.53

307.65

10.9

7.0

1.13

0.93

mmol/l

2.29

3309

13525

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

9131

32453

2.21

307.65

8.8

7.0

0.93

1.05

mmol/l

1.86

7240

25455

Provisional assignment of new diseases of uncertain etiology

3976

17543

2.53

307.65

10.9

7.0

1.13

0.93

mmol/l

2.25

3305

13504

Paralytic ileus and intestinal obstruction

2434

10768

2.58

307.65

9.3

6.6

1.22

1.12

mmol/l

0.53

1995

8371

Bacterial pneumoniae

4764

14774

3.39

307.65

9.9

6.3

1.91

0.70

mmol/l

62.62

3764

11478

Polyarthropathies

5519

20952

1.87

307.65

8.2

7.7

0.91

1.03

mmol/l

1.19

4415

16348

Influenza and pneumonia

11532

28778

2.99

307.65

9.6

6.7

1.53

0.73

mmol/l

65.86

9276

22435

Transplanted organ and tissue status

1120

3227

4.48

307.65

20.6

7.4

-0.53

1.04

mmol/l

25.97

947

2532

Non-allergic asthma (mode), excluding more controls

1609

5537

3.24

307.65

7.6

5.9

1.52

0.49

mmol/l

19.84

1288

4267

Non-ischemic cardiomyopathy

3258

9188

3.52

307.65

9.6

6.2

1.79

0.90

mmol/l

20.01

2692

7219

Any mental disorder

9129

27917

1.73

307.65

7.6

7.3

1.15

0.94

mmol/l

4.63

7200

21912

Type 2 diabetes, definitions combined, including avohilmo

7548

26915

1.76

307.65

8.3

6.8

1.03

1.10

mmol/l

0.71

5905

21380

Poisoning by medicine

1991

6908

3.32

307.65

8.3

7.8

1.17

0.84

mmol/l

2.62

1573

5377

Bleeding

8209

29028

2.29

307.65

9.4

6.9

1.17

1.02

mmol/l

2.26

6517

22932

Intracranial trauma

4664

15595

2.41

307.65

7.9

7.3

1.26

0.75

mmol/l

13.06

3669

12188

Poisoning by drugs, medicaments and biological substances

2190

7797

3.22

307.65

8.0

7.7

1.17

0.89

mmol/l

2.13

1721

6057

Asthma, unspecified (mode), excluding more controls

5120

12959

3.53

307.65

7.5

6.2

1.54

0.51

mmol/l

53.40

4131

10046

Non-invasive ventilation

5217

4262

20.50

307.65

9.3

5.6

2.29

0.65

mmol/l

119.32

4015

3398

Anaemias

2227

1756

9.79

307.65

11.2

5.4

0.70

0.75

mmol/l

0.17

1761

1291

Angina pectoris

5608

18963

2.22

307.65

7.9

6.9

1.33

1.06

mmol/l

5.32

4404

15155

COPD, hospital admissions 3, with asthma pneumonia sepsis

3285

10643

3.22

307.65

8.4

6.6

2.32

0.86

mmol/l

60.75

2721

8115

Complications of surgical and medical care, not elsewhere classified

9670

32462

2.36

307.65

9.2

6.7

1.09

1.01

mmol/l

1.01

7763

25338

Complications of procedures, not elsewhere classified

7664

31349

2.34

307.65

9.5

6.7

1.12

1.02

mmol/l

1.39

6171

24507

COPD, hospital admissions 1, only main diagnosis

3951

14273

2.80

307.65

7.8

6.7

2.14

0.89

mmol/l

56.24

3274

10984

Injuries to the head

8483

34991

1.66

307.65

7.8

7.3

1.08

0.99

mmol/l

1.03

6701

27377

Obesity

4881

24840

2.11

307.65

8.7

7.3

1.39

0.91

mmol/l

11.52

3970

19427

Covid-19 confirmed case

3225

11290

3.46

307.65

11.7

6.9

1.16

0.98

mmol/l

1.61

2726

8658

Myocardial infarction, strict

4522

16080

2.31

307.65

8.9

6.9

0.84

1.03

mmol/l

2.16

3510

12795

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2314

8152

3.18

307.65

8.1

7.3

1.14

0.81

mmol/l

3.07

1811

6260

Dentinal caries

2308

8734

3.06

307.65

11.7

7.3

0.63

1.02

mmol/l

3.73

1901

6827

Symptoms and signs involving the circulatory and respiratory systems

8678

21523

2.16

307.65

7.4

7.5

1.12

0.80

mmol/l

10.16

6746

16700

Dialysis, with operation codes

1666

4897

4.56

307.65

18.5

7.0

-0.69

1.17

mmol/l

40.40

1360

3831

General symptoms and signs

10079

24515

2.22

307.65

7.8

7.2

1.07

0.93

mmol/l

2.61

7909

19131

Coronary revascularization (ANGIO or CABG)

4420

15184

2.28

307.65

9.0

6.8

1.07

1.04

mmol/l

0.17

3482

12058

Neoplasms

5946

15951

2.12

307.65

7.7

8.1

0.77

1.06

mmol/l

6.33

4669

12195

Symptoms and signs involving the digestive system and abdomen

8219

25521

1.69

307.65

7.9

7.3

0.99

0.98

mmol/l

0.06

6458

19855

COPD, hospital admission 2, with asthma infections

3836

12671

3.14

307.65

8.3

6.7

2.20

0.86

mmol/l

60.85

3178

9720

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2843

5335

2.84

307.65

8.2

7.3

1.00

0.71

mmol/l

2.91

2202

4068

Pain in throat and chest

7696

20932

2.45

307.65

7.0

7.4

1.09

0.82

mmol/l

7.06

6062

16290

Aplastic and other anaemias

4127

20199

2.16

307.65

8.5

6.6

0.80

1.10

mmol/l

3.44

3236

15728

COPD related to multimorbidity

4548

15799

2.91

307.65

8.1

6.7

2.00

0.88

mmol/l

50.96

3740

12217

COPD/asthma related infections

9178

23096

2.14

307.65

8.3

6.5

1.39

0.70

mmol/l

42.55

7305

17983

Haemorrhage from respiratory passages

3179

12787

2.60

307.65

8.7

7.0

1.24

0.86

mmol/l

5.26

2519

10000

Fever of other and unknown origin

5175

20072

2.67

307.65

8.7

7.1

1.03

0.94

mmol/l

0.78

4145

15667

Abnormalities of breathing

9331

21451

2.88

307.65

7.4

7.5

1.35

0.80

mmol/l

27.37

7367

16645

Other acute lower respiratory infections

4414

22669

2.01

307.65

7.7

7.1

1.55

0.93

mmol/l

17.30

3589

17501

Oedema, not elsewhere classified

2696

11882

2.53

307.65

8.0

6.7

1.37

0.99

mmol/l

3.82

2210

9295

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

7994

23207

2.22

307.65

7.7

7.6

0.82

1.17

mmol/l

12.43

6504

18027

Hypertension, essential

7210

17070

2.66

307.65

8.6

6.9

1.05

1.03

mmol/l

0.17

5755

13409

Diabetes, varying definitions

8529

28503

1.91

307.65

9.1

6.8

0.93

1.08

mmol/l

2.11

6667

22537

Dyspnoea

10129

30180

2.96

307.65

7.3

7.2

1.48

0.88

mmol/l

37.44

8062

23583

Nausea and vomiting

2312

9813

2.59

307.65

8.4

6.5

1.11

1.04

mmol/l

0.30

1854

7587

Convulsions, not elsewhere classified

2219

7767

3.22

307.65

8.1

7.5

0.93

0.85

mmol/l

0.34

1738

6005

Diabetes medication

8454

29701

1.84

307.65

8.7

6.9

0.95

1.07

mmol/l

1.38

6584

23515

Abnormal findings on diagnostic imaging of lung

4668

22245

2.31

307.65

8.1

6.9

1.53

1.00

mmol/l

16.20

3883

17407

Endocrine, nutritional and metabolic diseases

6409

16423

2.11

307.65

8.9

6.5

0.89

0.97

mmol/l

0.67

4999

12751

Headache

4730

20783

2.02

307.65

6.9

7.1

1.11

0.91

mmol/l

3.08

3676

16229

Heart failure and coronary heart disease

3623

11597

2.77

307.65

9.4

6.2

1.26

1.10

mmol/l

1.27

2825

9066

Hard cardiovascular diseases

7972

23256

2.48

307.65

9.2

7.0

1.12

1.08

mmol/l

0.38

6351

18581

Diabetes mellitus

8560

28540

1.91

307.65

9.0

6.8

0.94

1.07

mmol/l

1.92

6686

22558

Other (not insulin) diabetes medications

7707

28381

1.73

307.65

8.1

6.9

1.08

mmol/l

0.03

6008

22545

Other intervertebral disc disorders

6803

24490

1.81

307.65

7.1

7.7

1.26

0.93

mmol/l

9.88

5243

19285

Obesity related asthma

2970

13242

2.54

307.65

8.0

7.3

1.72

0.90

mmol/l

22.65

2467

10391

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

7999

23204

2.22

307.65

7.7

7.6

0.82

1.17

mmol/l

12.58

6508

18025

Other pulmonary diagnosis

6805

16005

2.28

307.65

8.3

6.5

1.34

0.50

mmol/l

46.46

5375

12367

Use of hypnotics and sedatives

8462

31092

1.66

307.65

7.4

7.5

1.14

0.98

mmol/l

2.84

6719

24399

Substance abuse, excluding more controls

5425

21132

2.50

307.65

9.1

7.6

1.13

0.87

mmol/l

3.79

4327

16526

Pacemaker

3196

15545

2.28

307.65

9.8

6.3

1.29

1.11

mmol/l

1.69

2521

12021

Concussion

3594

15299

2.17

307.65

7.1

7.3

1.27

0.74

mmol/l

11.35

2814

11947

Oxycodone

3749

14303

2.96

307.65

7.6

6.8

1.66

1.03

mmol/l

17.09

3063

11144

Heart failure and bmi 25plus

4089

10849

3.16

307.65

9.6

6.4

1.66

1.00

mmol/l

15.36

3297

8393

Alcohol use disorder, ICD-based

3836

18746

2.28

307.65

9.4

7.7

1.13

0.93

mmol/l

1.82

3033

14697

Opioids

8582

22669

2.13

307.65

7.7

7.1

1.01

0.98

mmol/l

0.21

6764

17485

All-cause Heart Failure

7142

19095

3.29

307.65

9.8

6.5

1.51

0.92

mmol/l

20.34

5761

15018

Parasetamol

6900

15528

2.44

307.65

7.8

7.5

1.03

0.80

mmol/l

3.91

5338

12106

Heart failure,strict

6795

16000

3.82

307.65

10.2

6.5

1.47

0.86

mmol/l

20.00

5509

12613

Hypertensive Heart Disease

2227

7234

2.90

307.65

8.0

6.2

1.14

1.07

mmol/l

0.31

1839

5648

Glucagon-like peptide-1 (GLP-1) analogues

4910

22276

2.00

307.65

8.0

6.8

0.94

1.12

mmol/l

1.72

3698

17780

Oral corticosteroids

9865

30605

2.11

307.65

7.7

7.2

1.45

0.88

mmol/l

33.03

7848

23899

Hypothyroidism, drug reimbursement

876

1201

5.68

307.65

8.7

5.6

1.11

0.81

mmol/l

1.28

692

901

Obesity and other hyperalimentation

4898

24954

2.11

307.65

8.7

7.3

1.39

0.92

mmol/l

11.69

3985

19522

Heart failure and antihypertensive medication

3564

4737

6.48

307.65

12.3

6.3

1.34

1.12

mmol/l

1.82

2940

3757

Other bacterial diseases

10718

29004

2.93

307.65

9.5

6.7

1.12

1.01

mmol/l

1.50

8544

22810

Episodal and paroxysmal disorders

8854

27527

1.73

307.65

7.3

1.14

0.89

mmol/l

6.19

6894

21434

Other antidepressants

8438

27354

1.69

307.65

7.4

7.3

1.19

0.91

mmol/l

7.54

6656

21261

Neurological diseases

6701

19365

1.83

307.65

7.5

1.08

0.75

mmol/l

8.22

5162

15094

Asthma-related pneumonia

4163

14983

3.33

307.65

8.7

6.6

1.96

0.94

mmol/l

40.10

3401

11548

Valvular heart disease excluding rheumatic fever

4892

13551

3.05

307.65

9.9

6.4

1.13

0.91

mmol/l

3.23

4005

10646

Neurological diseases, wide definition

2320

4085

3.05

307.65

8.4

7.7

1.06

0.66

mmol/l

4.57

1784

3217

Atrial fibrillation and flutter with reimbursement

2848

4278

5.09

307.65

10.4

6.0

1.10

0.93

mmol/l

1.19

2363

3383

Metabolic disorders

9669

26466

2.53

307.65

8.9

6.9

1.03

1.06

mmol/l

0.30

7733

20743

Erysipelas

5332

22521

2.42

307.65

8.2

6.6

1.33

1.03

mmol/l

5.11

4275

17700

Bacterial pneumonia (organism specified)

4993

18034

2.94

307.65

9.8

6.4

1.87

0.84

mmol/l

50.08

3941

13936

Psychiatric diseases

8958

26982

1.75

307.65

7.6

7.3

1.16

0.92

mmol/l

5.50

7034

21191

Nephropathy related operations

1619

4827

4.53

307.65

18.5

7.2

-0.62

1.06

mmol/l

34.25

1331

3769

Pulmonary embolism

3072

12748

2.84

307.65

8.6

6.7

1.31

1.07

mmol/l

2.58

2451

9909

Other CVD (FINNGEN)

1138

1885

5.84

307.65

8.3

5.6

1.33

0.90

mmol/l

2.16

902

1452

Diseases of oesophagus, stomach and duodenum

8633

31843

1.74

307.65

8.3

7.1

1.01

1.04

mmol/l

0.28

6842

24957

Emergency coronary revascularization (for ACS)

5060

20769

1.93

307.65

8.6

6.8

1.08

1.07

mmol/l

0.05

3954

16314

Other disorders of fluid, electrolyte and acid-base balance

3485

11679

3.51

307.65

10.1

6.3

1.27

1.13

mmol/l

0.75

2772

9090

Chronic kidney disease

3070

13289

2.69

307.65

10.6

6.1

-0.36

1.18

mmol/l

47.36

2295

10296

Other neurological diseases

6072

28719

1.83

307.65

7.1

1.19

1.04

mmol/l

2.06

4736

22661

Statin medication

5206

15663

1.98

307.65

8.7

7.0

0.94

1.16

mmol/l

3.37

4147

12307

Disorders of lipoprotein metabolism and other lipidaemias

7841

24251

2.24

307.65

8.1

6.8

0.95

1.10

mmol/l

2.45

6294

19098

Asthma-related infections

5730

24241

2.61

307.65

8.1

7.0

1.72

0.89

mmol/l

40.25

4624

18812

Mental and behavioural disorders due to psychoactive substance use

5547

25646

2.25

307.65

9.1

7.5

1.13

0.94

mmol/l

2.34

4429

20050

Pulmonary heart disease

3072

12851

2.81

307.65

8.6

6.7

1.31

1.09

mmol/l

2.26

2451

9996

Chronic lower respiratory diseases

10702

30841

2.01

307.65

7.5

7.4

1.50

0.78

mmol/l

55.99

8542

23991

Cardiac arrhythmias

5199

12005

3.16

307.65

9.6

6.2

1.07

0.96

mmol/l

1.03

4152

9453

STROKE

5594

15332

2.86

307.65

9.0

6.5

1.14

1.06

mmol/l

0.82

4482

12289

Conduction disorders

2459

8876

2.57

307.65

8.4

6.0

1.01

0.94

mmol/l

0.34

1961

6877

GASTRO-related operations

6837

15044

2.44

307.65

8.6

5.9

0.85

1.06

mmol/l

3.60

5350

11435

COPD

5404

17227

3.12

307.65

8.0

7.0

2.01

0.81

mmol/l

70.18

4446

13454

Acute renal failure

2635

8788

3.87

307.65

15.6

6.3

-0.04

1.20

mmol/l

21.68

2064

6830

Hypo-osmolality and hyponatraemia

1858

6478

3.50

307.65

10.2

6.1

1.18

1.21

mmol/l

0.08

1491

5008

Dorsalgia

7875

25698

1.75

307.65

6.6

7.7

1.20

0.89

mmol/l

9.08

6187

20121

Renal failure

5108

18990

2.94

307.65

12.1

6.3

-0.02

1.21

mmol/l

46.66

3903

14869

Other heart diseases

4956

7649

4.93

307.65

11.5

6.1

1.09

0.88

mmol/l

2.41

4033

5913

Early onset COPD

2515

9472

3.23

307.65

9.2

7.7

2.12

0.83

mmol/l

40.88

2123

7372

Substance abuse

5425

25196

2.27

307.65

9.1

7.5

1.13

0.93

mmol/l

2.48

4327

19699

Paroxysmal tachycardia

1716

4252

3.82

307.65

9.4

5.9

0.93

0.83

mmol/l

0.46

1327

3316

Heart failure, strict

7278

19399

3.30

307.65

9.9

6.5

1.48

0.91

mmol/l

19.05

5870

15269

Tramadol

7922

21402

2.65

307.65

8.0

7.1

0.91

1.03

mmol/l

1.51

6445

16628

COPD/asthma/ILD related infections

9178

23096

2.14

307.65

8.3

6.5

1.39

0.70

mmol/l

42.55

7305

17983

Low back pain

5686

25069

1.86

307.65

6.9

7.7

1.34

0.90

mmol/l

14.07

4524

19674

Asthma/COPD (KELA code 203)

8151

30744

2.00

307.65

7.1

7.4

1.59

0.78

mmol/l

56.45

6520

23910

Other septicaemia

4443

15086

3.52

307.65

11.5

6.3

1.04

1.05

mmol/l

0.03

3517

11712

Any gastric operation

6837

15044

2.44

307.65

8.6

5.9

0.85

1.06

mmol/l

3.60

5350

11435

Other soft tissue disorders, not elsewhere classified

7363

26501

1.82

307.65

7.2

7.5

1.05

0.97

mmol/l

0.94

5873

20654

Renal tubulo-interstitial diseases

8914

29621

2.60

307.65

9.9

6.6

0.59

1.13

mmol/l

21.58

7030

23265

Intestinal stricture

2864

13638

2.39

307.65

9.5

6.8

1.09

mmol/l

0.01

2362

10598

Antihypertensive medication - note that there are other indications

4263

9409

2.64

307.65

8.8

6.3

0.77

0.89

mmol/l

1.07

3298

7160

Pure hypercholesterolaemia

7090

22832

2.32

307.65

7.6

6.7

1.02

1.11

mmol/l

1.07

5657

17991

Calcific aortic valvular stenosis

3007

13970

2.45

307.65

8.1

6.3

1.06

1.11

mmol/l

0.26

2423

10736

Calcific aortic valvular stenosis, including rheumatic fever

3006

14026

2.43

307.65

8.1

6.3

1.06

1.11

mmol/l

0.23

2420

10777

Type 2 diabetes, wide definition

7681

24711

2.24

307.65

8.6

6.7

1.02

1.12

mmol/l

1.17

5994

19697

Substance use, excluding alcohol

1716

6460

3.03

307.65

8.8

7.9

1.29

0.91

mmol/l

2.91

1419

5020

Operations 2 for CAVS

3002

13957

2.44

307.65

8.1

6.3

1.06

1.11

mmol/l

0.24

2418

10726

Spondylopathies

6770

23480

1.87

307.65

6.4

7.7

1.19

0.95

mmol/l

5.10

5331

18562

Codeine

8321

22429

2.20

307.65

7.2

7.1

1.01

0.99

mmol/l

0.14

6561

17318

Epilepsy

2888

12366

2.62

307.65

7.5

7.3

1.12

0.88

mmol/l

2.32

2265

9605

Suicide or other Intentional self-harm

2113

8536

2.79

307.65

8.4

7.6

1.21

0.92

mmol/l

2.44

1676

6629

All influenza

2372

8922

3.07

307.65

7.6

6.7

1.59

0.68

mmol/l

21.60

1863

6895

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1481

2216

6.37

307.65

9.6

7.4

1.39

0.94

mmol/l

3.03

1231

1772

ILD medications: prednisolone, methylprednisolone, prednisone

9897

29334

2.05

307.65

8.1

7.1

1.19

0.91

mmol/l

8.96

7874

22817

Dental caries

2574

9917

2.97

307.65

11.8

7.3

0.57

1.00

mmol/l

4.89

2123

7753

Infections, IBD-co-morbidities

1608

2962

4.58

307.65

10.3

7.3

0.96

0.79

mmol/l

0.69

1305

2379

Bacterial pneumonia, not elsewhere classified

4568

13968

3.45

307.65

10.0

6.2

1.93

0.71

mmol/l

61.73

3617

10823

ILD medications

9923

29627

1.97

307.65

8.2

7.1

1.17

0.90

mmol/l

7.99

7859

23018

Inflammatory bowel disease treatment related agents

10026

31172

1.96

307.65

7.6

7.3

1.32

0.87

mmol/l

21.24

7927

24298

Insulin medication

5536

23654

2.20

307.65

9.2

6.9

0.91

1.07

mmol/l

1.62

4244

18718

Asthma (diagnoses ohter than nonallergic)

7678

33845

2.11

307.65

7.4

7.2

1.49

0.91

mmol/l

27.95

6172

26354

Acute tubulo-interstitial nephritis

5417

23701

2.22

307.65

7.8

6.3

1.03

1.15

mmol/l

1.17

4285

18580

Hypothyroidism (congenital or acquired)

1604

1908

5.19

307.65

9.0

5.3

0.80

0.78

mmol/l

0.06

1232

1383

Ischaemic heart disease, wide definition

7461

22443

2.32

307.65

8.9

7.1

1.12

1.07

mmol/l

0.41

5935

17987

Other diseases of the respiratory system

2698

8751

4.00

307.65

11.4

6.5

3.02

0.95

mmol/l

97.47

2331

6656

Other chronic obstructive pulmonary disease, including avohilmo

5935

21542

2.68

307.65

7.9

7.0

1.95

0.89

mmol/l

61.81

4882

16851

Other heart diseases, wide

8697

22347

2.66

307.65

9.8

6.7

1.14

0.89

mmol/l

6.07

7033

17402

Myocardial infarction

4949

16899

2.38

307.65

9.2

6.9

0.85

1.04

mmol/l

2.30

3865

13469

Myocardial infarction, without ST-elevation

3946

18403

2.24

307.65

8.4

6.6

0.91

1.10

mmol/l

1.95

3028

14384

Insulin, combination of fast acting with intermediate-acting or long-acting

5546

27698

2.02

307.65

9.2

7.0

0.91

1.04

mmol/l

1.14

4250

21781

Asthma, including avohilmo

9646

33615

1.76

307.65

7.3

7.4

1.40

0.89

mmol/l

28.38

7676

26219

Asthma, excluding more controls

7099

14114

2.95

307.65

7.6

6.2

1.44

0.50

mmol/l

60.84

5679

10914

Cardiovascular diseases

4618

8010

3.40

307.65

9.4

6.1

0.82

0.70

mmol/l

1.03

3607

6000

Insulin, intermediate and long-acting

5121

25848

2.15

307.65

9.2

7.0

0.89

1.03

mmol/l

1.28

3933

20363

Calcific aortic valvular stenosis, diagnosis (helper)

3002

13957

2.44

307.65

8.1

6.3

1.06

1.11

mmol/l

0.24

2418

10726

Diabetes, insulin treatment (Kela reimbursement)

8496

30222

1.83

307.65

8.7

7.0

0.94

1.08

mmol/l

1.94

6622

24002

Heart failure, not strict

9654

21950

3.69

307.65

10.5

6.6

1.29

0.89

mmol/l

13.10

7859

17340

Diseases of the respiratory system

5026

13291

2.00

307.65

7.6

6.5

1.24

0.49

mmol/l

28.40

3897

10292

Hypothyroidism, levothyroxine purchases

1576

1897

5.13

307.65

8.8

5.3

0.83

0.77

mmol/l

0.19

1207

1373

Major coronary heart disease event excluding revascularizations

6310

22345

2.18

307.65

8.8

6.9

1.02

1.09

mmol/l

0.56

4938

17840

Valvular operations

1666

4965

4.20

307.65

13.6

6.3

0.94

0.91

mmol/l

0.14

1406

3814

Pulmonary heart disease, diseases of pulmonary circulation

3464

14095

2.92

307.65

8.7

6.7

1.39

1.06

mmol/l

4.76

2767

10961

Nerve, nerve root and plexus disorders

8266

33581

1.63

306.51

7.0

7.4

1.22

0.99

mmol/l

5.43

6452

26431

Iron deficiency anaemia

3456

17891

2.10

305.02

8.8

6.5

0.97

1.10

mmol/l

0.96

2740

13908

Cardiac arrest

681

1231

5.87

304.44

14.6

6.2

0.88

0.93

mmol/l

0.08

544

927

Nutritional anaemias

4029

21516

1.99

304.23

8.6

6.4

0.95

1.07

mmol/l

0.96

3170

16740

Diarrhoea and gastroenteritis of presumed infectious origin

5354

28735

1.80

303.99

8.4

7.0

0.97

0.99

mmol/l

0.11

4211

22418

Non-allergic asthma (mode)

1609

6037

2.95

303.58

7.6

6.1

1.52

0.49

mmol/l

19.85

1288

4651

Focal epilepsy, strict definition

1858

7679

2.80

301.62

7.5

7.3

1.13

1.01

mmol/l

0.69

1434

5924

AV-block

1590

5498

3.02

296.53

8.8

5.7

0.96

0.94

mmol/l

0.05

1241

4230

Ulcer of lower limb, not elsewhere classified

1516

5817

3.22

295.43

10.3

6.9

0.80

1.09

mmol/l

1.40

1244

4512

GI-bleeding

2955

14881

2.23

294.83

9.3

6.8

1.04

1.02

mmol/l

0.09

2319

11547

Intestinal infectious diseases

7071

34911

1.66

294.81

8.2

7.1

0.98

1.01

mmol/l

0.23

5560

27308

Benzodiazepine use

7681

35240

1.63

294.74

7.1

7.3

1.27

0.97

mmol/l

7.86

6196

27477

Other diseases of the digestive system

2932

14763

2.23

292.80

9.3

6.8

1.02

1.03

mmol/l

0.01

2313

11472

Unstable angina pectoris

3488

15304

2.10

292.34

7.3

6.6

1.32

1.09

mmol/l

2.88

2689

12095

Disorders of gallbladder, biliary tract and pancreas

7698

31978

1.63

291.72

8.3

7.1

0.95

1.06

mmol/l

1.44

6130

25137

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

675

1565

6.03

291.59

7.3

7.2

1.13

1.20

mmol/l

0.21

510

1215

Care involving dialysis

944

2785

4.45

291.15

14.6

7.3

-1.12

1.03

mmol/l

33.28

770

2194

Other disorders of urethra and urinary system

5276

23343

1.80

290.80

7.1

6.8

1.20

1.00

mmol/l

2.75

4196

18075

Focal epilepsy, mode (most common among epilepsy diagnosis)

1756

7200

2.83

289.82

7.4

7.2

1.13

0.98

mmol/l

0.86

1353

5550

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1551

5903

2.99

285.92

5.5

5.8

0.95

1.46

mmol/l

6.20

1271

4632

ILD, hospital admissions 1, main diag only

1466

5644

3.24

285.63

9.1

6.8

1.41

1.10

mmol/l

1.97

1227

4325

ILD medications: immunosuppressive drugs

4502

24782

1.85

285.47

10.1

7.2

0.82

0.93

mmol/l

1.01

3609

19478

Later onset COPD

2776

10775

2.32

284.99

6.6

6.0

1.97

0.85

mmol/l

32.27

2239

8206

Hernia

7221

31329

1.65

284.90

7.9

7.3

1.03

1.06

mmol/l

0.20

5789

24612

Insulin, fast-acting or short human

3135

16228

2.12

284.49

9.6

7.1

0.84

0.99

mmol/l

0.98

2423

12674

Alcohol dependence

2472

11805

2.35

283.38

8.9

7.7

1.34

0.94

mmol/l

4.07

1957

9186

Dizziness and giddiness

5772

28686

1.73

282.85

6.5

7.2

1.19

1.01

mmol/l

2.76

4500

22613

Pain, not elsewhere classified

2072

9148

2.49

281.40

7.5

7.0

1.26

0.94

mmol/l

2.96

1646

7146

Acute bronchitis

3355

17437

2.05

280.37

7.1

6.8

1.60

0.96

mmol/l

14.50

2708

13431

Anxiety disorders, excluding more controls

5891

23834

1.72

277.65

7.7

7.3

1.16

0.94

mmol/l

3.99

4687

18774

Sciatica+with lumbago

3867

20398

1.93

275.26

6.4

7.7

1.29

0.94

mmol/l

6.79

3026

16175

Schizophrenia or delusion, excluding more controls

2266

10419

2.35

271.84

7.2

7.4

1.96

0.91

mmol/l

24.90

1799

8145

Osteopathies and chondropathies

4281

23416

1.87

270.90

7.8

6.9

1.32

1.03

mmol/l

4.36

3449

18457

Obesity, other/unspecified

2492

12065

2.26

269.39

8.7

7.3

1.31

0.91

mmol/l

4.72

2044

9394

Vocal cord dysfunction

1002

2843

3.64

269.21

9.7

5.5

1.40

0.79

mmol/l

6.36

811

2263

Benign neoplasm of colon, rectum, anus and anal canal

5081

27801

1.78

269.09

7.2

7.0

0.93

1.11

mmol/l

2.34

4029

21986

Sequelae with surgical and medical care as external cause

1867

8182

2.66

268.54

9.8

6.9

1.29

1.07

mmol/l

1.55

1553

6339

Autoimmune diseases excluding thyroid diseases

8054

29399

1.59

267.84

8.3

7.2

0.92

1.00

mmol/l

0.91

6300

23052

Other disorders of skin and subcutaneous tissue

5333

29936

1.74

267.66

7.8

6.9

1.12

1.06

mmol/l

0.54

4203

23555

L04AD Calcineurin inhibitors

1079

3631

3.64

263.91

18.8

8.3

-0.31

1.02

mmol/l

19.92

899

2857

Symptoms and signs involving the urinary system

6048

29514

1.68

261.03

7.5

7.2

0.98

1.07

mmol/l

0.97

4801

23255

Secondary hypertension

651

1523

4.97

260.30

10.9

6.2

0.07

0.83

mmol/l

3.54

531

1171

Autoimmune diseases excluding thyroid diseases, strict definition

7798

28559

1.59

260.05

8.2

7.2

0.91

1.00

mmol/l

0.95

6098

22397

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

809

2309

4.48

259.22

7.1

1.13

1.16

mmol/l

0.10

614

1772

Abnormal findings on examination of blood, without diagnosis

3965

21305

1.90

258.77

7.7

7.4

0.90

1.00

mmol/l

0.79

3100

16705

Benign neoplasms

7416

26955

1.60

257.76

7.1

7.6

0.85

1.01

mmol/l

2.97

5734

21047

Infections of the skin and subcutaneous tissue

4274

24880

1.82

257.05

8.9

7.6

1.02

0.96

mmol/l

0.40

3462

19444

Volume depletion

975

3141

3.82

256.49

9.5

6.1

1.16

1.18

mmol/l

0.04

784

2383

Brain meningioma, excluding all cancers (controls excluding all cancers)

629

1531

5.66

255.17

4.9

6.7

1.24

1.28

mmol/l

0.09

435

1177

Benign neoplasm of meninges

970

3126

3.81

254.92

5.6

6.8

0.99

1.45

mmol/l

3.00

702

2437

Gout

2564

11744

2.24

254.57

8.8

7.3

0.63

1.09

mmol/l

4.91

2041

9130

General examination and investigation of persons without complaint and reported diagnosis

5018

15788

1.78

253.55

8.1

7.2

1.44

0.88

mmol/l

19.05

3933

12509

Gastrointestinal diseases

4238

11848

1.87

253.51

8.3

6.5

0.88

0.99

mmol/l

0.93

3272

9107

Mood [affective] disorders

7525

32729

1.58

252.72

7.7

7.4

1.14

1.00

mmol/l

2.12

5961

25726

Mood disorders

7545

32787

1.58

252.70

7.7

7.4

1.14

1.00

mmol/l

2.25

5975

25772

Pain (limb, back, neck, head abdominally)

5785

17766

1.71

250.99

7.6

7.7

1.01

0.93

mmol/l

0.77

4466

13748

Other and unspecified iron deficiency

2640

13479

2.16

250.10

8.4

6.4

0.95

1.06

mmol/l

0.58

2103

10441

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1593

6745

2.76

247.29

7.2

7.1

1.17

1.25

mmol/l

0.36

1328

5232

Cerebral aneurysm, nonruptured

936

3051

3.86

243.94

6.9

7.5

0.90

1.20

mmol/l

1.68

724

2376

Benign neoplasm: Cerebral meninges

891

2804

3.93

243.89

5.6

6.9

1.00

1.48

mmol/l

3.07

646

2172

Ischaemic Stroke, excluding all haemorrhages

4724

21645

1.78

243.70

7.4

6.9

1.13

1.10

mmol/l

0.22

3730

17053

Falls/tendency to fall

8189

27476

1.55

242.73

8.0

7.3

1.03

0.95

mmol/l

0.92

6436

21346

Hypokalaemia

1109

3962

3.34

242.04

10.0

6.5

2.22

1.20

mmol/l

7.40

928

3055

Abnormalities of heart beat

2492

12401

2.15

241.45

7.0

6.9

1.02

0.83

mmol/l

1.67

1946

9648

Constipation

6663

31231

1.61

241.19

7.3

7.2

1.24

1.00

mmol/l

5.14

5356

24488

Medical observation and evaluation for suspected diseases and conditions

5133

15837

1.74

239.33

7.6

7.2

1.00

0.88

mmol/l

1.28

3961

12543

Depression

6826

30861

1.59

238.43

7.8

7.4

1.11

0.98

mmol/l

1.72

5414

24261

Lumbar disc prolapse

4766

23024

1.74

238.40

7.4

7.9

1.18

0.94

mmol/l

4.27

3671

18263

Other functional intestinal disorders

3417

18223

1.92

237.70

6.9

6.7

1.33

1.07

mmol/l

3.04

2747

14149

Dorsopathies

7622

25848

1.56

235.85

6.9

7.7

1.12

0.89

mmol/l

5.17

5881

20241

Extreme obesity with alveolar hypoventilation

570

1390

6.09

235.50

9.7

8.0

3.83

1.04

mmol/l

35.35

513

1094

ILD-related respiratory insufficiency

526

1238

7.32

234.72

13.1

7.4

2.29

1.17

mmol/l

6.43

440

948

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1196

4552

3.18

234.47

7.3

6.8

-0.31

1.25

mmol/l

32.85

965

3494

Coronary angioplasty

3173

13343

2.00

234.05

6.9

6.8

1.14

1.04

mmol/l

0.64

2414

10595

Other or unspecified ileus, impaction or obstruction

1688

7492

2.57

232.87

8.9

6.6

1.29

1.13

mmol/l

0.76

1391

5787

Other diseases of urinary system

7622

28768

1.56

232.09

7.2

1.01

0.97

mmol/l

0.30

5988

22382

Viral hepatitis, IBD co-morbidity

469

934

5.88

230.25

10.1

7.3

0.75

0.65

mmol/l

0.17

378

746

Personality disorders

1915

8886

2.34

229.68

7.8

1.35

0.87

mmol/l

5.14

1526

6867

Diseases of pulp and periapical tissues

2760

14677

2.04

229.43

10.5

7.2

0.83

1.01

mmol/l

1.35

2242

11552

Alcohol abuse, main dg

1409

5818

2.79

228.54

8.5

8.3

1.27

0.91

mmol/l

2.03

1097

4513

Other symptoms and signs involving cognitive functions and awareness

3591

19480

1.87

226.67

6.3

7.0

1.26

1.02

mmol/l

2.69

2790

15271

Sleep disorders (combined)

7292

32193

1.55

225.31

7.4

1.35

0.95

mmol/l

13.99

5909

25204

Disorders of adult personality and behaviour

1976

9357

2.29

224.64

7.6

7.8

1.40

0.86

mmol/l

6.49

1577

7214

Emphysema

814

2573

4.06

224.52

8.3

7.1

1.51

0.76

mmol/l

5.08

663

1979

Colectomy operation

1607

7162

2.62

223.61

10.2

6.8

0.29

1.12

mmol/l

12.43

1326

5539

Anxiety (asthma-related co-morbidities)

3751

17166

1.81

218.38

8.0

7.5

1.03

0.90

mmol/l

1.14

2988

13404

Acute alcohol intoxication

2156

10762

2.21

217.91

8.0

7.5

1.25

0.91

mmol/l

2.81

1683

8290

Idiopathic pulmonary fibrosis

897

3091

3.80

217.52

9.1

6.7

1.72

1.07

mmol/l

4.87

734

2360

Direct fill therapy

1189

4644

2.97

216.65

11.8

7.9

0.79

0.99

mmol/l

0.87

985

3608

Benign neoplasm: Colon

4239

25512

1.76

216.53

7.3

7.0

0.93

1.12

mmol/l

2.29

3365

20202

Cardiomyopathies, Primary/intrinsic

1109

4198

3.07

215.02

13.8

6.5

0.67

0.89

mmol/l

0.76

872

3217

Chronic periapical parodontitis

1776

8318

2.39

213.56

11.8

7.2

0.89

1.05

mmol/l

0.81

1456

6523

Problems related to lifestyle

950

3315

3.34

213.54

8.7

7.5

1.39

0.95

mmol/l

2.10

737

2512

Intracranial injury

4271

25308

1.73

213.34

7.8

7.0

1.21

0.98

mmol/l

3.02

3338

19676

Exposure to unspecified factor

6941

36519

1.54

212.83

8.6

7.2

0.86

1.04

mmol/l

3.15

5685

28418

Unspecified mental disorder

2950

16361

1.93

212.44

7.2

7.6

1.77

0.90

mmol/l

23.98

2322

12788

Type 1 diabetes

1927

9241

2.27

212.43

10.1

6.9

0.45

1.01

mmol/l

5.24

1488

7182

Unspecified kidney failure

1035

3864

3.29

211.78

9.6

6.1

0.02

1.26

mmol/l

9.21

781

2994

Misadventures to patients during surgical and medical care

1255

5115

2.85

210.40

10.7

6.5

1.14

1.01

mmol/l

0.50

1016

3947

Cardiomyopathy (excluding other)

1136

4401

2.99

210.36

13.7

6.4

0.67

0.91

mmol/l

0.87

895

3363

Malignant neoplasm of brain

469

1077

6.40

207.75

7.2

8.1

1.10

1.13

mmol/l

0.07

340

842

Invasive ventilation

804

2648

3.86

207.30

16.8

7.4

1.20

0.99

mmol/l

0.58

670

2047

Peripheral artery operations in Hilmo

1273

5283

2.83

207.03

10.6

6.3

0.79

1.04

mmol/l

1.15

1008

4028

External causes of morbidity and mortality

4861

14990

1.69

206.46

7.7

6.8

1.02

0.92

mmol/l

0.89

3755

11608

Other disorders of teeth and supporting structures

1800

8587

2.34

206.14

9.5

7.0

1.23

1.09

mmol/l

0.72

1462

6728

Type 1 diabetes, wide definition, subgroup 1

1572

7039

2.45

206.04

9.7

6.8

0.50

1.02

mmol/l

4.06

1198

5462

Other reaction to severe stress, and adjustment disorders

2349

12206

2.05

205.04

8.2

7.5

0.90

0.92

mmol/l

0.05

1889

9444

Endovascular or surgical operations to intracerebral aneurysms

717

2229

4.13

203.11

7.9

7.8

1.23

1.19

mmol/l

0.10

559

1747

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

1037

3952

3.18

202.99

7.2

6.9

-0.21

1.23

mmol/l

25.63

843

3035

Allergic asthma (mode), excluding more controls

1426

5986

2.49

202.73

7.4

6.0

1.15

0.41

mmol/l

9.98

1119

4521

Chronic periodontitis

1386

6026

2.66

202.51

12.0

7.3

0.64

1.04

mmol/l

2.63

1161

4711

Specific personality disorders

1638

7511

2.37

202.42

7.7

7.9

1.48

0.84

mmol/l

7.57

1307

5788

Soft tissue disorders

7534

26827

1.51

201.10

7.0

7.5

0.97

0.96

mmol/l

0.08

5852

20889

Injuries to the abdomen, lower back, lumbar spine and pelvis

2982

16848

1.90

199.66

7.8

6.9

1.23

1.02

mmol/l

1.86

2380

13056

Explicit bacterial Sepsis

955

3485

3.23

199.51

10.5

6.1

1.19

1.03

mmol/l

0.48

762

2675

L04AA Selective immunosuppressants

1701

8043

2.36

198.77

13.2

7.5

0.31

1.05

mmol/l

10.25

1391

6342

Anxiety disorders

6097

28842

1.56

197.92

7.8

7.5

1.13

0.99

mmol/l

1.77

4832

22667

Brain meningioma

616

1786

4.70

197.61

4.9

7.4

1.22

1.25

mmol/l

0.06

423

1412

Neurotic, stress-related and somatoform disorders

6017

28488

1.56

197.43

7.8

7.5

1.13

1.00

mmol/l

1.79

4767

22393

Glomerular diseases

1597

7466

2.44

195.29

11.0

7.4

-0.32

1.05

mmol/l

25.35

1259

5782

Acute alcohol intoxication, ICD10

1640

7707

2.38

195.11

8.5

8.1

1.17

0.93

mmol/l

1.26

1268

6000

Kidney transplant status

603

1726

4.63

195.09

12.4

9.3

-1.34

1.07

mmol/l

30.39

501

1373

Gout, FINNGEN

2564

14176

2.01

195.03

8.8

7.0

0.63

1.05

mmol/l

4.32

2041

11032

Disorders of lens

5261

21534

1.63

194.88

7.8

7.6

1.16

1.00

mmol/l

1.83

4105

17202

Kela-code for severe mental illness

2677

14816

1.94

194.76

6.9

7.7

1.88

0.92

mmol/l

26.79

2101

11602

Diseases of the skin and subcutaneous tissue

7637

26457

1.50

194.69

8.0

7.1

1.05

0.98

mmol/l

0.69

6031

20567

Diaphragmatic hernia

2845

16148

1.92

194.51

7.4

6.6

0.96

1.13

mmol/l

1.46

2300

12663

Other postsurgical states

679

2092

4.11

193.85

8.0

7.1

1.56

1.10

mmol/l

3.11

540

1637

Injuries to the thorax

3477

20859

1.79

193.07

8.4

7.1

1.09

1.01

mmol/l

0.53

2775

16328

Other headache syndromes

2813

15799

1.89

193.05

7.0

7.1

1.29

0.95

mmol/l

5.50

2203

12360

Any operation in hilmo

266

15.47

192.59

10.2

3.9

1.13

1.65

mmol/l

0.47

209

Streptococcal septicaemia

836

2912

3.49

192.53

10.2

6.8

1.14

1.01

mmol/l

0.34

664

2258

Factors influencing health status and contact with health services

2526

6548

2.04

191.85

8.1

6.5

1.00

0.96

mmol/l

0.16

1961

5130

Finngen Rheumatological endpoints

6915

26976

1.52

190.27

7.3

7.5

1.05

0.97

mmol/l

0.74

5404

21024

Extracorporeal dialysis

696

2238

4.09

189.02

15.9

8.4

-0.59

1.01

mmol/l

16.50

568

1761

Persons encountering health services for examination and investigation

4979

15841

1.64

187.55

7.9

7.1

1.12

0.88

mmol/l

3.58

3782

12545

Disorders of thyroid, IBD co-morbidities

1125

3155

2.78

187.11

7.9

6.7

0.96

0.69

mmol/l

1.36

881

2495

Malignant neoplasm of eye, brain and central nervous system

534

1454

5.00

186.80

7.0

8.4

1.11

1.14

mmol/l

0.06

389

1142

Osteoporosis

2060

10206

2.14

186.70

7.1

6.0

1.73

1.19

mmol/l

6.02

1657

8001

Hyperkalaemia

611

1814

4.36

186.07

10.0

6.3

0.54

1.27

mmol/l

2.13

450

1376

Gout, idiopatic and unspecified

2171

11597

2.11

185.61

8.9

7.1

0.58

1.04

mmol/l

4.19

1740

8993

Cough

2704

14557

1.89

184.99

7.0

7.2

1.19

0.84

mmol/l

4.57

2193

11411

Cutaneous abscess, furuncle and carbuncle

1918

9711

2.16

184.89

9.6

7.5

1.07

0.96

mmol/l

0.57

1560

7502

Schizophrenia or delusion

2266

12126

2.01

183.51

7.2

7.8

1.96

0.92

mmol/l

24.60

1799

9459

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1599

7669

2.36

182.62

7.7

6.7

0.42

1.29

mmol/l

14.94

1312

5919

Benign neoplasm of meninges

970

3773

3.10

182.39

5.6

7.0

0.99

1.20

mmol/l

0.91

702

2952

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

603

1761

4.02

181.21

8.8

8.5

1.12

0.88

mmol/l

0.60

491

1371

Schizophrenia, schizotypal and delusional disorders

2269

12201

2.00

181.00

7.2

7.8

1.96

0.94

mmol/l

23.78

1802

9521

All anxiety disorders

3795

18766

1.70

179.54

7.9

7.7

1.03

0.95

mmol/l

0.55

3018

14657

Artificial opening status

609

1859

4.31

179.16

14.1

7.3

0.79

1.15

mmol/l

1.06

521

1451

Used for control exclusion in common control thyroid runs

7724

27548

1.47

179.11

8.0

7.2

0.86

1.00

mmol/l

2.05

5966

21589

Undetermined asthma, excluding more controls

895

3286

3.03

178.89

7.6

5.8

1.28

0.44

mmol/l

7.40

712

2526

Glomerular disorders in diseases classified elsewhere

1098

4567

2.84

178.64

12.4

7.6

-0.68

1.06

mmol/l

27.95

884

3543

Sequelae of cerebrovascular disease

2866

14601

1.88

178.42

7.3

6.6

1.10

1.06

mmol/l

0.18

2235

11274

Viral pneumonia (unknown virus, not influenza)

665

2124

3.84

177.33

18.9

8.0

1.10

0.92

mmol/l

0.52

568

1637

Allergic asthma (mode)

1426

6343

2.34

177.23

7.4

6.2

1.15

0.42

mmol/l

9.82

1119

4807

Spondylosis

3948

21285

1.69

176.29

6.1

7.7

1.18

0.98

mmol/l

2.67

3177

16913

Retention of urine

2843

13964

1.87

175.39

7.1

0.98

1.05

mmol/l

0.40

2206

10778

Diseases of liver

2601

14825

1.90

174.84

10.5

7.3

0.47

1.08

mmol/l

8.52

2070

11665

Type 1 diabetes, wide definition

1612

7787

2.24

174.26

9.7

6.9

0.51

1.02

mmol/l

3.96

1226

6042

Injuries to the hip and thigh

3571

20194

1.73

174.05

7.4

6.7

1.27

1.03

mmol/l

2.93

2902

15649

Transient ischemic attack

4073

21507

1.68

173.59

6.9

6.8

1.13

1.10

mmol/l

0.20

3156

16928

Benign neoplasm: Cerebral meninges

891

3409

3.17

173.52

5.6

6.9

1.00

1.15

mmol/l

0.59

646

2652

Other CVD

1686

8434

2.27

173.47

7.7

6.4

1.29

1.09

mmol/l

1.12

1325

6458

Deforming dorsopathies

2034

10725

2.05

173.00

6.6

7.4

1.41

0.95

mmol/l

5.99

1604

8432

1044

4242

2.77

172.79

11.2

7.0

0.76

1.06

mmol/l

1.35

862

3252

Sleep apnoea

6614

31293

1.50

172.71

7.6

7.5

1.38

0.98

mmol/l

13.15

5386

24670

Traumatic subdural haemorrhage

1145

4800

2.68

172.65

8.6

6.4

1.14

0.88

mmol/l

1.21

884

3674

Gastroduodenal ulcer

2227

12212

2.00

169.91

8.8

6.5

0.98

1.09

mmol/l

0.51

1713

9482

Emotionally unstable personality disorder

833

3032

3.05

169.21

7.1

7.8

1.23

0.72

mmol/l

2.88

657

2308

Hyperlipidaemia, other/unspecified

2937

16496

1.82

169.20

7.5

6.6

0.95

1.12

mmol/l

1.38

2335

12967

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2003

8880

2.09

168.24

7.6

6.9

1.58

1.25

mmol/l

3.35

1689

6846

Fungal Sepsis

445

1148

5.31

167.62

16.2

6.3

1.67

0.98

mmol/l

2.11

368

884

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

596

1847

3.95

166.54

6.3

6.2

0.72

1.55

mmol/l

5.93

503

1428

Other external causes of accidental injury

6035

20556

1.52

166.02

7.7

7.1

0.97

0.98

mmol/l

0.02

4721

15926

Amputation

980

4014

2.91

165.45

11.2

6.9

0.91

1.06

mmol/l

0.44

785

3097

Persons encountering health services for specific procedures, not carried out

676

2254

3.54

165.37

10.3

7.2

0.35

0.99

mmol/l

3.39

587

1744

Other/unspecified dorsalgia

2627

15091

1.84

164.83

6.8

7.4

1.28

0.95

mmol/l

4.03

2121

11821

Other anxiety disorders

2694

13763

1.82

164.45

8.1

7.4

0.99

0.89

mmol/l

0.64

2150

10623

Other pulmonary heart/vessel disease

551

1676

4.39

163.85

12.3

7.4

2.08

1.14

mmol/l

4.56

441

1294

Depression or dysthymia

5072

18792

1.57

163.54

7.5

7.6

0.98

0.86

mmol/l

1.17

4028

14725

Autoimmune diseases

8024

29507

1.43

163.49

8.2

7.2

0.89

1.00

mmol/l

1.46

6225

23128

Nontraumatic intracranial haemmorrhage

1697

8655

2.19

163.33

10.0

6.6

1.36

1.08

mmol/l

2.17

1330

6663

Senile cataract

4816

19770

1.60

162.98

7.7

7.6

1.18

1.01

mmol/l

1.94

3767

15789

Congenital malformations, deformations and chromosomal abnormalities

3708

22392

1.66

162.94

8.5

7.5

0.89

0.95

mmol/l

0.38

2950

17409

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

909

3614

3.00

162.91

10.1

7.5

1.48

1.06

mmol/l

2.41

729

2802

Unspecified acute lower respiratory infection

1237

5590

2.49

162.47

10.1

7.6

1.70

0.98

mmol/l

7.14

1033

4297

Secondary right heart disease

513

1505

4.65

162.01

12.1

7.1

2.09

1.13

mmol/l

4.29

414

1157

Persons encountering health services in other circumstances, wide

8704

33063

1.41

161.60

8.5

7.0

0.85

1.07

mmol/l

5.65

7112

25568

Accidents

6007

20556

1.52

161.43

7.6

7.1

0.97

0.98

mmol/l

0.02

4681

15926

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

613

1960

3.73

161.28

7.3

7.9

1.06

1.02

mmol/l

0.07

484

1508

Missing teeth due to accident, extraction or parodontitis

1043

4431

2.73

160.59

9.6

7.1

1.17

1.15

mmol/l

0.05

856

3449

Implicit fungal Sepsis

413

1044

5.47

160.23

16.0

6.4

1.64

1.00

mmol/l

1.75

341

802

Aortic aneurysm

1972

10486

2.05

159.29

11.2

6.6

0.93

0.99

mmol/l

0.28

1641

8072

Pain in joint

3932

16481

1.65

159.24

7.1

7.8

0.83

0.93

mmol/l

0.80

3152

12852

Enterocolitis due to Clostridium difficile

987

4122

2.80

158.24

9.8

6.7

1.11

1.21

mmol/l

0.29

782

3148

Shoulder lesions

5710

24029

1.52

157.98

6.5

7.5

1.20

1.04

mmol/l

2.62

4509

18931

Visual disturbances

3297

20539

1.71

156.68

7.5

7.1

1.12

1.04

mmol/l

0.51

2568

16156

Unspecified fall

3475

21731

1.68

156.66

8.6

7.0

1.08

1.03

mmol/l

0.28

2819

16918

Other bacterial intestinal infections

1449

7080

2.28

156.06

9.2

6.7

1.12

1.06

mmol/l

0.20

1139

5469

Undetermined asthma

895

3525

2.81

155.99

7.6

6.0

1.28

0.47

mmol/l

6.97

712

2713

Other complications of surgical and medical care, not elsewhere classified

817

3117

3.03

155.89

10.7

6.7

0.96

1.01

mmol/l

0.11

668

2411

Benign neoplasm of other and unspecified endocrine glands

986

4117

2.73

155.62

6.9

7.2

1.07

1.21

mmol/l

0.51

773

3163

Pleural effusion

1341

6416

2.38

155.40

8.7

6.4

1.77

0.84

mmol/l

12.54

1116

4878

Diagnoses used for exclusion with ILD

2053

11310

1.99

155.37

9.6

7.0

1.51

1.04

mmol/l

5.39

1642

8714

Cardiodefibrillation

2995

18390

1.77

155.24

9.6

6.9

0.86

1.07

mmol/l

2.12

2432

14413

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

773

2883

3.14

154.95

8.3

6.7

1.37

1.01

mmol/l

1.60

620

2224

Symptoms and signs involving the nervous and musculoskeletal systems

4044

26454

1.61

154.64

7.3

7.1

1.32

1.00

mmol/l

5.81

3207

20761

Visual disturbances and blindness

3540

22507

1.67

154.27

7.5

7.0

1.11

1.05

mmol/l

0.42

2758

17682

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

1090

4810

2.62

154.08

7.9

7.1

0.67

1.26

mmol/l

5.72

947

3709

Genitourinary diseases

4469

14545

1.60

153.02

9.1

7.6

0.82

1.02

mmol/l

2.37

3446

11459

Hernia of abdominal wall

3371

21321

1.69

151.82

8.5

7.3

1.13

1.02

mmol/l

0.84

2698

16825

Sleep apnoea, including avohilmo

6829

31760

1.45

151.72

7.4

7.5

1.38

0.97

mmol/l

14.24

5546

24970

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1743

9204

2.10

151.34

5.6

7.2

1.39

1.27

mmol/l

0.59

1361

7155

Chronic pancreatitis

1109

4978

2.58

151.30

12.2

7.4

0.62

1.00

mmol/l

1.87

921

3885

Gout, unspecified

1751

9346

2.12

150.36

8.8

7.1

0.51

1.05

mmol/l

4.47

1406

7242

Fracture of rib(s), sternum and thoracic spine

2320

13401

1.88

149.80

8.6

7.2

1.12

1.04

mmol/l

0.43

1861

10438

Complications of internal orthopaedic prosthetic devices, implants and grafts

1781

9519

2.07

149.31

7.5

6.0

1.32

1.14

mmol/l

1.05

1441

7392

Parodontitis or operation codes

6386

33588

1.46

148.54

8.2

7.3

0.90

1.09

mmol/l

3.26

5120

26504

Other and unspecified nonorganic psychotic disorders

1294

6120

2.29

147.97

8.1

8.0

1.58

0.77

mmol/l

8.70

1020

4734

Parodontitis

6376

33587

1.46

147.70

8.2

7.3

0.90

1.09

mmol/l

3.25

5110

26507

Chronic periodontitis, including avohilmo

6349

33573

1.46

147.12

8.2

7.3

0.90

1.09

mmol/l

3.11

5087

26501

Need for other prophylactic measures

576

1912

3.78

146.00

13.4

8.3

0.14

1.09

mmol/l

6.61

532

1495

Fracture of femur

2117

10931

1.93

144.73

7.3

6.0

1.23

1.15

mmol/l

0.39

1719

8344

Dialysis

455

1322

4.52

143.91

13.5

8.0

-1.43

1.20

mmol/l

23.42

364

1032

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1546

7989

2.15

143.45

7.5

6.8

0.84

1.27

mmol/l

3.91

1255

6169

Disorders of other endocrine glands

2919

17726

1.71

142.58

7.6

7.0

0.89

1.05

mmol/l

1.26

2336

13816

Gout, strict definition

1569

8237

2.17

142.47

8.9

7.2

0.56

1.05

mmol/l

3.34

1255

6367

Malignant neoplasm of digestive organs

3000

18492

1.72

142.40

8.1

6.7

0.89

1.10

mmol/l

2.18

2451

14344

Diabetic nephropathy, excluding more controls

1290

5207

2.38

142.16

10.8

8.3

0.00

0.84

mmol/l

7.99

1021

4055

Other cataract

3252

15887

1.69

141.86

7.1

7.4

1.13

1.01

mmol/l

0.81

2555

12604

Hypotension

1412

7141

2.24

141.16

7.4

6.3

1.31

1.09

mmol/l

1.08

1105

5449

Other and unspecified drugs and medicaments

743

2870

3.06

140.15

8.3

7.7

1.39

1.05

mmol/l

1.38

596

2223

Injury, poisoning and certain other consequences of external causes

3753

11953

1.63

139.76

7.7

6.7

1.04

0.89

mmol/l

1.31

2906

9259

Gastric ulcer

1516

7859

2.14

139.34

8.8

6.5

1.14

mmol/l

0.02

1191

6077

Cystitis

5700

24487

1.47

138.60

7.1

6.9

0.94

0.98

mmol/l

0.29

4582

18944

Benign neoplasm: Colon, unspecified

1776

9643

2.01

138.53

7.3

7.0

1.02

1.28

mmol/l

1.82

1418

7486

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

251

483

8.42

138.17

4.8

7.9

0.87

1.55

mmol/l

2.97

184

381

Selective serotonin reuptake inhibitors

7160

27428

1.42

137.90

7.2

7.4

1.17

0.90

mmol/l

6.00

5661

21317

Lung diseases due to external agents

1217

5876

2.35

137.31

9.8

6.6

1.75

1.05

mmol/l

6.34

975

4480

Intestinal adhesions without obstruction

770

3065

2.97

137.05

9.9

6.6

1.17

mmol/l

0.01

637

2362

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

494

1572

4.15

136.73

6.7

7.3

-0.08

1.19

mmol/l

10.62

398

1224

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1721

7732

2.05

136.41

7.3

6.7

1.59

1.26

mmol/l

3.19

1455

5954

Cardiomyopathy, other and unspecified

673

2494

3.15

136.32

11.5

6.5

0.57

0.93

mmol/l

1.08

558

1911

Cholelithiasis, broad definition with cholecystitis

6041

29652

1.45

135.92

7.2

6.9

1.08

mmol/l

0.01

4751

23276

Delirium, not induced by alcohol and other psychoactive substances

1008

4545

2.56

135.63

10.7

6.5

1.53

1.11

mmol/l

2.05

804

3486

Acute upper respiratory infections of multiple and unspecified sites

4902

25356

1.50

135.62

7.9

7.3

1.21

0.93

mmol/l

5.35

3877

19765

Ventral hernia

1823

10094

1.97

135.50

9.3

6.8

1.17

1.10

mmol/l

0.30

1461

7874

Mycoses

1908

10718

1.93

134.52

9.1

7.2

1.23

1.00

mmol/l

1.50

1527

8355

All influenza (not pneumonia)

1070

4891

2.40

134.32

8.0

6.8

1.40

0.69

mmol/l

6.90

845

3747

Unspecified haematuria

3199

17545

1.67

134.17

8.0

7.3

0.72

1.06

mmol/l

4.60

2506

13712

Bacterial intestinal infections, IBD co-morbidities

1434

7401

2.14

132.81

9.2

6.7

1.08

1.06

mmol/l

0.06

1129

5702

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1237

6108

2.31

132.60

11.5

7.7

0.02

1.07

mmol/l

9.90

1008

4761

Fracture of lumbar spine and pelvis

1671

9070

2.02

132.50

7.6

6.3

1.36

1.11

mmol/l

1.48

1330

6977

Mental and behavioural disorders due to opioids

346

858

4.91

132.39

10.7

8.8

1.49

0.81

mmol/l

2.13

296

659

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1277

5960

2.26

132.36

7.6

6.6

1.51

1.23

mmol/l

2.08

1105

4566

Mental and behavioural disorders due to sedatives or hypnotics

588

2061

3.35

131.94

9.1

8.3

1.25

1.00

mmol/l

0.71

479

1614

Other specific joint derangements/joint disorders

4736

21811

1.51

131.74

7.1

7.8

0.87

0.98

mmol/l

1.20

3768

16971

Disorders of choroid and retina

5806

30346

1.45

131.64

7.7

7.1

0.91

1.10

mmol/l

2.77

4529

23987

Dysphagia

1785

9914

1.95

130.39

7.7

6.6

1.61

1.05

mmol/l

6.66

1406

7729

Malignant neoplasm of urinary organs

931

4158

2.65

130.36

7.3

7.1

-0.24

1.12

mmol/l

20.52

737

3210

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1159

5365

2.30

129.76

12.5

7.8

0.53

0.92

mmol/l

2.63

964

4148

malignant neoplasm of female genital organs

1142

5489

2.34

129.70

5.7

5.9

1.07

1.36

mmol/l

1.89

916

4379

Exclusions for E4_PCOS_BROAD

1213

5918

2.25

129.64

8.1

7.7

0.91

0.97

mmol/l

0.21

960

4601

Ascites

672

2579

3.12

129.27

10.2

6.7

0.03

1.14

mmol/l

6.75

563

2022

Non-selective monoamine reuptake inhibitors

2741

16573

1.70

129.00

6.9

1.48

0.99

mmol/l

7.87

2208

12970

Congenital malformations of the circulatory system

1030

4576

2.42

128.72

13.4

7.9

0.95

0.90

mmol/l

0.18

854

3537

Bipolar affective disorders

1196

5783

2.23

128.68

7.0

7.6

1.12

0.86

mmol/l

1.27

938

4481

Vascular disorders of the intestines

656

2503

3.16

128.15

11.8

6.3

0.75

1.29

mmol/l

2.00

501

1905

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6765

32426

1.41

127.68

7.6

7.3

1.11

1.03

mmol/l

0.95

5388

25474

Other retinal disorders

4591

25685

1.51

126.06

7.7

6.9

0.91

1.10

mmol/l

2.30

3572

20235

Open wound of head

3633

23939

1.57

124.74

7.7

7.3

1.08

1.00

mmol/l

0.61

2877

18704

Gonarthrosis [arthrosis of knee](FG)

5542

23287

1.46

123.94

6.4

7.5

1.15

1.06

mmol/l

0.92

4366

18359

Diseases of the eye and adnexa

5501

19450

1.46

123.90

8.1

7.8

0.86

0.92

mmol/l

0.51

4255

15257

Injuries to the knee and lower leg

8072

34929

1.36

123.80

7.9

7.2

1.09

0.99

mmol/l

1.30

6480

27233

Other diseases of pericardium

423

1277

4.10

123.79

12.8

7.1

1.18

0.89

mmol/l

0.75

355

988

Benign neoplasm of other and ill-defined parts of digestive system

1252

6309

2.19

123.73

8.3

6.7

1.07

1.31

mmol/l

1.39

1028

4888

Amiodarone users

940

4317

2.58

123.65

14.2

7.3

0.78

1.10

mmol/l

1.53

775

3344

Other gastritis (incl. Duodenitis)

1750

9846

1.93

123.31

8.1

6.8

0.89

1.09

mmol/l

1.13

1397

7694

Sub-endpoint used in defining T1D endpoints

2096

12170

1.80

121.70

9.7

7.2

0.52

1.01

mmol/l

4.47

1610

9361

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

304

752

5.56

121.20

6.1

5.5

0.18

1.39

mmol/l

6.57

276

584

Malignant neoplasm of kidney, except renal pelvis

854

3795

2.67

121.19

7.0

7.2

-0.16

1.11

mmol/l

17.71

685

2937

Endocarditis

362

1008

4.56

120.25

16.3

6.8

1.02

1.06

mmol/l

0.07

294

769

Rotator cuff syndrome

4391

22680

1.50

118.88

6.5

7.5

1.21

1.05

mmol/l

2.08

3462

17939

Subarachnoid haemorrhage

895

4054

2.53

118.70

10.2

6.8

1.40

1.18

mmol/l

1.00

706

3117

Adjustment and management of implanted device

1500

8184

2.03

118.50

10.8

6.3

0.15

1.09

mmol/l

14.42

1280

6343

Parodontitis and operation codes

5861

33363

1.42

118.33

8.2

7.3

0.92

1.08

mmol/l

2.36

4684

26381

Deposits [accretions] on teeth

598

2158

3.11

118.17

14.8

7.9

0.55

0.98

mmol/l

1.68

488

1672

Myocarditis

340

892

4.35

117.89

12.7

6.7

0.90

0.78

mmol/l

0.22

269

686

Other pleural conditions

895

4078

2.53

117.76

8.4

6.5

1.73

0.85

mmol/l

7.86

719

3079

Acute pancreatitis

1514

8296

2.00

116.80

10.8

7.3

0.71

1.03

mmol/l

1.83

1230

6422

Abnormal serum enzyme levels

2392

14729

1.74

116.62

7.4

7.9

0.80

0.98

mmol/l

1.47

1853

11548

Diseases of oral cavity, salivary glands and jaws

6568

24842

1.40

116.42

7.6

6.9

0.90

1.05

mmol/l

2.25

5141

19332

ILD medications: azathioprine

1019

4841

2.29

115.98

10.3

7.3

0.96

0.86

mmol/l

0.27

797

3737

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2058

12278

1.79

115.91

7.7

7.3

1.63

0.96

mmol/l

11.41

1582

9563

Autoimmune diseases related-to ILD

5569

35737

1.42

115.68

7.9

7.2

1.05

1.01

mmol/l

0.28

4398

28017

Brain glioblastoma and astrocytoma

251

568

7.04

115.59

4.8

8.7

0.87

1.20

mmol/l

1.02

184

456

Disorders of eyelid, lacrimal system and orbit

5726

32895

1.41

115.19

6.4

7.3

1.28

1.02

mmol/l

5.49

4518

25856

Symptoms and signs concerning food and fluid intake

770

3282

2.63

114.98

7.8

6.9

1.37

0.93

mmol/l

1.66

615

2559

Cholelithiasis

5701

29182

1.42

114.95

7.0

6.9

1.09

mmol/l

0.01

4474

22903

Coxarthrosis

3743

17231

1.55

113.64

6.6

7.5

1.15

1.11

mmol/l

0.23

2965

13554

Fracture of lower leg, including ankle

3664

24923

1.53

113.39

8.7

7.1

1.09

1.04

mmol/l

0.33

2947

19594

Other arthrosis

3757

18297

1.54

112.96

7.1

7.7

1.10

mmol/l

0.01

2972

14439

Gonarthrosis

4752

19252

1.47

112.34

6.4

7.7

1.12

1.10

mmol/l

0.14

3742

15139

Cellulitis

1535

8522

1.95

112.31

8.7

7.5

1.04

0.99

mmol/l

0.17

1251

6598

Superficial injury of head

1561

8698

1.93

111.98

7.1

6.8

1.17

1.01

mmol/l

0.76

1250

6711

Other diseases of intestine

981

4707

2.35

111.95

12.8

6.9

0.91

1.12

mmol/l

0.85

801

3640

Diseases of the musculoskeletal system and connective tissue

3610

11997

1.56

111.76

7.2

8.2

0.92

0.83

mmol/l

0.70

2765

9300

Spondylolisthesis/Spondylolysis

1308

6929

2.06

111.00

6.1

7.6

1.28

1.00

mmol/l

1.83

1016

5482

Azathioprine

1019

4933

2.25

110.49

10.3

7.5

0.96

0.82

mmol/l

0.46

797

3822

Postprocedural musculoskeletal disorders, not elsewhere classified

643

2625

2.95

110.18

8.1

7.2

1.55

1.10

mmol/l

2.45

509

2051

Iron deficiency anaemia secondary to blood loss (chronic)

1233

6447

2.11

110.14

9.8

6.4

0.96

1.09

mmol/l

0.49

969

4991

Coxarthrosis [arthrosis of hip](FG)

3989

20007

1.51

109.81

6.6

7.3

1.17

1.07

mmol/l

0.88

3170

15764

Injuries to the shoulder and upper arm

5656

34990

1.40

109.54

7.3

7.4

1.12

1.03

mmol/l

0.88

4511

27527

Arthrosis

5132

20241

1.44

109.42

6.7

7.7

1.09

1.08

mmol/l

0.11

3980

15883

Decubitus ulcer and pressure area

562

2160

3.16

108.87

11.9

6.9

1.63

1.28

mmol/l

1.06

465

1665

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1667

9608

1.87

107.51

8.0

7.6

1.10

1.04

mmol/l

0.23

1290

7692

Chronic ulcer of skin, not elsewhere classified

634

2596

2.91

107.46

8.2

7.3

2.05

1.12

mmol/l

6.52

492

2045

Elevated blood glucose level

695

2949

2.72

107.28

8.9

7.6

0.70

1.07

mmol/l

1.19

550

2294

Migraine

2537

13642

1.64

107.08

6.5

7.3

0.99

0.85

mmol/l

1.15

1960

10596

Colorectal cancer

1817

10820

1.83

106.32

7.6

6.9

0.82

1.10

mmol/l

2.25

1480

8376

Dermatitis

3994

28074

1.48

106.08

7.8

7.1

1.13

1.03

mmol/l

0.89

3154

22057

Benign neoplasm: Sigmoid colon

1279

6852

2.05

106.06

7.2

7.0

0.73

1.28

mmol/l

4.60

1016

5309

Clear cell adenocarcinoma of kidney

494

1830

3.50

105.72

6.7

7.8

-0.08

1.11

mmol/l

9.91

398

1418

Amputation of toe

668

2835

2.82

105.57

10.5

7.3

0.76

1.10

mmol/l

1.11

531

2199

Other disorders of the musculoskeletal system and connective tissue

1119

5767

2.16

104.89

7.5

7.3

1.26

1.09

mmol/l

0.83

882

4466

Recurrent or chronic depression

2344

10504

1.68

104.43

7.7

7.8

0.94

0.86

mmol/l

0.46

1853

8203

Panic disorder

844

3856

2.35

104.36

9.6

7.1

1.20

0.77

mmol/l

2.26

660

2930

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

718

3125

2.62

104.04

4.5

5.6

1.18

1.60

mmol/l

2.33

570

2455

Chronic viral hepatitis

422

1398

3.50

103.87

9.6

9.2

0.76

0.89

mmol/l

0.20

341

1094

Pneumonitis due to solids and liquids

714

3119

2.65

103.69

12.1

6.7

1.97

1.04

mmol/l

5.60

569

2367

severe traumatic brain injury, does not include concussion

1690

9918

1.85

103.58

9.5

6.8

1.27

1.06

mmol/l

1.26

1329

7616

Unspecified privation

843

3938

2.41

102.75

9.8

7.4

0.48

1.06

mmol/l

3.61

701

3039

Acute upper respiratory infections

7016

33560

1.35

101.96

7.6

7.1

1.23

0.97

mmol/l

6.08

5544

26271

Benign neoplasm of brain and other parts of central nervous system

521

1969

3.08

101.90

7.0

1.16

1.26

mmol/l

0.21

393

1521

Symptoms and signs involving the skin and subcutaneous tissue

4428

31750

1.44

101.73

7.0

7.2

1.05

1.03

mmol/l

0.14

3532

24940

Left ventricular outflow tract obstruction (LVOTO), broad definition

797

3668

2.46

101.23

15.0

8.9

1.08

0.95

mmol/l

0.51

671

2894

Benign neoplasm of other and unspecified endocrine glands

986

4928

2.24

101.05

6.9

7.4

1.07

1.08

mmol/l

0.02

773

3824

Acute pancreatitis (for exclusion)

1514

8676

1.90

100.90

10.8

7.4

0.71

1.04

mmol/l

1.98

1230

6722

Diseases of the myoneural junction and muscle

956

4733

2.27

100.81

9.6

7.3

1.54

1.10

mmol/l

2.14

770

3664

Enlarged lymph nodes

1045

5280

2.14

100.64

7.8

7.3

1.23

0.97

mmol/l

1.35

823

4109

Suppurative and necrotic conditions of lower respiratory tract

531

2074

3.12

100.00

12.4

7.8

2.06

1.09

mmol/l

5.55

461

1604

Gingivitis and periodontal diseases

6326

24575

1.37

98.36

7.7

6.9

0.84

1.05

mmol/l

3.93

5015

19159

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2105

13167

1.69

98.29

7.4

7.0

1.04

1.07

mmol/l

0.14

1645

10374

Use of disulfiram, acamprosate or naltrexone

707

3149

2.55

97.09

8.8

9.0

1.21

0.98

mmol/l

0.72

577

2473

Gastro-oesophageal reflux disease

4451

28623

1.43

96.23

7.5

7.0

1.10

1.07

mmol/l

0.22

3552

22576

Nonorganic sleeping disorders, excluding more controls

1039

5302

2.09

96.14

7.6

7.3

1.17

0.85

mmol/l

1.85

841

4056

Carpal tunnel syndrome

3911

25126

1.46

95.57

6.6

7.3

1.26

1.02

mmol/l

3.55

3065

19970

Transport accidents

2811

16596

1.56

95.47

7.8

7.2

1.14

0.95

mmol/l

1.71

2187

12856

Non-small cell lung cancer

1277

7102

1.99

95.21

7.6

6.5

1.51

1.07

mmol/l

4.67

1105

5409

Schizophrenia

1100

5777

2.06

95.19

7.3

8.4

2.46

0.87

mmol/l

27.04

885

4504

Benign neoplasm: Rectum, anus and anal canal

1352

7615

1.93

95.08

7.0

6.9

0.93

1.28

mmol/l

2.39

1068

5914

Acute sinusitis

3103

19708

1.52

95.04

7.5

7.4

1.24

0.93

mmol/l

4.65

2419

15415

Assault

834

3960

2.28

94.80

9.5

8.5

0.76

0.89

mmol/l

0.34

639

3074

Other symptoms and signs involving the circulatory and respiratory systems

499

1905

2.98

94.51

7.4

7.2

1.64

0.88

mmol/l

4.23

378

1475

Colorectal adenocarcinoma

1546

9113

1.86

94.42

7.5

6.8

0.84

1.10

mmol/l

1.70

1255

7043

Acidosis

245

629

5.50

94.00

13.0

7.2

-0.71

1.18

mmol/l

3.15

173

472

Behavioural syndromes associated with physiological disturbances and physical factors

1779

10755

1.73

93.27

7.3

7.5

1.17

0.86

mmol/l

2.50

1440

8205

Other specified and unspecified personality disorders

632

2706

2.59

93.12

8.5

8.0

1.47

0.90

mmol/l

2.48

530

2082

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1450

8189

1.84

93.08

8.7

7.2

1.07

0.74

mmol/l

2.40

1135

6181

Abdominal aortic aneurysm (AAA)

888

4368

2.26

92.91

10.8

5.7

0.93

1.01

mmol/l

0.25

732

3276

Cervicobrachial syndrome

1418

8112

1.86

92.51

5.4

7.7

1.32

0.93

mmol/l

4.01

1112

6420

Toxic effects of substances chiefly nonmedicinal as to source

808

3855

2.31

92.21

7.8

0.92

0.98

mmol/l

0.17

627

2991

Aortic valve malfunction, age under 60 years

742

3451

2.44

92.16

13.8

8.7

1.11

0.94

mmol/l

0.67

622

2726

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7389

32773

1.32

91.83

8.8

7.0

0.65

1.08

mmol/l

15.24

6122

25384

Status epilepticus

350

1133

3.78

91.70

13.5

7.7

1.35

0.96

mmol/l

0.80

272

889

Polyneuropathies and other disorders of the peripheral nervous system

1616

9701

1.81

91.57

9.0

7.3

1.18

1.04

mmol/l

0.58

1293

7527

Other dialysis

324

1019

4.15

91.16

13.3

9.3

-1.40

1.07

mmol/l

16.68

266

803

Phobic anxiety disorders

712

3203

2.37

91.11

8.8

7.4

1.06

0.73

mmol/l

1.29

556

2429

Other viral hepatitis

468

1761

3.02

91.09

10.4

9.3

0.79

0.92

mmol/l

0.24

379

1382

Exclusions for E4_PCOS_CONSORTIUM

4120

18465

1.44

90.88

6.9

0.97

1.10

mmol/l

1.33

3296

14391

Primary_lymphoid and hematopoietic malignant neoplasms

1588

9470

1.80

90.44

8.7

7.0

1.24

1.25

mmol/l

0.02

1232

7314

Arthropathies

5940

22786

1.36

90.06

6.9

7.8

0.88

0.98

mmol/l

1.09

4561

17682

Abnormalities of gait and mobility

943

4850

2.19

90.01

7.9

6.9

0.70

1.00

mmol/l

1.27

768

3750

Benign neoplasm: Rectum

1204

6675

1.97

89.57

7.1

0.97

1.29

mmol/l

1.95

948

5192

Chronic periodontitis, complicated

780

3758

2.37

89.50

12.4

7.7

0.35

1.05

mmol/l

4.01

672

2932

Mental and behavioural disorders due to use of other stimulants, including caffeine

234

580

4.81

89.15

9.9

10.1

0.98

0.85

mmol/l

0.14

186

441

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

181

388

7.28

88.31

4.5

6.8

0.92

1.63

mmol/l

2.45

133

303

Other and unspecified nerve root and plexus disorders, also in other diseases

1257

7067

1.92

88.13

6.6

7.8

1.62

0.95

mmol/l

9.58

948

5569

Congenital malformations of heart and great arteries

852

4068

2.22

88.10

14.1

8.1

0.95

0.89

mmol/l

0.19

725

3149

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

311

963

4.02

87.99

6.4

5.7

0.67

1.41

mmol/l

3.04

271

741

Candidiasis

910

4618

2.16

87.89

11.6

7.2

1.24

1.03

mmol/l

0.78

732

3573

Fracture of shoulder and upper arm

2348

15467

1.60

87.32

7.9

7.1

1.14

1.06

mmol/l

0.37

1877

12096

Benign neoplasm: Transverse colon

752

3599

2.37

87.13

7.2

7.0

1.04

1.22

mmol/l

0.52

606

2789

Poisoning by narcotics and psychodysleptics [hallucinogens]

167

324

6.67

86.97

8.8

9.7

1.10

0.92

mmol/l

0.19

126

260

Diabetic retinopathy, excluding more controls

1887

6566

1.75

86.61

10.5

8.1

0.74

0.90

mmol/l

0.68

1488

5128

Other metabolic disorders

792

3822

2.24

86.47

8.0

6.6

1.04

1.08

mmol/l

0.13

640

2971

Other disorders of kidney and ureter

981

5179

2.11

86.29

10.1

7.1

0.29

1.09

mmol/l

7.22

794

4015

Benign neoplasm: Pituitary gland, craniopharyngeal duct

401

1440

3.24

86.22

6.3

7.7

0.76

1.16

mmol/l

1.58

283

1098

Thoracic aortic aneurysm

1064

5779

2.05

86.21

12.1

7.1

0.87

1.01

mmol/l

0.56

904

4492

Alcohol-induced chronic pancreatitis

576

2496

2.71

86.05

13.8

8.2

0.54

0.98

mmol/l

1.21

469

1964

Type of accident

1819

11351

1.70

85.94

7.4

7.2

1.65

0.96

mmol/l

10.63

1400

8832

Insulin, fast-acting (human)

941

4846

2.09

85.69

10.3

7.1

0.23

1.01

mmol/l

5.48

737

3760

Migraine with aura

1198

6637

1.89

85.22

6.9

1.02

0.80

mmol/l

1.25

915

5114

Other diseases of anus and rectum

1966

12517

1.66

85.07

7.3

6.6

1.07

1.10

mmol/l

0.10

1573

9747

Diseases of peritoneum

788

3884

2.27

83.86

11.2

7.3

0.75

1.15

mmol/l

1.63

615

3003

Mental and behavioural disorders due to tobacco

649

2970

2.47

83.70

8.2

7.9

1.44

0.97

mmol/l

1.87

553

2308

Other and unspecified polyneuropathies, also in other diseases

1421

8452

1.83

83.70

8.6

7.3

1.12

1.06

mmol/l

0.21

1138

6531

Neuromuscular dysfunction of bladder

708

3354

2.38

83.65

7.9

7.5

1.28

1.08

mmol/l

0.58

547

2595

Unspecified misadventure during surgical and medical care

480

1942

2.95

83.59

12.0

7.9

1.26

1.12

mmol/l

0.26

400

1501

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

770

3776

2.30

83.39

7.9

6.8

1.01

1.22

mmol/l

0.82

646

2892

Schizoaffective disorder

548

2322

2.64

83.20

6.8

8.2

2.59

0.96

mmol/l

12.97

426

1805

Alcohol withdrawal state with delirium

614

2775

2.57

83.14

10.2

8.2

1.11

0.98

mmol/l

0.23

506

2168

Smoking dependency

649

2980

2.47

83.03

8.2

7.9

1.44

0.98

mmol/l

1.76

553

2317

Pain in thoracic spine

963

5062

2.05

82.79

6.3

7.6

1.49

0.95

mmol/l

5.18

758

3968

Noninfective enteritis and colitis

2889

19998

1.50

82.69

8.3

7.3

0.88

0.99

mmol/l

0.77

2247

15637

Other joint disorders

5627

22735

1.35

82.43

6.6

7.8

0.89

0.98

mmol/l

0.97

4371

17641

Viral and other specified intestinal infections

1129

6056

1.91

82.35

8.1

7.5

1.02

0.84

mmol/l

0.71

867

4591

Cerebral palsy and other paralytic syndromes

820

4113

2.20

82.16

8.7

7.5

1.32

1.05

mmol/l

0.92

657

3169

Other disorders of glucose regulation and pancreatic internal secretion

641

2937

2.45

81.85

9.9

7.5

0.95

1.05

mmol/l

0.17

503

2278

Disorder of lipoprotein metabolism, unspecified

1003

5410

2.04

81.79

8.7

6.7

0.64

1.14

mmol/l

3.08

822

4183

Pneumonia due to other infectious organisms, not elsewhere classified

288

887

3.97

81.59

9.8

7.4

1.23

0.89

mmol/l

0.85

232

674

Other and unspecified dermatitis

3192

22605

1.47

81.48

7.7

7.0

1.08

1.01

mmol/l

0.43

2526

17763

Post-traumatic stress disorder

430

1617

2.87

81.42

7.1

7.2

0.77

0.73

mmol/l

0.07

322

1213

Fentanyl

749

3644

2.27

81.29

7.7

6.0

2.24

1.13

mmol/l

9.94

597

2731

Acute peritonitis

548

2378

2.68

81.17

13.8

7.7

0.54

1.11

mmol/l

2.02

440

1845

Cholecystectomy

4570

30271

1.38

81.03

7.7

6.9

1.01

1.10

mmol/l

0.82

3632

23780

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

869

4499

2.15

80.58

7.2

6.3

0.64

1.30

mmol/l

4.60

688

3450

Pneumothorax

578

2567

2.58

80.48

10.8

7.2

1.42

0.88

mmol/l

2.32

500

1957

Exposure to other specified factors

4510

31655

1.38

80.24

8.1

7.5

0.93

0.99

mmol/l

0.46

3694

24794

Asthma and allergy, excluding more controls

615

2711

2.36

79.25

7.3

5.7

1.00

0.24

mmol/l

5.00

495

2018

Other noninfective gastroenteritis and colitis

1558

9543

1.73

79.05

8.5

7.0

0.88

1.01

mmol/l

0.61

1226

7417

Benign neoplasm: Colon, unspecified

1776

11325

1.69

78.96

7.3

7.0

1.02

1.08

mmol/l

0.24

1418

8856

Haemorrhage, not elsewhere classified

337

1168

3.49

78.61

11.1

6.7

0.87

1.07

mmol/l

0.33

268

896

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

737

3641

2.27

78.20

7.7

6.7

0.97

1.20

mmol/l

0.93

619

2788

Coagulation defects, purpura and other haemorrhagic conditions

1252

7283

1.85

78.11

9.5

7.1

0.81

0.99

mmol/l

0.72

1005

5612

Other and unspecified myopathies

687

3319

2.35

78.03

10.0

7.1

1.65

1.13

mmol/l

1.87

554

2586

Soft tissue disorders related to use, overuse and pressure

1753

11117

1.67

77.70

6.9

7.4

1.08

1.05

mmol/l

0.11

1414

8784

Systemic connective tissue disorders

2240

14993

1.57

77.60

7.7

6.5

1.21

1.12

mmol/l

0.54

1818

11724

Pyothorax

405

1573

3.15

77.43

13.5

8.0

2.28

1.10

mmol/l

6.47

353

1223

Idiopathic gout

765

3877

2.26

77.38

8.5

7.4

0.64

1.09

mmol/l

1.93

604

2996

Disorders of mineral metabolism

587

2660

2.48

77.02

8.5

6.7

1.19

1.17

mmol/l

0.03

490

2061

Speech and linguistic disorders, excluding more controls

412

1458

2.86

76.93

8.6

8.3

0.75

0.69

mmol/l

0.09

301

1105

Preparatory care for dialysis

401

1558

3.15

76.72

10.9

8.4

-1.94

1.13

mmol/l

28.20

342

1220

Familial hypercholesterolemia

1135

6490

1.90

76.20

6.9

6.5

1.32

1.13

mmol/l

0.83

878

5038

Certain disorders involving the immune mechanism

1281

7562

1.82

76.08

10.5

7.4

0.96

1.05

mmol/l

0.32

1018

5910

Diseases of pulp and periapical tissues, including avohilmo

7243

29823

1.29

76.08

7.5

7.1

0.84

1.05

mmol/l

4.05

5733

23275

Dental pulpitis 4

7256

29887

1.29

75.96

7.5

7.1

0.84

1.06

mmol/l

4.14

5738

23333

Viral pneumonia (known virus, not influenza)

251

754

4.35

75.84

9.7

7.8

2.01

0.91

mmol/l

2.97

206

595

Benign neoplasm of other and ill-defined parts of digestive system

1252

7381

1.84

75.76

8.3

6.8

1.07

1.11

mmol/l

0.12

1028

5762

Dental pulpitis 1

7253

29892

1.29

75.69

7.5

7.1

0.84

1.06

mmol/l

4.31

5736

23338

Benign neoplasm: Adrenal gland

532

2338

2.59

75.68

7.6

7.0

1.22

1.24

mmol/l

0.03

445

1806

Alcoholic liver disease

793

4082

2.19

75.68

11.9

7.8

-0.13

1.10

mmol/l

8.31

660

3186

Diabetic nephropathy

1303

7742

1.85

75.66

10.8

8.3

-0.01

0.94

mmol/l

10.56

1030

5942

Organic, including symptomatic, mental disorders

3489

18280

1.44

75.61

6.6

1.45

1.07

mmol/l

5.94

2691

14334

Gonarthrosis,primary

6191

30508

1.32

75.57

6.5

7.4

1.18

1.07

mmol/l

1.55

4885

24171

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

597

2757

2.46

75.55

10.3

6.9

1.27

1.13

mmol/l

0.44

473

2126

Sequelae of other external causes

436

1754

2.88

75.52

10.3

7.8

0.56

1.04

mmol/l

1.33

365

1355

Chronic gastritis

1937

12699

1.62

74.81

7.5

6.4

0.85

1.14

mmol/l

2.39

1557

9955

Intracerebral haemorrhage

951

5195

2.01

74.67

10.5

6.3

1.35

1.11

mmol/l

0.99

737

3962

Other aneurysm

476

2020

2.76

74.46

10.6

6.9

1.10

1.15

mmol/l

0.10

378

1553

Benign neoplasm: Ascending colon

884

4723

2.06

74.46

6.9

6.8

1.04

1.26

mmol/l

0.86

697

3656

Disorders resulting from impaired renal tubular function

339

1226

3.43

74.35

12.5

9.1

-0.67

1.17

mmol/l

11.20

270

965

Total colectomy operation

361

1338

3.20

74.15

12.4

8.3

0.31

1.19

mmol/l

2.80

295

1062

Total colectomy

361

1338

3.20

74.15

12.4

8.3

0.31

1.19

mmol/l

2.80

295

1062

Brain glioblastoma

181

452

6.15

73.68

4.5

7.7

0.92

1.21

mmol/l

0.71

133

366

Fibrosis and cirrhosis of liver

600

2819

2.45

73.61

10.9

7.3

-0.07

1.18

mmol/l

8.10

480

2214

Other systemic involvement of connective tissue (FG)

1611

10060

1.68

73.57

6.8

6.6

1.33

1.08

mmol/l

1.85

1312

7833

L04AX Other immunosuppressants

3349

24322

1.43

73.49

8.5

7.3

1.09

1.03

mmol/l

0.37

2651

19229

Mixed and other personality disorders

518

2256

2.53

73.29

6.7

8.4

1.18

0.94

mmol/l

0.59

414

1745

Vascular diseases of the intestine

358

1338

3.25

73.29

14.8

6.6

0.50

1.22

mmol/l

1.72

283

1030

Other degenerative diseases of the nervous system

1707

8171

1.66

73.05

5.2

6.4

1.20

0.89

mmol/l

2.15

1298

6339

Other diseases of blood and blood-forming organs, wide

1445

8904

1.74

72.89

9.2

7.2

1.35

1.03

mmol/l

2.24

1159

6984

Disturbances of skin sensation

1580

9900

1.68

72.82

6.8

7.4

0.97

mmol/l

0.03

1245

7734

Second line medication for Crohn's disease

3411

24883

1.42

72.75

8.4

7.4

1.07

1.03

mmol/l

0.27

2702

19673

Postprocedural endocrine and metabolic disorders, not elsewhere classified

708

3497

2.19

72.66

7.5

6.6

1.00

1.08

mmol/l

0.24

573

2709

Rheumatoid arthritis

2098

12726

1.57

72.31

7.2

7.3

1.31

1.11

mmol/l

1.51

1661

9982

Other and unspecified effects of external causes

1548

9662

1.68

72.22

8.3

7.5

0.80

0.90

mmol/l

0.38

1228

7444

Asthma and allergy

615

2819

2.26

72.11

7.3

6.0

1.00

0.26

mmol/l

4.81

495

2109

Viral hepatitis

507

2218

2.54

71.64

10.1

8.9

0.74

0.99

mmol/l

0.59

408

1737

Sequelae of injuries, of poisoning and of other consequences of external causes

1498

9328

1.70

71.63

9.6

7.7

1.25

1.01

mmol/l

1.40

1179

7302

Lung transplantation

123

229

9.57

71.42

37.8

8.7

1.63

1.16

mmol/l

0.54

112

188

Other embolism and thrombosis

931

5117

1.99

71.33

9.4

7.2

0.93

1.14

mmol/l

0.79

744

3943

Attention to artificial openings

353

1327

3.20

71.24

10.5

7.3

1.09

1.12

mmol/l

0.04

291

1047

Abnormal involuntary movements

913

4988

2.00

71.14

6.4

7.3

1.03

1.01

mmol/l

0.04

737

3860

Arterial embolism and thrombosis

488

2126

2.64

71.13

12.0

6.0

0.71

1.14

mmol/l

1.23

383

1622

Cervical disc disorders

2341

16079

1.52

70.91

6.8

7.8

1.35

0.95

mmol/l

6.57

1840

12781

Fracture of skull and facial bones

1340

8128

1.75

70.91

9.6

7.5

1.04

0.97

mmol/l

0.22

1055

6331

Open wound of lower leg

974

5427

1.94

70.68

9.2

7.3

1.40

1.06

mmol/l

1.65

790

4171

Lung transplant status

122

229

9.45

70.23

38.1

8.7

1.45

1.16

mmol/l

0.32

111

188

Benign neoplasm of brain and other parts of central nervous system

521

2351

2.54

70.16

7.0

7.8

1.16

1.09

mmol/l

0.17

393

1850

Disorders of calcium metabolism

457

1940

2.68

70.08

8.1

6.4

1.13

1.23

mmol/l

0.16

379

1490

ILD medications: pirfenidone

159

384

7.34

69.69

12.1

8.0

1.52

1.05

mmol/l

1.04

136

303

In situ neoplasms

2014

12824

1.57

69.54

6.6

6.4

0.77

1.26

mmol/l

6.45

1616

9872

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

512

2302

2.53

69.17

7.8

6.9

0.68

1.28

mmol/l

2.71

431

1761

Cirrhosis of liver, NAS

444

1903

2.79

68.87

11.1

8.1

-0.21

1.11

mmol/l

6.59

358

1487

Tobacco use

404

1638

2.84

68.77

8.3

8.5

1.63

1.01

mmol/l

1.65

319

1282

Persistent mood disorders

1199

7117

1.79

68.69

7.4

7.1

1.20

1.02

mmol/l

0.78

953

5544

Other disorders of ear

6063

31949

1.30

68.52

6.7

7.4

1.16

1.02

mmol/l

1.98

4714

25317

Pneumonia due to Streptococcus pneumoniae

338

1254

3.12

68.42

8.7

7.4

1.42

0.74

mmol/l

2.04

267

961

Bronchiectasis

598

2876

2.35

68.37

7.0

6.7

1.98

0.87

mmol/l

7.60

480

2230

DVT of lower extremities

1327

8148

1.75

68.22

7.1

1.13

1.09

mmol/l

0.13

1059

6319

Benign neoplasm: Caecum

709

3633

2.18

68.03

7.8

6.8

0.90

1.29

mmol/l

1.85

564

2828

Other diseases of pancreas

590

2853

2.35

66.96

10.9

7.1

0.62

1.05

mmol/l

1.56

475

2229

Hypoglycaemia, other or unspecified

506

2288

2.49

66.89

10.2

7.8

0.83

1.05

mmol/l

0.44

397

1762

Artrosis, including avohilmo

5684

24431

1.31

66.81

6.5

7.9

1.08

1.01

mmol/l

0.60

4402

19186

Nonischemic cardiomyopathy

446

1921

2.67

66.74

14.9

7.6

0.66

0.95

mmol/l

0.61

358

1511

Other disorders of adrenal gland

348

1331

3.03

66.67

10.2

8.1

1.00

1.11

mmol/l

0.19

287

1059

Oesophageal varices

371

1489

3.00

66.17

11.7

8.0

-0.28

0.95

mmol/l

5.23

306

1158

Osteomyelitis

507

2325

2.49

65.72

10.0

7.8

1.03

1.01

mmol/l

0.04

422

1819

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

971

5536

1.90

65.63

7.0

7.4

1.52

1.21

mmol/l

1.74

782

4274

Postprocedural disorders of digestive system, not elsewhere classified

301

1092

3.37

65.27

10.2

8.2

1.18

1.26

mmol/l

0.11

253

868

Appendectomy

3782

27397

1.37

65.25

7.8

7.5

0.81

1.03

mmol/l

2.98

3026

21509

Sleep disorders

1219

7362

1.75

65.16

7.4

7.6

1.23

0.93

mmol/l

1.96

987

5662

Hydronephrosis

777

4150

2.05

65.01

7.9

6.5

0.15

1.20

mmol/l

7.38

589

3229

Dental caries 1

5522

22077

1.31

64.96

7.2

7.1

0.98

1.09

mmol/l

1.06

4325

17194

Other and unspecified local infections of skin and subcutaneous tissue

664

3370

2.17

64.78

10.0

7.6

0.90

1.04

mmol/l

0.36

541

2597

Abnormal findings on diagnostic imaging of other body structures

848

4666

1.98

64.68

7.3

6.9

1.10

1.03

mmol/l

0.17

669

3595

Pneumocystosis

198

577

4.90

64.53

12.0

8.4

0.92

1.25

mmol/l

0.56

158

458

Dental caries, including avohilmo

5511

22060

1.31

64.30

7.2

7.1

0.98

1.09

mmol/l

1.06

4316

17181

Familial hypercholesterolemia, with ischemic heart disease

717

3768

2.12

64.12

7.6

6.4

1.19

1.01

mmol/l

0.58

559

2935

Pericarditis

283

989

3.33

64.00

9.0

7.2

1.24

0.96

mmol/l

0.56

228

753

Serous carcinoma of ovary

311

1163

3.27

63.90

6.4

6.2

0.67

1.30

mmol/l

2.54

271

932

Benign neoplasm: Pituitary gland, craniopharyngeal duct

401

1681

2.74

63.66

6.3

8.4

0.76

1.10

mmol/l

1.28

283

1300

Other blood glucose lowering drugs, excl. Insulins

1182

7195

1.77

63.25

7.8

6.7

1.38

1.20

mmol/l

0.75

905

5638

Glomerulonephritis

723

3817

2.09

63.16

9.9

7.8

0.33

1.03

mmol/l

3.96

556

2976

Myocardial infarction, with ST-elevation

1334

8388

1.71

63.09

8.4

6.9

0.73

1.07

mmol/l

2.18

1031

6421

Seropositive rheumatoid arthritis

1608

10456

1.61

63.03

7.1

6.9

1.28

1.13

mmol/l

0.78

1275

8197

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

895

5049

1.93

62.89

8.0

6.5

-0.08

1.18

mmol/l

14.80

711

3830

Abnormal spermatozoa

199

5874

0.31

62.89

5.3

8.1

1.61

0.94

mmol/l

2.23

149

4522

Other local infections of skin and subcutaneous tissue

696

3633

2.10

62.52

9.9

7.5

0.89

1.04

mmol/l

0.45

566

2810

Somnolence, stupor and coma

363

1467

2.86

62.33

8.7

7.7

1.63

0.98

mmol/l

1.87

282

1139

KRA_PSY_EATING, excluding more controls

337

1271

2.79

62.27

7.3

6.4

0.84

0.32

mmol/l

1.12

270

910

Parodontitis or/and operation codes

3977

17889

1.36

62.12

8.4

7.3

0.89

1.15

mmol/l

3.37

3152

14081

Cholecystitis

993

5794

1.85

62.07

8.1

6.5

1.15

1.09

mmol/l

0.15

791

4448

Extrapyramidal and movement disorders

2400

17027

1.48

61.99

5.6

6.9

1.55

1.06

mmol/l

7.51

1929

13323

Disorders of parathyroid gland

1371

8571

1.68

61.93

6.7

6.2

0.87

1.26

mmol/l

2.64

1103

6704

Follow-up examination after treatment for conditions other than malignant neoplasms

2615

12116

1.46

61.91

7.5

7.0

0.78

0.88

mmol/l

0.60

2103

9605

Dental caries 3

5738

23188

1.30

61.86

7.1

1.00

1.06

mmol/l

0.50

4488

18094

Diplopia

885

5004

1.92

61.78

8.1

7.1

1.22

1.10

mmol/l

0.38

706

3872

Dental operations

4703

18633

1.33

61.37

7.4

7.0

1.06

0.99

mmol/l

0.62

3655

14572

Other arthritis (FG)

1865

12603

1.55

61.20

8.1

7.4

1.01

1.00

mmol/l

0.04

1520

9886

Adrenocortical insufficiency

297

1101

3.20

61.10

9.9

8.4

1.06

1.13

mmol/l

0.09

243

876

Osteoporosis with pathological fracture (FG)

499

2339

2.42

61.05

7.6

5.5

2.08

1.28

mmol/l

3.03

411

1836

Intentional self-harm by unspecified means

121

242

6.43

61.03

9.6

10.1

-0.15

0.87

mmol/l

1.64

184

Umbilical hernia

1727

11548

1.58

60.58

8.0

7.6

1.10

0.97

mmol/l

0.67

1387

9029

Asthma and opportunity respiratory infection

382

1616

2.78

60.35

7.7

7.0

2.05

0.99

mmol/l

5.50

309

1243

Other diseases of biliary tract

633

3252

2.17

60.31

10.5

6.9

0.45

1.15

mmol/l

4.11

522

2530

Benign neoplasm: Sigmoid colon

1279

8054

1.71

60.25

7.2

7.0

0.73

1.12

mmol/l

2.63

1016

6264

Somatoform disorder

943

5436

1.84

60.06

6.9

7.1

1.64

0.97

mmol/l

6.16

723

4220

Disorders of synovium and tendon

3144

20978

1.39

59.74

6.9

7.5

1.15

1.01

mmol/l

1.46

2454

16500

Combinations of oral blood glucose lowering drugs

1880

12870

1.54

59.28

8.6

7.3

1.05

1.09

mmol/l

0.13

1414

10274

Intentional self-harm by sharp object

181

499

4.20

59.28

7.6

9.7

0.81

mmol/l

0.00

134

389

Left ventricular outflow tract obstruction, narrow definition

369

1537

2.75

59.26

18.3

9.3

0.91

0.99

mmol/l

0.15

321

1222

Shock, not elsewhere classified

122

259

6.74

59.15

34.7

6.9

0.81

1.24

mmol/l

0.32

207

Focal brain injury

461

2101

2.42

59.01

10.1

7.1

1.29

0.91

mmol/l

1.09

362

1600

Toxic effect of carbon monoxide

188

552

4.43

58.79

4.3

8.5

1.06

1.12

mmol/l

0.08

142

437

Insomnia

904

5183

1.85

58.71

7.5

1.24

0.93

mmol/l

1.71

734

4009

Stomatitis and related lesions

545

2659

2.24

58.54

9.0

7.0

0.74

1.03

mmol/l

0.82

436

2041

Dental pulpitis 2

4949

19809

1.31

58.54

7.1

7.0

0.95

1.10

mmol/l

1.57

3865

15389

Paracetamol of NSAID medication

1129

3316

1.77

58.48

7.9

8.2

0.99

0.87

mmol/l

0.44

861

2530

Other and unspecified mood [affective] disorders

389

1642

2.56

58.34

7.8

0.69

0.88

mmol/l

0.37

300

1259

Cervicalgia

1244

7777

1.69

58.32

6.0

7.3

1.23

1.00

mmol/l

1.38

995

6107

Benign neoplasm: Stomach

626

3231

2.13

58.16

7.7

6.7

1.37

1.35

mmol/l

0.05

513

2490

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

14.80

58.01

5.5

15.3

0.76

1.67

mmol/l

1.23

Subjective visual disturbances

1444

9371

1.62

57.92

7.3

7.0

1.08

1.09

mmol/l

0.07

1137

7335

Viral infections characterized by skin and mucous membrane lesions

2465

17705

1.44

57.91

8.2

7.4

1.09

1.02

mmol/l

0.37

1949

13875

Ulcer of oesophagus

571

2882

2.24

57.86

7.9

7.2

1.68

1.08

mmol/l

2.85

453

2228

Short Achilles tendon (acquired)

233

776

3.57

57.80

6.9

7.5

2.16

1.20

mmol/l

4.61

173

623

Reimbursement for rheumatic diseases

3487

26405

1.36

57.41

7.8

7.0

1.17

1.06

mmol/l

0.89

2773

20831

Temporomandibular joint disorders

826

4620

1.88

57.35

6.4

7.0

1.17

0.96

mmol/l

1.00

628

3614

Nonorganic sleeping disorders

1039

6234

1.76

56.96

7.6

7.5

1.17

0.92

mmol/l

1.26

841

4804

Other mental disorders due to brain damage and dysfunction and to physical disease

816

4634

1.93

56.94

6.1

6.6

1.46

1.13

mmol/l

1.54

617

3592

Laparoscopic right hemicolectomy

464

2198

2.48

56.90

6.6

7.0

0.36

1.10

mmol/l

4.45

378

1711

Malignant neoplasm of colon

1066

6523

1.77

56.56

7.4

6.4

0.63

1.11

mmol/l

3.36

850

5016

Acute and transient psychotic disorders

722

3922

1.98

56.45

7.2

8.1

2.00

0.90

mmol/l

10.14

583

3048

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

688

3702

2.03

56.43

9.7

6.9

1.60

1.18

mmol/l

2.07

561

2839

Migraine without aura

854

4835

1.84

56.35

7.0

0.86

0.74

mmol/l

0.45

658

3694

Other and unspecified injuries of head

445

2052

2.43

56.27

7.4

7.8

0.90

1.04

mmol/l

0.29

371

1589

Other disorders of lacrimal gland

1991

13873

1.50

56.15

6.4

7.0

1.35

1.10

mmol/l

2.33

1579

10928

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

3296

16895

1.38

55.87

6.4

7.1

0.83

1.25

mmol/l

8.09

2579

13193

Paralytic ileus

330

1351

2.86

55.81

11.3

6.7

1.13

1.23

mmol/l

0.13

271

1035

Dental pulpitis 2, only avohilmo

5032

20307

1.30

55.56

7.1

0.94

1.09

mmol/l

1.72

3931

15788

Injury of intra-abdominal organs

216

706

3.66

55.47

12.9

8.9

1.10

1.04

mmol/l

0.07

161

564

Polyarthrosis

1267

7728

1.67

55.47

5.1

6.8

1.52

1.25

mmol/l

1.79

1029

6090

Other diseases of liver

1091

6708

1.73

55.42

9.4

7.3

0.54

1.11

mmol/l

4.17

892

5250

Right hemicolectomy

481

2324

2.37

55.21

11.3

6.9

0.55

1.18

mmol/l

2.47

380

1788

Conductive and sensorineural hearing loss

5277

29225

1.28

55.16

6.4

7.3

1.26

1.04

mmol/l

3.71

4063

23188

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

467

2220

2.37

55.13

9.0

6.2

0.37

1.19

mmol/l

4.68

381

1692

Disorders of skin appendages

2627

19199

1.41

55.06

7.9

7.4

0.94

0.96

mmol/l

0.06

2061

14962

Injury of other and unspecified intrathoracic organs

485

2341

2.33

55.05

10.9

7.9

1.24

1.09

mmol/l

0.31

369

1812

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

355

1508

2.72

55.04

10.4

6.6

1.49

1.32

mmol/l

0.47

305

1173

Dermatitis and eczema

6834

36753

1.24

54.96

7.8

7.3

1.11

1.00

mmol/l

1.38

5408

28786

Cytomegalovirus infection, IBD co-morbidity

208

676

3.84

54.89

14.5

10.1

0.05

1.17

mmol/l

3.89

163

536

Myalgia

1270

8079

1.65

54.88

7.6

7.3

1.02

1.03

mmol/l

0.05

1019

6327

Fall on and from stairs and steps

1547

10319

1.58

54.79

7.7

7.1

0.87

1.08

mmol/l

1.20

1236

8045

Benign neoplasm: Transverse colon

752

4234

1.98

54.75

7.2

7.0

1.04

1.08

mmol/l

0.09

606

3302

Scoliosis

494

2374

2.24

54.60

7.4

7.0

1.42

1.00

mmol/l

1.53

405

1834

Hypertension, Pulmonary Arterial

105

209

7.06

54.41

16.5

6.2

1.25

0.88

mmol/l

0.29

169

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

579

2991

2.16

54.41

6.8

6.3

1.16

1.24

mmol/l

0.16

463

2291

Noninfectious colitis NAS

850

4913

1.85

54.33

8.0

6.9

0.90

1.05

mmol/l

0.50

672

3810

Psychotic depression

392

1724

2.49

54.23

8.2

7.1

1.29

0.88

mmol/l

1.20

304

1305

Dental caries 3 and operation codes

6162

25622

1.26

53.57

7.4

7.2

0.96

1.04

mmol/l

0.75

4857

20004

Phlebitis and thrombophlebitis (not including DVT)

1411

9285

1.60

53.49

7.2

0.96

1.04

mmol/l

0.34

1139

7255

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

315

1293

2.89

53.38

17.5

7.3

1.16

1.23

mmol/l

0.11

282

991

Parkinson's disease, excluding more controls

869

4954

1.83

53.08

4.9

6.5

1.77

0.79

mmol/l

10.41

714

3832

Other diseases of lip and oral mucosa

1015

6201

1.74

52.87

8.2

6.9

1.26

1.16

mmol/l

0.34

785

4865

Visual field defects

611

3243

2.08

52.85

7.9

7.3

0.94

1.19

mmol/l

0.78

473

2516

Hypopituitarism

457

2175

2.32

52.80

8.1

8.8

0.90

0.95

mmol/l

0.10

359

1704

Disorders of lacrimal system

2445

17844

1.42

52.66

6.3

6.9

1.36

1.08

mmol/l

3.04

1927

14034

Purpura and other haemorrhagic conditions

859

5037

1.83

52.60

8.7

7.2

0.92

1.05

mmol/l

0.43

680

3885

Injuries to the neck

1282

8264

1.63

52.55

7.9

7.5

1.21

0.94

mmol/l

1.55

1020

6357

Blood alcohol or alcohol intoxication level

201

648

3.67

52.51

9.5

8.1

1.30

0.90

mmol/l

0.68

159

521

Cerebral cysts

378

1672

2.52

52.36

10.7

8.4

1.00

1.11

mmol/l

0.19

284

1279

Dental caries 1 and operation codes

5955

24736

1.26

52.27

7.3

7.1

0.96

1.05

mmol/l

0.85

4696

19293

Cytomegaloviral disease

209

700

3.67

52.24

14.4

9.7

0.05

1.12

mmol/l

3.67

164

560

Other disorders of skin and subcutaneous tissue, not elsewhere classified

938

5646

1.78

52.17

7.7

6.8

1.77

1.09

mmol/l

5.26

743

4374

Pneumonia derived septicemia

273

1052

3.03

51.88

9.5

8.3

1.71

1.05

mmol/l

1.51

218

814

Mental and behavioural disorders due to cannabinoids

189

582

3.64

51.87

9.9

9.8

1.34

0.66

mmol/l

0.96

146

443

Colon adenocarcinoma

869

5169

1.84

51.72

7.2

6.5

0.64

1.10

mmol/l

2.55

688

3965

Primary_lymphoid and hematopoietic malignant neoplasms

1588

10816

1.55

51.56

8.7

7.0

1.24

1.04

mmol/l

1.12

1232

8434

Brain astrocytoma

101

12.62

51.47

5.5

13.6

0.76

1.88

mmol/l

1.95

Assault by bodily force

442

2084

2.29

51.46

9.6

8.3

0.81

0.91

mmol/l

0.19

346

1627

Benign neoplasm: Rectum, anus and anal canal

1352

8929

1.62

51.45

7.0

0.93

1.11

mmol/l

0.86

1068

6948

Procreative management

1623

9244

1.53

51.41

8.9

8.5

0.90

0.98

mmol/l

0.41

1273

7279

Other viral diseases

1526

10207

1.55

51.40

10.1

7.8

1.03

0.90

mmol/l

0.66

1202

7867

Disorders of continuity of bone

585

3068

2.07

51.38

8.0

7.7

1.25

1.03

mmol/l

0.73

473

2395

Hydrocephalus

566

2961

2.13

51.36

7.4

6.9

1.57

1.14

mmol/l

2.08

434

2285

Other symptoms and signs involving the nervous and musculoskeletal systems

2430

17773

1.42

51.34

7.1

1.71

0.98

mmol/l

21.68

1893

13880

Dental pulpitis 4, only avohilmo

7182

31013

1.23

51.15

7.1

7.3

0.87

1.04

mmol/l

2.81

5689

24257

235

858

3.42

51.11

7.2

7.7

2.22

1.05

mmol/l

3.60

192

668

Toxic effect of other and unspecified substances

124

294

5.30

51.07

11.6

10.3

0.67

1.18

mmol/l

0.65

105

233

Congenital malformations of aortic and mitral valves

311

1287

2.78

50.86

18.2

9.1

0.98

0.95

mmol/l

0.04

271

1028

Other/unspecified cytomegaloviral diseases

178

552

4.07

50.80

15.0

11.0

-0.05

1.11

mmol/l

3.62

144

442

Charcot foot

155

436

4.42

50.76

12.4

8.6

1.02

1.06

mmol/l

0.04

128

339

Acute posthaemorrhagic anaemia

295

1199

2.87

50.55

9.2

7.5

0.65

1.31

mmol/l

1.42

231

927

Hypertensive Renal Disease

274

1069

2.94

50.37

8.0

6.5

0.37

0.98

mmol/l

1.30

208

813

Malignant neoplasm of ovary

347

1521

2.63

50.31

7.6

6.2

0.72

1.34

mmol/l

2.49

284

1211

Lesion of ulnar nerve

890

5353

1.78

49.45

8.7

8.0

1.37

0.98

mmol/l

2.21

721

4200

Cholangitis (primary sclerosing, PSC)

441

2138

2.30

49.25

10.9

7.2

0.30

1.05

mmol/l

2.94

359

1667

Pulmonary oedema

184

595

3.91

49.24

14.4

6.2

2.41

1.40

mmol/l

1.71

137

454

Other specified/unspecified arthritis

1575

10754

1.53

49.17

8.2

7.6

1.07

1.06

mmol/l

0.03

1279

8448

Superficial injury of lower leg

1360

9016

1.57

48.95

7.6

7.1

1.20

1.04

mmol/l

0.79

1102

6975

Benign neoplasm: Rectum

1204

7848

1.64

48.91

7.1

0.97

1.11

mmol/l

0.58

948

6112

Hyperparathyroidism

1175

7501

1.64

48.76

6.5

6.2

0.72

1.29

mmol/l

4.58

940

5856

Previous suicide attempt

101

212

6.21

48.54

8.4

9.7

0.86

0.94

mmol/l

0.07

166

Injuries to the elbow and forearm

4011

28578

1.30

48.48

7.4

7.2

1.05

1.04

mmol/l

0.07

3188

22453

Other systemic involvement of connective tissue

1641

11349

1.51

48.40

6.8

6.5

1.32

1.11

mmol/l

1.37

1333

8854

Inguinal hernia

3928

20752

1.31

48.37

7.6

0.99

0.98

mmol/l

0.05

3094

16249

Other condition

825

4890

1.80

48.15

8.4

7.6

1.73

1.01

mmol/l

6.05

638

3814

Sensorineural hearing loss

4996

28239

1.27

48.14

6.2

7.3

1.25

1.05

mmol/l

3.22

3836

22427

Traumatic subarachnoid haemorrhage

272

1084

2.88

48.06

12.7

7.2

1.38

0.94

mmol/l

0.94

222

834

Amputation of foot

247

960

3.22

48.04

10.3

8.3

0.29

1.14

mmol/l

1.94

195

741

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

726

4202

1.90

47.93

8.0

7.0

1.08

1.06

mmol/l

0.06

608

3248

Dental pulpitis 1, only avohilmo

7164

31134

1.22

47.83

7.1

7.3

0.87

1.04

mmol/l

2.80

5673

24358

Sulfonylureas

2491

14748

1.41

47.81

7.6

6.3

0.85

1.15

mmol/l

2.12

1879

11616

Injuries to the ankle and foot

3771

26908

1.31

47.75

7.7

7.6

1.01

0.95

mmol/l

0.39

3023

21012

Benign neoplasm: Brain, supratentorial

146

411

4.40

47.72

6.8

7.9

1.37

1.43

mmol/l

0.07

105

327

Fall on same level involving ice and snow

3337

25832

1.33

47.68

7.6

7.1

1.06

1.04

mmol/l

0.10

2663

20351

Functional dyspepsia

1530

10458

1.53

47.64

7.8

6.6

1.29

1.09

mmol/l

1.35

1213

8189

Acute gastritis

543

2865

2.08

47.52

6.7

6.9

1.45

1.17

mmol/l

0.88

428

2223

Other congenital malformations of circulatory system

218

787

3.33

47.50

8.5

8.9

0.94

1.18

mmol/l

0.42

162

634

ILD medications: nintedanib

100

227

8.03

47.46

11.0

7.5

1.92

0.99

mmol/l

1.77

176

Strabismus

1469

9947

1.54

47.33

9.0

7.4

1.20

0.97

mmol/l

1.51

1143

7709

Hyperkinetic disorders, excluding more controls

343

1444

2.41

47.31

8.0

8.3

0.67

0.39

mmol/l

0.60

260

1064

Coxarthrosis, primary

3915

26883

1.31

47.18

6.5

7.0

1.13

1.10

mmol/l

0.20

3108

21235

Anosmia

112

249

4.88

46.98

6.2

4.4

1.24

1.15

mmol/l

0.09

185

Type 1 diabetes, definitions combined

490

2462

2.10

46.96

9.9

7.4

-0.40

0.83

mmol/l

5.25

367

1914

Hepatic failure, not elsewhere classified

297

1258

2.76

46.89

19.2

8.6

0.24

1.31

mmol/l

3.11

229

984

Generalized anxiety disorder

691

3892

1.86

46.82

7.1

0.91

0.79

mmol/l

0.35

571

2940

Dissociative [conversion] disorders

233

861

3.00

46.58

6.1

7.1

1.09

0.94

mmol/l

0.23

176

662

Dental caries 1, only avohilmo

5521

22966

1.26

46.57

7.0

7.3

1.00

1.07

mmol/l

0.57

4325

17931

Injuries to unspecified part of trunk, limb or body region

633

3524

1.95

46.52

10.1

7.6

0.80

1.02

mmol/l

0.69

537

2729

Benign neoplasm: Adrenal gland

532

2826

2.10

46.49

7.6

7.4

1.22

1.12

mmol/l

0.23

445

2207

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

166

523

4.04

46.49

8.7

7.0

0.61

1.46

mmol/l

2.32

145

417

Disorders of ocular muscles, binocular movement, accommodation and refraction

2499

18464

1.38

46.37

8.8

7.3

1.12

0.94

mmol/l

1.53

1955

14386

Other problems related to primary support group, including family circumstances

546

2794

2.01

46.35

11.1

8.0

0.68

0.75

mmol/l

0.16

443

2151

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2950

15373

1.36

46.14

6.2

7.0

0.87

1.28

mmol/l

6.76

2297

11988

Other viral diseases, not elsewhere classified

1012

6354

1.67

45.92

9.9

7.8

1.26

0.93

mmol/l

1.97

798

4916

Recurring oral aphthae, including avohilmo

813

4872

1.78

45.73

7.4

7.3

0.97

1.08

mmol/l

0.35

652

3767

Radiculopathy

1045

6661

1.66

45.71

5.8

7.2

1.27

1.03

mmol/l

1.17

806

5218

Disorders of muscles

636

3561

1.92

45.47

8.6

7.9

1.06

1.08

mmol/l

0.05

510

2758

Type 1 diabetes, strict (exclude DM2)

484

2450

2.08

45.45

9.9

8.0

-0.46

0.84

mmol/l

5.67

361

1907

Dental caries 3, only avohilmo

5734

24006

1.25

45.42

6.8

7.3

1.00

1.05

mmol/l

0.33

4490

18773

Dermatophytosis

855

5225

1.76

45.27

6.5

7.4

1.18

1.01

mmol/l

0.57

678

4050

Malignant neoplasm of corpus uteri

558

3031

2.04

45.25

4.3

5.7

1.32

1.37

mmol/l

0.11

435

2418

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

485

2504

2.13

45.15

6.5

6.7

1.40

1.22

mmol/l

0.39

363

1913

Protozoal diseases

238

928

3.09

45.10

11.3

8.8

0.86

1.17

mmol/l

0.59

188

731

Duodenal ulcer

784

4691

1.80

45.03

9.3

6.5

0.80

1.06

mmol/l

0.76

579

3608

Other extrapyramidal and movement disorders in other diseases

1378

9369

1.55

44.98

5.9

7.0

1.35

1.07

mmol/l

1.73

1110

7322

Fall involving bed

266

1099

2.90

44.91

7.3

6.4

2.33

1.23

mmol/l

4.04

213

845

Social phobias

383

1789

2.27

44.89

8.5

7.7

0.82

0.77

mmol/l

0.08

297

1347

Failure and rejection of transplanted organs and tissues

132

366

4.65

44.73

11.9

8.2

-0.62

1.00

mmol/l

3.41

112

297

Parkinson's disease, strict definition, excluding more controls

788

4616

1.79

44.71

4.9

6.4

1.78

0.80

mmol/l

9.68

648

3570

Superficial injury of thorax

920

5723

1.71

44.67

8.5

7.2

1.05

1.04

mmol/l

0.02

748

4401

Speech and linguistic disorders

415

1920

2.20

44.65

9.9

9.0

0.73

0.63

mmol/l

0.19

303

1478

Other disorders of eyelid

2798

20670

1.36

44.48

6.3

6.8

1.32

1.10

mmol/l

2.53

2255

16275

Diseases of the ear and mastoid process

7409

31485

1.21

44.46

6.8

7.6

1.00

0.98

mmol/l

0.24

5710

24783

Kyphosis

136

389

4.51

44.16

8.0

6.2

3.14

1.44

mmol/l

4.94

103

317

Other sleep disorders

669

3836

1.86

44.01

6.3

7.5

1.63

0.93

mmol/l

4.81

527

2970

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

440

2227

2.21

44.00

7.7

6.1

1.29

1.20

mmol/l

0.22

372

1691

Tubulo-interstitial nephritis, not specified as acute or chronic

453

2299

2.15

43.94

7.3

6.1

1.12

1.20

mmol/l

0.14

356

1757

Adenocarcinoma and papilloma adenocarcinoma of rectum

690

4037

1.88

43.87

7.9

7.1

1.05

1.07

mmol/l

0.04

579

3119

Vitreous haemorrhage

678

3933

1.87

43.82

9.9

7.2

0.51

1.11

mmol/l

3.31

541

3045

Disorders of psychological development

514

2488

2.01

43.63

8.9

9.0

0.85

0.68

mmol/l

0.38

376

1893

Other symptoms and signs involving general sensations and perceptions

287

1230

2.66

43.43

7.2

7.6

1.32

1.14

mmol/l

0.32

240

955

Benign neoplasm: Descending colon

445

2274

2.18

43.25

7.0

6.6

0.93

1.24

mmol/l

0.78

338

1741

Disorders of oesophagus in diseases classified elsewhere

189

672

3.47

42.90

10.0

7.6

1.59

1.41

mmol/l

0.18

147

524

Symptoms and signs involving speech and voice

1923

13976

1.43

42.86

8.0

6.8

1.11

1.07

mmol/l

0.18

1555

10922

Zoster [herpes zoster]

1108

7279

1.61

42.81

7.7

6.7

1.24

1.13

mmol/l

0.34

903

5651

Other diseases of arteries and capillaries

591

3308

1.94

42.81

9.0

6.6

0.77

1.11

mmol/l

1.16

470

2559

Melanocytic naevi

1397

9555

1.51

42.80

6.8

7.1

0.84

1.12

mmol/l

1.66

1077

7343

Leisure time condition

1038

6706

1.63

42.72

6.7

7.2

1.66

1.00

mmol/l

5.79

795

5154

Use of pramipexole

1364

9360

1.54

42.65

6.6

6.9

1.37

1.11

mmol/l

1.82

1095

7317

Vascular syndromes of brain in cerebrovascular disorders

370

1789

2.37

42.64

6.8

1.78

1.06

mmol/l

2.54

278

1372

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

558

3088

1.98

42.46

7.1

6.6

1.34

1.20

mmol/l

0.30

428

2382

Malignant neoplasm of respiratory system and intrathoracic organs

1473

9445

1.51

42.19

7.4

6.4

1.58

1.00

mmol/l

7.28

1238

7183

Trochanteric bursitis

798

4862

1.74

42.01

6.1

6.8

1.11

1.18

mmol/l

0.21

645

3848

Benign neoplasm: Ascending colon

884

5575

1.72

41.83

6.9

1.04

1.09

mmol/l

0.14

697

4343

Superficial injury of hip and thigh

891

5587

1.69

41.79

6.5

1.61

1.07

mmol/l

3.77

720

4266

Benign neoplasm: Caecum

709

4238

1.83

41.72

7.8

6.9

0.90

1.13

mmol/l

0.84

564

3288

Event of undetermined intent

387

1891

2.24

41.70

8.0

8.7

1.00

1.06

mmol/l

0.11

316

1463

Pneumococcal septicemia

258

1078

2.77

41.66

9.3

8.8

1.75

1.20

mmol/l

1.08

204

838

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3090

23588

1.32

41.64

8.6

7.7

1.24

0.98

mmol/l

3.79

2471

18670

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2044

9707

1.41

41.53

5.5

6.4

1.13

1.40

mmol/l

2.62

1693

7588

Other symptoms and signs involving the digestive system and abdomen

898

5633

1.67

41.48

6.8

6.4

1.20

1.18

mmol/l

0.07

691

4420

Congenital malformations of cardiac septa

387

1824

2.23

41.46

14.0

8.7

0.97

0.93

mmol/l

0.07

329

1425

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2044

9710

1.41

41.45

5.5

6.4

1.13

1.40

mmol/l

2.62

1693

7591

Type 1 diabetes, strict definition, subgroup 1

333

1515

2.31

41.29

9.5

6.9

-0.84

0.72

mmol/l

4.86

244

1148

Follow-up examination after treatment for malignant neoplasms

674

3953

1.83

41.24

7.5

6.3

0.98

1.00

mmol/l

0.05

528

3160

Sulfasalazine

1609

11393

1.46

41.20

7.3

7.1

1.33

0.89

mmol/l

4.63

1259

8875

Other disorders of nervous system

454

2375

2.11

41.15

6.8

7.6

1.05

1.13

mmol/l

0.17

371

1867

Other or ill-defined heart diseases

317

1434

2.41

41.15

10.5

7.1

1.33

0.82

mmol/l

1.31

254

1091

Congenital malformations of the urinary system

365

1764

2.27

40.65

8.1

8.7

-0.57

1.05

mmol/l

9.32

281

1373

Mental disorders, not otherwise specified

440

2262

2.08

40.45

8.8

8.1

0.76

0.84

mmol/l

0.14

356

1750

Dentofacial anomalies [including malocclusion]

1349

9158

1.50

40.34

7.8

7.1

1.06

0.97

mmol/l

0.42

1053

7164

Personal history of risk-factors, not elsewhere classified

113

298

4.62

40.28

8.1

7.6

0.95

1.09

mmol/l

0.15

236

Dissocial personality disorder

143

445

3.89

40.04

10.0

10.1

1.53

0.94

mmol/l

0.88

118

352

Oesophagitis

390

1955

2.22

39.95

10.0

7.5

0.77

1.11

mmol/l

0.83

314

1526

Diseases of salivary glands

1101

7312

1.58

39.66

8.2

6.8

1.20

1.13

mmol/l

0.23

871

5739

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

810

5044

1.71

39.52

8.7

7.0

1.34

1.25

mmol/l

0.24

630

3882

Toxic effect of ethanol

275

1199

2.55

39.48

9.2

9.3

0.68

1.05

mmol/l

0.66

211

944

Other diseases of upper respiratory tract

7258

32093

1.20

39.43

7.5

7.3

1.06

0.99

mmol/l

0.69

5709

25110

Neuralgia and neuritis, unspecified

343

1642

2.31

39.37

8.0

8.1

1.42

1.07

mmol/l

0.91

260

1293

Arterial embolism and thrombosis of lower extremity artery

284

1274

2.56

39.16

11.1

6.0

0.46

1.15

mmol/l

1.67

221

984

Fracture of foot, except ankle

1273

8718

1.52

39.14

7.7

1.14

0.95

mmol/l

0.93

1017

6758

Benign neoplasm: Brain, supratentorial

146

470

3.80

38.99

6.8

8.6

1.37

1.25

mmol/l

0.17

105

379

Fracture of neck

425

2222

2.14

38.99

10.7

7.4

1.57

1.06

mmol/l

1.53

348

1732

Inflammatory diseases of the central nervous system

521

2886

1.95

38.93

9.4

7.9

1.11

1.06

mmol/l

0.10

414

2226

Cervicocranial syndrome

620

3601

1.83

38.87

5.3

7.3

1.26

0.98

mmol/l

1.09

478

2820

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

412

2125

2.13

38.69

9.8

6.1

0.86

1.25

mmol/l

1.20

345

1615

Other other unspecified disorders of the circulatory system

288

1308

2.53

38.67

9.1

8.0

1.23

1.21

mmol/l

0.03

231

1004

Secondary parkinsonism, excluding more controls

193

724

3.08

38.55

5.0

7.4

2.31

0.80

mmol/l

3.91

153

559

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2802

14957

1.33

38.54

6.2

6.9

0.89

1.29

mmol/l

6.19

2197

11652

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

244

1019

2.65

38.40

12.8

8.9

0.70

1.12

mmol/l

0.78

192

806

Malignant neoplasm of rectum

670

4031

1.81

38.39

7.8

7.0

1.19

1.09

mmol/l

0.29

562

3108

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2835

15136

1.33

38.13

6.2

7.0

0.87

1.28

mmol/l

6.80

2219

11805

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

715

3893

1.72

38.12

9.3

8.5

0.67

0.45

mmol/l

0.70

544

2897

Agranulocytosis

676

4061

1.79

38.10

9.1

7.5

1.67

1.09

mmol/l

4.23

543

3162

Oxicams

1711

6965

1.45

37.96

6.1

7.8

1.12

1.08

mmol/l

0.14

1310

5373

Bicuspidal aortic valve syndrome

269

1193

2.58

37.95

16.7

9.3

1.09

0.99

mmol/l

0.15

234

949

Alcohol-induced acute pancreatitis

291

1341

2.50

37.89

14.6

8.6

0.04

1.07

mmol/l

2.50

242

1061

Laparoscopic left hemicolectomy

169

611

3.51

37.85

10.3

7.9

-0.46

1.29

mmol/l

7.28

156

485

Benign neoplasm: Small intestine

285

1299

2.50

37.77

7.4

6.3

1.02

1.29

mmol/l

0.55

232

1005

Use of biperiden

371

1866

2.21

37.62

6.5

8.4

2.51

1.14

mmol/l

8.81

298

1464

Fibromyalgia

437

2300

2.02

37.42

7.3

6.9

1.50

1.01

mmol/l

2.29

347

1782

Necrotizing fasciitis

144

8.14

37.42

15.5

12.1

1.84

1.14

mmol/l

0.45

116

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

454

2432

2.00

37.31

7.3

1.16

1.24

mmol/l

0.19

365

1866

Other benign neoplasms of skin

1946

14178

1.39

37.30

6.3

6.9

1.11

1.25

mmol/l

0.85

1538

10982

Family history of malignant neoplasm

521

2905

1.90

37.23

7.1

6.5

0.91

1.13

mmol/l

0.85

423

2260

Dependence on enabling machines and devices, not elsewhere classified

117

339

4.39

36.99

22.4

6.8

-0.12

0.92

mmol/l

1.48

264

Polycystic ovarian syndrome, consortium definition

3457

16553

1.28

36.89

6.7

6.3

1.32

1.06

mmol/l

3.42

2729

12921

Cardiac murmurs and other cardiac sounds

455

2405

1.97

36.79

7.8

7.4

1.05

0.79

mmol/l

0.63

357

1847

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

533

3032

1.91

36.79

8.1

6.2

1.01

1.23

mmol/l

0.68

455

2310

Drug-induced adrenocortical insufficiency

153

527

3.56

36.64

8.5

9.4

1.58

1.11

mmol/l

0.96

130

430

Other/unspecified seropositive rheumatoid arthritis

1592

11523

1.44

36.64

7.1

6.8

1.27

1.13

mmol/l

0.71

1260

9062

Seropositive rheumatoid arthritis, wide

1608

11671

1.44

36.39

7.1

6.8

1.28

1.13

mmol/l

0.77

1275

9168

Methotrexate

824

5234

1.65

36.35

8.1

6.8

1.19

0.92

mmol/l

1.13

656

4090

Dental operations, only avohilmo

4839

20420

1.24

36.33

7.1

7.3

1.06

1.01

mmol/l

0.35

3778

15963

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1563

11304

1.44

36.17

7.1

6.8

1.29

1.13

mmol/l

0.82

1239

8890

Open wound of abdomen, lower back and pelvis

214

870

2.78

36.16

9.0

0.80

1.06

mmol/l

0.33

167

681

Polyuria

1381

9794

1.48

36.11

6.8

7.2

1.10

1.07

mmol/l

0.09

1117

7577

Dipeptidyl peptidase 4 (DPP-4) inhibitors

773

4890

1.70

35.91

8.7

6.9

1.17

1.19

mmol/l

0.04

608

3837

Primary gonarthrosis, bilateral

3197

22324

1.29

35.85

6.3

7.1

1.16

1.09

mmol/l

0.49

2537

17655

Alzheimer disease, excluding more controls

1086

4852

1.57

35.80

4.2

6.0

1.32

0.87

mmol/l

2.70

823

3770

Malignant neoplasm of other and unspecified female genital organs

135

445

3.94

35.65

5.7

6.4

0.69

1.47

mmol/l

1.70

120

359

Type 1 diabetes, strict definition

349

1714

2.13

35.59

9.6

7.3

-0.69

0.73

mmol/l

4.43

257

1312

Injury of unspecified body region

475

2636

1.96

35.52

10.3

7.6

0.78

1.06

mmol/l

0.77

405

2049

Infective dermatitis

713

4419

1.72

35.46

7.5

7.2

1.34

1.06

mmol/l

1.14

545

3427

Benign lipomatous neoplasm

1521

10962

1.44

35.40

6.6

7.1

1.04

1.25

mmol/l

1.42

1208

8551

Other maltreatment syndromes

206

828

2.78

35.33

8.2

8.9

0.47

1.11

mmol/l

1.03

161

664

Open wound of ankle and foot

599

3549

1.80

35.27

8.9

8.0

0.98

0.96

mmol/l

0.03

502

2749

Degeneration of macula and posterior pole

3010

19710

1.30

35.23

6.0

6.5

1.03

1.16

mmol/l

0.96

2335

15476

Filling of root of tooth

224

946

2.71

35.22

8.9

8.6

0.88

1.04

mmol/l

0.20

179

758

Cystic kidney disease

237

1029

2.63

35.07

7.7

8.5

-1.00

1.14

mmol/l

10.13

188

821

!Aliquae complicationes praecoces traumatis

292

1379

2.37

35.06

8.3

8.5

1.23

1.20

mmol/l

0.04

233

1089

Early complications of trauma

292

1379

2.37

35.06

8.3

8.5

1.23

1.20

mmol/l

0.04

233

1089

Rheumatoid arthritis, including avohilmo

2238

17154

1.35

34.96

7.0

6.8

1.28

1.12

mmol/l

1.22

1774

13513

Osteonecrosis

394

2081

2.10

34.91

10.0

7.6

1.19

1.10

mmol/l

0.18

329

1641

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

334

1670

2.25

34.85

6.9

6.1

1.24

1.30

mmol/l

0.09

282

1277

Anaemia in chronic diseases classified elsewhere

204

838

2.90

34.83

11.0

8.7

-0.26

1.24

mmol/l

4.67

144

652

Other diseases of oesophagus

632

3826

1.77

34.71

7.8

6.8

1.41

1.08

mmol/l

1.07

520

2949

Non-follicular lymphoma, hilmo, excluding all cancers

576

3405

1.82

34.67

9.2

6.8

1.50

1.22

mmol/l

0.86

450

2618

Allergic bronchopulmonary aspergillosis (ABPA)

11.37

34.64

5.6

9.3

2.19

0.66

mmol/l

1.21

Migraine with aura and triptan purchases

643

3867

1.73

34.63

6.2

7.5

1.02

0.86

mmol/l

0.54

481

2981

Other diseases of hard tissues of teeth

3654

22029

1.26

34.61

8.4

7.2

0.95

1.03

mmol/l

0.64

2927

17318

Amputation of thigh

240

1061

2.63

34.60

11.8

6.0

1.24

1.25

mmol/l

0.01

198

807

Assault by sharp object

135

442

3.60

34.56

8.7

10.2

0.70

1.19

mmol/l

0.48

355

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

290

1378

2.36

34.44

7.8

7.3

0.44

1.22

mmol/l

2.29

239

1064

Pleural plaque

694

4335

1.74

34.42

5.9

6.4

1.74

0.83

mmol/l

6.75

549

3239

Heartburn

574

3376

1.80

34.42

7.1

7.0

1.14

1.03

mmol/l

0.33

465

2615

Adverse effects, not elsewhere classified

986

6586

1.56

34.39

8.4

7.3

0.77

0.92

mmol/l

0.55

792

5094

Persons encountering health services in other circumstances

2046

15480

1.36

34.30

7.0

1.19

1.05

mmol/l

0.79

1640

11913

Other arterial embolism and thrombosis

226

976

2.67

34.06

14.0

6.1

0.96

1.43

mmol/l

0.88

181

762

Motor neuron disease (with DMD)

151

534

3.33

33.94

5.5

7.1

4.02

0.80

mmol/l

17.69

131

417

Artificial joint operation, meniscal resection

5835

32904

1.20

33.80

6.6

7.5

1.13

1.07

mmol/l

0.57

4661

26028

Benign neoplasm: Stomach

626

3825

1.77

33.52

7.7

6.9

1.37

1.15

mmol/l

0.77

513

2985

Motor neuron disease

148

522

3.35

33.51

5.5

7.1

4.08

0.79

mmol/l

18.11

128

407

Dental caries 2 and operation codes, only avohilmo

2743

21548

0.77

33.49

7.3

7.7

0.82

1.07

mmol/l

2.83

2196

16942

Behavioural disorders, excluding more controls

109

311

3.85

33.42

9.3

7.3

1.30

0.29

mmol/l

1.89

241

Hypothyroidism, strict autoimmune

4293

23410

1.24

33.39

7.1

6.8

1.12

1.00

mmol/l

1.09

3347

18311

Orchitis and epididymitis

625

3819

1.76

33.24

9.5

8.5

1.11

0.87

mmol/l

0.69

474

2973

Immunodeficiencies

308

1513

2.25

33.16

13.4

8.3

1.24

1.11

mmol/l

0.22

245

1165

Superficial injury of abdomen, lower back and pelvis

808

5221

1.62

33.08

7.1

1.11

0.93

mmol/l

0.59

644

3994

Abnormal results of function studies

499

2865

1.87

33.02

9.0

7.5

1.21

0.97

mmol/l

0.64

394

2220

Sarcoidosis

804

5219

1.63

32.89

9.7

7.4

1.17

1.08

mmol/l

0.28

638

4080

Carcinoma in situ of other and unspecified digestive organs

197

819

2.84

32.73

9.8

6.8

0.45

1.27

mmol/l

1.93

164

637

Other necrotizing vasculopathies (FG)

395

2128

2.03

32.71

8.8

7.3

0.99

1.11

mmol/l

0.24

319

1658

Congenital malformations and deformations of the musculoskeletal system

415

2232

1.95

32.65

8.4

9.0

1.08

0.76

mmol/l

0.94

335

1709

Eating disorder

337

1688

2.08

32.63

7.3

7.6

0.84

0.52

mmol/l

0.58

270

1217

Other disorders involving the immune mechanism, not elsewhere classified

224

981

2.60

32.51

10.3

9.2

-0.23

1.07

mmol/l

4.16

180

779

Volvulus

208

884

2.71

32.50

8.8

6.6

1.61

1.22

mmol/l

0.75

171

688

Lesion of lateral popliteal nerve

338

1736

2.15

32.41

10.1

8.4

1.67

1.08

mmol/l

1.63

257

1352

Benign neoplasm: Spinal cord

120

384

3.80

32.34

8.6

9.0

1.53

1.42

mmol/l

0.13

301

Left bundle-branch block

401

2166

1.99

32.33

6.9

6.3

0.27

0.91

mmol/l

2.11

349

1664

Other and unspecified abdominal hernia

292

1430

2.30

32.22

8.7

7.7

1.30

1.27

mmol/l

0.03

242

1115

Malignant neoplasm of bronchus and lung

1236

8210

1.48

32.08

7.0

6.3

1.58

1.05

mmol/l

5.81

1039

6227

Hypothyroidism, other/unspecified

5334

29724

1.20

31.93

7.2

7.1

1.10

1.00

mmol/l

1.15

4156

23238

Mental retardation, excluding more controls

205

841

2.61

31.92

9.5

9.0

2.11

0.88

mmol/l

3.20

166

678

Surgical ablation of atrial fibrillation

187

6.33

31.87

12.3

9.0

1.30

1.11

mmol/l

0.16

152

Disorders of the thyroid gland

5761

31996

1.20

31.86

7.3

7.2

1.05

0.99

mmol/l

0.59

4490

25038

Oter anti-inflammatory and antirheumatic agents, non-steroids

1629

6614

1.42

31.79

6.4

7.7

1.20

1.10

mmol/l

0.41

1271

5117

Amputation of ankle bones

189

783

2.87

31.78

13.1

7.4

1.12

1.30

mmol/l

0.22

155

598

Ovarian cyst

1836

7897

1.38

31.74

6.4

6.7

1.11

1.07

mmol/l

0.19

1429

6190

Hypothyreosis and Thyroxine purchase for inclusion criteria

5496

30716

1.20

31.74

7.2

7.1

1.10

1.00

mmol/l

1.08

4284

24041

Chronic sinusitis

2381

18599

1.31

31.65

7.5

7.3

1.07

0.98

mmol/l

0.46

1871

14654

Dissection of aorta

250

1166

2.45

31.54

18.3

6.1

1.47

1.24

mmol/l

0.50

210

906

Pyogenic arthritis

440

2474

1.92

31.53

7.4

7.6

1.02

1.16

mmol/l

0.28

349

1924

Embolic stroke with flimmer

195

814

2.74

31.45

6.4

5.9

1.31

1.23

mmol/l

0.09

156

618

Heart failure and hypertrophic cardiomyopathy

165

650

3.15

31.36

15.8

7.8

0.25

1.23

mmol/l

2.24

130

511

Artificial joint re-operation

473

2744

1.90

31.27

6.7

6.6

1.46

1.22

mmol/l

0.73

385

2152

Infection of intervertebral disc (pyogenic)

125

424

3.74

31.26

10.1

7.9

0.81

1.36

mmol/l

0.69

100

338

Abscess of anal and rectal regions

495

2879

1.83

31.12

8.8

7.7

0.55

0.98

mmol/l

1.41

388

2238

Immunodeficiency with predominantly antibody defects

179

721

2.82

31.00

15.9

8.8

1.00

1.27

mmol/l

0.33

142

575

Nonalcoholic fatty liver disease

527

3133

1.80

30.83

9.7

8.0

0.66

1.03

mmol/l

1.29

438

2464

Complications of cardiac and vascular prosthetic devices, implants and grafts

174

703

2.95

30.83

13.9

6.8

0.84

1.22

mmol/l

0.59

127

542

L01XE Protein kinase inhibitors

398

2205

2.00

30.79

6.5

7.2

1.33

1.08

mmol/l

0.60

305

1723

Malignant neoplasm of bladder

513

3049

1.83

30.77

8.5

6.6

-0.15

1.08

mmol/l

7.92

411

2302

Other eating disorders

206

872

2.50

30.62

7.9

8.6

0.67

0.52

mmol/l

0.16

168

620

Sequelae of injuries of neck and trunk

213

937

2.58

30.56

11.4

8.7

2.21

1.11

mmol/l

3.77

172

747

Presence of other functional implants

3466

20036

1.25

30.47

6.2

6.4

1.19

1.12

mmol/l

0.42

2666

15882

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

148

551

3.16

30.43

9.8

8.4

1.35

1.43

mmol/l

0.09

118

427

Meniscus derangement

3445

19204

1.25

30.43

6.6

7.8

1.04

1.09

mmol/l

0.33

2750

15133

Mixed disorders of conduct and emotions, excluding more controls

262

3.89

30.42

10.5

6.2

0.17

-0.05

mmol/l

0.19

191

Corns and callosities

441

2513

1.90

30.41

7.1

7.7

1.53

1.16

mmol/l

1.16

333

1982

Inflammatory bowel disease

1705

12811

1.37

30.41

8.4

7.6

0.82

0.97

mmol/l

0.73

1311

9998

Postmenopausal osteoporosis with pathological fracture

392

2173

1.99

30.12

7.2

5.3

2.14

1.38

mmol/l

2.30

322

1696

Rheumatism, unspecified

754

4904

1.61

30.12

5.2

7.0

1.55

1.14

mmol/l

2.52

597

3917

Open wound of forearm

543

3273

1.77

30.11

6.6

7.5

0.87

1.01

mmol/l

0.33

424

2510

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

207

908

2.59

29.98

10.0

9.5

-0.26

1.09

mmol/l

4.11

167

719

Embolic stroke

343

1821

2.08

29.91

7.5

6.3

1.22

1.24

mmol/l

0.04

272

1369

Hypothermia

159

624

3.05

29.89

8.4

8.7

1.46

1.13

mmol/l

0.34

118

497

Agoraphobia

156

589

2.87

29.79

14.3

7.9

1.51

0.70

mmol/l

1.42

127

447

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

105

325

3.84

29.58

6.9

10.5

1.77

1.01

mmol/l

1.11

255

Memory loss

608

3813

1.72

29.56

5.9

6.8

0.86

1.15

mmol/l

0.81

488

2941

Other strabismus

1079

7532

1.48

29.56

9.4

7.5

1.20

0.94

mmol/l

1.43

835

5818

Budesonide

691

4420

1.64

29.55

7.4

7.1

0.51

0.91

mmol/l

1.48

529

3410

Ulcerative colitis

1330

9670

1.42

29.45

8.1

7.4

0.85

0.94

mmol/l

0.34

1011

7542

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

217

985

2.54

29.44

9.7

6.8

0.12

1.31

mmol/l

4.67

181

752

Obsessive-compulsive disorder

274

1327

2.17

29.43

8.6

7.5

1.28

0.75

mmol/l

1.51

213

990

Explicit fungal Sepsis

177

5.56

29.24

30.5

4.9

0.98

1.15

mmol/l

0.12

136

Paralytic strabismus

455

2650

1.86

29.22

8.0

7.3

1.28

1.12

mmol/l

0.38

354

2058

Atrial septal defect

227

1031

2.40

29.13

15.6

9.0

1.16

0.99

mmol/l

0.27

198

823

Diabetic retinopathy

2327

11573

1.33

29.10

9.7

8.2

0.82

0.98

mmol/l

0.79

1816

9002

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

201

887

2.61

29.02

9.6

6.7

1.53

1.40

mmol/l

0.21

171

690

Other necrotizing vasculopathies

463

2718

1.85

28.99

8.9

7.2

0.96

1.14

mmol/l

0.47

377

2121

Weight loss

579

3593

1.72

28.97

7.1

7.2

1.29

1.11

mmol/l

0.37

465

2809

Gonarthrosis, primary, with knee surgery

3526

23755

1.24

28.95

6.1

7.1

1.15

1.09

mmol/l

0.35

2799

18827

Benign neoplasm: Duodenum

191

827

2.69

28.94

8.2

6.3

1.08

1.30

mmol/l

0.37

157

635

Sequelae of injuries of lower limb

536

3254

1.75

28.85

8.8

7.8

1.05

1.04

mmol/l

0.03

433

2536

Diseases of male genital organs

3532

14604

1.25

28.83

8.1

8.8

1.04

0.85

mmol/l

1.87

2713

11612

Septal defects

335

1732

2.03

28.71

12.7

9.4

0.95

0.90

mmol/l

0.08

281

1364

Other noninfective disorders of lymphatic vessels and lymph nodes

236

1110

2.37

28.70

8.5

7.5

1.49

1.17

mmol/l

0.57

192

875

Conotruncal defects

280

3.95

28.58

18.6

12.3

1.06

0.48

mmol/l

0.70

228

Acute alcohol intoxication ICD-9

265

1310

2.27

28.57

6.9

7.7

1.68

1.05

mmol/l

1.44

216

1023

Abscess of lung

133

488

3.30

28.52

7.5

1.42

1.34

mmol/l

0.07

114

392

Maltreatment syndromes

254

1216

2.23

28.49

8.7

9.4

0.57

0.87

mmol/l

0.50

199

934

Non-small cell lung cancer, adenocarcinoma

440

2568

1.88

28.48

7.7

6.6

1.29

1.15

mmol/l

0.40

372

1975

Non-small cell lung cancer, adenocarcinoma, helper endpoint

440

2568

1.88

28.48

7.7

6.6

1.29

1.15

mmol/l

0.40

372

1975

Other congenital malformations of the digestive system

253

1211

2.26

28.38

9.7

9.3

0.30

0.95

mmol/l

1.71

197

956

Operations for atrial fibrillation

150

596

3.17

28.35

13.0

8.2

0.92

1.08

mmol/l

0.21

124

468

Unspecified jaundice

330

1756

2.05

28.34

10.0

6.9

0.49

1.15

mmol/l

1.75

255

1372

Congenital malformations of great arteries

131

459

3.16

28.34

26.2

10.2

0.49

0.50

mmol/l

0.01

114

360

Arthropathies in other diseases classified elsewhere

248

1196

2.31

28.32

10.4

9.1

0.82

1.11

mmol/l

0.41

212

938

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

213

973

2.50

28.27

8.5

6.6

0.40

1.30

mmol/l

2.78

170

758

Urticaria and erythema

1814

13886

1.34

28.22

7.3

1.16

0.98

mmol/l

1.24

1445

10834

Evidence of alcohol involvement determined by level of intoxication

250

4.20

28.22

11.3

11.4

1.47

0.99

mmol/l

0.46

195

Communicating hydrocephalus

175

738

2.78

28.16

9.0

8.1

1.63

1.26

mmol/l

0.79

135

591

Evidence of alcohol involvement determined by blood alcohol level

121

421

3.39

28.11

9.3

9.2

1.17

1.12

mmol/l

0.04

333

Cramp and spasm

292

1496

2.14

28.11

6.0

9.2

0.66

1.05

mmol/l

0.91

238

1163

Ptosis of eyelid

679

4415

1.64

28.10

7.9

7.1

1.18

1.19

mmol/l

0.02

545

3429

Emotional disorders starting during childhood or adolecense, excluding more controls

147

536

2.81

28.10

8.8

8.0

0.37

0.10

mmol/l

0.31

110

382

5-aminosalicylic acid

1071

7559

1.46

28.01

8.5

7.5

0.76

0.81

mmol/l

0.14

830

5855

Asthma mixed form (mode), excluding more controls

257

1241

2.19

28.00

5.3

5.6

1.77

0.44

mmol/l

6.95

203

945

Nephrotic syndrome

220

1019

2.43

27.97

11.0

9.3

-0.25

1.11

mmol/l

3.79

170

810

Other symptoms and signs involving the urinary system

639

4097

1.66

27.89

7.7

7.5

1.15

1.04

mmol/l

0.32

504

3157

Disorders of speech understanding and production

221

994

2.36

27.85

10.4

8.1

0.89

0.77

mmol/l

0.15

159

786

Recurring oral aphthae

294

1517

2.13

27.76

8.8

8.2

1.05

1.11

mmol/l

0.09

237

1201

Melanocytic naevi of trunk

565

3500

1.69

27.72

7.1

7.2

0.82

1.09

mmol/l

0.71

449

2654

Other obstructive and reflux uropathy

254

1236

2.23

27.71

7.2

6.8

0.73

1.11

mmol/l

0.77

182

939

Problems related to social environment

188

813

2.57

27.71

6.1

7.2

2.53

1.20

mmol/l

3.12

137

630

Eating disorders

433

2484

1.81

27.68

6.8

7.6

1.19

0.74

mmol/l

1.17

347

1842

Other diseases of spinal cord

211

966

2.46

27.58

8.7

8.9

2.19

1.29

mmol/l

2.80

171

751

Overexertion and strenuous or repetitive movements

563

3502

1.70

27.56

9.1

7.9

0.53

1.02

mmol/l

2.00

467

2726

Speech therapy

1553

11714

1.37

27.56

7.7

7.1

1.03

1.11

mmol/l

0.29

1249

9186

Retinal vascular occlusion

774

5201

1.58

27.52

6.9

6.4

0.97

1.13

mmol/l

0.44

595

4010

Progressive vascular leukoencephalopathy

253

1258

2.30

27.37

4.3

5.3

0.30

1.44

mmol/l

3.23

217

947

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

214

992

2.45

27.37

5.7

6.6

0.11

1.28

mmol/l

3.17

165

770

Thrombocytopenia, unspecified

438

2570

1.84

27.34

9.7

7.6

0.94

1.08

mmol/l

0.29

341

2006

Exposure to unspecified smoke, fire and flames

274

4.16

27.32

5.7

9.3

1.09

0.93

mmol/l

0.15

218

Other diseases of stomach and duodenum

404

2317

1.89

27.28

9.4

6.9

0.62

1.11

mmol/l

1.44

325

1820

Right bundle-branch block

222

1038

2.36

27.15

11.0

6.6

1.16

0.95

mmol/l

0.26

181

794

Sequelae of injuries of head

331

1789

2.01

27.10

11.7

8.5

1.06

1.08

mmol/l

0.03

251

1420

Car occupant injured in other and unspecified transport accidents

940

6524

1.49

27.09

7.7

7.4

1.24

0.92

mmol/l

1.41

702

5016

Post-traumatic wound infection, not elsewhere classified

183

796

2.61

27.06

7.2

8.1

1.01

1.15

mmol/l

0.14

149

632

Multiple myeloma and malignant plasma cell neoplasms

305

1614

2.09

27.04

6.9

6.3

0.71

1.29

mmol/l

1.21

229

1226

Childhood asthma (age<16), excluding more controls

410

1818

1.83

27.03

9.8

6.3

0.30

-0.10

mmol/l

1.25

312

1312

Other fall from one level to another

1193

8648

1.43

27.00

8.8

7.8

1.26

0.89

mmol/l

2.30

949

6687

Ulcerative colitis, NAS

743

4934

1.57

26.99

8.8

7.6

0.79

0.95

mmol/l

0.49

566

3851

Irregular menses

1968

12366

1.32

26.82

6.9

6.7

1.03

0.98

mmol/l

0.19

1530

9603

Coxarthrosis, primary, with hip surgery

2903

22492

1.26

26.79

6.2

6.9

1.12

mmol/l

0.00

2320

17731

Other inflammatory liver diseases

401

2305

1.88

26.77

9.6

7.7

0.98

1.08

mmol/l

0.16

305

1806

Gangrene, not elsewhere classified

221

4.67

26.77

8.7

6.8

0.57

1.20

mmol/l

0.65

171

Other disorders of optic [2nd] nerve and visual pathways

380

2151

1.91

26.76

9.1

8.0

0.96

1.13

mmol/l

0.33

274

1670

Other coagulation defects

400

2291

1.87

26.73

10.5

7.7

0.60

1.04

mmol/l

1.16

328

1766

Irritable bowel syndrome

1334

9846

1.39

26.66

6.5

6.7

1.09

1.08

mmol/l

0.04

1076

7674

Retinal vascular disorders

782

5300

1.57

26.61

7.0

6.4

1.00

1.13

mmol/l

0.34

602

4088

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

731

4881

1.59

26.49

6.1

5.7

0.88

1.37

mmol/l

2.59

551

3712

Other infectious diseases

490

2986

1.76

26.44

9.5

7.2

0.89

1.07

mmol/l

0.36

383

2317

Cluster headache, wide

217

1012

2.33

26.40

7.9

8.3

1.25

1.05

mmol/l

0.35

165

793

Drug-induced neutropenia

429

2528

1.83

26.38

8.5

7.8

1.87

1.10

mmol/l

4.40

339

1980

Other and unspecified visual disturbances

534

3320

1.71

26.37

7.2

7.4

1.14

1.17

mmol/l

0.09

411

2576

Specific development disorders of speech and language

279

1366

2.09

26.37

8.9

9.1

0.81

0.73

mmol/l

0.11

205

1058

Benign neoplasm of middle ear and respiratory system

451

2688

1.79

26.25

7.6

7.1

1.39

1.17

mmol/l

0.61

363

2047

Discitis, unspecified

138

539

3.06

26.23

9.9

7.3

1.27

1.31

mmol/l

0.05

116

429

Benign neoplasm of ovary

787

5314

1.54

26.20

6.1

1.21

1.46

mmol/l

1.01

617

4178

Disorders of sclera, cornea, iris and ciliary body

2997

24581

1.25

26.17

7.3

1.06

1.03

mmol/l

0.19

2328

19389

Cluster headache, strict

198

893

2.41

26.13

8.5

8.6

1.12

1.04

mmol/l

0.11

152

701

Benign neoplasm: Small intestine

285

1500

2.13

26.05

7.4

7.5

1.02

1.18

mmol/l

0.28

232

1164

Intestinal malabsorption

277

1430

2.12

26.02

10.7

7.8

0.32

1.08

mmol/l

1.62

219

1127

Multiple myeloma, excluding all cancers (controls excluding all cancers)

304

1629

2.06

25.95

7.0

6.2

0.72

1.29

mmol/l

1.17

228

1233

Abnormal findings on examination of urine, without diagnosis

288

1513

2.09

25.94

8.5

7.8

0.35

1.09

mmol/l

1.69

214

1167

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

275

4.12

25.90

9.3

5.2

0.92

1.66

mmol/l

0.99

218

Type1 diabetes, definitions combined, early onset

272

1371

2.07

25.89

10.6

9.2

-0.48

0.67

mmol/l

3.01

204

1050

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

384

2191

1.86

25.86

7.5

7.4

1.22

1.27

mmol/l

0.08

308

1680

Excessive, frequent and irregular menstruation

1901

8135

1.33

25.82

6.8

6.6

1.19

1.05

mmol/l

0.72

1446

6349

Childhood asthma (age<16)

410

1845

1.80

25.80

9.8

6.8

0.30

-0.08

mmol/l

1.16

312

1337

Barrett oesophagus

328

1808

2.00

25.76

9.9

7.9

0.72

1.05

mmol/l

0.71

272

1425

Pruritus

581

3699

1.65

25.71

7.9

6.8

1.01

1.07

mmol/l

0.12

454

2858

Haemorrhoids and perianal venous thrombosis

1666

12791

1.34

25.69

6.0

6.5

1.01

1.11

mmol/l

0.50

1315

9947

Primary coxarthrosis, bilateral

1751

13586

1.34

25.68

6.7

1.14

mmol/l

0.00

1408

10681

Benign neoplasm of urinary organs

278

1450

2.10

25.44

6.3

0.46

1.21

mmol/l

2.84

222

1109

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

105

366

3.69

25.36

10.2

7.1

-1.06

1.45

mmol/l

9.98

281

Other misadventures during surgical and medical care

161

685

2.73

25.35

10.0

7.5

1.07

1.25

mmol/l

0.17

132

544

In situ neoplasms

2014

15892

1.30

25.33

6.6

6.4

0.77

1.12

mmol/l

3.60

1616

12383

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

331

1820

1.94

25.27

7.9

7.6

1.22

1.33

mmol/l

0.21

266

1393

Non-allergic asthma

528

3309

1.69

25.21

7.3

7.6

1.39

1.09

mmol/l

1.07

421

2552

Other/unspecified rheumatoid arthritis

749

5081

1.55

25.10

6.9

6.5

1.40

1.21

mmol/l

0.68

578

3947

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

164

707

2.69

25.10

9.5

6.6

1.53

1.52

mmol/l

0.01

139

546

Exposure to smoke, fire and flames

179

798

2.54

25.07

7.3

8.8

1.39

1.06

mmol/l

0.47

139

628

1836

12718

1.33

24.99

5.4

5.9

1.18

1.16

mmol/l

0.07

1395

9855

Hypertrophic cardiomyopathy

287

1534

2.09

24.98

12.9

8.2

0.17

1.06

mmol/l

2.92

229

1193

Benign neoplasm: Spinal cord

120

447

3.22

24.98

8.6

10.3

1.53

1.27

mmol/l

0.36

361

Collagenous colitis

506

3151

1.71

24.93

8.3

7.1

0.65

1.14

mmol/l

1.58

396

2472

Benign neoplasm: Kidney

217

1047

2.31

24.88

6.3

6.1

0.51

1.33

mmol/l

2.82

174

815

Respiratory disorders in diseases classified elsewhere

118

438

3.26

24.83

12.1

8.3

1.56

1.29

mmol/l

0.31

101

356

Voice disturbances

1419

10720

1.37

24.81

7.9

6.9

1.01

1.09

mmol/l

0.35

1154

8400

Poisoning by medicine, drug-induced

108

379

3.36

24.78

6.1

8.5

1.42

1.09

mmol/l

0.33

303

Benign neoplasm: Descending colon

445

2708

1.79

24.75

7.0

7.2

0.93

1.10

mmol/l

0.37

338

2114

D07AA Corticosteroids, weak (group I)

737

4960

1.54

24.72

7.1

7.7

1.36

0.88

mmol/l

2.09

574

3778

Obstructive hydrocephalus

120

447

3.15

24.70

10.8

8.9

1.61

1.22

mmol/l

0.48

359

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1992

9543

1.32

24.70

7.0

8.1

0.50

1.08

mmol/l

8.42

1544

7421

Vitamin deficiency, wide

288

1536

2.03

24.52

9.5

7.6

1.06

1.04

mmol/l

0.03

230

1173

Vitamin deficiency

288

1536

2.03

24.52

9.5

7.6

1.06

1.04

mmol/l

0.03

230

1173

Sequelae of intentional self-harm, assault and events of undetermined intent

140

5.24

24.40

10.0

10.2

1.62

1.34

mmol/l

0.20

106

Localized swelling, mass and lump of skin and subcutaneous tissue

1715

13324

1.32

24.35

7.1

7.3

1.07

1.06

mmol/l

0.05

1374

10428

Cyst of kidney

444

2709

1.78

24.32

8.7

7.4

0.72

1.13

mmol/l

1.27

362

2121

Olecranon bursitis

405

2407

1.82

24.27

9.3

8.5

1.19

1.01

mmol/l

0.42

330

1898

Specific development disorders of scholastic skills

168

713

2.46

24.26

11.5

9.5

0.57

0.42

mmol/l

0.15

124

549

Brachial plexus disorders

445

2685

1.74

24.23

4.8

8.1

1.30

0.93

mmol/l

1.64

332

2091

Dental pulpitis 3

375

1517

1.82

24.02

7.3

8.7

-0.08

mmol/l

0.00

269

1067

Follicular cysts of skin and subcutaneous tissue

1007

7258

1.44

23.95

7.5

1.00

1.02

mmol/l

0.03

811

5655

Drug-induced hypoglycaemia without coma

133

532

2.93

23.95

9.5

7.6

0.79

1.19

mmol/l

0.34

108

416

Abnormal weight loss

522

3316

1.68

23.88

7.4

7.3

1.21

1.11

mmol/l

0.16

417

2595

Open wound of hip and thigh

196

918

2.34

23.88

10.2

9.0

0.80

1.03

mmol/l

0.32

168

728

Endometroid carcinoma of ovary

290

3.89

23.86

9.3

5.6

0.92

1.51

mmol/l

0.74

240

Other enthesopathies

1573

12102

1.33

23.81

6.7

7.6

0.84

1.02

mmol/l

1.19

1249

9566

Benign neoplasm of mouth and pharynx

562

3617

1.63

23.79

7.0

7.1

1.01

1.23

mmol/l

0.62

450

2767

Alzheimer’s disease (Atypical or mixed), excluding more controls

470

2499

1.73

23.78

3.6

5.7

1.41

0.96

mmol/l

1.36

332

1874

Causalgia

116

430

3.08

23.76

7.0

10.1

2.15

1.24

mmol/l

1.84

341

Hyperosmolality and hypernatraemia

111

409

3.25

23.58

8.3

6.3

1.49

1.45

mmol/l

0.03

305

Cardiomyopathy, Hypertrophic obstructive

131

521

2.87

23.49

15.0

6.3

0.05

1.07

mmol/l

1.97

109

394

Amenorrhoea

270

1410

2.00

23.49

9.1

7.0

0.60

0.72

mmol/l

0.16

218

1067

Other bursopathies

753

5178

1.52

23.38

7.3

7.5

1.29

1.14

mmol/l

0.45

603

4068

Impingement syndrome of shoulder

1403

10678

1.36

23.34

7.1

7.9

1.15

0.98

mmol/l

1.03

1094

8509

Spondyloarthritis

982

7066

1.44

23.31

6.9

7.0

1.00

1.02

mmol/l

0.04

762

5452

Hyperplasia of prostate

2559

11864

1.27

23.25

7.1

8.4

1.03

0.85

mmol/l

1.39

1957

9413

Hemiplegia

316

1766

1.93

23.20

9.0

7.6

1.12

1.17

mmol/l

0.07

257

1358

Bulimia nervosa (incl. atypical)

136

542

2.66

23.18

6.9

9.3

0.45

0.47

mmol/l

0.01

108

379

Speech disturbances, not elsewhere classified

522

3341

1.67

23.12

8.1

6.9

1.39

1.13

mmol/l

0.78

415

2576

Diffuse brain injury

204

979

2.24

23.02

13.4

7.9

1.56

0.92

mmol/l

1.35

158

748

Haemolytic anaemias

226

1140

2.20

23.01

10.9

8.1

0.97

1.28

mmol/l

0.55

180

893

Alcoholic gastritis

128

514

2.94

22.97

9.7

8.2

0.69

0.94

mmol/l

0.25

109

408

Other and unspecified tonsillitis

1502

9734

1.33

22.96

8.4

8.5

0.83

0.73

mmol/l

0.46

1159

7549

Other congenital malformations

406

2425

1.76

22.94

10.3

8.4

0.39

0.94

mmol/l

1.54

325

1886

Conjunctivitis (acute, non atopic)

1382

10464

1.35

22.94

7.0

7.5

1.07

0.96

mmol/l

0.52

1100

8150

Fracture at wrist and hand level

1787

14037

1.30

22.92

7.8

7.9

1.04

0.97

mmol/l

0.32

1413

11010

Disorders of optic nerve and visual pathways

494

3113

1.67

22.92

8.3

7.8

0.85

1.00

mmol/l

0.32

356

2424

Trigeminal neuralgia

337

1926

1.88

22.89

6.1

7.9

1.00

1.21

mmol/l

0.49

268

1502

Spondylopathies in diseases classified elsewhere

104

379

3.34

22.74

7.8

7.2

1.27

1.42

mmol/l

0.11

303

Drug-induced osteoporosis with pathological fracture

125

502

2.98

22.62

10.3

6.0

2.04

1.35

mmol/l

0.81

103

400

Conduct disorder

111

407

2.97

22.61

9.1

9.5

1.31

0.54

mmol/l

1.32

332

Monoamine oxidase A inhibitors

652

4382

1.56

22.58

7.1

7.4

1.20

0.99

mmol/l

0.72

558

3394

ILD and respiratory illness in diseases classified elsewhere

168

5.24

22.56

10.0

7.0

1.72

1.12

mmol/l

0.49

138

Coxibs

1798

7448

1.31

22.56

6.2

7.8

0.91

1.04

mmol/l

0.65

1364

5705

Congenital malformations of cardiac chambers and connections

110

5.55

22.54

29.9

18.0

0.09

0.24

mmol/l

0.08

Unspecified event, undetermined intent

159

702

2.52

22.52

8.4

9.2

1.02

0.96

mmol/l

0.07

133

564

Abnormal findings on diagnostic imaging of central nervous system

251

1315

2.06

22.50

8.3

8.4

0.80

1.00

mmol/l

0.31

194

1026

Other skin changes

958

6939

1.44

22.40

7.0

1.42

1.11

mmol/l

1.72

760

5348

Carcinoma in situ of colon

120

480

3.07

22.20

10.5

6.4

0.32

1.43

mmol/l

1.93

102

378

Diabetic neuropathy

786

5526

1.52

22.19

9.0

8.8

0.57

0.88

mmol/l

1.00

615

4264

Migraine without aura and triptan purchases

606

4000

1.56

22.15

6.7

7.3

0.81

mmol/l

0.01

463

3078

Xerosis cutis

124

501

2.95

22.14

6.4

8.3

1.71

1.40

mmol/l

0.45

396

Malignant neoplasm of head and neck

522

3382

1.65

22.14

9.6

7.3

1.64

1.11

mmol/l

2.50

427

2618

Other intracranial haemorrhages

225

1156

2.18

22.07

8.5

6.8

1.24

1.30

mmol/l

0.09

174

877

Other congenital malformations of heart

147

4.85

22.04

24.3

11.3

0.37

0.48

mmol/l

0.10

115

Car occupant injured in noncollision transport accident

212

1055

2.18

22.00

9.6

9.1

1.28

1.11

mmol/l

0.20

162

824

Carcinoma in situ of other and unspecified digestive organs

197

974

2.34

21.96

9.8

8.1

0.45

1.21

mmol/l

1.71

164

768

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1871

12948

1.29

21.96

6.4

6.9

1.05

mmol/l

0.00

1442

10187

Other diseases of jaws

380

2270

1.78

21.86

9.1

7.1

1.17

1.08

mmol/l

0.15

309

1729

Adult respiratory distress syndrome

107

403

3.17

21.86

20.9

9.5

2.38

1.19

mmol/l

1.77

325

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

929

4269

1.44

21.82

6.3

6.7

0.05

0.60

mmol/l

3.69

647

3090

Other benign neoplasms of connective and other soft tissue

482

3052

1.66

21.82

7.2

7.4

0.94

1.23

mmol/l

0.79

377

2324

Prophylactic surgery

143

4.79

21.78

7.1

5.9

-0.38

0.62

mmol/l

1.67

119

Inflammatory diseases of female pelvic organs

2742

17026

1.23

21.77

6.7

6.4

1.15

1.10

mmol/l

0.29

2144

13367

Malignant neoplasm of mesothelium and soft tissue

296

1668

1.96

21.75

7.6

7.5

0.71

1.18

mmol/l

1.14

244

1281

Other specified/unspecified systemic involvement of connective tissue

331

1912

1.86

21.71

7.9

7.4

1.18

1.12

mmol/l

0.10

266

1492

Papulosquamous disorders

2171

17585

1.27

21.71

7.6

7.3

1.20

1.02

mmol/l

1.23

1737

13847

Other follicular disorders

363

2144

1.79

21.69

7.9

8.2

1.17

0.98

mmol/l

0.38

286

1650

Enthesopathies of lower limb, excluding foot

1097

8127

1.39

21.67

7.0

7.8

1.08

0.90

mmol/l

0.82

876

6432

Early lumbar disc prolapse, operated

413

2509

1.71

21.65

7.6

9.3

1.06

0.65

mmol/l

1.32

313

1997

Vitamin B12 deficiency anaemia

650

4418

1.55

21.62

7.2

6.3

0.89

1.14

mmol/l

0.76

483

3398

Urticaria

1394

10685

1.34

21.61

7.3

1.10

0.96

mmol/l

0.73

1109

8304

TMD related operations

790

5546

1.48

21.61

7.5

7.8

1.33

0.94

mmol/l

2.68

588

4347

Other disorders of eye and adnexa

690

4728

1.52

21.60

7.4

7.3

0.85

1.02

mmol/l

0.49

539

3645

Other obstetric conditions, not elsewhere classified

959

4445

1.43

21.56

6.3

6.7

0.12

0.62

mmol/l

3.39

673

3234

Hidradenitis suppurativa

182

859

2.28

21.49

8.3

9.4

1.21

1.05

mmol/l

0.21

144

673

Left hemicolectomy

184

891

2.37

21.49

11.8

7.7

0.33

1.38

mmol/l

2.69

160

701

Complications of other internal prosthetic devices, implants and grafts

241

1272

2.08

21.45

7.6

6.4

0.97

1.12

mmol/l

0.22

188

980

Diseases of spleen

133

561

2.76

21.45

10.3

8.3

0.99

1.12

mmol/l

0.13

107

444

Suggestive for eosinophilic asthma

516

3346

1.63

21.42

6.7

7.7

1.30

0.92

mmol/l

1.50

387

2610

Fracture of forearm

2903

22652

1.22

21.40

7.6

7.0

1.14

1.10

mmol/l

0.23

2314

17824

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

16.78

21.38

4.9

7.2

0.28

1.77

mmol/l

1.03

Behavioural disorders

109

408

2.90

21.38

9.3

9.5

1.30

0.43

mmol/l

1.62

331

Impotence

365

2193

1.81

21.33

8.2

8.9

0.96

0.82

mmol/l

0.28

274

1720

Morphin

126

517

2.80

21.33

7.5

5.6

2.37

1.29

mmol/l

2.58

110

397

Erythema intertrigo

167

777

2.44

21.31

7.6

6.8

2.24

1.33

mmol/l

1.76

131

606

Secondary thrombocytopenia

104

393

3.19

21.25

11.9

7.9

1.67

1.21

mmol/l

0.46

318

157

5.31

21.23

10.5

7.2

1.62

1.15

mmol/l

0.35

131

Asthma mixed form (mode)

257

1374

1.97

21.15

5.3

5.9

1.77

0.48

mmol/l

6.56

203

1047

Exposure to other and unspecified inanimate mechanical forces

370

2217

1.77

21.11

7.8

8.4

1.03

1.06

mmol/l

0.06

302

1723

Hypoparathyroidism

229

1198

2.11

21.07

7.4

6.4

1.82

1.23

mmol/l

1.00

191

943

Benign neoplasm: Brain, infratentorial

135

5.05

21.07

7.1

11.1

0.65

1.49

mmol/l

0.79

109

Unknown and unspecified causes of morbidity

367

2187

1.76

21.05

5.0

7.3

0.90

1.04

mmol/l

0.31

299

1714

Dronedarone medication

186

904

2.29

21.02

6.8

6.2

0.90

0.85

mmol/l

0.05

147

710

Malignant neoplasm of oral cavity

240

1284

2.09

20.99

9.2

7.6

1.46

1.28

mmol/l

0.37

204

998

Seborrhoeic keratosis

1268

9686

1.36

20.91

5.7

6.7

1.13

1.15

mmol/l

0.04

983

7602

Other and unspecified coagulation defects

258

1397

1.98

20.88

10.4

8.4

0.23

1.10

mmol/l

2.46

212

1087

Congenital malformations of trachea and bronchus

286

3.63

20.82

11.1

7.9

2.07

1.26

mmol/l

1.47

238

Viral warts

497

3207

1.62

20.77

7.4

7.8

1.07

1.01

mmol/l

0.11

385

2483

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

268

1485

1.97

20.63

10.4

6.3

1.33

1.30

mmol/l

0.04

209

1137

Diffuse large B-cell lymphoma, helper endpoint

268

1485

1.97

20.63

10.4

6.3

1.33

1.30

mmol/l

0.04

209

1137

IgA nephropathy (IgA glomerulonephritis)

164

766

2.41

20.60

10.2

9.5

-0.81

1.05

mmol/l

5.72

138

608

Benign neoplasm: Duodenum

191

954

2.29

20.60

8.2

7.4

1.08

1.21

mmol/l

0.19

157

744

Persons with potential health hazards related to communicable diseases

1614

12562

1.30

20.59

10.4

7.6

0.50

0.81

mmol/l

2.58

1312

9605

Varicose veins

3737

24095

1.19

20.58

6.4

6.9

1.40

1.07

mmol/l

6.02

2947

18923

Gout due to impairment of renal function

369

3.33

20.56

7.0

7.6

-0.12

0.99

mmol/l

1.19

301

Injury of urinary and pelvic organs

143

631

2.56

20.54

9.2

9.6

1.18

1.08

mmol/l

0.11

113

494

Hyperfunction of pituitary gland

243

1295

2.00

20.44

8.2

8.3

1.18

1.10

mmol/l

0.11

192

1011

Hypersensitivity pneumonitis due to organic dust

129

550

2.73

20.38

6.2

7.9

1.09

1.23

mmol/l

0.16

104

438

Epidural haemorrhage

238

3.70

20.36

10.6

8.8

2.46

0.82

mmol/l

2.65

187

Lesion of radial nerve

232

1231

2.06

20.30

9.6

8.5

2.04

1.24

mmol/l

1.90

189

968

101

374

2.93

20.23

9.0

6.3

1.49

0.93

mmol/l

1.05

273

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

220

4.20

20.23

10.5

7.3

1.54

1.57

mmol/l

0.03

176

Benign neoplasm of major salivary glands

504

3291

1.61

20.18

9.1

6.8

1.40

1.23

mmol/l

0.42

393

2510

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

225

1188

2.09

20.17

6.0

6.2

0.23

1.30

mmol/l

3.72

175

909

Other epidermal thickening

260

1434

1.97

20.14

7.8

8.0

1.45

1.04

mmol/l

1.10

194

1120

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1626

12795

1.29

20.11

7.7

7.8

0.94

0.88

mmol/l

0.28

1313

9888

Pure hyperglyceridaemia

151

688

2.46

20.10

11.1

7.0

1.30

1.19

mmol/l

0.13

119

509

Mental retardation

205

1039

2.12

20.06

9.5

9.9

2.11

0.79

mmol/l

3.62

166

827

Flat foot [pes planus] (acquired)

487

3156

1.62

20.05

6.9

7.7

1.53

1.12

mmol/l

2.05

384

2510

Other disorders of veins

2054

16664

1.26

20.05

7.1

6.9

1.21

1.08

mmol/l

0.73

1701

13146

Dislocation, sprain and strain of joint and ligaments of hip

231

1233

2.06

20.03

7.1

7.2

1.54

1.20

mmol/l

0.73

183

963

Secondary parkinsonism+Parkinsonism in other disease

198

1008

2.20

19.97

5.0

7.9

2.33

1.19

mmol/l

2.65

157

785

Inflammatory disease of uterus

569

3798

1.55

19.95

6.6

6.4

0.85

0.93

mmol/l

0.19

452

2922

Papilloedema, unspecified

138

605

2.54

19.92

8.6

9.4

0.50

0.95

mmol/l

0.54

484

Manic episode

173

828

2.27

19.91

7.3

8.6

2.14

1.06

mmol/l

2.84

134

665

Pregnancy hypertension

1628

11560

1.29

19.89

6.3

6.9

1.02

mmol/l

0.00

1249

9023

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1920

9239

1.28

19.86

6.6

8.0

0.51

1.08

mmol/l

7.88

1480

7178

Encephalitis

179

874

2.26

19.83

10.1

8.7

1.33

1.04

mmol/l

0.37

138

688

Need for immunization against other single viral diseases

143

643

2.53

19.83

10.9

9.3

-0.87

1.13

mmol/l

4.91

121

517

Carbimazole or st.post thyroidectomy, condition for graves disease

995

7374

1.39

19.77

7.4

6.9

1.02

1.06

mmol/l

0.13

791

5792

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

102

397

3.10

19.76

9.3

5.7

-1.05

1.49

mmol/l

6.68

295

Trigger finger

743

5254

1.47

19.74

7.8

7.7

1.19

1.05

mmol/l

0.44

583

4138

Myocardial infarction, unclassifiable

1445

10076

1.32

19.72

7.6

6.2

0.98

1.07

mmol/l

0.35

1058

7681

Disorders of vestibular function (Vertigo)

2616

21669

1.23

19.64

5.8

6.9

1.23

1.09

mmol/l

1.16

2066

17142

Other disorders of central nervous system

314

3.27

19.62

7.0

8.8

0.49

1.38

mmol/l

0.86

252

Paraplegia, diplegia of upper limbs

155

723

2.42

19.60

8.9

7.8

1.61

1.11

mmol/l

0.65

123

562

Hallux valgus (acquired)

1813

10482

1.28

19.54

6.1

7.1

1.09

1.18

mmol/l

0.45

1449

8236

Crohn disease

640

4408

1.51

19.49

8.9

7.6

0.64

0.94

mmol/l

1.02

498

3431

Dental pulpitis 3, only avohilmo

333

1409

1.77

19.37

7.0

8.7

-0.17

-0.14

mmol/l

0.03

237

995

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

286

1623

1.84

19.29

8.4

7.2

1.07

0.87

mmol/l

0.43

224

1239

Mixed connective tissue disease

350

2121

1.76

19.29

8.2

7.5

1.11

1.12

mmol/l

0.02

279

1648

Other disorders of bone

984

7308

1.39

19.25

7.4

0.87

0.96

mmol/l

0.32

787

5680

358

3.11

19.24

8.4

8.7

1.34

1.26

mmol/l

0.06

293

Chronic tubulo-interstitial nephritis

220

1164

2.04

19.19

6.7

6.4

-0.05

1.20

mmol/l

3.21

168

919

Benign neoplasm of other and unspecified intrathoracic organs

326

3.26

19.18

11.0

6.1

1.36

1.54

mmol/l

0.16

258

Lichen simplex chronicus and prurigo

369

2277

1.73

19.08

8.0

7.2

0.83

1.08

mmol/l

0.52

285

1771

Cushing syndrome

320

3.24

19.08

9.3

6.6

0.87

1.16

mmol/l

0.26

257

Adenocarcinoma and Papillary adenocarcinoma of kidney

105

428

3.09

19.08

10.2

8.6

-1.06

1.26

mmol/l

9.37

331

Generalized epilepsy

217

1142

2.03

19.03

7.6

8.6

1.05

0.95

mmol/l

0.12

171

894

Preparation and fitting of bite rail to mouth

638

4412

1.50

19.02

7.1

8.0

1.29

0.93

mmol/l

1.88

471

3457

Other disorders starting during childhood or adolecense, excluding more controls

147

636

2.31

18.97

10.9

9.2

0.30

0.16

mmol/l

0.13

114

482

Other inflammation of eyelid

683

4801

1.48

18.93

6.4

7.4

1.03

1.11

mmol/l

0.19

525

3752

Acute suppurative otitis media

1037

7229

1.37

18.92

8.7

8.2

0.48

0.81

mmol/l

1.66

783

5475

Erosion of teeth

101

392

2.89

18.91

18.5

8.3

0.89

1.23

mmol/l

0.27

315

Correction of physiology of bite - demanding therapy visit

331

1984

1.76

18.73

7.3

7.9

1.52

1.03

mmol/l

2.21

238

1543

Secondary parkinsonism

193

997

2.17

18.73

5.0

7.9

2.31

1.20

mmol/l

2.44

153

778

Abnormal findings on antenatal screening of mother

249

1363

1.89

18.69

4.2

6.7

1.31

0.42

mmol/l

4.46

142

975

Other neurotic disorders

301

1771

1.83

18.68

6.2

7.7

1.08

1.11

mmol/l

0.04

246

1383

Mucosal proctocolitis

627

4340

1.50

18.64

8.2

7.8

0.44

0.90

mmol/l

1.84

490

3373

Fibroblastic disorders

1354

10582

1.32

18.61

7.7

7.3

0.98

1.01

mmol/l

0.13

1075

8297

Congenital malformations of the respiratory system

120

514

2.66

18.58

13.2

8.9

1.63

1.03

mmol/l

1.25

109

420

Respiratory conditions due to other external agents

147

690

2.43

18.53

7.2

7.0

1.67

1.33

mmol/l

0.50

126

542

Cauda equina syndrome

384

2.98

18.44

10.5

9.2

2.34

1.21

mmol/l

2.00

302

Mixed disorders of conduct and emotions

356

2.84

18.42

10.5

8.6

0.17

0.21

mmol/l

0.03

263

Cholangitis (primary sclerosing, PSC), with reimbursement 202

114

476

2.68

18.41

14.7

10.3

0.18

1.09

mmol/l

1.36

379

Mental retardation, wide definition

217

1156

2.01

18.41

9.2

9.9

2.03

0.88

mmol/l

3.10

175

926

Diabetic retinopathy, strict definition

1146

7741

1.36

18.39

11.6

8.4

0.69

0.89

mmol/l

0.76

889

6007

Small fibre neuropathy

188

970

2.18

18.36

13.4

7.7

1.11

1.16

mmol/l

0.05

149

759

Assault by unspecified means

119

505

2.60

18.36

10.3

10.4

0.24

1.14

mmol/l

1.20

407

Gestational [pregnancy-induced] hypertension

920

6775

1.38

18.31

6.0

6.7

1.07

0.90

mmol/l

0.68

690

5212

Benign neoplasm: Spinal meninges

307

3.28

18.25

5.0

5.5

0.48

1.55

mmol/l

1.62

241

Benign neoplasm: Parotid gland

405

2579

1.66

18.23

9.6

7.2

1.22

1.21

mmol/l

0.02

321

1982

Congenital malformations of the nervous system

117

493

2.59

18.21

7.8

10.5

0.64

0.85

mmol/l

0.20

382

Vitamin D deficiency

107

435

2.74

18.20

7.7

8.9

1.77

0.95

mmol/l

1.04

344

Acute appendicitis

3807

31029

1.17

18.18

7.7

7.6

1.01

0.98

mmol/l

0.14

3015

24356

Occupational exposure to risk-factors

219

1189

2.03

18.17

5.5

8.7

1.80

1.03

mmol/l

3.89

168

918

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

611

4232

1.50

18.15

6.4

7.3

1.00

1.19

mmol/l

0.69

488

3233

Injuries to the wrist and hand

5599

35919

1.14

18.05

7.8

7.5

1.00

mmol/l

0.00

4410

28230

Nail disorders

433

2804

1.62

18.05

8.1

8.2

1.07

1.04

mmol/l

0.04

342

2187

Benign neoplasm: Bronchus and lung

101

407

2.89

18.00

8.6

6.3

1.66

1.55

mmol/l

0.10

312

Other (seronegative) rheumatoid arthritis, wide

1045

7932

1.36

17.99

7.4

6.7

1.34

1.14

mmol/l

0.97

828

6214

Adhesive capsulitis of shoulder

918

6832

1.39

17.99

7.1

7.6

1.25

1.10

mmol/l

0.61

725

5386

Exclusion endpoint for clefts

109

448

2.67

17.95

14.9

9.7

0.24

0.87

mmol/l

0.68

359

Personal history of other diseases and conditions

419

2665

1.62

17.91

9.7

6.7

0.61

0.82

mmol/l

0.43

333

2023

Non-follicular lymphoma

576

3986

1.53

17.87

9.2

7.1

1.50

1.10

mmol/l

1.52

450

3094

Disorders of tooth development and eruption

217

1128

1.96

17.86

14.0

8.1

0.22

0.67

mmol/l

0.92

173

871

Multiple myeloma and malignant plasma cell neoplasms

305

1836

1.81

17.85

6.9

6.8

0.71

1.14

mmol/l

0.80

229

1414

2457

19366

1.22

17.79

6.1

6.4

1.04

1.15

mmol/l

0.73

1927

15145

Dermatitis due to substances taken internally

299

1775

1.79

17.78

8.1

7.2

1.35

1.09

mmol/l

0.57

228

1376

Carcinoma in situ of colon

120

535

2.71

17.73

10.5

6.9

0.32

1.17

mmol/l

1.29

102

434

Dislocation, sprain and strain of joints and ligaments at neck level

671

4740

1.46

17.73

6.2

7.7

1.03

0.88

mmol/l

0.49

522

3647

Other encephalitis

167

830

2.21

17.72

10.6

8.9

1.41

1.05

mmol/l

0.49

130

651

Panniculitis affecting regions of neck and back

215

1160

1.99

17.70

8.7

8.6

1.20

1.15

mmol/l

0.07

164

930

Psoriasis

1518

12100

1.29

17.67

7.9

7.6

1.22

0.99

mmol/l

1.43

1238

9509

Disturbance of activity and attention

322

1904

1.72

17.67

8.4

9.0

0.67

0.51

mmol/l

0.28

242

1412

Polymyalgia rheumatica

776

5664

1.44

17.67

6.5

6.1

1.57

1.20

mmol/l

2.02

647

4379

Right ventricular outflow tract obstruction

146

4.19

17.67

23.0

15.2

0.52

0.43

mmol/l

0.06

120

Drug-induced cataract

157

768

2.29

17.62

8.1

8.3

1.07

1.17

mmol/l

0.11

126

617

Gingival hyperplasia

194

1019

2.07

17.53

9.9

8.1

0.29

1.13

mmol/l

1.73

155

792

Polyarthritis, unspecified

222

1218

1.97

17.52

7.8

7.4

1.17

1.06

mmol/l

0.14

178

957

Redundant prepuce, phimosis and paraphimosis

1108

8459

1.34

17.48

8.5

9.0

1.11

0.85

mmol/l

1.28

878

6759

Hyperkinetic disorders

346

2092

1.68

17.44

8.2

9.4

0.65

0.50

mmol/l

0.28

263

1552

Phakomatoses, not elsewhere classified

283

3.21

17.41

6.4

10.6

0.02

1.01

mmol/l

0.91

225

Other secondary coxarthrosis

213

1160

2.01

17.41

6.6

8.0

1.53

1.18

mmol/l

0.71

171

917

Third [oculomotor] nerve palsy

133

617

2.47

17.31

9.5

7.2

1.45

1.30

mmol/l

0.17

106

485

Leiomyoma of uterus

1913

8724

1.25

17.29

6.6

6.5

1.01

1.34

mmol/l

3.53

1532

6732

Somnolence

347

2.96

17.29

11.9

8.6

1.95

1.06

mmol/l

1.23

277

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

149

708

2.25

17.22

13.6

10.9

0.71

0.80

mmol/l

0.08

125

569

Intracranial and intraspinal abscess and granuloma

389

2.95

17.19

12.1

8.8

0.82

1.11

mmol/l

0.29

315

1260

9347

1.32

17.18

5.1

5.8

1.22

mmol/l

0.00

960

7199

Diseases of inner ear

3063

25644

1.19

17.17

6.1

7.0

1.19

1.07

mmol/l

1.01

2416

20293

Bronchitis, not specified as acute or chronic

452

2983

1.58

17.17

7.2

7.7

1.46

0.79

mmol/l

3.45

361

2292

Parodontitis, under 40 years, or operation codes

296

1748

1.74

17.16

7.8

8.2

-0.03

0.36

mmol/l

0.63

207

1272

Faecal incontinence

454

3004

1.59

17.15

6.2

6.0

0.91

1.27

mmol/l

1.09

359

2362

Postprocedural disorders of nervous system

305

1827

1.74

17.14

5.7

8.0

1.31

0.93

mmol/l

1.16

244

1406

Burns and corrosions of multiple and unspecified body regions

140

659

2.35

17.13

10.3

10.7

0.74

1.04

mmol/l

0.36

110

529

Lymphoid leukaemia

307

1861

1.76

17.09

7.9

7.0

1.17

1.19

mmol/l

0.03

234

1424

Benign neoplasm: Skin of eyelid, including canthus

740

5368

1.43

17.07

6.4

6.8

1.06

1.31

mmol/l

0.90

585

4164

Other shoulder lesions

460

3050

1.57

17.06

6.1

7.9

1.07

1.00

mmol/l

0.16

362

2377

Parodontitis, under 40 years

295

1744

1.74

17.04

7.9

8.2

-0.00

0.36

mmol/l

0.56

206

1270

Colitis, primary sclerosing

337

2.95

17.02

16.3

10.3

-0.75

1.07

mmol/l

3.36

272

Herpesviral [herpes simplex] infections

575

3992

1.50

17.00

7.6

7.3

1.12

1.06

mmol/l

0.14

439

3093

Other interventions on the root canals of the tooth

113

488

2.58

16.98

12.0

9.1

-0.15

1.12

mmol/l

2.10

390

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

365

2.95

16.97

10.1

8.8

1.69

1.43

mmol/l

0.30

286

Acetic acid derivatives and related substances

1769

7411

1.27

16.96

6.4

7.8

0.80

1.04

mmol/l

1.61

1365

5677

Thyrotoxicosis

1224

9549

1.32

16.94

7.4

6.8

1.19

1.12

mmol/l

0.26

959

7511

Entropion and trichiasis of eyelid

524

3599

1.54

16.93

6.1

6.4

1.27

1.14

mmol/l

0.30

423

2738

Unspecified nephritic syndrome

150

732

2.28

16.90

8.2

8.7

0.90

1.23

mmol/l

0.55

119

580

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

335

3.01

16.90

7.6

6.9

1.34

1.26

mmol/l

0.08

270

Complex cardiac defects

129

4.48

16.84

33.4

12.5

0.86

1.22

mmol/l

0.27

105

Emotional disorders and disorders of social functioning with onset specific to childhood

163

791

2.11

16.82

8.3

8.8

0.49

0.11

mmol/l

0.52

125

578

Biomechanical lesions, not elsewhere classified

282

1682

1.80

16.80

6.0

7.6

0.30

1.22

mmol/l

4.31

226

1308

Other specified/unspecified dorsopathies

202

1088

2.00

16.78

8.4

8.6

1.16

1.23

mmol/l

0.09

167

869

Malnutrition

133

622

2.41

16.77

10.1

8.1

2.09

1.35

mmol/l

0.97

487

Other hammer toe(s) (acquired)

945

6689

1.37

16.76

6.3

6.7

1.27

mmol/l

0.02

752

5266

Alzheimer’s disease (Late onset), excluding more controls

844

4146

1.41

16.76

3.6

5.8

1.14

0.88

mmol/l

0.94

644

3188

Acquired haemolytic anaemia

159

798

2.22

16.69

12.3

7.9

0.75

1.29

mmol/l

1.01

128

632

Other ulcerative colitis

303

1837

1.75

16.64

8.5

8.1

0.86

0.96

mmol/l

0.15

215

1434

Diseases of appendix

4091

32574

1.16

16.63

7.8

7.6

1.03

1.00

mmol/l

0.19

3242

25588

Glaucoma suspect

2027

16792

1.24

16.62

5.9

6.8

1.31

1.13

mmol/l

1.34

1504

13289

Acute appendicitis, no complications

2867

24352

1.19

16.62

7.3

7.8

0.99

0.95

mmol/l

0.28

2276

19062

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1519

12192

1.28

16.60

7.5

7.8

1.23

0.97

mmol/l

2.07

1221

9547

Toxic effect of alcohol

143

689

2.30

16.59

9.9

9.1

1.00

1.13

mmol/l

0.12

115

541

234

3.54

16.56

7.4

6.5

2.45

1.28

mmol/l

2.48

179

Internal derangement of knee

2011

16568

1.23

16.52

7.4

7.9

0.98

1.04

mmol/l

0.26

1591

13013

Wet age-related macular degeneration

1030

7774

1.35

16.51

5.7

1.21

1.22

mmol/l

0.02

786

5953

Appendicitis, broad definition

4054

32390

1.16

16.48

7.7

7.6

1.03

0.99

mmol/l

0.21

3213

25441

Other disorders of gingiva or/and edentulous alveolar ridge

275

1634

1.79

16.42

9.0

7.6

0.71

1.08

mmol/l

0.74

221

1257

Ingrowing nail

283

1692

1.77

16.41

6.6

8.4

0.73

1.10

mmol/l

0.69

227

1327

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

272

3.24

16.38

8.4

8.8

0.95

1.40

mmol/l

0.45

215

Drug-induced osteoporosis

379

2.89

16.35

10.9

6.8

0.65

1.27

mmol/l

0.49

307

Brain mixed glioma

11.63

16.35

4.9

8.4

0.28

1.77

mmol/l

1.52

Ependymoma, excluding all cancers (controls excluding all cancers)

10.14

16.33

6.3

6.4

0.51

0.87

mmol/l

0.22

Any dementia, excluding more controls

2072

11910

1.24

16.32

4.7

6.2

1.48

1.05

mmol/l

4.35

1565

9215

Seropositive rheumatoid arthritis, strict definition

800

5929

1.40

16.27

7.9

7.1

1.28

1.09

mmol/l

0.69

648

4651

Cluster headache, wide,, including avohilmo

257

1499

1.82

16.25

7.2

8.8

1.23

1.07

mmol/l

0.31

195

1171

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

134

638

2.37

16.24

9.7

6.3

0.28

1.48

mmol/l

3.44

112

485

Complications following infusion, transfusion and therapeutic injection

103

438

2.67

16.22

10.1

6.3

1.35

1.22

mmol/l

0.15

346

Other and unspecified paralytic syndromes

100

420

2.72

16.22

7.4

7.6

0.59

1.09

mmol/l

0.46

340

Other specified congenital malformation syndromes affecting multiple systems

355

2.79

16.20

14.5

9.7

0.21

0.80

mmol/l

0.55

288

Hypothyroidism, strict autoimmune, 3 medication purchases required

4697

28235

1.15

16.17

7.0

1.14

1.00

mmol/l

1.74

3674

22079

Other and unspecified immunodeficiencies with predominantly antibody defects

318

2.98

16.17

14.9

9.9

1.01

1.24

mmol/l

0.19

251

Congenital malformations of the musculoskeletal system, not elsewhere classified

292

3.00

16.17

6.1

7.4

1.02

1.13

mmol/l

0.10

231

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

191

1022

2.01

16.16

9.1

8.8

0.52

1.08

mmol/l

1.40

169

801

Other specified/unspecified hearing loss

471

3192

1.56

16.13

7.1

6.9

0.84

1.15

mmol/l

0.94

393

2469

Malignant neoplasm of bone and articular cartilage

289

3.22

16.07

10.5

10.1

1.37

1.07

mmol/l

0.31

242

Acute nasopharyngitis (common cold)

607

4270

1.46

16.07

7.3

8.8

1.02

0.94

mmol/l

0.21

475

3409

Disorders of magnesium metabolism

218

3.68

16.05

11.4

6.9

1.62

1.26

mmol/l

0.23

174

Hypotension due to drugs

111

496

2.62

16.02

8.5

6.8

1.34

1.32

mmol/l

0.02

391

Mixed hyperlipidaemia

240

1387

1.86

16.01

11.3

7.5

0.96

1.19

mmol/l

0.40

201

1079

Cluster headache, strict, including avohilmo

238

1365

1.85

15.96

7.6

9.2

1.12

1.02

mmol/l

0.17

182

1076

Algoneurodystrophy

169

871

2.09

15.96

7.4

8.8

0.81

1.12

mmol/l

0.49

139

696

Other disorders of binocular vision

283

3.02

15.95

3.9

8.5

2.13

1.17

mmol/l

1.24

219

Assault by blunt object

360

2.80

15.94

9.6

10.0

0.60

1.09

mmol/l

0.32

290

Ductal carcinoma of pancreas

255

3.56

15.93

10.5

7.2

1.54

1.21

mmol/l

0.45

211

Cerebral palsy

370

2.73

15.91

7.7

11.0

0.91

0.81

mmol/l

0.07

293

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

205

3.57

15.90

5.8

9.6

1.49

1.42

mmol/l

0.05

161

Abnormal blood-pressure reading, without diagnosis

218

1219

1.90

15.89

6.4

7.1

0.85

1.01

mmol/l

0.25

181

961

Nonhereditary hypogammaglobulinemia

282

3.13

15.85

15.9

10.5

0.59

1.36

mmol/l

0.63

224

Mouth breathing

2212

18520

1.22

15.85

7.1

8.1

1.16

0.96

mmol/l

1.84

1780

14661

Meralgia paraesthetica

196

1070

1.99

15.82

6.9

8.6

1.25

1.11

mmol/l

0.19

169

851

Tuberculosis, IBD comorbidity

439

2945

1.57

15.79

7.2

6.4

1.43

1.15

mmol/l

0.81

360

2254

Chronic rhinitis, nasopharyngitis and pharyngitis

1571

12720

1.26

15.76

7.9

7.4

0.95

0.97

mmol/l

0.05

1288

9978

Benign neoplasm: Kidney

217

1230

1.94

15.75

6.3

7.1

0.51

1.26

mmol/l

2.50

174

976

Arthropod-borne viral fevers and viral haemorrhagic fevers

533

3715

1.50

15.73

7.2

8.0

1.26

1.00

mmol/l

0.97

401

2897

Congenital malformations of pulmonary and tricuspid valves

134

4.12

15.72

20.8

14.8

1.10

0.95

mmol/l

0.10

111

Benign neoplasm: Brain, infratentorial

167

4.02

15.71

7.1

11.3

0.65

1.42

mmol/l

0.72

137

Systemic atrophies primarily affecting the central nervous system

255

1513

1.83

15.67

5.6

7.7

3.01

1.19

mmol/l

10.96

210

1179

Salpingitis and oophoritis

815

6081

1.38

15.60

7.7

6.5

1.35

1.17

mmol/l

0.65

648

4859

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

995

7328

1.34

15.59

5.8

5.9

1.10

1.45

mmol/l

2.17

832

5743

Chronic nephritic syndrome

243

1423

1.85

15.57

10.9

8.1

-0.16

1.17

mmol/l

4.72

190

1107

Myasthenia gravis

123

579

2.42

15.49

8.9

7.5

1.82

1.33

mmol/l

0.89

448

Lack of expected normal physiological development

228

2.97

15.44

22.6

10.7

-0.78

-0.20

mmol/l

0.47

180

Iridocyclitis

1163

9136

1.31

15.37

6.9

7.2

0.96

1.06

mmol/l

0.37

874

7160

Alzheimer’s disease, wide definition, excluding more controls

873

4455

1.38

15.36

4.0

5.9

1.12

0.89

mmol/l

0.89

673

3439

Opening and dilatation of root channel of tooth

308

1912

1.69

15.36

9.3

8.1

0.57

1.09

mmol/l

1.26

245

1482

Carcinoma in situ of other and unspecified genital organs

102

441

2.58

15.34

3.8

5.8

0.92

1.43

mmol/l

0.72

350

Thyrotoxicosis, other and/or unspecified

947

7243

1.34

15.28

7.7

6.8

1.08

1.09

mmol/l

0.03

740

5685

Carcinoma in situ of endometrium

132

4.51

15.16

3.1

5.0

1.32

2.10

mmol/l

1.19

110

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1349

8725

1.28

15.09

5.2

6.1

1.23

1.43

mmol/l

1.19

1113

6863

Acute bronchiolitis

219

1107

1.84

15.05

8.4

9.7

0.82

0.45

mmol/l

0.54

174

844

Parodontitis, operation under 40 years and operation codes

274

1644

1.71

15.04

8.1

8.0

-0.16

0.32

mmol/l

0.76

189

1198

Paranoid personality disorder

116

534

2.40

15.04

6.2

9.6

2.26

1.02

mmol/l

2.75

429

Other secondary gonarthrosis

309

1944

1.70

15.02

7.4

8.1

1.19

1.05

mmol/l

0.26

249

1531

Mild mental retardation

135

657

2.23

15.01

9.6

9.2

2.66

0.79

mmol/l

4.21

109

524

Divergent concomitant strabismus

376

2458

1.60

15.01

8.1

8.0

1.60

1.07

mmol/l

1.97

286

1898

Examination and encounter for administrative purposes

243

1434

1.81

14.96

6.2

7.2

0.83

mmol/l

0.01

184

1161

Osteopathy in diseases classified elsewhere

210

3.58

14.95

5.9

6.8

1.31

1.30

mmol/l

0.01

167

Other and unspecified disorders of adult personality and behaviour

116

4.37

14.92

4.9

11.2

-0.16

1.12

mmol/l

1.20

Malignant neoplasm of retroperitoneum and peritoneum

245

3.41

14.90

8.6

6.3

0.19

1.36

mmol/l

2.07

202

Motor disorders, excluding more controls

192

3.26

14.87

19.6

14.5

-0.36

0.03

mmol/l

0.26

158

Gastrojejunal ulcer

401

2.70

14.87

10.1

6.5

0.95

1.29

mmol/l

0.32

311

Cardiomyopathy in other diseases

123

4.45

14.83

6.2

5.0

0.57

1.22

mmol/l

0.37

Benign neoplasm of other and unspecified intrathoracic organs

373

2.81

14.83

11.0

7.1

1.36

0.99

mmol/l

0.41

294

Other disorders of bladder

683

5025

1.42

14.80

7.3

7.4

1.28

1.03

mmol/l

0.79

532

3870

Parodontitis, under 40 years and operation codes

273

1644

1.71

14.79

8.1

8.0

-0.13

0.32

mmol/l

0.70

188

1198

Monoplegia

104

464

2.54

14.77

6.1

7.2

0.36

1.24

mmol/l

1.28

366

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1949

19073

0.82

14.76

6.5

7.2

0.96

1.01

mmol/l

0.22

1515

14826

Metatarsalgia

453

3088

1.53

14.76

7.1

7.5

0.94

1.13

mmol/l

0.48

364

2429

Other and unspecified hydrocephalus

127

615

2.32

14.74

10.7

8.0

1.83

1.37

mmol/l

0.92

104

483

Viral haemorrhagic fevers, not elsewhere classified/unspecified

433

2938

1.55

14.74

7.4

8.2

1.17

1.06

mmol/l

0.27

319

2291

Glaucoma

3305

25241

1.17

14.73

6.0

6.8

1.14

1.11

mmol/l

0.20

2498

19953

Bell's palsy

597

4289

1.45

14.70

7.5

7.6

0.93

1.05

mmol/l

0.27

448

3346

Malignant neoplasm of endocrine gland

373

2457

1.60

14.60

7.0

7.9

1.27

1.18

mmol/l

0.19

302

1925

Tuberculosis, wide

450

3084

1.53

14.59

7.1

6.5

1.42

1.12

mmol/l

0.86

370

2355

Erosion of teeth, including avohilmo

869

6372

1.35

14.58

10.3

7.1

1.29

1.10

mmol/l

0.69

695

4969

Other peripheral vascular diseases

400

2671

1.57

14.56

5.9

6.9

1.17

1.11

mmol/l

0.09

312

2073

Other and unspecified injuries of lower leg

343

2212

1.62

14.52

6.3

7.7

1.11

1.05

mmol/l

0.12

283

1703

Malignant neoplasm of skin

3770

24920

1.16

14.45

6.1

6.9

0.91

1.13

mmol/l

2.91

2954

19617

Benign intracranial hypertension

156

3.65

14.45

11.1

12.8

-0.02

0.88

mmol/l

0.72

116

Acquired absence of organs, not elsewhere classified

369

2.74

14.45

10.2

6.3

0.57

1.20

mmol/l

0.90

287

Superficial injury of forearm

446

3042

1.52

14.45

7.0

8.0

0.80

0.97

mmol/l

0.38

365

2323

Other specified/unspecified spondylopathies

162

860

2.07

14.42

6.5

7.5

1.87

1.27

mmol/l

1.19

131

681

Complications peculiar to reattachment and amputation

203

3.54

14.41

11.1

6.2

1.20

1.01

mmol/l

0.13

160

Acute laryngitis and tracheitis

454

3044

1.51

14.40

10.4

7.8

1.11

0.74

mmol/l

1.11

355

2316

Schizotypal disorder

124

593

2.26

14.39

6.4

9.7

2.48

1.03

mmol/l

2.94

477

Burns and corrosions

667

4894

1.41

14.35

8.0

8.2

1.15

0.92

mmol/l

0.78

530

3787

143

724

2.14

14.35

8.4

9.7

2.23

1.12

mmol/l

4.24

109

584

Other congenital malformations of upper alimentary tract

238

3.35

14.33

6.1

10.1

1.72

1.12

mmol/l

0.91

198

Other and unspecified intracranial injuries

178

974

1.98

14.29

7.4

8.0

0.85

1.14

mmol/l

0.35

140

756

Beningn neoplasm: Meninges, unspecified

105

477

2.48

14.28

5.3

5.9

1.18

1.55

mmol/l

0.59

372

Aspergillosis

261

3.20

14.26

6.3

6.6

1.91

0.92

mmol/l

1.06

206

Open wound of thorax

101

450

2.51

14.26

7.0

9.6

1.39

0.94

mmol/l

0.48

351

Thyroiditis, ILD-related definition

522

3676

1.47

14.25

8.5

7.0

1.02

1.06

mmol/l

0.08

418

2859

Benign neoplasm of urinary organs

278

1729

1.73

14.25

6.3

7.2

0.46

1.14

mmol/l

2.56

222

1354

Melanocytic naevi

1397

11303

1.26

14.22

6.8

7.2

0.84

0.99

mmol/l

0.70

1077

8773

Any prescribed medicine buy

5.69

14.21

5.5

11.5

0.64

0.71

mmol/l

0.02

Benign neoplasm: Cranial nerves

167

899

2.03

14.20

7.2

6.5

0.83

1.32

mmol/l

0.68

120

704

Covid-19 suspected case

864

6581

1.34

14.18

8.3

7.1

0.95

0.89

mmol/l

0.16

661

5053

Benign neoplasm of eye and adnexa

472

3275

1.50

14.17

7.0

1.00

1.27

mmol/l

0.88

367

2502

Assault by other specified means

218

3.23

14.13

13.2

10.0

0.97

1.37

mmol/l

0.39

165

Squamous cell neoplasms and carcinomas of the skin

731

5483

1.39

14.11

6.1

0.88

1.12

mmol/l

0.86

551

4184

Early lumbar disc prolapse operation

428

2902

1.52

14.10

7.6

8.8

1.12

0.83

mmol/l

0.83

324

2275

Injury of nerves and spinal cord at neck level

145

749

2.15

14.09

8.8

7.6

2.55

1.19

mmol/l

3.61

118

592

Cytomegaloviral pneumonitis

8.15

14.07

17.8

8.1

1.21

1.52

mmol/l

0.16

Other diseases of blood and blood-forming organs

379

2531

1.58

14.06

8.8

7.8

1.13

1.03

mmol/l

0.15

312

1975

Benign neoplasm: Rectosigmoid junction

228

1352

1.82

14.02

6.6

0.81

1.27

mmol/l

0.98

188

1044

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

210

1217

1.86

13.99

6.7

5.9

1.13

1.30

mmol/l

0.20

163

918

Late syphilis

439

2.57

13.96

9.9

8.5

1.53

1.21

mmol/l

0.30

355

Other/unspecified disorders of vestibular function

230

1371

1.81

13.91

5.2

7.4

0.97

1.20

mmol/l

0.45

174

1078

Systemic sclerosis (FG)

136

686

2.16

13.89

10.8

8.0

0.90

1.08

mmol/l

0.24

107

545

Hydrocele

714

5339

1.39

13.89

7.8

8.1

0.92

0.84

mmol/l

0.19

539

4185

314

2002

1.64

13.88

5.7

5.6

1.91

1.33

mmol/l

2.15

252

1501

Psoriasis vulgaris

972

7572

1.32

13.88

8.1

7.8

1.20

1.04

mmol/l

0.60

785

5921

Benign neoplasm: Spinal meninges

355

2.80

13.83

5.0

6.3

0.48

1.39

mmol/l

1.31

294

Otitis externa

1073

8462

1.30

13.76

6.8

7.4

1.01

0.97

mmol/l

0.14

834

6543

Skin changes due to chronic exposure to nonionizing radiation

2288

18449

1.20

13.76

6.0

6.2

1.05

1.16

mmol/l

0.66

1792

14440

Benign neoplasm: Bronchus and lung

101

462

2.52

13.75

8.6

7.0

1.66

1.19

mmol/l

0.59

368

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

270

1675

1.71

13.75

6.3

6.0

1.77

1.19

mmol/l

1.73

224

1241

Symptoms and signs involving emotional state

149

775

2.06

13.73

7.5

7.8

0.87

1.12

mmol/l

0.31

123

611

Pyoderma gangrenosum

197

3.45

13.71

8.2

10.0

0.12

1.18

mmol/l

1.30

156

Personal history of certain other diseases

310

2.70

13.67

10.6

7.1

0.85

0.70

mmol/l

0.11

233

Keratitis

1778

14803

1.22

13.66

7.6

7.4

1.15

1.05

mmol/l

0.52

1395

11598

Other congenital malformations of nervous system

183

3.35

13.65

7.3

7.8

0.99

0.90

mmol/l

0.06

139

Erectile dysfunction

524

3761

1.48

13.64

12.8

7.6

0.56

0.92

mmol/l

1.29

384

2886

Heterophoria

356

2347

1.58

13.63

8.4

7.8

1.40

1.02

mmol/l

1.43

278

1811

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

175

3.90

13.62

6.5

6.7

-0.66

1.41

mmol/l

3.61

138

Ependymoma

8.22

13.61

6.2

7.2

0.51

1.51

mmol/l

1.15

Benign neoplasm of middle ear and respiratory system

451

3138

1.51

13.60

7.6

7.5

1.39

1.11

mmol/l

0.88

363

2446

Portal vein thrombosis

103

475

2.45

13.58

10.1

8.7

0.44

1.10

mmol/l

0.86

377

Convergence insufficiency and excess

302

2.77

13.56

5.8

7.1

1.21

mmol/l

0.00

229

Encephalopathy

302

2.90

13.53

11.1

7.6

1.03

1.15

mmol/l

0.09

240

Benign neoplasm: Liver/bile ducts

124

609

2.21

13.52

10.0

7.3

0.40

1.39

mmol/l

2.19

105

468

Acute pharyngitis

604

4359

1.41

13.52

8.6

8.4

0.75

0.74

mmol/l

0.03

472

3414

Actinic keratosis

2228

18020

1.20

13.51

6.1

6.2

1.05

1.16

mmol/l

0.63

1746

14087

Pain associated with micturition

581

4218

1.43

13.50

6.3

7.2

1.28

1.10

mmol/l

0.56

464

3260

Other hearing loss

1595

12955

1.24

13.49

6.4

6.5

1.12

1.09

mmol/l

0.14

1251

10060

Other factor of the environment

368

2.65

13.45

8.5

7.3

2.00

1.13

mmol/l

1.11

287

Use of rotigotine

378

2.69

13.44

3.9

7.6

1.55

1.27

mmol/l

0.30

304

Persistent delusional disorders

400

2720

1.54

13.44

6.6

7.4

2.03

1.01

mmol/l

6.04

325

2100

Other disorders of binocular movement

119

577

2.23

13.39

7.2

8.9

1.09

1.05

mmol/l

0.04

453

Sixth [abducent] nerve palsy

202

1177

1.86

13.34

7.1

7.7

1.24

1.22

mmol/l

0.02

152

917

Other enthesopathy of foot (+metatarsalgia)

475

3333

1.48

13.32

6.9

7.5

0.90

1.12

mmol/l

0.58

380

2621

Other Crohn's disease

325

2115

1.60

13.27

8.2

7.9

0.23

1.05

mmol/l

2.41

254

1652

Cerebral oedema

7.36

13.27

11.3

5.6

1.67

0.76

mmol/l

0.67

Other general symptoms and signs

211

1216

1.80

13.26

11.4

8.1

1.46

0.82

mmol/l

1.45

177

940

Parkinson's disease, including avohilmo

919

7175

1.33

13.26

5.0

6.7

1.71

1.06

mmol/l

5.35

755

5534

Dental caries 2, only avohilmo

2933

26610

0.86

13.20

7.3

7.7

0.80

0.99

mmol/l

2.09

2335

20899

Intentional self-harm by jumping from a high place

117

4.12

13.18

18.0

12.0

0.99

1.21

mmol/l

0.13

Other specified/unspecified necrotizing vasculopathies

102

476

2.44

13.18

8.1

8.2

1.12

1.19

mmol/l

0.06

374

Other abnormal findings in urine

111

536

2.35

13.15

9.7

7.0

1.01

1.21

mmol/l

0.18

423

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

406

2.48

13.12

7.5

9.4

0.29

0.88

mmol/l

0.61

332

Other meningitis

420

2.47

13.11

8.5

8.8

0.83

1.28

mmol/l

0.51

332

Benign paroxysmal vertigo

1505

12403

1.24

13.10

6.1

6.9

1.23

1.14

mmol/l

0.47

1198

9751

Renal cell carcinoma of kidney

225

1359

1.80

13.10

6.0

6.7

0.23

1.20

mmol/l

3.24

175

1041

Complications of genitourinary prosthetic devices, implants and grafts

141

736

2.08

13.10

9.0

6.2

0.63

1.21

mmol/l

0.77

109

567

Haemangioma and lymphangioma, any site

385

2604

1.54

13.07

5.8

7.5

1.07

1.23

mmol/l

0.33

302

1990

Neovascular glaucoma

240

1469

1.75

13.07

7.1

0.81

1.19

mmol/l

0.70

178

1134

Other and unspecified urticaria

868

6702

1.33

13.07

7.6

7.2

1.15

0.97

mmol/l

0.77

689

5210

Malignant neoplasm of rectosigmoid junction

116

573

2.30

13.03

8.7

7.1

0.51

1.27

mmol/l

1.45

449

Malignant neoplasm of tongue

134

696

2.16

13.02

8.3

7.9

1.50

1.23

mmol/l

0.37

108

543

Emotional disorders starting during childhood or adolescence

147

760

1.98

13.02

8.8

9.4

0.37

0.11

mmol/l

0.32

110

553

Prurigo nodularis

154

834

2.03

13.01

8.0

7.3

0.36

1.31

mmol/l

1.54

126

654

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

273

2.99

12.99

12.7

6.2

2.07

1.44

mmol/l

1.03

212

Urolithiasis

1857

15625

1.22

12.98

7.2

7.5

0.71

0.99

mmol/l

2.24

1479

12179

Chronic hepatitis, not elsewhere classified

187

1070

1.88

12.97

8.5

7.9

0.55

1.19

mmol/l

1.23

140

849

Nummular dermatitis

445

3115

1.50

12.97

8.9

7.2

0.96

1.05

mmol/l

0.18

364

2429

Secondary polycythaemia

148

792

2.06

12.97

7.7

9.1

1.91

1.08

mmol/l

1.15

117

624

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

217

1290

1.78

12.96

6.5

7.7

1.20

1.28

mmol/l

0.11

160

1004

Embedded teeth, including avohilmo

324

2108

1.58

12.94

7.6

8.1

1.04

0.81

mmol/l

0.47

239

1588

Erectile dysfunction, exclusion

112

4.53

12.90

15.1

13.5

1.28

0.51

mmol/l

0.32

Haemangioma, any site

360

2409

1.55

12.90

5.9

7.5

1.17

1.22

mmol/l

0.08

283

1849

Chromophobe cell carcinoma of kidney

181

3.76

12.90

6.5

7.5

-0.66

1.18

mmol/l

3.07

153

Benign neoplasm: Liver

111

533

2.26

12.87

9.1

7.5

0.44

1.36

mmol/l

1.91

407

Other/unspecified synovitis and tenosynovitis

569

4145

1.42

12.87

7.5

1.16

1.12

mmol/l

0.10

442

3220

Superficial injury of ankle and foot

494

3508

1.45

12.83

7.5

8.0

0.99

0.84

mmol/l

0.35

387

2683

Disorders of plasma-protein metabolism, not elsewhere classified

188

3.40

12.81

14.1

5.6

1.70

1.11

mmol/l

0.59

146

Oesophageal obstruction

219

1320

1.79

12.78

10.3

7.2

1.38

1.16

mmol/l

0.31

183

1019

Other noninflammatory disorders of uterus, except cervix

1155

6293

1.28

12.76

5.6

6.4

1.36

1.25

mmol/l

0.42

926

5060

Other disorders of prostate

233

1430

1.76

12.75

5.4

7.7

0.81

mmol/l

0.01

184

1101

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3298

22871

1.16

12.74

6.0

6.8

0.93

1.14

mmol/l

2.39

2572

17990

Congenital malformations of gallbladder, bile ducts and liver

256

2.98

12.74

12.5

7.8

-0.12

1.04

mmol/l

1.68

211

Restless leg syndrome

610

4516

1.40

12.67

6.3

7.3

1.11

1.12

mmol/l

0.03

498

3515

Dissection of cerebral arteries, nonruptured

200

3.28

12.64

7.4

7.9

0.96

1.37

mmol/l

0.31

165

Calculus of kidney and ureter

1708

14305

1.22

12.61

7.1

7.5

0.68

0.98

mmol/l

2.42

1360

11144

Anankastic personality disorder

170

948

1.89

12.58

6.6

8.6

1.22

0.94

mmol/l

0.48

130

735

Liposarcoma, excluding all cancers (controls excluding all cancers)

326

2.76

12.57

8.2

6.2

0.20

1.32

mmol/l

1.76

246

Other retinal artery occlusion

161

898

1.99

12.57

7.1

7.4

0.82

1.20

mmol/l

0.45

119

687

Other mycoses, not elsewhere classified/unspecified

5.07

12.53

21.9

6.8

2.17

1.02

mmol/l

0.52

Anterior Iridocyclitis

1022

8113

1.29

12.52

7.0

7.3

1.02

1.05

mmol/l

0.09

770

6337

Fistulae involving female genital tract

104

496

2.33

12.52

7.2

7.7

1.30

1.35

mmol/l

0.04

403

Glaucoma secondary to other eye disorders

241

1494

1.72

12.51

7.1

7.6

0.81

1.21

mmol/l

0.75

179

1159

Lactose intolerance

145

771

2.00

12.50

11.4

7.6

0.79

1.20

mmol/l

0.48

113

593

Implicit parasitic Sepsis

118

4.17

12.49

13.5

4.9

1.21

1.12

mmol/l

0.04

Special screening examination for other diseases and disorders

384

2615

1.52

12.49

9.2

6.4

0.87

0.78

mmol/l

0.19

290

2068

Dislocation, sprain and strain of joints and ligaments of knee

2981

24166

1.16

12.48

7.2

7.7

0.98

0.96

mmol/l

0.14

2368

18960

Mental and behavioural disorders due to hallucinogens

102

4.24

12.47

4.2

13.0

1.27

0.60

mmol/l

0.49

Dependent personality disorder

122

617

2.16

12.47

8.8

7.7

1.88

1.13

mmol/l

1.03

506

Retinal detachments and breaks

1987

16881

1.20

12.44

7.2

7.0

0.74

1.10

mmol/l

3.41

1561

13280

Amyloidosis

129

669

2.13

12.42

7.7

6.8

0.86

1.44

mmol/l

0.78

102

497

Oral leukoplakia and related diseases

322

2140

1.60

12.41

8.0

7.7

1.28

1.13

mmol/l

0.31

258

1673

IBD patients in KELA-register

1073

8561

1.28

12.40

8.1

7.8

0.60

0.92

mmol/l

1.71

834

6665

Normal-pressure hydrocephalus

308

2035

1.63

12.39

3.9

6.3

1.47

1.22

mmol/l

0.62

239

1562

Diabetes insipidus

266

2.92

12.39

10.0

10.6

1.12

1.29

mmol/l

0.13

220

Visual impairment including blindness (binocular or monocular)

355

2399

1.55

12.38

8.0

6.9

0.89

1.19

mmol/l

0.67

278

1850

Colitis, primary sclerosing, strict definition

258

2.88

12.37

16.3

11.5

-0.31

1.22

mmol/l

2.37

204

Melanocytic naevi of trunk

565

4143

1.41

12.36

7.1

7.6

0.82

1.00

mmol/l

0.41

449

3215

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

227

3.14

12.33

7.9

8.0

1.14

1.31

mmol/l

0.15

185

Menorrhagia

1657

7586

1.23

12.31

6.5

6.7

1.43

1.13

mmol/l

2.28

1287

6005

Foreign body in alimentary tract

290

1881

1.63

12.31

7.9

8.1

1.20

1.08

mmol/l

0.19

235

1475

Other disorders affecting eyelid function

275

2.92

12.28

5.1

6.8

1.70

1.13

mmol/l

1.06

219

Accidental poisoning by and exposure to other gases and vapours

156

3.70

12.27

2.9

12.3

0.69

1.25

mmol/l

0.57

127

Other specified/unspecified soft tissue disorders

265

1683

1.66

12.25

6.3

6.7

1.69

1.25

mmol/l

1.25

209

1308

Maze procedure for atrial fibrillation

176

3.73

12.21

15.1

6.9

-0.15

0.98

mmol/l

1.52

145

Viral infections of the central nervous system

353

2385

1.54

12.20

6.8

7.8

1.02

1.07

mmol/l

0.08

286

1853

Carcinoma in situ of endometrium

153

3.84

12.17

3.1

6.3

1.32

1.83

mmol/l

0.77

128

Meningitis

257

1624

1.67

12.15

8.2

8.7

1.04

1.19

mmol/l

0.27

208

1263

Thrombotic microangiopathy

184

3.41

12.13

14.0

9.7

0.85

1.24

mmol/l

0.35

143

Acute and subacute iridocyclitis

963

7621

1.30

12.13

7.0

7.2

1.03

1.05

mmol/l

0.05

730

5946

Pre-eclampsia or eclampsia

809

6244

1.32

12.10

6.2

6.8

0.90

1.00

mmol/l

0.30

631

4879

Isolated proteinuria

167

946

1.91

12.10

7.6

8.3

-0.25

1.03

mmol/l

2.58

126

740

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

177

3.35

12.08

6.4

8.4

0.67

1.53

mmol/l

0.71

140

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

264

2.90

12.05

7.3

8.4

0.56

1.87

mmol/l

2.66

214

Myositis

154

853

1.96

12.02

10.9

8.2

1.01

1.24

mmol/l

0.22

128

678

Ehlers-Danlos syndrome

159

3.33

11.98

5.5

8.4

1.09

1.23

mmol/l

0.13

122

Tuberculosis

374

2574

1.53

11.97

7.0

6.5

1.67

1.13

mmol/l

1.77

313

1952

Psoriatic and enteropathic arthropathies

561

4130

1.40

11.92

6.8

7.8

1.25

0.94

mmol/l

1.16

449

3231

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

279

1816

1.64

11.92

8.1

6.7

0.40

1.24

mmol/l

3.00

213

1392

Other or unspecified immunodeficiency

4.98

11.91

6.6

7.1

1.81

1.55

mmol/l

0.16

Injuries involving multiple body regions

190

1117

1.81

11.89

14.0

9.0

1.09

1.13

mmol/l

0.04

154

883

Infarction of spleen

194

3.40

11.84

13.1

6.9

1.89

1.05

mmol/l

0.88

157

Other specified disorders of muscle

165

937

1.89

11.78

9.4

8.1

1.02

1.26

mmol/l

0.29

125

735

Syphilis

155

867

1.94

11.77

8.9

9.8

1.13

1.14

mmol/l

0.02

133

694

Other disorders of white blood cells

295

1943

1.60

11.75

9.5

7.7

0.99

1.06

mmol/l

0.10

230

1510

Other diseases of peritoneum

245

1547

1.68

11.75

5.7

7.3

1.23

1.27

mmol/l

0.05

176

1205

Acromegaly and pituitary gigantism

198

3.22

11.72

5.3

6.9

0.26

1.17

mmol/l

1.03

155

Other and unspecified mononeuropathies, also in other diseases

173

1000

1.86

11.68

6.9

7.3

1.47

1.18

mmol/l

0.37

134

776

Convalescence

263

1685

1.64

11.68

15.3

7.0

1.73

1.10

mmol/l

1.87

211

1309

Magnesium deficiency

107

4.74

11.68

9.3

7.7

-0.52

1.45

mmol/l

1.29

Carcinoma in situ of rectum

246

2.99

11.67

9.3

6.1

0.48

1.49

mmol/l

1.17

198

Pre-eclampsia

734

5620

1.33

11.66

6.1

6.8

0.79

0.98

mmol/l

0.64

567

4382

Unspecified contracted kidney

166

3.48

11.64

5.9

6.7

-0.52

1.10

mmol/l

1.41

135

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

300

2.74

11.62

15.7

5.6

1.39

1.62

mmol/l

0.29

242

Epileptic seizures related to alcohol

219

3.19

11.60

8.4

1.64

1.13

mmol/l

0.41

172

Beningn neoplasm: Meninges, unspecified

105

520

2.26

11.60

5.3

6.5

1.18

1.45

mmol/l

0.40

420

Disorders of vitreous body and globe

2751

23477

1.16

11.56

7.2

7.1

1.08

1.12

mmol/l

0.20

2244

18677

Fissure and fistula of anal and rectal regions

1205

9825

1.25

11.54

7.4

7.2

0.96

1.02

mmol/l

0.23

955

7681

Other diseases of gallbladder

251

1602

1.66

11.53

8.3

6.4

1.00

1.11

mmol/l

0.19

202

1247

Basal cell carcinoma, including avohilmo

3414

23829

1.15

11.50

5.9

6.8

0.91

1.15

mmol/l

2.93

2672

18750

Schizoid personality disorder

109

546

2.19

11.50

5.8

9.1

2.22

0.96

mmol/l

1.92

439

Diffuse large B-cell lymphoma

268

1746

1.65

11.50

10.4

7.1

1.33

1.13

mmol/l

0.32

209

1350

Burns classified according to extent of body surface involved

288

2.74

11.50

14.5

11.0

-0.18

0.91

mmol/l

1.13

238

Femoral hernia

249

1588

1.66

11.48

8.5

7.0

1.08

1.10

mmol/l

0.02

197

1229

Other orthopaedic follow-up care

282

1844

1.60

11.47

6.1

7.3

1.19

1.11

mmol/l

0.13

229

1443

Basal cell carcinoma

3336

23535

1.15

11.46

6.0

6.7

0.92

1.15

mmol/l

2.80

2611

18511

Pedestrian injured in transport accident

347

2371

1.53

11.43

8.5

7.8

0.97

1.13

mmol/l

0.31

281

1851

Hypoplasia of dental enamel, including avohilmo

117

3.69

11.42

24.7

13.4

-0.30

-0.31

mmol/l

0.01

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

436

2.29

11.40

9.1

8.9

0.28

1.07

mmol/l

1.30

346

Melanocytic naevi, other sites/unspecified

328

2211

1.54

11.39

6.2

7.7

1.01

1.16

mmol/l

0.31

246

1689

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

220

1365

1.72

11.38

8.6

6.1

1.61

1.28

mmol/l

0.48

163

1042

Open wound of neck

235

2.93

11.37

8.5

9.1

0.98

1.08

mmol/l

0.06

184

Parkinson's disease

869

6874

1.31

11.36

4.9

6.7

1.77

1.05

mmol/l

6.25

714

5304

Ectropion of eyelid

244

1558

1.68

11.36

5.1

6.0

1.66

1.23

mmol/l

0.97

186

1184

Simple and mucopurulent chronic bronchitis

225

1400

1.70

11.34

5.7

7.1

1.51

0.81

mmol/l

1.87

179

1074

Acute generalized exanthematous pustulosis

231

1450

1.69

11.32

8.9

7.8

1.14

1.10

mmol/l

0.06

176

1134

Other specified disorders of kidney and ureter

186

1108

1.80

11.31

9.5

7.7

0.58

1.20

mmol/l

1.40

160

867

Other and unspecified vascular occlusions

534

3956

1.41

11.31

6.4

1.10

1.22

mmol/l

0.25

415

3048

Atrioventricular septal defect

4.33

11.30

17.2

14.3

0.71

1.33

mmol/l

0.37

Crohn's disease NAS

305

2032

1.57

11.29

7.4

7.8

0.59

1.03

mmol/l

0.91

248

1579

Malignant neoplasm of stomach

302

2021

1.58

11.29

9.7

6.9

0.86

1.19

mmol/l

0.68

249

1552

Systemic sclerosis

136

740

1.99

11.24

10.8

7.4

0.90

1.26

mmol/l

0.59

107

587

Anoxic brain damage

453

2.34

11.22

12.9

8.9

0.38

1.25

mmol/l

0.80

345

Other/unspecified enthesopathies of lower limb, excluding foot

316

2121

1.55

11.21

6.3

8.1

0.67

1.10

mmol/l

1.11

242

1680

Spondylopathies (FG)

629

4751

1.36

11.20

6.6

7.8

0.99

0.92

mmol/l

0.16

481

3700

Malignant neoplasm of small intestine

142

791

1.99

11.19

5.2

8.0

-0.03

1.33

mmol/l

2.91

109

622

Burns and corrosions of external body surface, specified by site

508

3723

1.41

11.17

8.1

8.2

1.12

0.91

mmol/l

0.56

401

2901

Recurrent and persistent haematuria

238

2.90

11.13

7.3

8.8

0.85

1.19

mmol/l

0.21

189

Lyme disease

837

10575

0.77

11.12

6.8

7.4

0.65

1.09

mmol/l

3.38

718

8344

Malignant neoplasm of oesophagus

165

963

1.89

11.11

14.4

7.6

1.64

1.02

mmol/l

0.95

149

738

Primary biliary cholangitis (PBC)

122

643

2.06

11.11

13.6

6.0

0.22

1.07

mmol/l

1.36

100

517

Specific developmental disorder of motor function

234

2.73

11.07

19.6

17.2

-0.36

0.01

mmol/l

0.24

193

Other disorders of electrolyte and fluid balance, not elsewhere classified

263

2.80

11.06

11.5

7.4

2.37

1.35

mmol/l

0.81

202

Fluid overload

4.87

11.05

7.4

12.0

2.41

1.52

mmol/l

0.25

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

167

974

1.85

11.04

6.3

5.8

1.16

1.28

mmol/l

0.12

129

737

Chronic lymphocytic leukaemia, helper endpoint

167

976

1.86

11.03

8.0

6.5

1.15

1.23

mmol/l

0.11

133

751

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

167

976

1.86

11.03

8.0

6.5

1.15

1.23

mmol/l

0.11

133

751

Injury of nerves and spinal cord at thorax level

144

3.60

11.02

15.4

7.5

1.64

0.94

mmol/l

0.43

117

Use of levodopa decarboxylase inhibitor

755

5895

1.33

11.01

4.9

6.6

1.80

1.06

mmol/l

5.49

623

4513

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

166

3.40

11.00

8.4

6.5

1.75

1.40

mmol/l

0.25

131

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

120

628

2.05

11.00

6.4

6.1

1.44

1.36

mmol/l

0.08

482

Eosinophilic disease (BM)

353

2.44

10.99

10.4

6.0

0.86

0.44

mmol/l

0.39

270

Habit and impulse disorders

378

2.37

10.99

5.3

10.2

1.03

0.95

mmol/l

0.07

301

Inflammatory bowel disease, strict (require KELA)

1073

8686

1.26

10.97

8.1

7.8

0.60

0.94

mmol/l

1.89

834

6770

Anxious personality disorder

390

2.33

10.96

7.3

8.5

1.64

0.92

mmol/l

1.26

300

Kela reimbursement Agammaglobulinemia (D80-84)

192

3.07

10.93

22.4

11.1

0.88

1.43

mmol/l

0.35

149

Amyloidosis, other/unspecified

107

546

2.18

10.89

8.3

7.0

0.42

1.49

mmol/l

1.70

401

Carcinoma in situ of other and unspecified genital organs

102

510

2.20

10.89

3.8

6.5

0.92

1.53

mmol/l

0.95

407

Tooth eruption problems

441

3120

1.43

10.89

9.0

8.0

0.77

0.61

mmol/l

0.36

327

2310

Malignant neoplasm of other and unspecified parts of tongue

101

508

2.25

10.87

8.8

7.9

1.50

1.23

mmol/l

0.35

409

Suppurative and unspecified otitis media

1497

11080

1.21

10.85

8.3

7.7

0.73

0.87

mmol/l

0.63

1124

8459

Intussusception

120

634

2.05

10.84

7.4

7.1

2.01

1.38

mmol/l

1.30

506

Biological medication for rheuma

656

5009

1.34

10.82

8.6

8.0

0.90

mmol/l

0.01

520

3919

Generalized skin eruption due to drugs and medicaments

204

1258

1.72

10.78

8.7

7.6

1.26

1.11

mmol/l

0.23

152

981

Benign neoplasm: Pancreas

146

826

1.93

10.77

8.0

6.5

0.79

1.34

mmol/l

1.29

119

633

IBD (strict) with PSC

228

2.84

10.76

15.4

9.2

-0.70

1.00

mmol/l

2.58

176

Diseases of external ear

1716

14573

1.20

10.74

6.5

7.3

1.02

1.00

mmol/l

0.09

1347

11375

Anorexia (incl.atypical)

225

1411

1.65

10.67

5.1

8.2

1.68

0.84

mmol/l

1.55

180

1055

Cardiomyopathies, Secondary/extrinsic

151

3.38

10.65

17.6

6.5

1.47

1.06

mmol/l

0.30

117

Other acute viral hepatitis

328

2.50

10.65

14.5

10.6

1.59

1.06

mmol/l

0.65

267

Other and specified injuries of hip and thigh

129

705

1.99

10.59

5.0

7.6

1.28

1.16

mmol/l

0.12

103

554

Lactose intolerance, other/unspecified

129

699

1.96

10.59

11.6

7.7

0.68

1.21

mmol/l

0.63

100

539

Otitis externa, unspecified

496

3657

1.40

10.53

6.2

7.7

0.96

0.99

mmol/l

0.08

374

2838

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

311

2117

1.54

10.50

6.5

7.4

1.23

1.13

mmol/l

0.18

247

1630

Intermittent heterotropia

228

1443

1.64

10.50

11.6

8.6

1.23

0.89

mmol/l

0.61

174

1112

Malignant neoplasm of thyroid gland

333

2299

1.51

10.49

6.9

8.0

1.33

1.19

mmol/l

0.28

268

1806

Dermatopolymyositis (FG)

416

2.31

10.45

13.8

7.0

1.47

0.97

mmol/l

0.38

326

Benign neoplasm: Other and unspecified parts of small intestine

103

527

2.17

10.44

8.1

5.8

1.07

1.60

mmol/l

0.65

413

Congenital malformations of great veins

4.94

10.43

16.9

11.9

-0.18

0.61

mmol/l

0.46

Systemic sclerosis, icd10

134

744

1.95

10.43

10.9

7.5

0.92

1.30

mmol/l

0.63

105

600

Papillary adenocarcinoma of thyroid gland

259

1703

1.60

10.40

7.7

7.6

1.24

1.14

mmol/l

0.16

211

1342

Use of ropinirole

222

1422

1.69

10.39

4.8

8.1

2.05

1.17

mmol/l

2.96

183

1113

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

171

3.24

10.39

9.3

6.4

1.25

1.45

mmol/l

0.21

132

Anorexia

362

2.37

10.39

5.2

8.6

1.40

1.08

mmol/l

0.23

290

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

168

3.42

10.38

9.2

9.0

1.78

1.19

mmol/l

0.44

138

Other spirochaetal diseases

855

10686

0.78

10.36

6.8

7.4

0.68

1.09

mmol/l

3.07

736

8428

Vascular dementia (mixed)

106

551

2.15

10.34

5.2

5.8

1.96

1.29

mmol/l

0.79

414

Pre-eclampsia or poor fetal growth

1039

8397

1.25

10.33

7.3

6.7

0.81

0.90

mmol/l

0.34

797

6439

Vascular dementia

470

3336

1.41

10.32

4.5

5.4

1.75

1.13

mmol/l

2.31

348

2503

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

256

2.83

10.32

9.8

6.4

-0.91

1.47

mmol/l

5.18

197

Nonpyogenic thrombosis of intracranial venous system

234

2.79

10.30

12.4

11.4

1.02

1.42

mmol/l

0.38

190

Systemic sclerosis,strict definition

247

2.76

10.27

11.7

6.8

0.27

1.28

mmol/l

1.28

202

Disorders of purine and pyrimidine metabolism

185

3.20

10.27

11.4

8.0

1.20

1.35

mmol/l

0.07

142

Superficial injury of wrist and hand

834

6612

1.29

10.25

7.8

7.9

1.01

0.91

mmol/l

0.36

658

5112

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

198

1228

1.71

10.23

8.0

7.5

1.29

1.21

mmol/l

0.12

157

952

Carcinoma in situ of oral cavity, oesophagus and stomach

168

3.31

10.22

6.8

5.4

0.28

1.62

mmol/l

1.64

127

Superficial injury of shoulder and upper arm

537

4029

1.37

10.21

5.5

7.1

0.91

1.01

mmol/l

0.22

439

3110

Peritonsillar abscess

941

7569

1.27

10.19

7.5

7.9

1.15

0.86

mmol/l

1.77

734

5880

Benign neoplasm of other and unspecified sites

168

1001

1.79

10.17

7.4

7.6

1.42

1.20

mmol/l

0.30

127

779

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

693

5393

1.32

10.16

6.2

6.9

0.82

1.26

mmol/l

2.20

557

4139

Lichen simplex chronicus

190

1172

1.73

10.13

8.5

7.5

1.05

1.09

mmol/l

0.04

141

918

Ocular pain

355

2491

1.48

10.13

7.3

7.8

1.01

1.08

mmol/l

0.11

271

1932

Bruxism

431

2.22

10.13

6.8

10.0

0.95

1.11

mmol/l

0.21

341

Disorders of vitreous body

2649

22847

1.15

10.11

7.3

7.1

1.05

1.11

mmol/l

0.34

2173

18176

Renal tubulo-interstitial disorders in diseases classified elsewhere

313

2.56

10.11

8.4

7.7

-0.11

1.24

mmol/l

0.94

257

Degeneration of nervous system due to alcohol

150

877

1.88

10.08

9.6

8.9

0.83

1.12

mmol/l

0.32

121

682

Muscle strain

157

918

1.81

10.07

8.1

8.3

1.00

1.03

mmol/l

0.04

128

714

Blepharochalasis

1554

13183

1.20

10.05

6.0

6.7

1.37

1.15

mmol/l

1.57

1279

10410

Benign neoplasm: Cranial nerves

167

1002

1.80

10.03

7.2

7.5

0.83

1.22

mmol/l

0.51

120

790

Crohn's disease of large intestine

241

1568

1.61

10.03

9.7

8.0

0.33

1.09

mmol/l

1.94

190

1229

Postmenopausal bleeding

1424

6532

1.22

9.99

6.2

6.7

1.41

1.27

mmol/l

0.70

1163

5264

Inguinal hernia, unilateral

155

911

1.83

9.99

7.1

7.8

1.15

1.31

mmol/l

0.19

123

705

Femoral hernia, unilateral

155

911

1.83

9.99

7.1

7.8

1.15

1.31

mmol/l

0.19

123

705

Inguinal of femoral hernia, unilateral

155

911

1.83

9.99

7.1

7.8

1.15

1.31

mmol/l

0.19

123

705

Degeneration of the brain due to alcohol

150

880

1.87

9.97

9.6

9.3

0.83

1.13

mmol/l

0.33

121

681

Vasculitis limited to skin, not elsewhere classified

151

883

1.85

9.96

6.1

7.6

1.26

1.31

mmol/l

0.04

113

684

Infective bursitis

176

1073

1.77

9.95

9.5

8.6

1.54

1.11

mmol/l

0.71

139

847

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

183

1126

1.74

9.94

8.1

6.6

1.19

1.33

mmol/l

0.23

156

877

Chronic laryngitis and laryngotracheitis

710

5559

1.31

9.94

7.9

7.1

1.19

1.00

mmol/l

0.71

576

4358

Excessive attrition of teeth

1877

8701

1.19

9.92

7.3

6.9

0.93

1.12

mmol/l

1.23

1499

6762

Hodgkin lymphoma

138

782

1.88

9.91

9.6

7.3

1.43

1.18

mmol/l

0.38

109

611

Striking against or struck by other objects

1514

12797

1.20

9.87

8.2

8.1

1.07

0.91

mmol/l

0.88

1214

9973

Disorder of external ear, unspecified

172

1042

1.77

9.86

6.2

8.6

0.84

1.23

mmol/l

0.66

130

816

Other and unspecified psoriasis

345

2430

1.49

9.86

10.1

8.2

1.16

1.08

mmol/l

0.14

294

1899

Autonomic disorders

125

692

1.96

9.86

7.2

7.8

1.33

1.32

mmol/l

0.01

100

545

Seronegative rheumatoid arthritis

576

4390

1.35

9.84

7.7

6.9

1.40

1.09

mmol/l

1.13

467

3441

Selective deficiency of immunoglobulin G [IgG] subclasses

175

3.08

9.84

12.7

11.5

1.85

1.43

mmol/l

0.20

141

Hypertrophic disorders of skin

247

1621

1.58

9.83

7.8

7.9

0.80

1.02

mmol/l

0.45

186

1248

Other and unspecified vasculitis limited to skin

140

805

1.89

9.82

6.0

7.6

1.27

1.31

mmol/l

0.03

105

626

Enteropathic arthropathies

115

618

1.99

9.79

6.7

10.2

1.17

1.09

mmol/l

0.08

486

Benign neoplasm: Oesophagus

362

2.38

9.78

16.8

6.4

1.33

1.56

mmol/l

0.19

283

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

156

3.39

9.77

11.9

8.8

1.36

1.56

mmol/l

0.09

120

Impetigo

184

1128

1.70

9.76

6.8

8.5

1.29

0.95

mmol/l

0.66

151

878

Juvenile arthritis (FINNGEN)

169

1010

1.73

9.75

6.8

8.7

0.56

0.82

mmol/l

0.33

127

775

Other immunodeficiencies

277

2.56

9.74

8.9

8.6

1.93

1.21

mmol/l

0.88

215

Motor disorders

254

2.55

9.72

19.6

15.8

-0.36

-0.11

mmol/l

0.15

207

Other juvenile arthritis

144

824

1.81

9.71

7.2

9.1

0.40

0.76

mmol/l

0.41

105

628

Central retinal artery occlusion

144

841

1.88

9.70

8.4

7.5

0.65

1.26

mmol/l

1.05

109

637

Neuroendocrine tumor and carcinoma of lung

257

2.74

9.69

7.9

8.4

1.14

1.30

mmol/l

0.14

209

Wegener granulomatosis

100

520

2.12

9.68

11.9

8.1

0.87

1.19

mmol/l

0.37

410

Oral leukoplakia and related diseases, including avohilmo

456

3377

1.41

9.67

7.7

7.4

1.17

1.12

mmol/l

0.11

366

2645

Generalized epilepsy, mode (most common among epilepsy diagnosis)

144

830

1.83

9.66

7.3

8.8

1.12

1.00

mmol/l

0.12

115

652

Endometriosis

1550

7776

1.20

9.63

5.6

6.7

1.02

1.09

mmol/l

0.31

1187

6111

Nosocomial condition (hospital)

185

3.09

9.63

6.6

5.9

1.89

1.36

mmol/l

0.44

144

Otalgia

350

2475

1.47

9.61

6.2

7.7

0.80

1.06

mmol/l

0.62

275

1936

Molar incisor enamel hypoplasia, with caries

3.72

9.61

23.0

9.2

-0.58

-0.66

mmol/l

0.04

Carcinoma in situ of skin of upper limb, including shoulder

133

761

1.92

9.60

9.0

5.6

0.62

1.35

mmol/l

1.10

103

582

Lifestyle-related condition

338

2.41

9.59

8.7

7.3

1.98

1.16

mmol/l

0.79

268

Unspecified maternal hypertension

186

2.84

9.57

6.1

10.0

0.48

0.98

mmol/l

0.35

129

Dislocation, sprain and strain of joints and ligaments of thorax

164

987

1.76

9.55

6.3

8.4

0.93

1.06

mmol/l

0.17

130

770

Single delivery by forceps and vacuum extractor

234

2174

0.64

9.55

5.8

8.3

-0.10

0.64

mmol/l

1.99

163

1642

Contact with heat and hot substances

252

1676

1.57

9.54

7.1

8.8

1.24

0.98

mmol/l

0.47

198

1304

Nontoxic multinodular goitre

1004

8217

1.25

9.53

5.6

6.3

1.51

1.24

mmol/l

1.32

806

6523

Carcinoma in situ of skin

401

2921

1.43

9.50

5.9

5.8

0.64

1.37

mmol/l

3.16

320

2233

Monoarthritis, not elsewhere classified

214

1375

1.63

9.50

7.4

8.6

0.74

1.03

mmol/l

0.61

182

1064

Crohn's disease of small intestine

306

2115

1.50

9.49

8.3

8.0

0.72

1.01

mmol/l

0.58

237

1648

Accidental poisoning by and exposure to alcohol

463

2.13

9.49

10.6

8.6

2.16

0.88

mmol/l

2.13

355

Malignant melanoma, excluding all cancers (controls excluding all cancers)

822

6587

1.28

9.48

6.2

6.9

0.86

1.31

mmol/l

2.72

660

5082

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

141

3.43

9.48

8.2

11.7

0.82

1.46

mmol/l

0.77

112

Disorders of brain, other and unspecified

302

2.51

9.46

11.3

8.0

1.57

1.34

mmol/l

0.18

237

Benign neoplasm of mouth and pharynx

562

4302

1.35

9.45

7.0

7.3

1.01

1.12

mmol/l

0.26

450

3340

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

178

1070

1.69

9.44

10.5

10.2

0.09

0.54

mmol/l

0.66

140

816

Toxic liver disease

461

2.17

9.43

10.0

7.7

1.12

1.09

mmol/l

0.03

370

Sicca syndrome [Sjögren]

410

2993

1.42

9.42

7.6

6.9

1.06

1.18

mmol/l

0.29

329

2336

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

161

970

1.77

9.42

7.0

7.5

1.49

1.12

mmol/l

0.55

119

751

Benign neoplasm: Liver/bile ducts

124

693

1.92

9.42

10.0

7.7

0.40

1.18

mmol/l

1.54

105

548

Fourth [trochlear] nerve palsy

134

771

1.89

9.41

7.2

1.04

1.24

mmol/l

0.21

105

605

Other renal tubulo-interstitial diseases

115

626

1.96

9.40

9.4

6.8

0.09

1.44

mmol/l

2.87

490

Other and unspecified mononeuropathies of upper limb

152

900

1.79

9.40

6.5

9.5

1.81

1.12

mmol/l

1.81

120

715

Disease of hard tissues of teeth, NOS

269

2.55

9.38

13.8

8.0

0.63

1.21

mmol/l

0.84

219

Achalasia of cardia

107

574

2.03

9.37

9.3

7.0

1.34

1.32

mmol/l

0.02

452

Other and unspecified disorders of white blood cells

215

1393

1.64

9.36

9.1

8.2

1.00

1.16

mmol/l

0.20

173

1086

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

125

705

1.93

9.36

10.2

6.6

2.23

1.25

mmol/l

1.35

100

540

Sequelae of poisoning by drugs, medicaments and biological substances

7.19

9.36

6.6

24.9

1.06

mmol/l

0.00

Coeliac disease

546

4159

1.35

9.33

7.3

7.2

1.30

1.06

mmol/l

0.65

412

3223

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

369

2.33

9.33

11.8

5.6

0.94

1.56

mmol/l

1.04

291

Special screening examination for neoplasms

235

1551

1.59

9.30

8.6

7.0

0.23

0.84

mmol/l

1.46

191

1228

Bullous disorders

307

2144

1.50

9.29

6.3

7.2

1.07

1.13

mmol/l

0.07

228

1662

Hyperaldosteronism

161

978

1.77

9.28

8.6

8.1

1.33

1.27

mmol/l

0.05

133

764

Tumor necrosis factor alpha inhibitors

574

4403

1.33

9.24

8.6

8.0

0.77

0.91

mmol/l

0.35

453

3447

Exposure to other and unspecified forces of nature

142

3.29

9.22

16.0

8.2

-0.17

0.95

mmol/l

0.90

110

Frostbite

324

2.41

9.22

8.7

10.1

1.40

1.08

mmol/l

0.24

257

Colitis due to radiation

381

2.35

9.22

9.0

7.1

1.44

1.28

mmol/l

0.11

288

Lymphoid leukaemia

307

2149

1.50

9.21

7.9

7.3

1.17

1.05

mmol/l

0.24

234

1659

Malignant neoplasm of adrenal gland

100

3.88

9.21

7.0

6.6

1.41

1.28

mmol/l

0.07

Acne

316

2196

1.47

9.20

9.5

8.5

0.23

0.56

mmol/l

0.66

238

1633

Rash and other nonspecific skin eruption

473

3545

1.38

9.17

7.3

7.5

0.80

1.09

mmol/l

0.84

389

2764

Other keratitis

501

3782

1.36

9.15

8.3

7.5

1.02

1.01

mmol/l

0.02

400

2956

Lateral epicondylitis

610

4728

1.32

9.15

6.4

8.0

0.91

0.99

mmol/l

0.25

471

3726

Thyrotoxicosis with toxic multinodular goitre

307

2149

1.50

9.15

6.1

6.4

1.76

1.28

mmol/l

1.42

261

1692

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

361

2.36

9.12

5.5

6.4

0.30

1.68

mmol/l

2.23

285

Postmenopausal atrophic vaginitis

859

6403

0.79

9.12

5.6

6.9

0.99

1.26

mmol/l

1.50

695

5172

Other specified and unspecified disorders of eye and adnexa

198

1265

1.65

9.11

8.0

7.6

0.60

1.09

mmol/l

0.84

165

984

Benign neoplasm: Liver

111

606

1.97

9.10

9.1

7.9

0.44

1.16

mmol/l

1.32

474

Myeloid leukaemia

138

806

1.84

9.09

10.7

7.7

1.53

1.33

mmol/l

0.19

103

626

Infection due to other mycobacteria

474

2.13

9.09

6.6

6.9

1.62

1.23

mmol/l

0.33

367

Neurofibromatosis, type 2

5.88

9.07

8.4

5.8

0.19

2.12

mmol/l

1.00

Other specified/unspecified inflammatory spondylopathies

197

1251

1.64

9.05

7.4

8.6

1.18

1.07

mmol/l

0.17

157

990

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

436

2.20

9.04

4.2

6.2

0.23

1.51

mmol/l

2.20

342

Disorders of conjunctiva

4168

31673

1.11

9.01

7.4

0.94

1.02

mmol/l

0.70

3336

24851

Parkinson's disease, strict definition

788

6342

1.28

9.00

4.9

6.5

1.78

1.07

mmol/l

5.64

648

4879

Malignant neoplasm of other connective and soft tissue

145

866

1.82

8.99

7.2

7.8

0.49

1.35

mmol/l

1.31

115

669

Sequelae of injuries of upper limb

461

3452

1.38

8.98

8.3

8.1

1.30

1.03

mmol/l

0.86

357

2698

Abnormal findings in nipple discharge synovial fluid wound secretions

441

2.16

8.98

8.6

8.7

-1.53

1.18

mmol/l

3.75

357

Benign lipomatous neoplasm

1521

12999

1.19

8.96

6.6

7.4

1.04

1.09

mmol/l

0.25

1208

10214

Acne vulgaris

245

1630

1.54

8.94

9.5

8.4

0.29

0.49

mmol/l

0.28

179

1199

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

107

584

2.00

8.94

9.0

7.6

1.72

1.40

mmol/l

0.47

446

Seborrhoeic dermatitis

486

3676

1.37

8.92

8.0

7.1

1.56

1.04

mmol/l

2.09

373

2845

Other benign neoplasms of connective and other soft tissue

482

3640

1.37

8.90

7.2

7.5

0.94

1.08

mmol/l

0.30

377

2840

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

294

2.54

8.89

8.2

6.3

-1.07

1.62

mmol/l

4.40

227

Respiratory tuberculosis

314

2218

1.48

8.89

7.4

6.8

1.38

1.17

mmol/l

0.44

260

1695

Respiratory tuberculosis, confirmed and not-confirmed

314

2218

1.48

8.89

7.4

6.8

1.38

1.17

mmol/l

0.44

260

1695

Hepatomegaly and splenomegaly, not elsewhere classified

264

2.54

8.88

14.2

8.4

0.20

0.92

mmol/l

0.57

220

Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)

210

2.80

8.88

6.1

6.4

0.31

1.44

mmol/l

0.76

166

Hypertension, portal

4.06

8.87

9.4

6.8

-0.43

1.32

mmol/l

1.32

Perichondritis of external ear

113

631

1.97

8.86

6.2

6.5

2.27

1.25

mmol/l

1.61

487

Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)

304

2.43

8.85

6.9

6.2

0.65

1.62

mmol/l

0.81

239

Delayed milestone in childhood

262

2.38

8.84

26.6

17.6

-0.69

-0.15

mmol/l

0.47

217

Collapsed vertebra, not elsewhere classified

248

2.64

8.84

10.1

5.9

1.56

1.58

mmol/l

0.01

198

Correction of physiology of bite - very demanding therapy visit

126

719

1.85

8.83

6.3

7.5

1.34

1.09

mmol/l

0.43

106

567

Medical abortion

2856

13772

1.14

8.79

6.2

6.4

0.99

1.13

mmol/l

0.99

2226

10806

Atopic dermatitis, strict definition with reimbursement

1145

9240

1.22

8.78

7.1

7.6

0.76

0.79

mmol/l

0.09

921

7049

Pilonidal cyst

355

2552

1.43

8.78

9.3

8.6

0.93

0.89

mmol/l

0.06

289

1965

Injury of blood vessels at abdomen, lower back and pelvis level

114

3.61

8.78

10.4

11.1

1.80

1.04

mmol/l

0.58

Acquired pure red cell aplasia [erythroblastopenia]

119

3.49

8.76

8.7

6.0

-0.19

1.09

mmol/l

0.76

100

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

336

2394

1.44

8.75

7.1

8.6

0.95

1.00

mmol/l

0.08

267

1866

Inflammatory disorders of male genital organs, not elsewhere classified

454

2.14

8.75

10.0

10.9

1.34

0.85

mmol/l

0.48

349

CR(E)ST syndrome

453

2.13

8.74

9.5

7.5

0.49

1.50

mmol/l

1.95

365

Viral agents as the cause of diseases classified to other chapters

115

644

1.92

8.74

9.9

8.6

0.48

1.10

mmol/l

1.05

503

Benign neoplasm of ovary

787

6337

1.27

8.70

6.1

6.2

1.21

1.27

mmol/l

0.15

617

5054

Failure of sterile precautions during surgical operation

101

4.06

8.67

7.8

8.3

1.90

1.34

mmol/l

0.29

Mixed specific developmental disorders

308

2.25

8.65

15.8

15.4

-0.06

0.34

mmol/l

0.34

249

Carcinoma in situ of skin of other and unspecified parts of face

405

3004

1.41

8.64

5.7

0.45

1.44

mmol/l

4.43

322

2282

Disorders of refraction and accommodation

1100

9117

1.22

8.63

8.7

7.6

0.92

0.90

mmol/l

0.08

872

7072

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

339

2435

1.44

8.57

6.0

7.9

0.87

1.22

mmol/l

0.76

266

1875

Pyoderma

109

605

1.94

8.57

8.2

8.4

1.15

1.12

mmol/l

0.02

473

Secondary and unspecified malignant neoplasm of lymph nodes

434

3254

1.39

8.56

7.2

7.3

1.41

1.09

mmol/l

0.91

337

2547

Other and unspecified diseases of blood and blood-forming organs

142

853

1.79

8.54

8.9

8.3

0.37

1.28

mmol/l

1.59

124

668

Neuroendocrine tumor and carcinoma of pancreas

191

2.91

8.54

8.4

8.2

1.75

1.14

mmol/l

0.50

158

Polyarteritis nodosa and related conditions

422

2.15

8.53

6.8

8.4

0.99

1.20

mmol/l

0.17

330

Disorders in reading

252

2.44

8.52

7.6

11.4

0.69

0.37

mmol/l

0.20

198

Other drug-induced secondary parkinsonism

325

2.40

8.51

4.7

9.4

2.77

1.22

mmol/l

1.23

267

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

148

897

1.76

8.49

10.0

6.0

1.30

1.38

mmol/l

0.07

121

673

Diseases of tongue

309

2192

1.47

8.48

6.0

6.7

1.51

1.21

mmol/l

0.65

244

1689

Benign neoplasm: Anus and anal canal

148

899

1.76

8.47

6.1

6.0

0.35

1.31

mmol/l

1.66

119

698

Carcinoma in situ of breast, intraductal

318

2263

1.45

8.44

5.6

6.5

1.09

1.40

mmol/l

0.80

259

1768

Hypothyroidism due to medicaments and other exogenous substances

317

2.36

8.41

6.8

6.9

0.34

1.46

mmol/l

1.76

252

Fibrosis of liver

198

2.82

8.38

10.0

7.7

1.29

1.51

mmol/l

0.10

161

Hypertrophic scar

223

1485

1.56

8.37

7.8

8.0

0.71

0.99

mmol/l

0.56

167

1148

Benign neoplasm: Other and unspecified parts of mouth

167

1047

1.69

8.37

7.3

6.5

1.15

1.30

mmol/l

0.19

132

818

Melanocytic naevi of other and unspecified parts of face

239

1615

1.53

8.35

5.5

7.1

0.83

1.23

mmol/l

0.78

177

1227

Perforation of tympanic membrane

478

3640

1.35

8.34

8.5

7.1

1.04

1.10

mmol/l

0.10

360

2837

Other disorders of iris and ciliary body

148

904

1.75

8.33

6.8

6.7

0.50

1.24

mmol/l

1.24

120

695

Ankylosing spondylitis

410

3049

1.38

8.33

6.6

8.4

1.01

0.95

mmol/l

0.11

314

2403

Acquired absence of limb

293

2.43

8.32

11.9

6.1

1.90

1.11

mmol/l

0.96

223

Carcinoma in situ of oral cavity, oesophagus and stomach

188

2.92

8.31

6.8

5.7

0.28

1.32

mmol/l

1.15

152

Atypical facial pain

235

1590

1.54

8.28

6.1

7.7

1.19

1.18

mmol/l

0.00

186

1246

Campylobacter enteritis

141

852

1.76

8.21

7.6

8.7

1.15

1.19

mmol/l

0.04

108

668

Autoimmune hyperthyroidism

261

1801

1.50

8.21

6.9

6.8

1.00

1.05

mmol/l

0.06

200

1404

Osteonecrosis due to drugs

447

2.14

8.20

9.1

7.6

1.75

1.23

mmol/l

0.63

364

Other and unspecified epidermal thickening

139

837

1.77

8.20

6.8

8.5

1.51

1.30

mmol/l

0.28

112

653

Contusion of other and unspecified parts of foot

194

1258

1.60

8.20

7.0

8.9

0.84

1.05

mmol/l

0.41

148

973

Other salmonella infections

185

1193

1.63

8.19

7.7

0.83

1.24

mmol/l

0.74

144

928

Injury of nerves at shoulder and upper arm level

334

2.30

8.18

7.3

8.4

0.46

0.79

mmol/l

0.35

268

Open wound of shoulder and upper arm

103

569

1.94

8.18

7.2

8.5

0.85

1.01

mmol/l

0.12

447

Temporomandibular joint disorders, including avohilmo

1683

14545

1.17

8.18

5.8

7.2

1.03

0.94

mmol/l

0.54

1268

11285

Dystonia

260

1801

1.51

8.15

5.9

8.1

1.42

1.05

mmol/l

0.96

208

1415

Sequelae of infectious and parasitic diseases

373

2747

1.40

8.15

7.2

7.3

1.79

1.03

mmol/l

3.18

304

2119

Other and unspecified injuries of abdomen, lower back and pelvis

393

2.15

8.15

6.4

8.1

0.74

1.03

mmol/l

0.30

305

Alzheimer’s disease (Atypical or mixed)

480

3669

1.35

8.15

3.6

5.3

1.45

1.22

mmol/l

0.54

340

2761

Postzoster neuralgia

525

2.02

8.13

6.8

6.7

2.24

1.35

mmol/l

1.49

410

Neurofibromatosis, type 1

163

2.90

8.13

7.0

12.4

-0.46

1.05

mmol/l

1.32

127

Injury of eye and orbit

635

5025

1.29

8.12

8.0

1.15

0.92

mmol/l

0.72

491

3900

Ganglion

923

7602

1.23

8.11

6.3

7.5

1.13

0.98

mmol/l

0.61

719

5973

Crystal arthropathies, rheuma endpoint

115

664

1.89

8.11

4.4

8.2

1.48

1.13

mmol/l

0.34

504

Crushed, pushed or stepped on by crowd or human stampede

279

1953

1.47

8.07

7.8

8.7

0.77

0.90

mmol/l

0.25

226

1523

Diabetes mellitus in pregnancy

940

4989

1.23

8.06

6.3

7.3

0.32

0.70

mmol/l

1.99

670

3774

Frostbite involving multiple body regions and unspecified frostbite

4.72

8.05

8.3

18.2

1.73

1.61

mmol/l

0.04

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

718

5770

1.27

8.04

7.7

8.0

0.75

0.91

mmol/l

0.55

563

4487

Secondary uncertain malignant neoplasm

668

5343

1.29

8.04

6.5

6.9

1.47

1.03

mmol/l

2.15

513

4125

Benign neoplasm of major salivary glands

504

3895

1.34

8.02

9.1

7.3

1.40

1.14

mmol/l

0.79

393

3041

Other disorders starting during childhood or adolescence

148

892

1.69

8.02

11.0

10.4

0.29

0.21

mmol/l

0.08

115

670

Other and unspecified aplastic anaemias

330

2.28

8.00

9.8

8.0

-0.35

1.32

mmol/l

1.62

260

Benign neoplasm: Parotid gland

405

3039

1.38

7.98

9.6

7.6

1.22

1.15

mmol/l

0.15

321

2382

Benign neoplasm: Other and unspecified parts of small intestine

103

579

1.96

7.98

8.1

6.6

1.07

1.27

mmol/l

0.19

463

Excessive vomiting in pregnancy

275

1921

1.47

7.97

4.6

6.7

0.78

0.91

mmol/l

0.21

205

1462

Dermatopolymyositis

469

2.05

7.94

13.7

6.9

1.46

1.16

mmol/l

0.22

376

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

132

794

1.79

7.93

10.6

7.7

1.57

1.37

mmol/l

0.27

113

615

Recurrent dislocation of patella

170

1074

1.63

7.93

8.5

8.6

1.32

0.77

mmol/l

1.07

125

812

Other and unspecified primary disorders of muscles

228

2.59

7.91

8.1

10.0

1.56

1.43

mmol/l

0.06

191

Ulcerative enterocolitis

151

935

1.70

7.91

10.0

8.0

-0.04

1.02

mmol/l

1.77

114

739

Other nutritional anaemias

325

2.29

7.90

6.2

7.8

1.22

1.55

mmol/l

0.19

251

Pneumoconiosis due to asbestos and other mineral fibres

143

882

1.75

7.90

6.6

6.5

1.80

1.18

mmol/l

1.13

110

658

Other abnormalities of plasma proteins

508

2.02

7.89

8.8

6.8

2.01

1.26

mmol/l

0.84

398

Other and unspecified injuries of shoulder and upper arm

150

930

1.71

7.88

7.9

8.1

1.49

1.06

mmol/l

0.77

125

729

Alcohol induced polyneuropathy

355

2.26

7.88

12.4

8.3

1.24

1.00

mmol/l

0.19

282

Malignant neoplasm of other and unspecified parts of mouth, excluding all cancers (controls excluding all cancers)

274

2.44

7.88

11.5

5.5

0.99

1.54

mmol/l

0.89

216

Allergic urticaria

339

2469

1.41

7.86

6.8

7.7

0.71

1.02

mmol/l

0.71

273

1899

Acute drug-induced interstitial lung disorder

263

2.51

7.85

7.7

5.7

1.33

1.00

mmol/l

0.24

209

Drug-induced thyroiditis

4.56

7.84

19.3

5.2

0.72

1.21

mmol/l

0.25

Burn and corrosion of trunk

149

924

1.71

7.84

10.2

8.3

1.41

1.07

mmol/l

0.39

117

726

Other benign neoplasms of skin

1946

17107

1.15

7.83

6.3

6.9

1.11

1.08

mmol/l

0.09

1538

13410

Rheumatic fever incl heart disease

179

1161

1.63

7.83

9.4

6.7

1.14

1.28

mmol/l

0.19

133

882

Benign neoplasm: Skin of other and unspecified parts of face

481

3698

1.34

7.82

5.4

6.7

1.17

1.31

mmol/l

0.33

372

2820

Allergic purpura

143

876

1.72

7.82

6.3

8.3

0.50

1.20

mmol/l

1.27

114

697

Benign neoplasm: Choroid

262

1834

1.49

7.81

6.5

6.7

1.18

1.31

mmol/l

0.25

200

1416

Plantar fascial fibromatosis

434

3290

1.36

7.79

6.4

7.6

1.14

1.10

mmol/l

0.07

349

2578

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

347

2542

1.40

7.76

6.5

6.7

1.04

1.06

mmol/l

0.05

270

1981

Benign neoplasm: salivary glands, exclude unknown (D119)

447

3417

1.36

7.74

9.4

7.5

1.23

1.14

mmol/l

0.18

351

2671

Pedal cyclist injured in transport accident

1005

8393

1.22

7.73

6.9

7.6

1.12

0.97

mmol/l

0.59

785

6504

Carcinoma in situ, bladder

180

1178

1.63

7.73

7.3

6.8

0.16

1.28

mmol/l

3.52

145

907

Other crystal arthropathies

115

674

1.86

7.72

4.4

7.9

1.48

1.25

mmol/l

0.21

513

Any dementia

2184

13621

1.15

7.72

4.5

6.1

1.45

1.10

mmol/l

3.19

1645

10528

Inguinal or femoral hernia, bilateral

601

4778

1.30

7.71

7.2

7.5

0.89

1.00

mmol/l

0.31

473

3678

Ulcerative colitis (strict) with PSC

185

2.69

7.70

16.0

8.9

-0.16

1.10

mmol/l

2.10

147

Cysts of oral region, not elsewhere classified

218

1477

1.54

7.69

6.6

7.7

0.94

1.07

mmol/l

0.19

173

1163

Chondrocostal junction syndrome [Tietze]

176

1140

1.62

7.68

6.6

7.7

1.17

1.19

mmol/l

0.03

141

912

Pemphigoid

156

990

1.69

7.67

4.7

6.3

1.16

1.35

mmol/l

0.24

104

770

Idiopathic thrombocytopenic purpura

156

985

1.68

7.67

8.2

7.8

0.69

1.18

mmol/l

0.87

124

765

Cystic fibrosis

4.79

7.66

8.7

4.4

0.85

0.52

mmol/l

0.12

Carcinoma in situ of rectum

300

2.40

7.64

9.3

7.4

0.48

1.19

mmol/l

0.72

245

Conjunctivitis

3613

28631

1.11

7.62

7.3

0.88

1.03

mmol/l

1.51

2882

22446

Ovarian dysfunction

216

1451

1.52

7.62

6.1

6.3

0.61

0.74

mmol/l

0.20

169

1073

Benign neoplasm: Oesophagus

400

2.14

7.61

16.8

6.8

1.33

1.15

mmol/l

0.15

316

Background retinopathy and retinal vascular changes

118

697

1.82

7.60

10.3

8.1

0.65

1.37

mmol/l

1.25

545

Bullous pemphigoid

131

800

1.78

7.59

4.7

6.7

1.21

1.39

mmol/l

0.19

623

Malignant neoplasm of nasal cavity and sinuses

215

2.64

7.55

6.2

7.4

0.78

1.20

mmol/l

0.27

171

Inguinal hernia, bilateral

590

4694

1.30

7.54

7.1

7.5

0.88

1.01

mmol/l

0.32

464

3612

Personal history of medical treatment

258

2.41

7.52

11.3

6.6

1.57

1.13

mmol/l

0.35

198

246

2.33

7.51

6.1

8.6

-0.72

0.21

mmol/l

0.76

184

Benign neoplasm: Rectosigmoid junction

228

1578

1.53

7.45

6.6

7.5

0.81

1.22

mmol/l

0.84

188

1237

Polymyositis

260

2.42

7.45

18.1

6.9

1.97

1.15

mmol/l

0.49

208

Other menopausal disorders

883

6160

0.81

7.45

6.4

7.1

1.13

1.19

mmol/l

0.17

726

4984

Lumbosacral plexus disorders

3.59

7.44

3.9

6.5

1.05

1.22

mmol/l

0.10

Propionic acid derivatives

1747

7626

1.16

7.44

7.9

1.00

mmol/l

0.02

1346

5855

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

429

2.05

7.43

9.1

7.1

0.81

1.28

mmol/l

0.67

344

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

464

2.00

7.43

6.7

8.8

1.54

1.01

mmol/l

0.78

369

Glucosamine medication

2870

20651

1.12

7.42

6.2

6.7

1.30

1.14

mmol/l

1.54

2308

16304

Disorders of phosphorus metabolism and phosphatases

125

3.16

7.42

7.5

6.1

0.07

0.97

mmol/l

0.75

103

Other and unspecified acquired haemolytic anaemias

294

2.33

7.41

12.4

8.8

1.44

1.31

mmol/l

0.10

237

Myotonic disorders

208

2.56

7.39

9.0

8.5

1.86

1.40

mmol/l

0.29

165

Acute nephritic syndrome

117

694

1.80

7.38

6.7

8.8

0.94

1.17

mmol/l

0.19

542

Scabies

197

1317

1.56

7.38

12.0

8.7

1.49

0.92

mmol/l

1.38

166

1046

Ankylosing hyperostosis [Forestier]

432

2.06

7.37

4.9

7.8

2.09

1.19

mmol/l

1.67

347

Deviated nasal septum

1788

15690

1.16

7.34

7.9

8.0

1.00

0.93

mmol/l

0.38

1432

12407

Other congenital malformations, not elsewhere classified

183

2.64

7.34

8.4

12.3

0.78

0.72

mmol/l

0.03

148

Presbycusis

771

6296

1.25

7.34

5.4

5.7

1.28

1.14

mmol/l

0.43

580

4813

Burn and corrosion of other internal organs

3.86

7.34

10.8

15.0

3.00

0.85

mmol/l

1.33

Unspecified threat to breathing

247

2.40

7.31

6.2

10.1

0.13

1.19

mmol/l

1.34

193

Contusion of toe(s) without damage to nail

100

565

1.86

7.29

7.4

8.8

0.93

1.14

mmol/l

0.20

444

Benign neoplasm of other and unspecified sites

168

1094

1.62

7.26

7.4

8.3

1.42

1.20

mmol/l

0.31

127

863

Cachexia

138

3.01

7.26

8.4

5.8

1.28

1.07

mmol/l

0.06

114

Restrictive cardiomyopathy

123

3.32

7.26

21.5

8.3

0.58

1.24

mmol/l

0.30

101

Other/unspecified postprocedural disorders of ear and mastoid process

107

3.60

7.23

7.0

6.3

2.54

1.05

mmol/l

1.57

Carcinoma in situ of other and unspecified sites

188

1260

1.59

7.22

7.1

6.8

0.24

1.24

mmol/l

3.14

152

967

Malignant neoplasm of base of tongue, excluding all cancers (controls excluding all cancers)

264

2.39

7.21

9.2

6.2

1.58

1.38

mmol/l

0.14

205

Injury of muscle and tendon at forearm level

102

586

1.87

7.20

6.2

9.7

0.56

1.09

mmol/l

0.81

480

Other and unspecified myoneural disorders

111

3.34

7.19

12.0

6.3

1.06

1.78

mmol/l

0.56

Dementia

2407

14860

1.14

7.16

4.5

6.2

1.39

1.08

mmol/l

2.88

1812

11629

Psoriatic arthropathies

466

3613

1.32

7.14

6.8

8.0

1.28

1.02

mmol/l

0.76

380

2847

Other injuries of lower limb, level unspecified

245

2.43

7.14

7.7

8.1

0.80

1.25

mmol/l

0.42

194

Toxic effect of corrosive substances

127

3.05

7.14

6.5

9.1

0.92

1.06

mmol/l

0.10

100

Hypermobility syndrome

179

1176

1.57

7.13

4.9

7.4

1.05

0.98

mmol/l

0.11

142

892

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

401

2.07

7.11

8.0

5.0

0.77

1.82

mmol/l

1.18

317

Other surgical follow-up care

144

905

1.67

7.11

8.2

7.4

0.51

1.14

mmol/l

0.83

109

699

Single spontaneous delivery

1464

9011

0.85

7.10

5.6

6.5

1.15

mmol/l

0.01

1147

7127

Sexual assault by bodily force

4.99

7.10

7.2

0.29

1.59

mmol/l

0.64

Exposure to excessive natural cold

347

2.18

7.09

10.6

9.3

1.27

1.21

mmol/l

0.04

271

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

532

1.92

7.07

5.3

5.6

1.25

1.44

mmol/l

0.20

411

Necrobiosis lipoidica, not elsewhere classified

133

2.95

7.07

5.8

11.1

1.28

1.14

mmol/l

0.08

102

Injury of muscle and tendon at wrist and hand level

666

5403

1.26

7.03

7.8

8.2

0.99

0.98

mmol/l

0.04

525

4243

Cerebral arteritis

4.10

6.92

5.0

6.6

-0.50

2.27

mmol/l

3.95

Other disorders of penis

501

3947

1.31

6.92

9.7

8.9

1.00

0.84

mmol/l

0.37

395

3103

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

802

6631

1.23

6.92

8.1

8.0

0.70

0.91

mmol/l

0.82

631

5179

Microscopic polyangiitis

199

2.66

6.91

6.5

11.3

0.30

1.50

mmol/l

1.37

166

Corneal ulcer

830

6889

1.23

6.91

7.1

7.4

1.03

0.99

mmol/l

0.11

648

5382

Other rupture of muscle

159

2.76

6.89

8.8

8.6

1.86

0.87

mmol/l

0.91

124

Panniculitis, unspecified

301

2.23

6.89

6.6

9.0

1.27

1.59

mmol/l

0.35

245

Nontoxic goitre/thyroid nodule

1447

12584

1.17

6.89

5.5

6.5

1.36

1.20

mmol/l

0.86

1161

9982

Non-small cell lung cancer, squamous, helper endpoint

270

1950

1.45

6.88

6.3

6.4

1.77

1.07

mmol/l

2.46

224

1470

Non-small cell lung cancer, squamous

270

1950

1.45

6.88

6.3

6.4

1.77

1.07

mmol/l

2.46

224

1470

Postprocedural disorders of ear and mastoid process, not elsewhere classified

312

2.26

6.86

5.8

7.3

2.51

1.28

mmol/l

1.71

244

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

144

2.98

6.84

11.2

7.0

1.72

1.28

mmol/l

0.25

116

Achilles tendinitis

476

3724

1.31

6.84

7.9

8.4

1.41

0.97

mmol/l

1.72

395

2935

Disorder of pancreatic internal secretion, other and/or unspecified

204

2.53

6.82

8.4

10.3

1.48

1.20

mmol/l

0.15

166

Atlantoaxial subluxation

198

2.57

6.82

3.6

7.1

1.38

1.47

mmol/l

0.03

166

Isolated proteinuria with specified morphological lesion

366

2.11

6.81

6.5

7.2

0.62

1.17

mmol/l

0.63

285

Anti-inflammatory and antirheumatic products, non-steroids

1736

7627

1.16

6.79

7.6

7.9

1.04

1.00

mmol/l

0.16

1336

5856

Spontaneous rupture of synovium and tendon

399

3059

1.35

6.77

7.0

7.6

1.05

1.18

mmol/l

0.32

319

2390

Haemolytic-uraemic syndrome

4.31

6.77

27.1

10.5

1.02

1.55

mmol/l

0.24

Benign neoplasm of bone and articular cartilage

319

2360

1.39

6.76

7.6

7.7

1.12

1.17

mmol/l

0.08

257

1806

Other disorders of patella

732

6007

1.24

6.76

6.7

8.1

0.96

mmol/l

0.02

570

4726

Pain and other conditions associated with female genital organs and menstrual cycle

671

5222

1.25

6.74

6.0

7.0

0.79

0.86

mmol/l

0.18

494

4077

Viral encephalitis, not elsewhere classified/unspecified

108

644

1.79

6.73

8.3

8.4

0.29

1.05

mmol/l

0.80

506

Benign neoplasm: Tongue

136

859

1.68

6.73

7.1

6.7

1.05

1.33

mmol/l

0.31

113

669

Other facial nerve disorders

135

850

1.67

6.71

5.8

9.1

1.38

1.28

mmol/l

0.09

664

conjunctival haemorrhage

380

2904

1.36

6.71

8.7

7.1

1.32

1.20

mmol/l

0.21

302

2267

Other superficial mycoses

101

590

1.82

6.71

6.4

8.7

0.95

mmol/l

0.01

473

Congenital deformities of hip

362

2.03

6.70

8.6

9.0

0.08

0.93

mmol/l

0.95

285

Ulcerative colitis (strict definition, require KELA)

734

6040

1.24

6.66

7.8

8.0

0.71

0.91

mmol/l

0.73

574

4704

Myeloproliferative diseases

427

3317

1.33

6.66

7.4

7.0

1.11

1.14

mmol/l

0.05

330

2583

Torsion of ovary, ovarian pedicle and fallopian tube

514

1.85

6.65

4.7

7.5

0.72

1.15

mmol/l

0.59

405

Traumatic ischaemia of muscle

396

2.03

6.64

10.7

9.2

0.92

1.06

mmol/l

0.11

315

Preterm labour and delivery

945

7953

1.20

6.64

6.0

7.1

1.26

1.11

mmol/l

0.54

728

6279

Female infertility, associated with anovulation

202

1377

1.49

6.63

7.5

6.7

1.11

0.39

mmol/l

1.86

139

1004

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

4.49

6.63

5.3

9.9

1.69

1.38

mmol/l

0.17

Radial styloid tenosynovitis [de Quervain]

223

1559

1.48

6.63

6.8

8.1

1.14

1.03

mmol/l

0.17

182

1224

Benign neoplasm: Other/unspecified site

446

1.95

6.61

6.6

6.2

1.57

1.48

mmol/l

0.07

351

Other female pelvic inflammatory diseases

663

5404

1.25

6.61

6.5

6.3

1.37

1.15

mmol/l

0.84

508

4290

SLE (Finngen)

154

1002

1.61

6.60

7.4

6.5

0.73

0.99

mmol/l

0.29

124

799

Disorders of optic nerve, not elsewhere classified

116

711

1.75

6.60

7.2

8.4

1.43

1.33

mmol/l

0.09

564

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

147

956

1.65

6.59

6.7

6.6

1.08

1.36

mmol/l

0.25

108

727

Multiple myeloma

147

956

1.65

6.59

6.7

6.6

1.08

1.36

mmol/l

0.25

108

727

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

217

1518

1.49

6.59

6.5

8.3

1.20

mmol/l

0.00

160

1200

Sequelae of other and unspecified effects of external causes

133

2.91

6.58

11.3

11.5

0.91

1.48

mmol/l

0.59

105

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

111

3.21

6.58

5.2

4.7

1.70

1.89

mmol/l

0.14

Reactive arthropathies, FINNGEN

313

2323

1.39

6.57

9.4

8.1

1.00

1.03

mmol/l

0.04

244

1790

Hereditary hypogammaglobulinemia

3.45

6.57

10.0

13.4

1.59

1.34

mmol/l

0.09

Lumbosacral root disorders, not elsewhere classified

384

2.05

6.57

5.8

7.8

1.69

1.29

mmol/l

0.38

303

Other abnormal uterine and vaginal bleeding

1069

6476

1.20

6.56

6.1

6.4

1.31

1.20

mmol/l

0.39

865

5163

Hyperprolactinaemia

129

804

1.67

6.55

9.0

1.47

1.00

mmol/l

0.82

106

615

Other and unspecified follicular disorders

180

1215

1.55

6.54

7.0

9.4

0.89

1.16

mmol/l

0.36

141

955

TMD muscular pain linked with fibromyalgia

206

2.43

6.54

10.0

9.8

1.41

1.23

mmol/l

0.13

163

Unspecified severe protein-energy malnutrition

4.75

6.54

16.6

5.8

1.63

1.50

mmol/l

0.02

Tuberculosis of other organs, strict

142

915

1.65

6.54

6.1

7.3

1.20

1.38

mmol/l

0.19

116

696

Bursitis of shoulder

127

795

1.69

6.51

5.2

8.3

1.25

1.22

mmol/l

0.03

105

628

Anuria and oliguria

216

2.47

6.49

9.6

8.1

1.02

1.23

mmol/l

0.12

169

Atrophic disorders of skin

614

4980

1.26

6.48

5.6

6.8

1.05

1.16

mmol/l

0.31

473

3953

Disorders of orbit

202

1398

1.51

6.46

6.9

7.9

1.40

1.14

mmol/l

0.44

159

1100

Hyphaema and other vascular disorders of iris and ciliary body

108

653

1.77

6.45

7.6

6.9

0.31

1.25

mmol/l

1.36

498

Erythema multiforme

117

720

1.72

6.45

7.3

7.8

1.74

1.31

mmol/l

0.79

570

Gastrointestinal stromal tumor and sarcoma

412

2.03

6.43

5.5

6.9

0.30

1.33

mmol/l

1.47

331

Mesothelioma, excluding all cancers (controls excluding all cancers)

446

1.96

6.43

9.0

6.0

1.82

1.37

mmol/l

0.62

339

Liposarcoma

272

2.31

6.43

8.3

7.4

0.25

0.95

mmol/l

0.69

216

Neuroendocrine tumor and carcinoma of small intestine

492

1.92

6.41

4.2

7.3

0.23

1.24

mmol/l

1.52

393

Residual foreign body in soft tissue

226

1598

1.47

6.40

7.8

8.7

0.93

1.03

mmol/l

0.16

186

1255

Injury of muscle and tendon at shoulder and upper arm level

1942

17315

1.14

6.40

6.9

7.8

1.06

0.98

mmol/l

0.43

1539

13721

Fenamates

817

4578

1.22

6.39

6.3

7.8

0.92

1.05

mmol/l

0.37

634

3551

Hallux rigidus

687

5651

1.24

6.39

6.9

7.4

0.94

1.15

mmol/l

0.74

550

4467

Congenital deformities of feet

103

611

1.77

6.39

5.9

8.3

1.31

0.95

mmol/l

0.42

497

Noninflammatory disorders of female genital tract

1857

8235

1.14

6.39

5.9

6.7

0.93

1.04

mmol/l

0.49

1391

6414

Palmar fascial fibromatosis [Dupuytren]

865

7279

1.22

6.38

7.7

7.2

0.83

1.05

mmol/l

1.02

673

5669

Adalimumab

352

2668

1.35

6.38

8.5

8.3

0.68

0.95

mmol/l

0.65

277

2095

Other autoimmune haemolytic anaemias

404

2.02

6.38

7.1

8.5

0.63

1.09

mmol/l

0.42

335

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

277

2.24

6.37

9.6

5.7

1.10

1.60

mmol/l

0.31

218

Macular pucker

790

6609

1.23

6.35

6.6

6.7

0.87

1.14

mmol/l

1.16

625

5168

Calcific tendinitis of shoulder

264

1921

1.42

6.34

6.2

8.5

1.32

1.11

mmol/l

0.50

198

1530

Respiratory tuberculosis, confirmed

107

648

1.76

6.32

8.8

7.2

1.23

1.33

mmol/l

0.09

493

Malignant neoplasm of bone and articular cartilage of limbs

119

3.05

6.32

12.5

12.1

0.84

0.66

mmol/l

0.13

103

Congenital musculoskeletal deformities of head, face, spine and chest

268

2.19

6.30

4.6

10.2

1.57

0.56

mmol/l

1.06

210

Respiratory tuberculosis, bacteriologically and histologically confirmed

110

672

1.75

6.28

8.6

7.2

1.24

1.32

mmol/l

0.08

512

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1206

10410

1.17

6.28

7.5

7.9

1.06

0.93

mmol/l

0.64

947

8107

Other specified and unspecified retinal disorders

182

1247

1.54

6.28

6.1

7.7

0.23

1.19

mmol/l

2.52

139

974

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

131

2.90

6.26

8.0

6.0

0.85

1.57

mmol/l

0.33

102

Mild or no visual impairment, binocular

131

2.88

6.25

5.1

5.4

0.90

1.04

mmol/l

0.08

100

Tuberculosis of other organs

127

809

1.68

6.21

6.3

7.6

1.30

1.46

mmol/l

0.16

103

623

Other and unspecified medical devices associated with adverse incidents

170

2.69

6.20

9.2

7.6

0.11

1.14

mmol/l

1.14

141

Bicipital tendinitis

235

1687

1.45

6.20

6.9

7.9

0.80

1.08

mmol/l

0.57

193

1338

Acute lymphadenitis

243

1748

1.43

6.19

8.6

8.2

0.92

1.01

mmol/l

0.13

185

1342

Polypectomy (DHB20)

351

2685

1.35

6.17

7.4

8.1

1.17

1.03

mmol/l

0.29

262

2103

Benign neoplasm: Pharynx, unspecified

193

2.46

6.16

7.3

6.1

1.71

1.38

mmol/l

0.21

156

Atopic dermatitis, strict definition

1073

9001

1.18

6.14

7.1

8.0

0.67

0.78

mmol/l

0.40

865

6861

Nonspecific lymphadenitis

256

1862

1.42

6.13

7.3

8.2

1.20

1.03

mmol/l

0.31

191

1473

Drug-induced obesity

219

2.34

6.12

10.7

9.4

1.43

1.10

mmol/l

0.22

174

Benign neoplasm: Pancreas

146

965

1.62

6.12

8.0

7.2

0.79

1.26

mmol/l

1.02

119

748

Haemorrhagic disorder due to circulating anticoagulants

440

1.96

6.11

9.5

7.7

1.13

1.33

mmol/l

0.13

332

Pigmented purpuric dermatosis

317

2.13

6.10

5.1

6.8

1.84

1.21

mmol/l

0.94

257

Pedal cyclist injured in other and unspecified transport accidents

491

3915

1.28

6.08

6.8

7.7

1.10

0.99

mmol/l

0.27

390

3030

Premature rupture of membranes

400

3786

0.77

6.06

7.2

7.0

0.91

0.68

mmol/l

0.57

277

2852

Bacterial, viral and other infectious agents

379

2928

1.33

6.06

8.8

8.7

0.48

1.03

mmol/l

1.67

300

2304

Benign neoplasm: Heart

117

3.10

6.05

14.4

5.8

1.96

1.58

mmol/l

0.18

Hodgkin lymphoma, hilmo

138

897

1.62

6.05

9.6

8.4

1.43

1.13

mmol/l

0.48

109

708

Tetraplegia

236

2.33

6.04

15.6

10.1

2.52

1.08

mmol/l

1.22

187

Personal history of allergy to drugs, medicaments and biological substances

260

2.20

6.03

9.2

8.1

1.82

1.40

mmol/l

0.27

206

Injury of blood vessels at neck level

117

3.02

5.98

14.7

6.3

0.79

0.81

mmol/l

0.00

Malignant neoplasm of liver and intrahepatic bile ducts

182

1262

1.52

5.98

8.3

7.3

0.26

1.13

mmol/l

2.14

138

969

Other and/or unspecified nontoxic goitre

384

2982

1.33

5.98

5.7

6.6

1.12

1.23

mmol/l

0.23

319

2332

Other specified/unspecified bacterial intestinal infections

310

2340

1.37

5.97

7.4

0.90

1.19

mmol/l

0.60

241

1823

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

126

803

1.64

5.96

7.4

8.7

0.92

1.10

mmol/l

0.25

106

639

Medial epicondylitis

170

1157

1.53

5.94

5.6

9.2

0.90

1.19

mmol/l

0.41

143

923

Supervision of normal pregnancy

428

3127

0.77

5.93

5.0

8.0

0.41

0.85

mmol/l

2.08

316

2403

Vasomotor and allergic rhinitis

1639

14290

1.14

5.91

7.0

7.6

0.90

0.89

mmol/l

0.03

1275

11146

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

178

2.51

5.90

8.9

5.5

1.16

1.87

mmol/l

0.56

147

Juvenile rheumatoid arthirtis

451

1.85

5.89

8.0

10.5

0.99

1.08

mmol/l

0.07

353

Abscess of external ear

405

1.93

5.85

7.8

8.9

0.66

1.06

mmol/l

0.24

321

Disorders of synovium and tendon in diseases classified elsewhere

110

685

1.71

5.85

5.2

8.7

1.06

1.18

mmol/l

0.12

539

Giant cell arteritis

218

1568

1.46

5.85

6.8

6.4

1.12

1.19

mmol/l

0.11

180

1215

Histrionic personality disorder

148

2.69

5.85

3.2

6.6

1.87

1.46

mmol/l

0.32

116

Chronic lymphocytic leukaemia

167

1147

1.55

5.85

8.0

7.3

1.15

1.31

mmol/l

0.25

133

888

Other disorders of pigmentation

206

1462

1.47

5.84

5.5

7.6

1.53

1.11

mmol/l

1.17

155

1145

Injury of nerves at wrist and hand level

176

1212

1.51

5.84

10.1

9.3

0.81

1.08

mmol/l

0.52

143

964

Acute epiglottitis

457

1.87

5.83

9.6

8.4

1.31

1.08

mmol/l

0.21

362

Optic atrophy

594

1.76

5.82

10.8

10.0

0.93

1.15

mmol/l

0.17

468

Benign neoplasm: Larynx

151

1011

1.57

5.80

5.7

7.5

1.43

1.30

mmol/l

0.16

121

783

Benign neoplasm: Peripheral nerves and autonomic nervous system

451

1.88

5.79

8.5

8.6

1.31

1.56

mmol/l

0.21

345

Other hereditary haemolytic anaemias

167

2.55

5.79

6.4

7.2

0.96

1.14

mmol/l

0.08

132

Traction detachment of retina

267

2.19

5.77

10.6

7.0

0.12

1.13

mmol/l

0.89

205

Pustular psoriasis

214

1532

1.45

5.76

6.7

8.2

1.31

1.21

mmol/l

0.12

178

1218

Diseases of middle ear and mastoid

2620

19492

1.11

5.76

7.7

7.5

0.85

0.94

mmol/l

0.48

1996

15090

Dislocation, sprain and strain of joints and ligaments of head

158

1064

1.54

5.75

7.3

8.7

1.19

0.95

mmol/l

0.39

127

826

Other proliferative retinopathy

125

2.86

5.74

9.7

7.4

0.40

1.09

mmol/l

0.40

Malignant neoplasm of other and unspecified parts of biliary tract

486

1.87

5.74

9.3

7.4

0.58

1.31

mmol/l

0.93

387

Synovial cyst of popliteal space [Baker]

349

2692

1.34

5.74

7.9

7.4

1.02

1.26

mmol/l

0.50

292

2112

Horner syndrome

395

1.95

5.74

6.3

9.2

0.80

1.20

mmol/l

0.30

323

Hyperkinetic disorders (excl. ADHD)

301

2.03

5.73

5.8

11.4

0.34

0.46

mmol/l

0.11

247

Peptic ulcer

309

2.08

5.72

7.4

6.4

0.44

1.42

mmol/l

0.99

242

Exposure to ignition or melting of other clothing and apparel

3.48

5.72

9.0

7.0

2.19

1.12

mmol/l

0.49

Hypertrichosis

397

1.89

5.71

7.4

6.8

1.03

0.93

mmol/l

0.08

300

Other lack of coordination

521

1.81

5.71

4.5

8.7

1.05

1.29

mmol/l

0.23

414

Pedestrian injured in collision with pedal cycle

154

1040

1.55

5.68

9.3

8.3

1.21

1.23

mmol/l

0.03

130

817

Convergent concomitant strabismus

220

1580

1.43

5.67

11.5

8.6

1.17

1.05

mmol/l

0.16

163

1230

Carcinoma in situ of skin of trunk

154

1045

1.56

5.67

7.3

5.7

0.62

1.24

mmol/l

1.14

122

790

Adenocarcinoma and ductal carcinoma of pancreas

183

1286

1.50

5.63

8.1

7.3

1.19

1.20

mmol/l

0.02

156

1006

Exposure to uncontrolled fire in building or structure

208

2.34

5.63

8.3

9.1

1.52

1.03

mmol/l

0.29

166

Cystic fibrosis, other manifestations/unspecified

5.30

5.63

10.2

4.1

0.51

0.98

mmol/l

—

Hyperhidrosis

107

663

1.67

5.61

3.9

7.0

0.66

0.76

mmol/l

0.11

524

Rare circulating lymphoid malignancy

161

1103

1.54

5.61

7.0

8.2

1.49

1.02

mmol/l

0.80

119

863

Use of levodopa decarbox-comt-inhibitor

184

1298

1.50

5.60

4.2

7.1

1.76

1.15

mmol/l

1.57

154

996

Other chondrocalcinosis

461

1.89

5.60

3.5

8.4

1.66

1.45

mmol/l

0.14

362

Pustulosis palmaris et plantaris

192

1356

1.47

5.59

6.5

8.3

1.36

1.23

mmol/l

0.16

158

1074

Macular hole

288

2181

1.38

5.59

5.3

6.7

0.70

1.18

mmol/l

1.26

237

1707

Other and unspecified types of non-Hodgkin lymphoma, hilmo

220

1597

1.44

5.58

8.6

7.3

1.61

1.18

mmol/l

0.69

163

1232

Other abnormal findings of blood chemistry

202

1441

1.46

5.58

7.0

8.1

1.00

1.04

mmol/l

0.04

154

1133

Iliotibial band syndrome

268

2.12

5.56

7.4

6.6

1.07

1.12

mmol/l

0.04

217

Dementia, including avohilmo

2555

16043

1.11

5.54

4.6

6.4

1.40

1.09

mmol/l

3.03

1935

12567

Combined immunodeficiencies

334

2.01

5.53

11.4

8.8

1.90

1.06

mmol/l

0.95

266

Other and unspecified glaucoma

357

2783

1.33

5.52

7.3

6.5

0.58

1.22

mmol/l

2.20

280

2155

Injury of muscle and tendon at hip and thigh level

428

3403

1.29

5.52

8.5

8.0

0.97

mmol/l

0.00

349

2666

Migraine without aura, drug-induced

269

2.10

5.50

4.4

9.2

0.99

1.36

mmol/l

0.26

214

Oligomenorrhoea

126

816

1.59

5.48

6.4

7.0

0.21

1.03

mmol/l

1.28

101

640

Benign lipomatous neoplasm of other sites/unspecified

387

3043

1.31

5.47

6.8

6.7

0.87

1.27

mmol/l

1.37

316

2311

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

505

1.80

5.46

6.7

5.6

1.28

1.42

mmol/l

0.12

384

Carcinoma in situ of skin of upper limb, including shoulder

133

887

1.61

5.46

9.0

6.5

0.62

1.38

mmol/l

1.20

103

690

Carcinoma in situ of skin of scalp and neck

128

845

1.62

5.46

6.6

5.8

0.03

1.27

mmol/l

2.67

107

640

Deficiency of other B group vitamins

108

682

1.68

5.44

9.7

7.5

0.35

1.27

mmol/l

1.38

524

Benign neoplasm: Skin of ear and external auricular canal

179

1255

1.49

5.44

6.3

6.5

1.32

1.22

mmol/l

0.13

147

952

Benign neoplasm: Carotid body

3.61

5.43

4.5

17.3

1.95

1.38

mmol/l

0.27

Superficial injuries involving multiple body regions

117

751

1.63

5.42

10.6

8.6

0.98

1.16

mmol/l

0.14

595

Recurrent dislocation and subluxation of joint

268

2002

1.37

5.40

7.2

8.6

1.00

1.05

mmol/l

0.07

214

1563

UC patients in KELA-register (code 208), prior to 1994

226

1655

1.42

5.40

10.1

8.1

0.72

1.18

mmol/l

0.91

174

1299

Nonsuppurative otitis media

852

6249

1.19

5.40

9.2

7.5

0.78

mmol/l

0.01

655

4684

Other disorders of the genitourinary system

590

4872

1.24

5.40

7.6

6.5

0.71

1.24

mmol/l

2.09

457

3842

Myeloid leukaemia

138

925

1.58

5.39

10.7

7.8

1.53

1.34

mmol/l

0.19

103

718

Injury of blood vessels at hip and thigh level

113

3.04

5.38

18.4

6.2

2.10

1.06

mmol/l

0.64

Maternal care for other conditions predominantly related to pregnancy

597

4845

1.23

5.38

8.0

7.2

0.70

0.77

mmol/l

0.17

444

3704

Bitten or struck by other mammals

414

3283

1.29

5.37

9.3

7.9

0.84

0.94

mmol/l

0.19

325

2533

Rheumatic valve diseases

126

828

1.60

5.35

9.1

6.0

1.08

1.23

mmol/l

0.15

625

Reactive arthropathies

390

3076

1.30

5.35

9.6

8.0

1.03

1.05

mmol/l

0.04

308

2398

Other and unspecified injuries of ankle and foot

157

1073

1.51

5.35

8.5

8.4

0.60

1.16

mmol/l

1.11

128

850

Carcinoma in situ of cervix uteri

236

1727

1.39

5.34

6.2

0.67

0.78

mmol/l

0.14

174

1266

Leiomyosarcoma

242

2.23

5.33

5.9

9.0

0.28

1.45

mmol/l

1.56

191

Prepatellar bursitis

230

1692

1.41

5.33

6.3

8.7

0.56

1.06

mmol/l

1.14

181

1338

Chronic hepatitis NAS

404

1.89

5.32

11.1

8.4

-0.49

1.25

mmol/l

2.00

323

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

518

1.79

5.32

5.2

6.2

1.44

1.48

mmol/l

0.04

400

Thyroiditis

294

2238

1.35

5.31

7.9

7.4

1.38

1.13

mmol/l

0.59

240

1742

Injury of cranial nerves

187

2.38

5.30

6.9

7.4

0.63

1.34

mmol/l

0.52

149

Other acquired deformities of musculoskeletal system and connective tissue

223

1633

1.42

5.30

7.6

8.2

1.65

1.05

mmol/l

1.72

168

1291

Inflammatory disorders of breast

213

1540

1.42

5.29

6.6

6.7

0.88

1.04

mmol/l

0.24

158

1168

Lesion of sciatic nerve

240

1781

1.40

5.29

6.0

6.2

1.11

1.21

mmol/l

0.15

187

1364

Delivery

1511

9025

0.88

5.27

6.0

6.5

1.12

1.15

mmol/l

0.10

1181

7137

Fitting and adjustment of other devices

1455

15241

0.88

5.27

5.8

6.2

1.21

1.08

mmol/l

0.59

1071

11860

Oral leukoplakia

101

636

1.70

5.27

6.6

7.0

1.72

1.24

mmol/l

0.74

508

Common variable immunodeficiency

161

2.48

5.27

8.3

11.0

0.51

1.43

mmol/l

0.57

127

Hypersensitivity angiitis

176

2.47

5.26

9.1

9.9

-0.67

1.46

mmol/l

1.81

143

Sleep disorders, other/unspecified

125

818

1.58

5.26

8.3

8.9

0.84

0.97

mmol/l

0.12

104

644

Malignant neoplasm of cervix uteri

389

1.88

5.25

7.1

5.9

1.33

1.34

mmol/l

0.01

312

Liver disorders in diseases classified elsewhere

3.41

5.24

11.2

6.9

0.27

1.51

mmol/l

0.76

Pediculosis, acariasis and other infestations

252

1881

1.38

5.23

11.3

8.5

1.21

1.02

mmol/l

0.36

213

1481

Other erythematous conditions

163

1133

1.50

5.23

6.8

7.7

1.46

1.24

mmol/l

0.26

130

897

Malignant neoplasm of renal pelvis

204

2.37

5.22

7.4

6.2

-0.61

1.09

mmol/l

1.22

158

Chronic Coagulation defects

616

1.68

5.21

11.1

9.1

0.93

1.22

mmol/l

0.28

486

Unspecified/other endometriosis

283

2139

1.35

5.21

4.9

6.6

0.85

mmol/l

0.01

211

1647

Polyp of the female genital tract

1418

7271

1.15

5.20

6.2

6.7

1.13

1.18

mmol/l

0.17

1135

5794

Blindness, monocular

285

2.08

5.19

9.2

9.0

1.17

1.25

mmol/l

0.05

229

Chromosomal abnormalities, not elsewhere classified

454

1.79

5.19

15.2

11.6

0.57

0.68

mmol/l

0.08

354

Chronic myeloid leukaemia [CML], BCR/ABL-positive

300

2.05

5.17

9.6

7.2

1.10

1.13

mmol/l

0.01

246

Disorders of aromatic amino-acid metabolism

3.25

5.16

3.3

5.8

0.43

0.89

mmol/l

0.22

Hepatocellular carcinoma

122

808

1.62

5.16

8.8

7.7

0.23

1.17

mmol/l

1.87

609

Iron deficiency

374

1.86

5.14

9.8

8.4

1.87

0.87

mmol/l

1.45

280

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

198

1432

1.44

5.13

8.0

8.1

1.29

1.16

mmol/l

0.19

157

1119

Other and unspecified mental retardation

369

1.89

5.12

9.7

11.9

0.90

0.57

mmol/l

0.26

297

Benign neoplasm: Heart

128

2.80

5.11

14.4

6.4

1.96

1.54

mmol/l

0.20

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

108

695

1.65

5.10

11.8

7.2

1.54

1.40

mmol/l

0.18

547

Non-Hodgkin lymphoma, all

212

1555

1.43

5.10

8.4

7.2

1.44

1.20

mmol/l

0.26

156

1191

Other and unspecified rosacea

368

2904

1.30

5.10

6.9

7.5

0.93

1.08

mmol/l

0.26

268

2261

Other overlap syndromes

537

1.74

5.09

6.1

8.2

0.74

1.31

mmol/l

0.60

424

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

611

5093

1.22

5.07

6.4

7.7

1.00

1.07

mmol/l

0.21

488

3966

Degenerative conditions of globe

158

2.48

5.07

2.8

6.1

2.12

1.32

mmol/l

0.63

124

Contact with other hot fluids

126

836

1.57

5.04

5.5

8.8

1.12

0.97

mmol/l

0.18

663

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

3.00

5.04

5.0

13.8

0.50

1.48

mmol/l

0.77

Moderate mental retardation

151

2.47

5.03

6.9

12.3

2.78

1.38

mmol/l

1.42

118

Lichen planus

609

5083

1.23

5.02

6.4

7.2

1.09

1.14

mmol/l

0.13

460

3979

Perineal laceration during delivery

259

3058

0.75

5.02

5.3

6.7

0.55

0.59

mmol/l

0.05

181

2247

Benign neoplasm: Brain, unspecified

158

2.45

5.02

8.5

9.3

2.10

1.25

mmol/l

0.84

128

Muscular dystrophy

239

2.16

5.02

4.3

10.6

1.24

1.11

mmol/l

0.06

200

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

296

2.04

5.01

7.0

8.8

1.59

1.04

mmol/l

0.37

240

Mucinous and mucinous cystic tumor of rectum

168

2.51

4.99

11.2

7.3

1.72

1.19

mmol/l

0.33

135

Other ill-defined and unspecified causes of mortality

315

2454

1.33

4.97

6.3

6.6

2.48

1.17

mmol/l

7.23

230

1866

Sequelae of tuberculosis

106

683

1.64

4.96

4.5

6.0

2.96

1.37

mmol/l

3.21

517

Systemic lupus erythematosus

154

1069

1.50

4.95

7.4

7.6

0.73

1.14

mmol/l

0.53

124

848

Essential (haemorrhagic) thrombocythaemia

168

1188

1.47

4.94

7.3

6.2

0.70

1.25

mmol/l

0.81

129

918

Other injuries of upper limb, level unspecified

296

2.00

4.93

10.8

6.9

0.48

1.01

mmol/l

0.50

231

Contact with sharp object, undetermined intent

587

1.68

4.93

9.1

9.9

0.11

1.00

mmol/l

1.78

478

Congenital iodine-deficiency syndrome/hypothyroidism

142

973

1.52

4.93

7.6

6.1

1.23

1.21

mmol/l

0.02

112

755

Defects in the complement system

172

2.35

4.93

10.2

7.9

1.83

1.45

mmol/l

0.25

127

Melanocytic naevi of upper limb, including shoulder

619

1.66

4.91

5.9

7.5

0.97

1.31

mmol/l

0.39

474

Other primary thrombocytopenia

104

2.85

4.90

8.2

12.6

-0.48

2.07

mmol/l

1.27

Adenocarcinoma and papillary adenocarcinoma of stomach

148

1026

1.51

4.90

10.0

6.8

1.30

1.23

mmol/l

0.06

121

771

Benign neoplasm: Conjunctiva

135

916

1.54

4.89

7.1

0.70

1.31

mmol/l

1.11

109

708

Leukaemia of unspecified cell type

248

2.11

4.89

10.8

7.9

1.56

1.42

mmol/l

0.10

186

Effects of foreign body entering through natural orifice

1136

9968

1.16

4.88

7.5

8.2

1.15

0.93

mmol/l

1.14

904

7768

Dental caries 2

3186

27072

0.92

4.88

7.9

7.7

0.67

1.01

mmol/l

5.40

2563

21259

TMD related pain

127

849

1.55

4.87

7.1

8.2

1.33

1.19

mmol/l

0.26

663

Colonic or urogenital fistula

1316

11663

1.14

4.87

8.0

7.4

0.93

1.00

mmol/l

0.27

1042

9159

Atypical mycobacterium lung infection

364

1.90

4.86

5.3

7.7

2.86

1.20

mmol/l

2.47

287

Etanercept

245

1841

1.37

4.86

9.4

8.5

1.25

1.01

mmol/l

0.44

193

1448

Drug-induced tremor

209

2.26

4.86

5.0

7.0

1.38

1.35

mmol/l

0.02

173

Other bursitis of knee

446

1.80

4.85

5.2

8.3

0.67

1.13

mmol/l

0.42

350

Follicular lymphoma

188

1361

1.44

4.84

6.9

6.7

1.95

1.21

mmol/l

1.93

147

1047

Carcinoma in situ of skin of lower limb, including hip

103

666

1.65

4.84

8.9

5.4

0.97

1.35

mmol/l

0.43

513

Anomalies of pupillary function

551

1.70

4.84

7.3

9.2

1.25

1.19

mmol/l

0.06

445

Hypermetropia

281

2154

1.34

4.84

7.1

7.8

0.91

0.97

mmol/l

0.10

213

1669

Hordeolum and other deep inflammation of eyelid

235

1759

1.38

4.83

6.9

8.6

0.84

1.07

mmol/l

0.38

193

1368

Atopic conjunctivitis

172

1223

1.45

4.80

5.4

7.8

1.38

0.95

mmol/l

0.83

136

957

Vascular dementia (subcortical)

154

1081

1.50

4.80

4.4

5.8

1.56

1.36

mmol/l

0.23

127

822

Malignant neoplasm of vulva

316

1.99

4.79

7.2

5.3

0.71

1.73

mmol/l

0.87

251

Personality and behavioural disorders due to brain disease, damage and dysfunction

501

1.74

4.78

7.7

8.7

2.43

1.08

mmol/l

2.03

406

Postpartum care and examination

370

1854

1.29

4.78

5.8

7.4

0.54

0.80

mmol/l

0.59

248

1358

Sequelae of other accidents

478

1.76

4.78

5.6

7.2

1.48

1.20

mmol/l

0.17

371

Myopia

448

3634

1.25

4.77

8.4

7.6

0.97

0.83

mmol/l

0.31

349

2790

Benign neoplasm of eye and adnexa

472

3866

1.25

4.77

7.0

7.1

1.00

1.15

mmol/l

0.41

367

3005

Bacterial meningitis

162

1146

1.47

4.76

8.5

9.3

0.91

1.21

mmol/l

0.50

132

905

Burns and corrosions of multiple body regions

250

2.08

4.76

9.3

1.38

0.96

mmol/l

0.40

211

Dermatographic urticaria

250

1890

1.36

4.75

5.9

7.9

1.54

1.02

mmol/l

1.47

186

1472

Spinal instabilities

123

824

1.55

4.74

7.2

9.3

1.29

1.31

mmol/l

0.02

100

669

Use of antiglaucoma preparations and miotics

416

3369

1.27

4.71

6.1

5.9

0.79

1.26

mmol/l

1.34

308

2593

Syndrome of inappropriate secretion of antidiuretic hormone

199

2.31

4.71

7.0

5.9

0.97

1.54

mmol/l

0.44

156

Other lesions of median nerve

141

977

1.51

4.68

6.2

7.1

0.81

1.22

mmol/l

0.43

107

766

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

210

1554

1.40

4.67

5.5

5.8

1.46

1.27

mmol/l

0.30

167

1179

Other and unspecified erythematous conditions

145

1010

1.50

4.66

6.9

8.0

1.46

1.27

mmol/l

0.21

117

807

Caught, crushed, jammed or pinched in or between objects

204

1503

1.40

4.66

8.5

9.2

1.21

1.00

mmol/l

0.35

155

1189

Infections with a predominantly sexual mode of transmission

1098

9622

1.15

4.65

8.3

7.4

0.76

0.85

mmol/l

0.32

873

7377

Fasciculation

309

1.94

4.64

4.7

9.1

2.40

0.83

mmol/l

2.20

246

Burn and corrosion of hip and lower limb, except ankle and foot

106

692

1.60

4.64

10.4

8.4

1.22

1.16

mmol/l

0.06

544

Melanocytic naevi of lower limb, including hip

162

1148

1.46

4.64

5.8

8.0

0.55

1.24

mmol/l

1.45

126

888

Open wound of wrist and hand

2083

18776

1.11

4.64

8.1

8.0

0.83

0.93

mmol/l

0.55

1636

14696

Other osteochondrodysplasias

203

2.17

4.63

7.1

10.8

1.18

1.31

mmol/l

0.07

165

Drug-induced systemic lupus erythematosus

191

2.25

4.62

9.9

5.6

-0.18

1.33

mmol/l

1.04

151

Polycythaemia vera

167

1197

1.46

4.61

5.9

7.1

0.97

1.29

mmol/l

0.36

123

923

Use of rasagiline

141

985

1.52

4.61

3.6

7.4

1.96

1.22

mmol/l

1.41

117

767

Pedal cyclist injured in noncollision transport accidents

472

3872

1.24

4.61

7.7

8.0

1.12

0.97

mmol/l

0.34

379

2998

Unspecified visual impairment (binocular)

429

1.78

4.61

10.2

10.0

0.45

1.30

mmol/l

0.73

351

Hirsutism in women

336

1.86

4.60

7.8

6.3

1.05

0.87

mmol/l

0.16

254

Tuberous sclerosis 1

4.29

4.60

5.2

8.3

-0.06

1.44

mmol/l

—

Other noninflammatory disorders of vulva and perineum

339

2679

1.29

4.59

5.9

6.4

0.76

1.10

mmol/l

0.98

269

2128

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

298

1.98

4.59

8.0

6.5

2.21

1.34

mmol/l

0.76

225

All dysplastic lesions of the vulva

168

1203

1.44

4.56

6.4

6.7

0.88

1.27

mmol/l

0.62

132

938

Nasal polyp

981

8576

1.16

4.55

6.9

7.6

1.17

0.95

mmol/l

1.10

741

6708

Molar incisor enamel hypoplasia

439

1.72

4.54

16.3

12.5

-0.55

0.22

mmol/l

0.91

338

Cholesteatoma of external ear

257

2.08

4.54

5.4

6.6

2.05

1.12

mmol/l

0.76

198

HSIL lesion of the cervix uteri, vagina or vulva

589

4933

1.21

4.51

6.6

6.4

0.74

0.85

mmol/l

0.27

442

3752

Unspecified chronic bronchitis

166

1189

1.44

4.51

9.5

7.1

1.81

0.84

mmol/l

2.71

127

900

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

172

1244

1.44

4.49

7.3

7.0

1.25

1.18

mmol/l

0.06

138

975

Pyogenic granuloma

493

1.71

4.49

6.2

7.9

1.51

1.13

mmol/l

0.27

395

Temporal arteritis

189

1393

1.42

4.48

6.9

6.5

0.99

1.20

mmol/l

0.35

154

1076

Benign neoplasm: Skin of eyelid, including canthus

740

6349

1.19

4.47

6.4

7.0

1.06

1.13

mmol/l

0.17

585

4950

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

536

4456

1.22

4.47

6.3

1.15

0.90

mmol/l

0.96

417

3409

Benign neoplasm: Other and unspecified parts of mouth

167

1204

1.45

4.47

7.3

7.7

1.15

1.27

mmol/l

0.14

132

948

Carcinoma in situ of lip, oral cavity and pharynx

3.14

4.46

6.9

6.5

0.49

1.67

mmol/l

0.73

Folate deficiency anaemia

272

2.01

4.45

10.7

9.0

0.91

1.15

mmol/l

0.12

213

Pulmonary eosinophilia, not elsewhere classified

405

1.81

4.45

6.9

7.0

1.75

1.29

mmol/l

0.38

327

Effects of other external causes

110

729

1.56

4.44

6.3

9.1

0.58

0.93

mmol/l

0.62

573

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

498

1.73

4.44

8.4

5.8

1.87

1.34

mmol/l

0.51

381

Exophthalmic conditions

322

1.90

4.43

8.2

9.2

1.95

1.31

mmol/l

0.78

260

HSIL lesion of the vulva

480

1.72

4.43

4.5

6.1

0.44

1.50

mmol/l

1.35

382

Benign neoplasm: Orbit, unspecified

174

2.28

4.43

7.3

9.1

0.48

1.39

mmol/l

1.63

138

Certolizumab pegol

356

1.82

4.43

8.3

8.5

-0.18

1.07

mmol/l

1.19

281

Inflammatory diseases of prostate (prostatitis)

696

5954

1.19

4.41

7.1

8.6

1.16

0.83

mmol/l

1.57

548

4734

Drug-induced polyneuropathy

273

2.01

4.41

6.2

7.1

0.50

1.31

mmol/l

0.91

223

Other/unspecified soft tissue disorders related to use, overuse and pressure

126

863

1.52

4.39

7.1

7.4

1.35

1.15

mmol/l

0.23

100

684

Arthropathy in ulcerative colitis

345

1.85

4.36

7.6

10.1

1.19

1.17

mmol/l

0.02

268

Personal history of malignant neoplasm

150

1063

1.46

4.35

8.6

6.4

1.12

1.29

mmol/l

0.26

116

840

Complications of labour and delivery

2135

13051

0.91

4.34

6.5

6.9

0.96

1.11

mmol/l

1.01

1654

10346

Astigmatism

237

1803

1.35

4.33

13.6

7.8

0.88

0.91

mmol/l

0.04

204

1391

Other acute skin changes due to ultraviolet radiation

169

1227

1.43

4.33

6.0

8.0

0.79

1.28

mmol/l

0.66

130

962

Primary ovarian failure

373

1.79

4.33

9.8

7.5

0.62

1.15

mmol/l

0.37

286

Biological medicines for asthma

338

1.85

4.33

7.6

10.1

1.65

1.20

mmol/l

0.60

261

Ulcerative proctitis

247

1893

1.34

4.32

7.4

8.0

1.14

1.04

mmol/l

0.15

197

1473

Benign neoplasm of breast

421

3437

1.25

4.30

6.8

6.2

1.26

1.41

mmol/l

0.36

353

2697

Senility

264

1.96

4.30

3.5

4.4

0.03

1.52

mmol/l

1.17

205

Ulcer of oesophagus, drug-induced

185

2.27

4.30

6.7

5.6

2.87

0.85

mmol/l

3.15

149

Malignant neoplasm of breast

2261

14942

1.10

4.30

5.5

6.3

1.19

1.28

mmol/l

0.54

1871

11922

Dental caries 2 and operation codes

3116

26646

0.92

4.30

7.9

7.7

0.70

1.00

mmol/l

4.42

2499

20914

Retinal detachment with retinal break

652

5562

1.20

4.29

7.3

7.0

0.58

1.08

mmol/l

2.31

518

4314

Otorrhagia

219

2.13

4.29

11.8

8.1

1.33

0.96

mmol/l

0.27

178

Benign neoplasm: Anus and anal canal

148

1055

1.47

4.28

6.1

6.7

0.35

1.27

mmol/l

1.56

119

825

Nonalcoholic steatohepatitis

225

2.09

4.28

7.0

10.7

0.58

1.31

mmol/l

0.76

177

Infections of genitourinary tract in pregnancy

317

2507

1.29

4.27

6.2

6.9

0.88

0.94

mmol/l

0.10

231

1925

Crohn disease (strict definition, require KELA, min 2 HDR)

239

1826

1.34

4.27

10.0

8.3

0.41

1.05

mmol/l

1.41

185

1422

Other abnormal immunological findings in serum

507

1.67

4.26

11.7

8.3

1.02

0.98

mmol/l

0.03

407

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

410

1.77

4.24

9.8

7.8

-0.33

1.39

mmol/l

1.76

321

Alzheimer’s disease (undefined)

363

0.31

4.22

1.6

3.8

4.17

1.34

mmol/l

—

258

Polycystic ovarian syndrome

133

921

1.47

4.22

5.3

6.4

0.74

0.33

mmol/l

0.77

656

Endometriosis of pelvic peritoneum

553

4577

1.21

4.21

5.4

7.2

1.03

0.95

mmol/l

0.22

408

3651

Acute lymphocytic leukaemia, helper endpoint

117

2.48

4.20

12.2

12.9

0.72

0.47

mmol/l

0.11

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

117

2.48

4.20

12.2

12.9

0.72

0.47

mmol/l

0.11

Benign neoplasm: Other/unspecified site

512

1.68

4.19

6.6

7.2

1.58

1.27

mmol/l

0.27

413

Multiple delivery

181

2438

0.73

4.18

7.4

0.59

0.97

mmol/l

0.56

143

1908

SLE, strict definition

146

1039

1.46

4.18

7.1

7.6

0.51

1.24

mmol/l

1.15

118

827

SLE, ICD10

146

1039

1.46

4.18

7.1

7.6

0.51

1.24

mmol/l

1.15

118

827

Contact with other and unspecified heat and hot substances

178

2.21

4.17

4.8

8.6

1.70

0.79

mmol/l

0.53

139

Myeloproliferative diseases (CML excluded)

371

3013

1.27

4.16

7.0

1.11

1.15

mmol/l

0.05

291

2354

Haemangioma and lymphangioma, any site

385

3133

1.26

4.15

5.8

7.8

1.07

1.04

mmol/l

0.05

302

2433

Pedestrian injured in collision with car, pick-up truck or van

113

768

1.54

4.15

8.3

7.2

0.32

1.28

mmol/l

1.26

610

Other sideroblastic anaemias

120

2.56

4.14

8.4

5.4

2.26

1.28

mmol/l

0.32

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

3.98

4.14

45.6

9.8

2.51

1.93

mmol/l

—

Purulent endophthalmitis

194

2.19

4.13

7.0

5.3

2.06

1.54

mmol/l

0.22

151

Effects of heat and light

228

2.06

4.13

10.0

8.8

0.93

1.21

mmol/l

0.12

181

Chondrosarcoma

102

2.76

4.12

6.3

0.53

1.26

mmol/l

0.61

Other disorders of optic disc

359

1.81

4.12

9.9

9.3

0.60

1.16

mmol/l

0.78

296

Erythema nodosum

130

909

1.49

4.11

5.4

7.3

1.08

1.28

mmol/l

0.25

109

725

Other specified and unspecified disorders of eyelid

477

1.71

4.10

5.3

9.2

1.18

1.25

mmol/l

0.06

371

Malignant neoplasm of nasal cavity and middle ear

154

2.36

4.10

5.9

6.3

0.77

0.98

mmol/l

0.08

122

Giant cell arteritis with polymyalgia rheumatica

189

1415

1.40

4.10

6.9

6.5

0.99

1.28

mmol/l

0.51

154

1099

Benign neoplasm: Connective and other soft tissue of head, face and neck

466

1.69

4.09

6.5

8.1

0.66

1.58

mmol/l

1.26

358

Hypersplenism

134

2.45

4.08

7.0

9.9

0.97

1.39

mmol/l

0.21

107

Scar conditions and fibrosis of skin

159

1152

1.42

4.07

6.1

7.8

0.72

1.09

mmol/l

0.69

117

908

Assault by hanging, strangulation and suffocation

3.82

4.07

9.0

5.4

-0.49

0.86

mmol/l

0.43

Respiratory tuberculosis, not confirmed

217

1655

1.36

4.06

6.5

7.0

1.46

1.22

mmol/l

0.40

177

1264

Tongue abnormality

280

2208

1.31

4.06

5.8

7.4

1.59

1.20

mmol/l

0.88

222

1734

Sequelae of burns, corrosions and frostbite

147

2.35

4.06

7.7

11.8

0.15

1.17

mmol/l

0.65

122

Other disorders of Eustachian tube

126

879

1.49

4.05

7.6

7.5

0.85

1.20

mmol/l

0.43

100

695

Retinal haemorrhage

123

858

1.51

4.04

10.8

7.4

1.04

1.29

mmol/l

0.33

656

L01XX Other antineoplastic agents

280

2213

1.31

4.04

7.3

7.1

0.95

1.15

mmol/l

0.30

211

1722

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

202

2.12

4.03

5.7

5.6

1.08

1.59

mmol/l

0.48

162

Crohn disease (strict definition, require KELA)

242

1868

1.33

4.03

9.9

8.3

0.42

1.06

mmol/l

1.45

187

1451

L04AC Interleukin inhibitors

191

1427

1.38

4.03

8.3

9.3

0.88

1.10

mmol/l

0.34

158

1140

Hyperchylomicronaemia

3.26

4.03

9.8

3.7

2.15

1.34

mmol/l

0.35

Malignant neoplasm of larynx

607

1.61

4.02

11.5

7.9

2.38

1.30

mmol/l

1.23

475

Oral leukoplakia, including avohilmo

134

950

1.48

4.02

6.7

9.0

1.50

1.26

mmol/l

0.30

761

Granulomatous disorders of skin and subcutaneous tissue

110

748

1.53

4.02

7.1

8.0

1.53

1.19

mmol/l

0.51

594

Von Willebrand disease

293

1.87

4.01

5.8

7.5

0.90

1.42

mmol/l

0.35

237

Superficial injury of neck

467

1.67

4.01

6.4

9.4

1.43

1.02

mmol/l

0.47

358

Benign neoplasm: Tongue

136

967

1.47

4.00

7.1

7.4

1.05

1.18

mmol/l

0.13

113

767

Polycystic ovarian syndrome, broad definition

263

2046

1.30

4.00

7.0

6.0

0.93

0.52

mmol/l

1.04

180

1478

Leukaemia of unspecified cell type

267

1.95

3.99

10.8

8.9

1.56

1.00

mmol/l

0.55

211

Haemangioma, any site

360

2923

1.26

3.99

5.9

7.8

1.17

1.05

mmol/l

0.23

283

2274

Carcinoma in situ of skin

401

3304

1.25

3.98

5.9

6.2

0.64

1.22

mmol/l

2.22

320

2535

Other disorders of bone density and structure

104

700

1.54

3.98

6.2

8.2

0.92

1.07

mmol/l

0.18

557

Contact with sharp glass

143

1021

1.44

3.97

12.0

9.0

0.80

1.01

mmol/l

0.26

121

809

Traumatic cerebral oedema

2.95

3.95

13.1

6.6

1.26

0.26

mmol/l

0.33

Toxic effect of other gases, fumes and vapours

148

2.29

3.94

8.9

11.1

1.81

1.07

mmol/l

0.40

117

Osteomalacia

231

2.00

3.93

5.4

9.4

1.54

1.08

mmol/l

0.46

189

Alzheimer’s disease (Early onset)

116

1655

0.68

3.92

6.1

6.0

1.09

1.35

mmol/l

0.29

1257

Benign neoplasm: Skin of lower limb, including hip

117

810

1.50

3.92

7.8

7.5

1.38

1.32

mmol/l

0.08

631

Exclusion endpoint for supernumerary teeth

251

1.92

3.91

12.6

11.7

1.19

0.67

mmol/l

0.30

198

Other degenerative diseases of the basal ganglia

605

1.62

3.91

5.9

7.3

2.08

1.16

mmol/l

1.12

470

All dysplastic lesions of the cervix uteri, vagina or vulva

895

7792

1.15

3.91

6.6

6.7

0.89

0.90

mmol/l

0.03

679

5967

Delivery, wide proxy

1294

7687

0.89

3.88

6.0

6.2

1.04

1.19

mmol/l

0.60

990

6041

Henoch-Schönlein purpura nephritis (HSPN)

104

2.60

3.88

7.9

13.4

-1.48

1.12

mmol/l

1.18

Pedestrian injured in other and unspecified transport accidents

343

1.80

3.87

6.9

6.8

1.24

1.21

mmol/l

0.02

270

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

256

2002

1.31

3.87

9.6

8.1

0.38

1.06

mmol/l

1.61

195

1548

Other bullous disorders

129

914

1.47

3.87

8.3

8.2

1.58

1.33

mmol/l

0.42

108

720

Benign neoplasm: other/unspecified salivary gland

125

880

1.48

3.87

7.0

5.8

1.91

1.42

mmol/l

0.60

680

Protein-energy malnutrition of moderate and mild degree

248

1.97

3.87

9.1

7.1

1.72

1.21

mmol/l

0.32

199

Other and unspecified corneal deformities and disorders

142

1022

1.44

3.86

7.7

7.8

1.14

1.28

mmol/l

0.14

111

818

Autoimmune hepatitis

190

2.09

3.85

8.0

5.6

1.03

1.40

mmol/l

0.19

156

Disorders of globe

124

874

1.48

3.84

5.1

7.0

1.77

1.28

mmol/l

0.53

676

Porphyria cutanea tarda

4.72

3.84

8.0

4.2

1.86

0.44

mmol/l

—

Ankylosing spondylitis, ICD10

385

3161

1.24

3.84

6.7

8.2

1.05

1.00

mmol/l

0.10

297

2455

Other or unspecified common variable immunodeficiency

2.71

3.83

8.6

12.8

0.13

1.75

mmol/l

0.98

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

172

2.22

3.83

14.6

6.6

1.49

1.59

mmol/l

0.08

136

Superficial frostbite

191

2.10

3.83

8.0

11.2

1.42

1.00

mmol/l

0.19

148

Cholera

189

1425

1.37

3.83

7.8

6.7

0.11

1.33

mmol/l

3.54

165

1136

Malignant neoplasm of ureter

2.82

3.82

9.8

5.4

-2.10

1.31

mmol/l

2.13

Other and unspecified haemorrhagic conditions

484

1.66

3.81

10.4

6.9

1.50

1.18

mmol/l

0.28

388

Chondropathies

646

5552

1.18

3.81

7.0

7.8

0.92

1.00

mmol/l

0.18

513

4313

Other dermatomyositis

144

2.31

3.81

10.2

7.5

1.78

1.17

mmol/l

0.32

111

Other specified and unspecified strabismus

299

1.84

3.81

8.8

7.4

0.91

0.99

mmol/l

0.05

237

Guillain-Barre syndrome

533

1.63

3.80

11.5

7.5

1.76

1.02

mmol/l

1.08

423

258

3254

0.77

3.80

10.0

7.3

0.72

1.02

mmol/l

0.32

186

2507

Listeriosis

145

2.33

3.79

24.7

5.3

0.96

1.33

mmol/l

0.20

121

Melanocytic naevi of upper limb, including shoulder

660

1.55

3.79

5.9

8.5

0.97

1.15

mmol/l

0.19

517

Ill-defined and unknown causes of mortality

344

2804

1.26

3.78

6.1

6.6

2.42

1.18

mmol/l

7.26

253

2131

Malignant neoplasm of heart, mediastinum and pleura

465

1.69

3.77

6.8

9.0

1.71

1.25

mmol/l

0.61

358

Carcinoma in situ of skin of other and unspecified parts of face

405

3361

1.24

3.77

5.7

0.45

1.20

mmol/l

2.87

322

2553

Carcinoma in situ, bladder

180

1360

1.39

3.76

7.3

7.4

0.16

1.09

mmol/l

2.65

145

1042

Other and unspecified disorders of binocular movement

151

2.24

3.76

9.2

10.1

0.63

0.98

mmol/l

0.21

118

Disorders of puberty, all

246

1.89

3.76

10.1

10.9

0.44

0.41

mmol/l

0.01

193

Benign neoplasm: Carotid body

2.85

3.75

4.5

14.4

1.95

1.38

mmol/l

0.28

Other and unspecified trigeminal disorders

454

1.67

3.75

6.9

7.2

0.87

1.25

mmol/l

0.33

363

Benign neoplasm: Peripheral nerves and autonomic nervous system

511

1.64

3.75

8.5

9.2

1.31

1.28

mmol/l

0.02

407

Thyrotoxicosis with diffuse goitre

550

4674

1.19

3.73

7.0

1.15

1.09

mmol/l

0.12

425

3655

Amblyopia ex anopsia

152

1110

1.41

3.72

8.6

7.9

0.48

1.00

mmol/l

0.75

115

883

Malignant immunoproliferative diseases

319

1.83

3.72

10.8

8.0

1.10

1.53

mmol/l

0.35

246

Benign neoplasm: Ill-defined sites within the digestive system

180

2.14

3.71

4.0

5.7

0.88

1.74

mmol/l

0.61

138

Acute lymphocytic leukaemia

124

2.33

3.71

12.2

12.5

0.72

0.00

mmol/l

0.38

Herpesviral keratitis and keratoconjunctivitis

201

1538

1.35

3.71

7.3

7.7

1.42

1.19

mmol/l

0.41

157

1206

False labour

866

4754

1.15

3.70

4.7

7.5

0.89

0.76

mmol/l

0.50

604

3602

Contact with other hot metals

456

1.66

3.70

7.8

8.5

1.58

1.06

mmol/l

0.52

367

Hypoplasia of dental enamel , including avohilmo

407

1.67

3.70

17.0

12.4

-0.38

0.14

mmol/l

0.48

316

Hereditary deficiency of other clotting factors

214

1.99

3.69

19.3

10.4

1.28

1.43

mmol/l

0.10

163

Exposure to other and unspecified man-made environmental factors

448

1.66

3.69

7.5

9.2

0.47

1.14

mmol/l

0.71

352

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

146

2.27

3.68

15.2

11.5

2.45

1.58

mmol/l

0.66

124

Rosacea

463

3885

1.21

3.68

7.5

0.96

1.08

mmol/l

0.26

348

3020

Localized skin eruption due to drugs and medicaments

326

1.80

3.67

6.2

7.5

1.86

1.17

mmol/l

0.70

269

Prolonged pregnancy

252

2920

0.78

3.67

5.4

7.2

0.56

0.57

mmol/l

0.02

181

2162

Other/unspecified enthesopathies, not elsewhere classified

397

3287

1.23

3.66

6.5

7.5

0.49

1.16

mmol/l

3.06

314

2550

Benign neoplasm: Skin of trunk

163

1209

1.39

3.66

6.6

7.6

0.91

1.26

mmol/l

0.53

124

931

Other deformities of toe(s)

156

1151

1.40

3.66

5.6

8.2

0.71

1.16

mmol/l

0.68

115

905

Other and unspecified disorders of psychological development

161

2.10

3.66

6.3

14.2

1.60

0.29

mmol/l

1.16

131

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

311

2517

1.27

3.65

6.5

7.9

1.23

1.03

mmol/l

0.46

247

1975

Otitis media, unspecified

371

2799

1.24

3.64

9.8

8.4

1.18

0.79

mmol/l

1.02

281

2115

Haemorrhage in early pregnancy

930

8016

1.14

3.63

5.3

7.0

1.20

0.99

mmol/l

1.12

699

6308

Other and unspecified injuries of wrist and hand

149

1091

1.41

3.63

7.0

8.1

0.61

1.09

mmol/l

0.74

119

859

Dementia in other diseases classified elsewhere

217

1685

1.33

3.62

6.3

6.8

1.31

1.17

mmol/l

0.14

171

1288

Other and unspecified acute skin changes due to ultraviolet radiation

133

961

1.45

3.62

5.9

7.7

0.55

1.36

mmol/l

1.07

100

753

Carcinoma in situ of vulva

188

2.06

3.60

4.6

5.6

0.06

1.94

mmol/l

1.76

150

Melanocytic naevi of scalp and neck

634

1.54

3.60

7.3

7.6

0.06

1.28

mmol/l

2.48

484

Flatulence and related conditions

268

1.86

3.56

7.8

7.3

1.25

1.11

mmol/l

0.07

214

Benign neoplasm: Skin of upper limb, including shoulder

572

1.57

3.56

8.3

6.9

1.08

1.37

mmol/l

0.32

448

Torticollis

388

1.69

3.56

8.5

9.2

1.03

1.04

mmol/l

0.01

313

Malignant neoplasm of breast, HER2-negative

2189

14851

1.09

3.55

5.5

6.3

1.18

1.29

mmol/l

0.69

1816

11848

Benign neoplasm: Brain, unspecified

183

2.09

3.54

8.5

9.5

2.10

1.14

mmol/l

1.04

151

Urethral stricture

292

2357

1.27

3.54

6.2

8.0

0.90

1.05

mmol/l

0.26

220

1815

Melanocytic naevi, other sites/unspecified

328

2675

1.25

3.53

6.2

8.1

1.01

1.07

mmol/l

0.11

246

2077

Other nonthrombocytopenic purpura

286

1.85

3.52

3.4

9.4

0.48

1.38

mmol/l

0.81

228

Carcinoma in situ of skin of lip

2.64

3.52

6.1

1.21

1.46

mmol/l

0.06

Other/unspecified reactive arthropathies

278

2228

1.28

3.52

9.9

8.2

1.01

1.09

mmol/l

0.12

219

1733

Osteomyelitis of vertebra

103

2.54

3.51

9.8

5.1

-0.53

1.17

mmol/l

0.57

Testicular hypofunction

144

1058

1.41

3.51

10.6

10.7

0.95

0.98

mmol/l

0.02

127

827

Conductive hearing loss, unspecified

368

3040

1.24

3.50

7.9

7.5

1.36

1.12

mmol/l

0.49

296

2384

Female genital prolapse

1348

7018

1.12

3.50

5.3

6.7

1.32

1.20

mmol/l

0.48

1055

5624

Spinal osteochondrosis

315

1.78

3.49

6.4

8.6

1.63

0.88

mmol/l

1.02

258

Benign neoplasm: Pharynx, unspecified

242

1.92

3.49

7.3

7.1

1.71

1.09

mmol/l

0.47

196

Hypersomnia

408

1.68

3.48

9.1

9.8

1.72

1.27

mmol/l

0.48

332

Drug-induced Cushing's syndrome

4.19

3.48

11.8

4.5

0.20

1.88

mmol/l

0.68

Benign neoplasm: Long bones of lower limb

117

828

1.46

3.48

10.2

8.6

1.24

1.31

mmol/l

0.09

649

Ulcerative colitis (strict definition, all Crohn cases excluded)

593

5103

1.18

3.48

7.3

7.9

0.73

0.94

mmol/l

0.70

461

3968

Sickle-cell disorders

2.87

3.47

9.8

5.6

0.22

1.62

mmol/l

0.52

Acute appendicitis, with complications

940

8354

1.14

3.47

8.7

7.5

1.05

1.01

mmol/l

0.11

739

6496

Sacrococcygeal disorders, not elsewhere classified

117

829

1.45

3.46

9.2

8.1

1.24

1.08

mmol/l

0.20

674

malignant neoplasm of male genital organs

2525

14913

1.09

3.46

6.6

7.8

0.58

0.99

mmol/l

5.61

1928

11652

Gonococcal infection

136

991

1.42

3.46

7.0

8.0

1.30

1.20

mmol/l

0.13

114

803

Acute myeloid leukaemia, helper endpoint

287

1.82

3.44

8.6

6.6

1.28

1.67

mmol/l

0.27

221

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

287

1.82

3.44

8.6

6.6

1.28

1.67

mmol/l

0.27

221

Mixed conductive and sensorineural hearing loss

602

5202

1.18

3.44

6.6

6.9

1.35

1.05

mmol/l

1.11

463

4057

Carcinoma in situ of lip, oral cavity and pharynx

2.69

3.44

6.9

8.2

0.49

1.65

mmol/l

0.71

Benign neoplasm: Skin of scalp and neck

104

724

1.49

3.43

6.2

8.0

1.00

1.42

mmol/l

0.55

551

Mesothelioma

534

1.61

3.42

9.0

7.7

1.82

1.30

mmol/l

0.76

412

Contusion of ankle

142

1042

1.40

3.41

7.2

8.7

1.23

1.11

mmol/l

0.11

116

818

Contact with hot air and gases

200

2.01

3.41

12.5

6.8

0.46

1.06

mmol/l

0.37

163

Macular cyst

132

966

1.43

3.40

6.8

7.7

0.81

1.22

mmol/l

0.59

109

760

Benign neoplasm: Central nervous system, other parts/unspecified

111

2.43

3.39

6.8

12.8

1.23

1.16

mmol/l

0.03

Motorcycle rider injured in noncollision transport accidents

118

841

1.45

3.39

7.4

9.7

0.63

0.90

mmol/l

0.35

674

Eosinophilia

524

1.59

3.38

10.4

8.7

0.86

1.36

mmol/l

0.50

413

Degenerative diseases of the nervous system

1836

12715

1.10

3.38

4.4

6.0

1.23

1.15

mmol/l

0.34

1360

9804

Intercostal neuropathy

245

1.89

3.36

6.2

10.2

1.34

1.16

mmol/l

0.14

196

Sacroiliitis, not elsewhere classified

148

1094

1.38

3.35

6.8

8.5

1.07

0.90

mmol/l

0.19

117

864

221

1.91

3.35

5.9

10.0

0.58

0.89

mmol/l

0.19

168

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

183

1400

1.34

3.34

5.9

8.5

1.36

1.13

mmol/l

0.36

137

1096

Chronic conjunctivitis

125

904

1.43

3.34

7.3

7.9

1.17

1.22

mmol/l

0.07

100

714

Other otitis externa (chronic)

277

2235

1.27

3.34

7.3

8.1

1.23

1.05

mmol/l

0.31

202

1732

Vertical strabismus

142

1049

1.40

3.34

8.1

7.9

0.47

1.20

mmol/l

1.45

112

831

Retinal breaks without detachment

566

6551

0.85

3.34

7.7

7.3

0.66

1.09

mmol/l

1.90

455

5151

Viral meningitis

135

987

1.41

3.33

7.2

9.1

0.54

1.03

mmol/l

0.68

108

782

Melanocytic naevi of other and unspecified parts of face

239

1895

1.29

3.33

5.5

7.6

0.83

1.11

mmol/l

0.49

177

1467

Status post-ami

371

2522

1.23

3.33

6.2

5.5

1.69

0.99

mmol/l

2.69

254

1925

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

559

1.56

3.32

11.6

7.1

1.46

1.41

mmol/l

0.04

436

Other corneal oedema

262

1.87

3.32

5.9

6.1

0.99

1.37

mmol/l

0.32

217

Other and unspecified injuries of forearm

172

2.04

3.32

13.0

11.8

1.33

0.97

mmol/l

0.13

130

Exposure to other and unspecified animate mechanical forces

103

720

1.47

3.29

7.9

8.8

1.30

0.92

mmol/l

0.40

578

Prolapse and hernia of ovary and fallopian tube

202

1561

1.32

3.28

4.4

4.8

1.43

mmol/l

0.00

159

1220

Disorders of iron metabolism

399

1.66

3.28

11.3

9.3

1.11

1.14

mmol/l

0.03

312

Injury of nerves at lower leg level

284

1.80

3.26

14.3

7.6

0.78

1.00

mmol/l

0.12

228

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

156

1177

1.37

3.25

5.4

6.7

1.19

1.33

mmol/l

0.17

124

910

Other contact dermatitis

332

2735

1.24

3.25

8.0

7.1

1.19

1.02

mmol/l

0.30

252

2117

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

197

2.00

3.24

5.5

10.6

-2.03

1.07

mmol/l

2.30

163

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

368

1.68

3.24

9.4

10.0

1.73

0.93

mmol/l

0.77

286

Foreign body or object entering through skin

261

2099

1.27

3.24

8.5

8.3

0.72

1.00

mmol/l

0.52

219

1641

therapeutic use

139

1032

1.40

3.23

7.3

7.2

0.87

1.09

mmol/l

0.31

114

817

Systemic lupus erythematosus, unspecified

123

893

1.42

3.23

7.3

7.9

0.63

1.25

mmol/l

0.78

710

Pregnancy examination and test

411

2138

1.21

3.22

7.0

7.6

0.66

0.85

mmol/l

0.42

289

1588

Benign neoplasm: Appendix

332

1.74

3.22

8.9

6.0

0.84

1.67

mmol/l

0.97

266

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

126

2.24

3.22

6.3

0.39

1.83

mmol/l

0.99

104

Motorcycle rider injured in other and unspecified transport accidents

214

1680

1.30

3.21

11.3

9.2

1.04

0.88

mmol/l

0.34

167

1331

Other, unspecified and serous retinal detachments

145

1085

1.39

3.21

6.8

8.0

0.84

1.16

mmol/l

0.60

122

843

Drug-induced gout

170

2.11

3.21

9.2

6.3

2.25

1.08

mmol/l

0.59

133

Disorders of other and unspecified cranial nerves

147

2.14

3.20

12.0

10.3

1.49

1.09

mmol/l

0.18

111

Polyhydramnios

129

940

1.40

3.20

6.2

6.5

1.13

0.63

mmol/l

0.80

698

Certain conditions originating in the perinatal period

224

1560

1.29

3.20

12.4

9.8

-0.03

0.51

mmol/l

1.02

169

1175

Malignant neoplasm of pancreas

303

2486

1.25

3.20

7.3

6.6

1.43

1.21

mmol/l

0.54

251

1907

Drug-induced interstitial lung disorders, unspecified

3.05

3.19

4.9

8.3

0.59

2.14

mmol/l

0.71

Spermatocele

407

3436

1.21

3.18

6.9

8.6

1.18

0.87

mmol/l

0.93

314

2668

Tinnitus

1105

9970

1.12

3.17

7.7

7.5

0.91

1.04

mmol/l

0.65

897

7866

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

257

1.83

3.16

5.2

6.2

0.85

1.69

mmol/l

0.71

204

Vulvovaginal ulceration/inflammation in other diseases

171

1304

1.34

3.16

6.1

7.0

0.57

0.86

mmol/l

0.58

137

997

Alzheimer’s disease (undefined), excluding more controls

304

0.37

3.16

1.6

4.0

4.17

1.23

mmol/l

—

225

Hypertrophy of breast in women and men

733

6453

1.15

3.14

7.0

7.2

1.18

1.09

mmol/l

0.25

582

5076

Degenerative macular diseases

610

5320

1.17

3.13

6.0

6.3

1.13

1.21

mmol/l

0.23

483

4104

Other disorders of cornea

415

3509

1.21

3.13

7.7

7.2

1.22

1.11

mmol/l

0.21

327

2747

Disorders of adrenal gland, other and/or unspecified

149

2.14

3.13

14.1

5.8

1.83

1.28

mmol/l

0.39

115

Burn and corrosion, body region unspecified

170

2.05

3.13

8.6

8.0

1.49

1.06

mmol/l

0.26

135

Other haemoglobinopathies

3.04

3.12

4.5

7.3

2.24

1.02

mmol/l

—

Factitial dermatitis

156

2.10

3.12

8.7

5.5

2.07

1.01

mmol/l

0.66

121

Carcinoma in situ of other and unspecified sites

188

1470

1.33

3.12

7.1

7.2

0.24

1.11

mmol/l

2.56

152

1122

Other and unspecified bullous disorders

304

1.76

3.11

7.4

6.8

1.33

mmol/l

0.00

241

Arthropathy in Crohn disease

257

1.81

3.11

6.5

9.2

1.23

1.12

mmol/l

0.06

204

Other specified/unspecified deforming dorsopathies

475

1.57

3.10

10.5

7.8

1.64

1.25

mmol/l

0.53

380

Injury of muscle and tendon at lower leg level

691

6075

1.15

3.10

8.0

1.24

0.98

mmol/l

1.26

565

4743

Migraine with aura, drug-induced

288

1.76

3.09

9.9

7.1

1.64

1.39

mmol/l

0.20

228

Desensitization to allergens

1194

0.68

3.09

9.1

8.5

0.35

0.80

mmol/l

0.91

917

Sequelae of other and unspecified infectious and parasitic diseases

220

1745

1.29

3.08

8.6

8.3

1.12

1.05

mmol/l

0.10

174

1369

Other bacterial agents as the cause of diseases classified to other chapters

297

1.75

3.08

13.0

8.1

1.14

1.24

mmol/l

0.06

239

Other disorders of skin and subcutaneous tissue related to radiation

3.07

3.08

2.6

6.1

2.74

1.49

mmol/l

—

Other congenital malformations of intestine

236

1.85

3.07

9.0

11.2

-0.42

1.08

mmol/l

1.29

194

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

3.72

3.05

11.5

8.3

3.71

1.77

mmol/l

1.00

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

2.88

3.04

6.2

6.4

0.56

0.59

mmol/l

—

Use of selegiline

231

1853

1.29

3.04

4.3

6.8

1.84

1.11

mmol/l

2.40

188

1427

Vascular dementia (undefined)

174

1330

1.33

3.04

3.5

5.5

2.16

1.33

mmol/l

1.61

120

993

Family history of other conditions

250

1.79

3.04

15.4

6.2

1.26

1.19

mmol/l

0.05

190

Contact with other sharp object(s)

239

1916

1.27

3.04

9.9

8.9

0.60

0.94

mmol/l

0.67

191

1481

Carcinoma in situ of skin of scalp and neck

128

954

1.41

3.03

6.6

6.7

0.03

1.21

mmol/l

2.50

107

725

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

141

2.06

3.03

4.7

5.3

0.38

0.58

mmol/l

0.08

103

Disorder of the sleep-wake schedule

438

1.59

3.02

3.9

10.6

1.76

0.94

mmol/l

0.99

350

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

536

1.53

3.01

10.9

8.8

0.76

1.14

mmol/l

0.49

417

Contact with and exposure to communicable diseases

848

9477

0.89

3.00

8.1

7.8

1.06

0.73

mmol/l

2.11

625

7217

Testicular dysfunction

160

1228

1.34

2.97

10.1

10.2

0.92

0.93

mmol/l

0.02

142

967

Endometriosis diagnosis and infertility diagnosis occurring together

308

2539

1.23

2.96

5.1

6.7

0.69

0.92

mmol/l

0.62

218

1949

Benign neoplasm: Orbit, unspecified

203

1.93

2.96

7.3

10.1

0.48

1.28

mmol/l

1.43

163

Urethritis and urethral syndrome

662

1.47

2.96

7.1

9.3

1.33

1.02

mmol/l

0.32

520

Benign neoplasm: Central nervous system, other parts/unspecified

118

2.27

2.96

6.8

13.5

1.23

1.71

mmol/l

0.29

Inhalation and ingestion of other objects causing obstruction of respiratory tract

173

1.99

2.96

9.2

11.8

1.09

1.38

mmol/l

0.20

138

Disorders of myoneural junction and muscle in diseases classified elsewhere

240

1.84

2.96

7.1

6.5

0.93

1.25

mmol/l

0.16

195

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

3.21

2.95

23.5

19.9

0.30

1.14

mmol/l

0.29

Lichen planus, including avohilmo

828

7389

1.14

2.95

6.4

7.0

1.09

1.10

mmol/l

0.02

633

5817

Chronic suppurative otitis media

291

2394

1.24

2.95

7.8

7.6

0.91

1.11

mmol/l

0.30

225

1835

Suppurative otitis media, unspecified

101

721

1.44

2.93

5.4

7.5

1.63

1.22

mmol/l

0.51

559

Other and unspecified nail disorders

640

1.48

2.93

12.4

7.7

1.59

1.23

mmol/l

0.32

511

Carcinoma in situ of vulva

203

1.89

2.91

4.6

6.2

0.06

1.47

mmol/l

1.18

170

Other specified/unspecified nutritional deficiencies

203

1.89

2.91

7.1

6.7

1.30

1.13

mmol/l

0.11

155

Acute poliomyelitis

453

1.58

2.91

4.6

6.4

1.19

1.38

mmol/l

0.13

368

Type 1 diabetes, wide definition, subgroup 2

553

0.54

2.90

11.2

6.2

0.54

1.35

mmol/l

0.37

424

Other disorders of conjunctiva

665

5865

1.15

2.90

8.5

7.0

1.24

1.09

mmol/l

0.48

538

4542

Phlebitis and thrombophlebitis of unspecified site, drug-induced

5.54

2.89

9.4

4.8

0.23

2.09

mmol/l

—

Other infective otitis externa

253

2058

1.26

2.89

8.7

8.0

0.64

1.03

mmol/l

0.75

204

1604

Female infertility, tubal origin

157

1201

1.33

2.88

5.6

7.5

0.58

0.94

mmol/l

0.54

125

968

Unspecified renal colic

190

1.93

2.87

8.2

6.7

1.40

1.04

mmol/l

0.24

146

Pregnancy with abortive outcome

2837

13918

1.07

2.86

6.1

6.4

1.09

1.13

mmol/l

0.20

2199

10912

Benign neoplasm: Hypopharynx

133

2.14

2.86

13.3

7.2

1.98

1.32

mmol/l

0.47

105

Pterygium

1173

0.68

2.85

7.1

7.8

1.32

1.14

mmol/l

0.23

904

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

113

826

1.40

2.82

9.4

10.3

0.41

0.86

mmol/l

0.76

648

Epiphora

101

730

1.44

2.82

5.5

6.9

1.74

1.34

mmol/l

0.54

570

Kela-code for behavioural disturbances in mental retardation

290

1.73

2.82

5.2

9.1

2.78

1.07

mmol/l

2.77

237

Nezelof syndrome

134

2.14

2.82

13.6

10.9

1.40

1.59

mmol/l

0.12

102

Congenital malformations of genital organs

278

2268

1.23

2.82

9.6

7.7

0.93

0.79

mmol/l

0.25

217

1739

Alcohol abuse counselling and surveillance

529

1.52

2.81

8.8

9.3

1.30

0.93

mmol/l

0.38

430

Cardiovascular devices associated with adverse incidents

4.72

2.81

7.6

5.6

1.47

1.58

mmol/l

—

Other bursitis of elbow

275

1.76

2.81

9.1

7.1

2.18

1.03

mmol/l

0.48

212

Other and unspecified pemphigoid

291

1.74

2.81

3.8

6.4

1.22

1.37

mmol/l

0.11

230

Transient synovitis

175

1.92

2.80

6.8

10.5

0.58

1.02

mmol/l

0.36

138

Mature T/NK-cell lymphomas, hilmo

458

1.57

2.79

9.8

8.8

-0.33

1.26

mmol/l

1.58

367

Lesion of femoral nerve

221

1.83

2.79

4.6

7.1

1.45

1.53

mmol/l

0.07

182

Other bursitis of hip

638

1.47

2.79

6.6

6.3

0.94

1.29

mmol/l

0.34

504

ILD medications: acetylcysteine

235

1.79

2.79

10.8

5.1

1.87

1.35

mmol/l

0.30

178

Other congenital malformations of skin

151

1158

1.34

2.79

9.5

8.4

0.40

1.07

mmol/l

1.07

118

899

Benign neoplasm: Appendix

346

1.66

2.78

8.9

7.3

0.84

1.33

mmol/l

0.48

283

Dermatopolymyositis, unspecified

156

2.02

2.77

6.5

7.3

0.47

1.50

mmol/l

1.09

122

Sequelae of inflammatory diseases of the central nervous system

2.43

2.77

3.5

8.0

1.02

1.08

mmol/l

0.03

Kwashiorkor

3.22

2.76

3.6

7.1

4.67

1.36

mmol/l

—

Psoriatic arthropathies, ICD10

447

3847

1.18

2.75

6.7

8.1

1.19

1.03

mmol/l

0.42

366

3001

Arthropathic psoriasis

482

4172

1.17

2.75

6.8

7.9

1.16

1.02

mmol/l

0.33

397

3239

Crohn disease (strict definition, all UC cases excluded)

186

1468

1.29

2.75

11.2

7.9

0.38

1.04

mmol/l

1.20

148

1152

Dislocation of lens

500

1.53

2.74

7.3

6.9

1.52

1.00

mmol/l

0.54

394

215

1720

1.26

2.74

8.8

6.3

-0.32

0.50

mmol/l

1.93

178

1237

Disorders of puberty

212

1.79

2.73

8.7

11.7

-0.10

0.31

mmol/l

0.17

168

Pseudomembranous colitis

245

1.77

2.73

7.0

6.4

-0.32

1.32

mmol/l

0.68

195

Spinal enthesopathy

136

1029

1.35

2.73

4.4

5.0

1.08

1.41

mmol/l

0.45

106

779

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

300

1.70

2.72

5.1

5.8

0.80

1.53

mmol/l

0.49

231

Other prurigo

347

1.64

2.72

5.9

6.2

1.09

1.23

mmol/l

0.10

271

Acute myeloid leukaemia and myelodysplastic syndromes

626

1.47

2.72

7.0

1.15

1.38

mmol/l

0.17

481

Long labour

551

5509

0.87

2.71

6.8

7.2

0.61

0.84

mmol/l

0.82

412

4214

Typhoid and paratyphoid fevers

143

2.06

2.70

11.5

6.4

1.82

1.27

mmol/l

0.37

114

Lichen sclerosus et atrophicus

402

3437

1.19

2.70

5.3

6.5

1.21

1.19

mmol/l

0.03

313

2705

Calculus of lower urinary tract

263

2171

1.24

2.69

7.4

7.8

0.85

1.16

mmol/l

0.54

208

1657

Carcinoma in situ of skin of lower limb, including hip

103

757

1.43

2.69

8.9

6.1

0.97

1.40

mmol/l

0.51

589

Muscle wasting and atrophy, not elsewhere classified

210

1.86

2.68

8.6

9.5

1.39

1.23

mmol/l

0.11

167

Pseudopolyposis of colon

2.51

2.68

11.8

7.4

2.75

0.96

mmol/l

—

Golimumab

114

844

1.38

2.68

6.1

9.0

0.22

1.07

mmol/l

0.97

677

Benign neoplasm: Connective and other soft tissue, unspecified

324

1.65

2.68

6.8

6.7

-0.21

1.47

mmol/l

1.16

255

Wide developmental disorders, excluding more controls

411

1.54

2.67

5.5

9.9

0.91

0.20

mmol/l

0.59

326

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1269

8175

0.91

2.67

6.1

7.4

0.92

0.97

mmol/l

0.19

945

6343

Other disorders following mastoidectomy

145

2.08

2.66

5.7

6.0

3.44

1.28

mmol/l

1.76

116

Sequelae of poliomyelitis

304

1.70

2.65

6.6

6.8

2.07

1.13

mmol/l

1.03

244

Endometriosis ASRM stages 1,2

570

4998

1.15

2.64

5.6

6.6

1.05

1.01

mmol/l

0.11

423

3882

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

210

1.83

2.63

6.5

6.0

1.65

mmol/l

0.00

163

Demyelinating diseases of the central nervous system

302

2522

1.22

2.63

7.7

8.3

1.16

1.02

mmol/l

0.26

229

1961

Other bursal cyst

513

1.51

2.62

4.1

7.6

2.20

1.06

mmol/l

1.58

404

Other disorders of choroid

481

1.53

2.61

7.3

6.9

1.45

1.19

mmol/l

0.29

367

Family history of other specific disorders

270

1.69

2.61

9.9

6.8

1.80

0.92

mmol/l

1.00

200

Certain zoonotic bacterial diseases

614

1.46

2.60

5.8

8.2

1.81

1.09

mmol/l

0.97

488

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

124

2.10

2.57

6.9

11.3

0.34

1.54

mmol/l

0.67

100

Carcinoma in situ of skin of trunk

154

1208

1.33

2.56

7.3

6.5

0.62

1.30

mmol/l

1.34

122

927

Increased muscle tone

197

1.84

2.56

7.7

11.0

0.73

1.15

mmol/l

0.31

151

Acquired clawhand, clubhand, clawfoot and clubfoot

131

2.05

2.55

8.5

11.7

2.76

1.48

mmol/l

0.54

102

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

290

1.69

2.55

8.2

7.9

0.90

1.64

mmol/l

0.66

226

Dementia due to Parkinsons disease, excluding more controls

718

1.42

2.55

4.5

6.7

1.85

1.04

mmol/l

1.66

558

Postviral fatigue syndrome

130

2.01

2.54

9.2

12.3

2.04

1.30

mmol/l

0.48

107

Secondary sideroblastic anaemia

2.45

2.54

8.1

6.7

1.92

1.54

mmol/l

0.08

Lesion of plantar nerve

256

2118

1.23

2.53

4.9

7.1

0.94

1.22

mmol/l

0.55

208

1673

Allergic rhinitis

1132

10240

1.10

2.53

7.1

7.9

0.80

0.84

mmol/l

0.13

884

7904

Disorders of pituitary gland, other and/or unspecified

176

1.89

2.51

21.5

9.8

0.60

1.46

mmol/l

0.48

141

Lagophthalmos

412

1.56

2.51

7.9

6.5

2.19

1.30

mmol/l

1.16

326

Impacted maxillary canine

167

1.88

2.50

9.9

11.9

0.72

0.58

mmol/l

0.06

139

Benign neoplasm: Hypopharynx

140

2.02

2.50

13.3

7.7

1.97

1.08

mmol/l

0.73

110

Other congenital malformations of limb(s)

131

1.99

2.49

24.0

7.2

-0.21

0.74

mmol/l

0.65

101

Ankle and foot

237

1.74

2.47

7.4

5.8

2.24

1.07

mmol/l

1.33

186

Eclampsia

2.85

2.47

7.6

6.5

1.08

1.66

mmol/l

0.24

Other psoriatic arthropathies

431

3735

1.17

2.47

6.4

8.1

1.15

1.02

mmol/l

0.30

352

2911

Other vitreous opacities

174

1388

1.29

2.46

5.8

7.6

1.63

1.16

mmol/l

1.20

147

1071

Burn and corrosion of wrist and hand

139

1075

1.32

2.46

5.7

9.3

0.75

0.94

mmol/l

0.20

108

855

Ectopic pregnancy

586

5177

1.14

2.46

5.9

6.7

1.01

1.02

mmol/l

0.03

465

4119

Recurrent cholesteatoma of postmastoidectomy cavity

2.25

2.46

6.4

7.3

1.35

1.34

mmol/l

0.00

Other congenital malformations of tongue, mouth and pharynx

257

1.68

2.45

8.9

11.6

-0.69

0.34

mmol/l

0.54

200

Carcinoma in situ of skin of lip

114

2.20

2.45

6.1

5.5

1.21

1.41

mmol/l

0.05

Choroidal detachment

2.45

2.7

7.0

0.82

1.00

mmol/l

—

Unspecific neurodegenerative disorder

2226

14413

1.07

2.45

4.1

6.1

1.36

1.11

mmol/l

1.99

1659

11175

Scleritis and episcleritis

233

1915

1.24

2.45

7.1

7.9

0.95

1.07

mmol/l

0.17

184

1499

Benign neoplasm: Skin of lower limb, including hip

117

886

1.36

2.45

7.8

8.3

1.38

1.31

mmol/l

0.09

708

Autoimmune thyroiditis

477

1.49

2.45

7.3

7.6

1.65

1.37

mmol/l

0.21

376

Frostbite with tissue necrosis

2.29

2.44

13.7

13.8

2.27

0.79

mmol/l

1.74

Severe visual impairment, binocular

171

1.91

2.44

7.0

9.2

0.33

1.55

mmol/l

0.78

132

Corneal scars and opacities

118

896

1.36

2.44

7.1

7.6

1.81

1.26

mmol/l

0.78

698

HSIL lesion of the cervix uteri

491

4286

1.15

2.44

7.0

6.5

0.78

0.81

mmol/l

0.05

369

3241

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

513

1.49

2.43

8.1

7.1

0.69

1.50

mmol/l

1.03

391

Juvenile osteochondrosis

111

832

1.36

2.43

8.1

8.9

0.54

0.89

mmol/l

0.46

649

Malignant neoplasm of base of tongue

202

1.83

2.43

6.8

8.7

1.45

0.90

mmol/l

0.32

160

Outcome of delivery

317

2330

0.84

2.42

6.0

7.8

-0.74

0.86

mmol/l

11.30

254

1749

Carcinoma in situ of stomach

4.34

2.42

6.5

5.9

-0.28

0.84

mmol/l

—

Malignant neoplasm of prostate

2458

14624

1.07

2.42

6.4

7.7

0.60

0.98

mmol/l

5.04

1870

11415

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.55

2.41

7.7

17.3

-1.45

1.42

mmol/l

—

Atypical virus infections of central nervous system

294

1.65

2.41

4.5

7.7

0.92

1.40

mmol/l

0.25

239

Benign neoplasm: Bladder

286

1.66

2.41

5.4

5.5

0.46

1.31

mmol/l

0.84

221

Placental disorders

147

1.91

2.40

8.9

7.8

-0.30

0.85

mmol/l

0.94

112

Other congenital malformations of ear

206

1.75

2.40

6.5

10.3

1.27

0.28

mmol/l

1.08

151

Melanocytic naevi of ear and external auricular canal

134

1.99

2.40

5.1

7.5

1.84

1.27

mmol/l

0.24

103

Effects of other deprivation

2.52

2.39

2.1

7.2

0.44

1.55

mmol/l

—

Unspecified protein-energy malnutrition

172

1.89

2.39

2.9

9.3

2.04

1.43

mmol/l

0.27

128

Other and unspecified iridocyclitis

175

1400

1.28

2.39

5.6

7.9

0.61

1.15

mmol/l

1.10

124

1103

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

2.18

2.39

3.8

4.8

0.69

1.51

mmol/l

0.55

Malignant neoplasm of oropharynx

584

1.46

2.39

10.2

8.4

1.58

1.08

mmol/l

0.72

463

Other abnormal auditory perceptions

294

1.64

2.38

5.2

7.5

1.30

1.22

mmol/l

0.05

237

Labour and delivery complicated by fetal stress [distress]

459

3522

0.86

2.37

4.9

7.0

-0.02

0.63

mmol/l

2.92

312

2584

Viral conjunctivitis

547

1.45

2.37

7.0

8.9

1.03

1.12

mmol/l

0.08

432

Injury of nerves at forearm level

375

1.56

2.37

6.8

9.0

0.44

0.87

mmol/l

0.27

293

Other demyelinating diseases of the central nervous system

124

949

1.34

2.36

11.3

9.3

1.14

0.94

mmol/l

0.23

739

Burn and corrosion of ankle and foot

433

1.52

2.36

6.6

9.3

1.26

1.04

mmol/l

0.18

351

Benign neoplasm: Ill-defined sites within the digestive system

211

1.79

2.36

4.0

6.2

0.88

1.48

mmol/l

0.39

170

Benign neoplasm: Larynx

151

1192

1.31

2.36

5.7

8.3

1.43

1.17

mmol/l

0.36

121

929

Varicella [chickenpox]

172

1374

1.28

2.36

11.9

9.9

0.21

0.89

mmol/l

1.12

134

1098

Contact with machinery

518

4568

1.15

2.35

7.7

8.3

0.92

1.00

mmol/l

0.17

385

3587

Supervision of high-risk pregnancy

576

3067

1.14

2.35

5.7

8.0

0.56

0.87

mmol/l

1.25

422

2365

Other and unspecified hypertrophic disorders of skin

172

1.86

2.35

9.0

9.8

1.50

1.53

mmol/l

0.02

130

Other benign neoplasm of uterus: Other parts/unspecified

129

1653

0.76

2.34

4.0

5.0

1.05

1.43

mmol/l

0.54

104

1283

Carcinoma in situ of vagina

100

2.16

2.34

4.7

5.8

1.11

1.40

mmol/l

0.17

Vasomotor rhinitis (mode)

304

2576

1.20

2.34

5.5

7.8

1.25

1.07

mmol/l

0.44

229

2006

Tarsal tunnel syndrome

288

1.64

2.33

4.9

7.0

0.63

1.46

mmol/l

0.91

235

Malignant immunoproliferative diseases

363

1.59

2.33

10.8

8.8

1.10

1.21

mmol/l

0.08

285

Procedures for purposes other than remedying health state

633

1.41

2.33

4.4

6.7

0.81

1.13

mmol/l

0.25

508

6-mercaptopurine

683

1.39

2.32

6.9

7.5

0.22

0.83

mmol/l

0.81

537

Scleritis

344

1.58

2.32

6.5

7.1

0.15

1.29

mmol/l

1.81

276

Burns and corrosions confined to eye and internal organs

107

806

1.36

2.32

7.3

9.3

1.98

1.11

mmol/l

1.45

641

Benign neoplasm: Skin of upper limb, including shoulder

628

1.42

2.31

8.3

7.4

1.08

1.20

mmol/l

0.11

497

Open wounds involving multiple body regions

101

2.16

2.30

20.7

13.3

0.68

1.33

mmol/l

0.27

Graves ophthalmopathy, strict

636

1.41

2.30

7.6

7.2

1.16

1.48

mmol/l

0.41

514

Viral infections of central nervous system, not elsewhere classified/unspecified

313

1.60

2.29

6.8

8.7

1.77

1.06

mmol/l

0.79

249

Ulcer of vagina/vulva

627

1.41

2.29

5.0

6.2

0.72

1.17

mmol/l

0.63

503

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

205

1.78

2.28

7.8

6.5

-0.13

1.11

mmol/l

0.82

149

Alopecia areata

687

1.39

2.28

8.5

8.3

1.29

1.25

mmol/l

0.03

546

Ulcerative rectosigmoiditis

330

2821

1.19

2.27

8.2

7.8

1.06

mmol/l

0.00

260

2196

Congenital malformations of uterus and cervix

376

1.53

2.27

14.2

8.1

0.92

1.06

mmol/l

0.08

284

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

2.46

2.27

9.1

6.2

1.52

1.84

mmol/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

940

8580

1.11

2.27

6.4

7.1

1.04

1.12

mmol/l

0.25

723

6760

Other peripheral vertigo

408

3551

1.17

2.26

5.4

6.9

1.30

1.17

mmol/l

0.28

321

2766

Cellulitis of external ear

314

1.60

2.26

8.1

8.0

1.39

1.04

mmol/l

0.36

243

Explosion of other materials

2.19

2.26

4.7

6.8

-0.34

1.15

mmol/l

1.11

Hereditary angioödema type 1

3.81

2.25

5.0

3.8

1.96

1.25

mmol/l

—

Chronic suppurative otitis media, including avohilmo

329

2815

1.19

2.25

7.4

7.9

0.93

1.04

mmol/l

0.16

251

2184

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

173

1.80

2.25

5.3

11.6

0.26

0.58

mmol/l

0.10

131

Glaucoma, exfoliation

543

4820

1.14

2.24

4.6

5.8

1.32

1.20

mmol/l

0.30

395

3709

Ulcerative ileocolitis

152

1206

1.29

2.23

7.5

8.4

0.09

1.08

mmol/l

1.61

117

946

Chronic myeloid leukaemia

139

1.97

2.23

11.4

7.8

-0.31

1.21

mmol/l

0.54

111

Narcolepsy and cataplexy

167

1.83

2.22

3.3

7.5

0.89

0.83

mmol/l

0.04

133

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

238

1.71

2.22

11.8

6.1

1.61

1.19

mmol/l

0.29

184

Benign neoplasm: Connective and other soft tissue of head, face and neck

539

1.44

2.22

6.5

8.4

0.66

1.12

mmol/l

0.49

420

Acute myeloid leukaemia

325

1.59

2.22

8.6

7.0

1.28

1.12

mmol/l

0.09

256

Hereditary ataxia

415

1.51

2.21

4.3

9.1

1.05

1.14

mmol/l

0.06

329

Autism spe, excluding more controls

281

1.59

2.21

4.9

7.3

1.17

0.26

mmol/l

0.63

222

Varus deformity, not elsewhere classified

308

1.59

2.20

11.1

6.7

1.80

1.32

mmol/l

0.56

246

Disorders of other digestive organs in diseases classified elsewhere

5.00

2.20

7.7

3.5

-2.47

1.64

mmol/l

—

Lymphangioma, anys site

175

1.80

2.20

4.7

10.0

-0.03

1.04

mmol/l

0.85

133

Other sexually transmitted chlamydial diseases

1301

0.74

2.19

9.7

8.4

-0.51

0.66

mmol/l

1.81

953

Hyposplenism

2.93

2.19

8.4

17.9

-1.98

1.31

mmol/l

1.23

Biliary cirrhosis, NAS

112

2.12

2.17

6.8

5.5

-0.99

1.40

mmol/l

1.15

Calcific tendinitis

294

1.61

2.17

3.8

9.6

2.14

1.02

mmol/l

1.22

235

Cerebral atherosclerosis

424

1.50

2.16

7.5

5.8

1.30

mmol/l

0.00

324

Sexual dysfunction

441

1.48

2.16

9.5

9.6

0.93

0.95

mmol/l

0.01

350

Unspecified organic or symptomatic mental disorder

111

2.05

2.15

6.4

2.36

1.08

mmol/l

1.11

Abscess of Bartholin gland

608

1.40

2.14

6.5

7.2

-0.28

1.20

mmol/l

2.47

477

Androgenic alopecia

216

1.70

2.12

12.9

6.1

0.90

1.36

mmol/l

0.27

173

Secondary systemic amyloidosis

2.15

2.12

9.5

4.6

2.27

1.08

mmol/l

0.42

Disturbances of smell and taste

169

1369

1.26

2.12

6.2

8.3

1.72

1.10

mmol/l

1.08

129

1091

Melanocytic naevi of scalp and neck

706

1.37

2.11

7.3

8.5

0.06

1.11

mmol/l

2.00

554

Other disorders of peripheral nervous system

202

1.75

2.11

16.8

7.8

1.92

1.10

mmol/l

0.47

158

Other and unspecified injuries of thorax

527

1.43

2.11

9.2

8.8

1.37

1.14

mmol/l

0.21

410

Patellar tendinitis

400

1.49

2.11

5.2

11.1

0.57

0.99

mmol/l

0.47

323

Congenital malformations of eye, ear, face and neck

213

1763

1.23

2.10

10.1

8.5

1.23

0.94

mmol/l

0.55

160

1353

Other osteochondropathies

282

2399

1.19

2.09

7.6

8.5

1.15

0.98

mmol/l

0.31

225

1879

Generalized epilepsy, strict definition

560

1.41

2.09

8.3

9.7

1.31

0.83

mmol/l

0.36

447

Short stature, not elsewhere classified

335

1.51

2.09

11.3

15.2

-0.73

0.05

mmol/l

0.65

271

Frontotemporal dementia, wide, incl. Pick's disease

235

1.69

2.08

9.8

6.9

1.13

0.96

mmol/l

0.05

189

Endometriosis of fallopian tube

186

1.75

2.08

7.4

10.7

1.16

1.52

mmol/l

0.30

150

Adenocarcinomas of cervix

105

2.04

2.07

3.8

6.3

0.69

1.26

mmol/l

0.35

Occlusion and stenosis of arteries, not leading to stroke

479

1.45

2.07

7.3

6.0

1.17

1.56

mmol/l

0.31

359

Oral lichen ruber planus wide, hypothyreosis or thyroxin

221

1846

1.22

2.06

6.3

6.5

0.93

1.31

mmol/l

1.04

167

1470

Benign neoplasm: Choroid

262

2224

1.20

2.06

6.5

7.3

1.18

1.21

mmol/l

0.05

200

1729

Multifocal fibrosclerosis

228

1.69

2.04

7.9

5.8

2.22

1.52

mmol/l

0.52

180

Benign neoplasm: Skin of ear and external auricular canal

179

1468

1.25

2.03

6.3

7.4

1.32

1.22

mmol/l

0.12

147

1125

Carcinoma in situ of vagina

106

2.03

4.7

6.0

1.11

1.31

mmol/l

0.12

Disorders of lacrimal system and orbit in diseases classified elsewhere

720

1.36

2.02

7.5

6.9

1.19

1.35

mmol/l

0.20

577

Benign neoplasm: Nasopharynx

251

1.63

2.02

9.2

6.2

1.29

1.59

mmol/l

0.20

197

Melanocytic naevi of lower limb, including hip

162

1314

1.26

2.01

5.8

8.6

0.55

1.15

mmol/l

1.19

126

1036

Accidental poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours

2.37

2.01

4.8

6.7

3.32

1.07

mmol/l

1.43

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

166

1.79

1.99

12.2

5.9

0.72

1.63

mmol/l

0.62

133

Other/unspecified crystal arthropathies

214

1.71

1.99

6.4

5.7

0.25

1.38

mmol/l

0.95

175

Disorders of copper metabolism

3.61

1.98

8.6

4.1

-0.39

0.15

mmol/l

—

Contracture of joint

391

1.49

1.98

6.5

7.7

1.05

1.36

mmol/l

0.28

298

Other and unspecified mononeuropathies of lower limb

114

890

1.32

1.97

8.1

7.4

1.55

1.10

mmol/l

0.68

710

Acute mastoiditis

228

1.65

1.97

9.2

8.3

1.29

1.25

mmol/l

0.03

180

Cleft palate

196

1.69

1.97

9.4

12.9

1.36

0.81

mmol/l

0.42

148

LSIL lesion of the vulva

101

775

1.33

1.96

7.4

7.3

1.29

1.34

mmol/l

0.05

611

Cleft lip, lip and palate or palate

340

1.51

1.96

11.6

10.1

1.21

1.02

mmol/l

0.13

264

Stenosis and insufficiency of lacrimal passages

399

3506

1.15

1.96

5.4

7.1

1.67

1.23

mmol/l

1.56

296

2723

Inflammation of lacrimal passages (acute and unspecified)

527

1.41

1.95

8.7

6.2

0.80

1.42

mmol/l

0.61

415

Other specified and unspecified disorders of lens

303

1.57

1.95

5.7

6.5

1.32

1.36

mmol/l

0.05

244

Labour and delivery complicated by umbilical cord complications

151

1218

1.26

1.94

6.3

6.6

1.52

0.99

mmol/l

1.14

112

947

Tularaemia

410

1.47

1.94

5.3

9.2

2.29

0.94

mmol/l

2.30

330

Fall on and from ladder

368

3224

1.16

1.94

7.5

8.0

0.80

1.02

mmol/l

0.61

296

2499

Enteropathogenic Escherichia coli infection

2.14

1.93

13.7

7.4

2.56

1.27

mmol/l

1.08

Graves ophthalmopathy

717

1.35

1.93

7.5

7.0

1.17

1.41

mmol/l

0.31

581

Orthopaedic devices associated with adverse incidents

654

0.66

1.93

4.6

6.4

1.08

1.39

mmol/l

0.21

525

Benign neoplasm: Pineal gland

2.85

1.93

8.9

5.1

1.50

1.55

mmol/l

—

Torsion of testis

458

1.43

1.93

11.5

11.1

1.01

0.77

mmol/l

0.20

364

Dermatitis herpetiformis

606

1.38

1.93

8.7

7.5

1.74

1.30

mmol/l

0.65

480

Burn and corrosion of head and neck

648

1.37

1.93

7.4

9.4

1.50

0.89

mmol/l

0.80

510

Hereditary retinal dystrophy

452

1.45

1.92

4.7

7.4

1.35

1.32

mmol/l

0.02

356

Other disorders of thyroid

402

1.48

1.92

13.2

6.1

1.15

1.52

mmol/l

0.24

320

Alzheimer disease, including avohilmo

1852

12601

1.07

1.92

4.0

5.9

1.29

1.16

mmol/l

0.64

1372

9689

Nystagmus and other irregular eye movements

360

1.50

1.91

8.2

11.4

0.70

0.99

mmol/l

0.16

284

Renal agenesis and other reduction defects of kidney

123

1.90

1.91

5.5

12.4

0.96

1.23

mmol/l

0.06

Endometriosis of ovary

613

5512

1.12

1.90

6.4

6.8

1.12

1.07

mmol/l

0.13

475

4402

Benign neoplasm: Skin of scalp and neck

104

807

1.33

1.90

6.2

8.5

1.00

1.25

mmol/l

0.28

632

Chronic iridocyclitis

198

1650

1.22

1.90

6.3

7.7

1.21

1.16

mmol/l

0.06

139

1292

Contact with other specified venomous animals

176

1.74

1.90

9.7

10.4

1.38

1.17

mmol/l

0.13

138

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

313

1.55

1.90

8.2

9.2

0.90

1.25

mmol/l

0.26

250

Guttate psoriasis

394

1.47

1.90

5.9

8.6

0.69

1.08

mmol/l

0.21

311

Foreign body in respiratory tract

197

1641

1.22

1.89

8.6

8.3

1.46

1.09

mmol/l

0.71

157

1295

Hypothyroidism, autoimmune, DX-based

2.13

1.89

4.6

6.5

-0.23

1.19

mmol/l

0.66

Episcleritis

191

1587

1.22

1.88

7.3

8.2

1.15

1.13

mmol/l

0.03

147

1260

Disorders of breast

1940

16973

1.06

1.88

6.7

6.4

1.04

1.18

mmol/l

0.95

1555

13401

Injury of blood vessels of thorax

102

2.01

1.88

9.9

12.4

1.81

1.75

mmol/l

0.03

Benign neoplasm of other and unspecified female genital organs

143

1153

1.26

1.88

5.7

6.2

2.10

1.39

mmol/l

1.33

113

885

Carcinoma in situ of skin of ear and external auricular canal

473

1.44

1.88

6.3

5.7

0.04

1.36

mmol/l

2.36

357

Allergic conjunctivitis

2380

22243

1.06

1.88

7.4

7.1

0.78

1.05

mmol/l

2.74

1907

17427

Idiopathic urticaria

495

1.41

1.88

4.7

8.8

0.58

1.13

mmol/l

0.64

387

Other and unspecified disorders of autonomic nervous system

102

2.00

1.87

8.9

11.8

1.79

1.49

mmol/l

0.19

Burn and corrosion of shoulder and upper limb, except wrist and hand

599

1.37

1.87

10.5

9.0

1.06

1.02

mmol/l

0.03

472

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

339

2958

1.16

1.87

6.0

8.1

0.87

1.11

mmol/l

0.46

266

2320

Family history of certain disabilities and chronic diseases leading to disablement

127

1010

1.28

1.85

6.6

7.0

1.13

0.98

mmol/l

0.20

770

Struck by thrown, projected or falling objec

184

1527

1.23

1.85

6.2

8.8

1.46

1.01

mmol/l

1.24

138

1202

Failed induction of labour

127

1009

1.27

1.85

4.6

6.5

-0.12

0.44

mmol/l

0.93

725

Disorders of eyelid in diseases classified elsewhere

132

1059

1.28

1.84

5.5

8.2

0.92

1.20

mmol/l

0.43

101

818

Nail dystrophy

194

1.69

1.84

11.8

10.5

2.48

1.35

mmol/l

0.70

157

All dysplastic lesions of the cervix uteri

713

6474

1.11

1.83

6.7

0.88

0.83

mmol/l

0.12

536

4904

Disorder of thyroid, unspecified

390

1.47

1.81

13.5

5.9

1.18

1.32

mmol/l

0.07

310

Presence of other devices

1107

10281

1.08

1.81

6.2

6.0

1.26

1.13

mmol/l

0.56

823

7967

Small plaque parapsoriasis

2.05

1.81

2.9

5.5

2.55

1.02

mmol/l

0.77

Pneumonia due to Haemophilus influenzae

2.06

1.81

13.5

4.9

3.66

0.71

mmol/l

1.51

Chondromalacia

881

0.72

1.81

5.4

8.4

0.48

1.13

mmol/l

0.79

702

Aphakia

465

1.42

1.81

9.1

7.8

0.57

1.15

mmol/l

0.36

361

Major anomalies of jaw size

733

1.33

1.80

8.1

9.1

1.88

1.02

mmol/l

1.08

593

361

1.45

1.80

12.7

14.4

-0.56

-0.22

mmol/l

0.27

278

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

252

1.60

1.80

11.1

6.7

0.89

1.59

mmol/l

0.64

195

Adenomyosis (Endometriosis of uterus)

535

4811

1.12

1.80

5.6

6.5

0.82

1.17

mmol/l

1.33

415

3880

Vascular dementia (other)

204

1.68

1.79

4.5

6.3

0.88

1.32

mmol/l

0.30

157

Carrier of infectious disease

665

1.34

1.78

7.8

8.0

1.20

1.11

mmol/l

0.09

524

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2268

21181

1.06

1.78

7.5

7.1

0.75

1.05

mmol/l

3.21

1822

16595

Dislocation, sprain and strain of joints and ligaments of elbow

214

1807

1.20

1.77

7.2

8.3

1.09

1.05

mmol/l

0.05

167

1407

Crushing injury of ankle and foot

112

1.92

1.76

7.0

11.8

2.36

0.95

mmol/l

1.23

Other inflammation of vagina/vulva

769

1.31

1.76

6.7

7.1

0.32

1.09

mmol/l

1.05

587

Other and unspecified disorders of skin and subcutaneous tissue

194

2304

0.83

1.76

6.4

7.4

0.96

1.09

mmol/l

0.18

159

1801

Mental and behavioural disorders associated with the puerperium

171

1.68

1.75

4.7

6.6

0.38

1.33

mmol/l

0.57

127

Use of donepezil

843

8790

0.91

1.75

3.8

5.6

1.33

1.19

mmol/l

0.49

632

6686

Other melanin hyperpigmentation

100

784

1.32

1.75

6.1

6.8

2.01

1.35

mmol/l

1.57

621

Toxic effect of other noxious substances eaten as food

2.01

1.74

8.1

6.5

0.63

1.53

mmol/l

0.64

Chalazion

457

4083

1.13

1.74

6.4

7.7

1.12

1.02

mmol/l

0.20

348

3173

Venous complications and haemorrhoids in pregnancy

291

1.51

1.74

6.3

9.5

0.31

0.93

mmol/l

0.69

207

Other abortion

180

1.67

1.73

8.0

7.4

1.25

1.02

mmol/l

0.14

140

Other and unspecified injuries of neck

196

1.64

1.73

4.0

7.2

0.82

1.07

mmol/l

0.15

153

Benign neoplasm: Retina

127

1.83

1.73

5.4

4.3

0.38

1.41

mmol/l

0.51

Contusion of toe(s) with damage to nail

277

1.53

1.72

9.5

9.8

0.38

0.97

mmol/l

0.43

223

Immunodeficiency associated with other major defects

2.09

1.72

8.1

9.1

0.80

1.36

mmol/l

0.19

Benign neoplasm: Conjunctiva

135

1097

1.26

1.72

7.1

8.1

0.70

1.28

mmol/l

1.05

109

864

Iridocyclitis in diseases classified elsewhere

583

1.36

1.72

5.5

7.6

1.19

1.24

mmol/l

0.04

453

Frontotemporal dementia

199

1.67

1.71

11.1

6.9

0.84

1.09

mmol/l

0.07

162

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

114

910

1.29

1.71

6.6

6.5

0.95

1.39

mmol/l

0.65

706

Primary angle-closure glaucoma

201

1701

1.21

1.70

5.6

7.1

1.13

1.25

mmol/l

0.14

155

1326

Lipomatosis, not elsewhere classified

2.12

1.70

9.7

6.1

2.30

1.58

mmol/l

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

359

1.45

1.70

9.0

7.6

1.11

0.96

mmol/l

0.12

256

Hypertrophy of tongue papillae

379

1.45

1.69

7.8

8.8

1.49

1.14

mmol/l

0.28

303

Tooth agenesis EXCLUDE clefts and syndromes

650

1.32

1.69

13.9

9.1

0.94

0.54

mmol/l

0.44

502

Wilms' tumor, excluding all cancers (controls excluding all cancers)

191

1.66

1.68

4.4

5.3

-0.28

1.47

mmol/l

0.96

146

Benign neoplasm: Skin of other and unspecified parts of face

481

4324

1.13

1.68

5.4

7.0

1.17

1.19

mmol/l

0.04

372

3332

Poor fetal growth

280

2424

1.16

1.67

10.6

6.6

0.37

0.62

mmol/l

0.47

203

1770

Glaucoma-related operations

256

2214

1.18

1.67

6.7

1.00

1.18

mmol/l

0.33

197

1710

Male infertility

160

1324

1.23

1.67

8.4

10.0

0.90

0.92

mmol/l

0.02

126

1053

Edwards' syndrome and Patau's syndrome

3.36

1.65

15.8

4.8

0.47

2.09

mmol/l

—

Benign neoplasm: Long bones of lower limb

117

939

1.27

1.65

10.2

9.4

1.24

1.18

mmol/l

0.07

757

Abnormality of white blood cells, not elsewhere classified

240

1.57

1.65

12.0

8.4

0.87

1.13

mmol/l

0.11

195

Hypertrophy of breast

570

5167

1.11

1.65

7.0

6.8

1.21

1.13

mmol/l

0.19

460

4081

Benign neoplasm: other/unspecified salivary gland

125

1014

1.27

1.65

7.0

7.1

1.91

1.34

mmol/l

0.75

802

HSIL lesion of the vagina

355

1.46

1.65

6.3

6.7

0.97

1.49

mmol/l

0.51

291

Anogenital herpesviral [herpes simplex] infection

180

1508

1.21

1.64

9.7

8.2

0.30

0.80

mmol/l

1.33

144

1158

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

161

1.72

1.64

6.3

7.0

0.38

1.62

mmol/l

0.81

135

Atopic dermatitis

2245

18228

1.05

1.63

7.3

7.6

0.80

0.91

mmol/l

0.60

1806

14144

Malignant neoplasm of testis

528

1.37

1.62

10.4

9.6

0.62

0.83

mmol/l

0.21

422

Other articular cartilage disorders

106

845

1.29

1.62

6.1

9.0

1.31

1.09

mmol/l

0.20

664

Moderate visual impairment, monocular

123

1.83

1.62

7.6

5.6

-0.17

1.18

mmol/l

0.59

100

Mucinous and mucinous cystic tumor

123

1.82

1.61

13.6

5.3

1.67

1.53

mmol/l

0.06

105

Other congenital malformations of female genitalia

129

1.75

1.61

8.3

6.8

1.76

1.01

mmol/l

0.28

Postprocedural disorders of eye and adnexa, not elsewhere classified

1.99

1.60

6.0

-1.77

1.46

mmol/l

—

Lupus erythematosus

766

1.30

1.60

5.8

7.0

0.29

1.28

mmol/l

1.19

609

Carcinoma in situ of breast, intraductal

318

2798

1.15

1.60

5.6

6.4

1.09

1.27

mmol/l

0.42

259

2210

Melanocytic naevi of lip

217

1.58

1.59

4.7

8.6

1.46

1.45

mmol/l

0.01

173

Malignant neoplasm of parotid gland

251

1.55

1.58

5.2

7.0

1.14

1.13

mmol/l

0.00

203

Tick-borne viral encephalitis

101

1.91

1.58

2.5

7.0

2.62

1.30

mmol/l

0.85

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

147

1.74

1.58

3.8

2.01

1.67

mmol/l

0.14

109

Other specified/unspecified disorders of bone/cartilage

113

910

1.27

1.58

10.2

7.9

0.09

1.05

mmol/l

1.63

730

Secondary malignant neoplasm of respiratory and digestive organs

489

1.39

1.58

4.2

7.3

2.01

1.33

mmol/l

0.84

382

Inhalation and ingestion of food causing obstruction of respiratory tract

309

1.49

1.58

13.4

8.6

2.49

1.24

mmol/l

1.70

246

Injury of muscle and tendon at ankle and foot level

724

1.30

1.55

6.7

9.5

1.02

1.17

mmol/l

0.14

573

Glycosuria

2.44

1.55

9.0

6.4

4.80

1.66

mmol/l

—

Malignant neoplasm of other and unspecified urinary organs

103

1.92

1.54

16.3

5.4

-1.48

1.28

mmol/l

1.33

Vestibular neuronitis

379

3382

1.14

1.54

6.0

7.5

1.18

1.12

mmol/l

0.11

304

2636

Osteitis due to dental implant

221

1.59

1.53

13.1

8.3

1.34

1.43

mmol/l

0.05

182

Exposure to electric transmission lines

2.81

1.53

8.6

9.8

1.90

0.35

mmol/l

—

Premature separation of placenta [abruptio placentae]

496

1.36

1.53

3.8

7.8

0.67

1.08

mmol/l

0.50

374

Placenta praevia

114

919

1.26

1.53

7.2

6.7

0.35

0.82

mmol/l

0.82

686

Benign neoplasm: Lip

665

1.31

1.52

5.4

6.3

1.38

1.31

mmol/l

0.05

513

Benign neoplasm: Pineal gland

2.53

1.51

8.9

5.2

1.50

1.63

mmol/l

—

Carcinoma in situ of bronchus and lung

2.56

1.51

15.9

9.9

3.94

1.86

mmol/l

—

Injury of blood vessels at wrist and hand level

221

1.57

1.51

9.9

10.6

1.71

1.12

mmol/l

0.47

175

Benign neoplasm: Connective and other soft tissue, unspecified

371

1.43

1.51

6.8

7.0

-0.21

1.18

mmol/l

0.89

303

Congenital hydrocephalus

1.89

1.50

8.2

12.0

0.81

1.33

mmol/l

—

Use of teriflunomide

215

0.50

1.50

3.6

7.4

1.02

mmol/l

—

162

Cleft hard palate NOS

1.95

1.49

6.9

17.3

0.62

1.22

mmol/l

—

Spirochaetal infections, other/unspecified

272

3099

0.87

1.49

7.3

7.8

0.64

1.16

mmol/l

1.84

232

2438

Benign leiomyoma with endometriosis

539

5914

0.90

1.49

6.1

1.06

1.28

mmol/l

0.79

425

4717

Eustachian salpingitis and obstruction

238

2061

1.17

1.48

7.4

8.3

0.88

0.96

mmol/l

0.12

201

1612

Benign neoplasm of bone and articular cartilage

319

2823

1.14

1.48

7.6

8.1

1.12

1.06

mmol/l

0.13

257

2186

Rhinophyma

240

1.55

1.48

5.3

7.5

1.39

1.08

mmol/l

0.16

188

Use of apomorphine

3.06

1.48

14.5

7.4

-0.25

1.86

mmol/l

—

Secondary malignant neoplasm of other and unspecified sites

495

1.37

1.47

5.7

7.5

2.70

1.24

mmol/l

1.96

388

Failed attempted abortion

204

1.56

1.47

3.5

8.6

0.27

0.64

mmol/l

0.17

146

Fibrosarcoma

248

1.53

1.46

5.3

6.9

0.41

1.42

mmol/l

0.74

199

Other papulosquamous disorders

331

1.44

1.45

7.2

7.1

1.23

1.25

mmol/l

0.01

263

Nondiabetic hypoglycaemic coma

104

1.84

1.45

8.6

12.4

3.20

1.75

mmol/l

—

Oral lichen ruber planus

769

1.28

1.44

8.5

7.8

0.89

1.28

mmol/l

0.68

618

Benign neoplasm: Bladder

324

1.45

1.43

5.4

6.6

0.46

1.08

mmol/l

0.56

259

Peroneal tendinitis

399

1.39

1.43

4.9

8.4

0.77

1.34

mmol/l

0.40

331

Severe visual impairment, monocular

282

1.48

1.43

4.8

6.2

1.00

1.39

mmol/l

0.24

226

319

1.42

1.43

10.7

14.1

-0.47

-0.30

mmol/l

0.11

246

Radiodermatitis

1.99

1.43

12.1

5.0

0.27

1.85

mmol/l

0.81

Primary open-angle glaucoma

1648

15255

1.06

1.43

5.9

6.3

1.12

1.16

mmol/l

0.16

1228

11963

Mandibular prognathia

365

1.40

1.42

7.8

9.4

1.15

0.83

mmol/l

0.28

293

Congenital malformations of lung

2.07

1.42

5.1

13.3

0.41

1.08

mmol/l

0.33

Benign neoplasm: Respiratory system, unspecified

2.15

1.42

16.4

4.5

2.50

1.06

mmol/l

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

359

1.42

1.41

10.3

5.6

1.26

1.58

mmol/l

0.29

275

Exposure to other specified electric current

298

1.45

1.41

11.4

10.1

1.14

0.82

mmol/l

0.27

232

Disorders of male genital organs in diseases classified elsewhere

192

1.59

1.41

10.2

13.4

1.86

0.85

mmol/l

1.44

147

Other bursitis, not elsewhere classified

308

1.45

1.40

4.2

7.8

0.81

1.36

mmol/l

0.63

239

Carcinoma in situ of cervix uteri, endocervix

215

1.53

1.40

7.2

9.3

-0.05

0.81

mmol/l

0.53

162

Labyrinthitis

1.86

1.40

3.7

6.1

0.62

1.32

mmol/l

0.67

Acute otitis externa, noninfective

506

1.34

1.40

7.2

7.3

1.93

1.18

mmol/l

0.68

411

Other congenital malformations of peripheral vascular system

316

1.43

1.39

21.3

9.8

1.41

0.89

mmol/l

0.26

259

Benign neoplasm: Skin, unspecified

139

1161

1.22

1.39

6.9

7.0

0.88

1.25

mmol/l

0.76

113

901

Early syphilis

395

1.39

1.38

7.3

10.0

0.51

1.25

mmol/l

0.74

324

Acne conglobata

113

1.75

1.37

7.1

14.4

0.01

1.21

mmol/l

0.53

Other complications of labour and delivery, not elsewhere classified

174

1967

0.85

1.37

4.1

6.7

0.17

0.44

mmol/l

0.38

125

1397

Periodontal disease, other/unspecified

130

1.73

1.37

10.8

7.6

1.32

1.15

mmol/l

0.08

103

Other disorders originating in the perinatal period

192

1.55

1.37

10.9

13.9

-0.00

-0.02

mmol/l

0.01

158

Alzheimer disease

1558

11148

1.06

1.37

3.9

5.7

1.31

1.17

mmol/l

0.62

1148

8506

Gluteal tendinitis

127

1054

1.23

1.36

5.9

7.4

1.23

1.16

mmol/l

0.07

101

847

Tibial collateral bursitis [Pellegrini-Stieda]

327

1.42

1.35

8.2

6.6

1.12

1.42

mmol/l

0.19

266

Mental and behavioural disorders of puerperium, not classified elsewhere

184

1.56

1.35

4.7

6.5

0.38

1.25

mmol/l

0.51

139

Pedal cyclist injured in collision with pedestrian or animal

227

1.52

1.35

9.2

7.3

1.63

1.17

mmol/l

0.36

181

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

119

983

1.23

1.35

8.5

8.7

0.76

1.26

mmol/l

0.96

101

793

Thyroiditis, unspecified

439

1.36

1.34

6.7

1.92

1.32

mmol/l

0.84

344

Malignant neoplasm of tonsil

538

1.33

1.34

9.8

8.4

1.60

1.04

mmol/l

0.71

434

Symptoms and signs involving appearance and behaviour

227

1.51

1.33

4.5

6.5

1.87

0.96

mmol/l

1.02

183

Foreign body in ear

492

1.33

10.4

9.4

0.78

1.11

mmol/l

0.20

395

Congenital malformation of optic disc

2.48

1.32

65.8

6.1

0.46

1.17

mmol/l

—

L02BA Anti-estrogens

632

5832

1.09

1.32

5.1

6.5

0.85

1.25

mmol/l

2.08

522

4651

Postpartum haemorrhage

584

5530

0.92

1.31

6.5

7.3

0.13

0.85

mmol/l

5.00

426

4221

Malignant neoplasm of breast, HER-negative

857

7998

1.08

1.31

5.9

6.1

1.10

1.32

mmol/l

0.96

714

6383

Respiratory tuberculosis, clinically confirmed

469

1.34

1.30

9.5

7.5

2.08

1.28

mmol/l

0.77

358

Carcinoma in situ of cervix uteri

236

2066

1.15

1.30

6.2

6.4

0.67

0.85

mmol/l

0.28

174

1555

Benign neoplasm: Short bones of lower limb

245

1.47

1.29

5.8

9.3

0.97

1.26

mmol/l

0.22

196

Other appendicitis

337

3023

1.13

1.29

8.5

7.5

0.97

1.08

mmol/l

0.20

271

2366

Follicular lymphoma, hilmo

188

1627

1.18

1.29

6.9

7.5

1.95

1.11

mmol/l

2.44

147

1267

Ménière disease

420

3815

1.11

1.29

4.7

7.0

1.30

1.18

mmol/l

0.25

323

2966

Benign neoplasm: Short bones of upper limb

390

1.37

1.28

4.2

7.5

0.82

1.43

mmol/l

0.84

314

Benign neoplasm: Nasopharynx

280

1.45

1.28

9.2

7.5

1.29

1.37

mmol/l

0.04

228

Carcinoma in situ of skin, other sites/unspecified

401

1.37

1.28

4.9

5.2

1.72

1.59

mmol/l

0.13

308

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

691

1.27

1.28

7.7

6.6

1.59

1.41

mmol/l

0.16

532

Other and unspecified acne

287

1.43

1.28

10.6

9.0

0.46

0.93

mmol/l

0.43

220

Pathological resorption of teeth

108

889

1.24

1.27

11.7

7.8

0.82

1.24

mmol/l

0.76

692

Maxillary retrognathism

398

0.67

1.27

12.9

9.2

1.84

0.93

mmol/l

0.40

315

Benign neoplasm: Respiratory system, unspecified

2.04

1.26

16.4

6.0

2.50

0.85

mmol/l

—

Complications of the puerperium, not elsewhere classified

789

1.24

1.25

7.9

7.6

0.47

0.99

mmol/l

0.54

586

Additional codes for the location of defect, injury or illness

216

1890

1.16

1.25

7.6

8.0

1.47

1.10

mmol/l

0.84

167

1474

Benign neoplasm: Endocrine gland, other/unspecified

1.81

1.25

3.6

5.0

-0.03

1.33

mmol/l

0.92

Vitiligo

298

1.42

1.24

6.8

8.8

-0.15

1.31

mmol/l

0.77

237

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

190

1.54

1.24

12.2

6.2

0.72

1.39

mmol/l

0.42

149

Benign neoplasm: Skin of trunk

163

1399

1.18

1.23

6.6

8.5

0.91

1.21

mmol/l

0.44

124

1103

Myopathy due to other toxic agents

3.01

1.23

12.4

6.3

3.92

0.82

mmol/l

—

Reiter disease

182

1.55

1.23

4.6

8.0

0.87

0.99

mmol/l

0.05

146

Mantle cell lymphoma

362

1.39

1.22

7.0

2.05

1.20

mmol/l

0.58

280

Other chromosome abnormalities, not elsewhere classified

1.85

1.21

24.9

20.0

0.29

0.90

mmol/l

—

Wilms' tumor

208

1.51

1.21

4.4

5.9

-0.28

0.91

mmol/l

0.58

169

Unspecified parasitic disease

258

1.45

1.21

5.7

7.2

0.11

1.11

mmol/l

0.98

211

Pedal cyclist injured in collision with motor vehicle

110

913

1.22

1.21

6.8

8.5

1.45

1.12

mmol/l

0.50

720

Xanthelasma of eyelid

275

1.43

1.21

7.4

6.9

0.54

1.51

mmol/l

1.06

218

Glaucoma secondary to eye inflammation

275

1.43

1.21

6.0

9.8

0.87

1.26

mmol/l

0.24

220

Other benign neoplasm of uterus: Corpus uteri

216

1.49

1.20

6.0

5.2

1.66

1.85

mmol/l

0.12

168

Melanocytic naevi of ear and external auricular canal

167

1.57

1.19

5.1

6.7

1.84

0.92

mmol/l

0.43

130

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

208

1.50

1.19

3.5

6.6

0.14

1.77

mmol/l

2.16

161

Obstructed labour due to malposition and malpresentation of fetus

523

5356

0.92

1.19

6.1

7.6

0.68

0.88

mmol/l

0.57

394

4097

Antenatal screening

529

3244

0.91

1.18

5.4

8.0

0.37

0.85

mmol/l

2.09

388

2489

Varicose veins of other sites

266

2370

1.14

1.18

6.6

8.1

1.26

1.04

mmol/l

0.45

214

1862

Childhood allergy (age < 16)

313

2308

1.12

1.18

9.0

8.6

-0.01

-0.00

mmol/l

0.01

240

1626

Routine general health check-up of defined subpopulation

386

1.34

1.17

5.2

6.1

1.15

0.78

mmol/l

0.29

298

Dental caries 1 and operation codes, only avohilmo

1359

7195

0.94

1.17

8.0

8.1

0.99

1.18

mmol/l

1.01

1086

5598

Moderate visual impairment, binocular

123

1037

1.21

1.17

6.9

6.5

0.90

1.38

mmol/l

0.56

801

Crossbite

183

1471

1.16

1.17

12.8

9.2

0.85

0.68

mmol/l

0.27

148

1168

Shoulder region

442

1.33

1.17

7.3

7.0

1.16

1.05

mmol/l

0.10

358

Other hypersecretion of intestinal hormones

2.85

1.17

26.6

11.6

0.64

3.04

mmol/l

—

Dysplasia of cervi uteri

780

5634

1.08

1.17

6.5

7.1

0.91

0.95

mmol/l

0.11

593

4418

Use of glatiramer acetate

353

1.36

1.16

6.6

9.5

0.64

0.97

mmol/l

0.18

273

Other congenital malformations of skull and face bones

1.87

1.16

4.5

24.8

1.61

1.14

mmol/l

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

3229

22588

0.97

1.16

7.1

7.8

0.91

1.02

mmol/l

0.95

2537

17866

Triptan medication for migraine, single purchase ok

3229

22588

0.97

1.16

7.1

7.8

0.91

1.02

mmol/l

0.95

2537

17866

Traumatic amputation of wrist and hand

195

1709

1.16

1.15

8.1

8.5

1.44

1.01

mmol/l

0.97

152

1330

Rapidly progressive nephritic syndrome

1.90

1.15

33.3

7.5

0.83

1.28

mmol/l

—

Hereditary motor and sensory neuropathy

253

1.43

1.13

7.7

7.2

2.59

1.18

mmol/l

0.73

211

Victim of lightning

2.59

1.13

2.4

10.6

1.38

1.33

mmol/l

—

Other disorders of male genital organs

148

1272

1.18

1.12

7.0

9.4

1.15

0.82

mmol/l

0.57

123

1013

Endometriosis of intestine

277

1.40

1.12

6.4

8.5

0.90

0.86

mmol/l

0.02

217

Crushing injury of wrist and hand

543

1.29

1.12

10.9

8.6

0.93

1.07

mmol/l

0.10

427

Acute inflammation of orbit

161

1.54

1.12

8.7

6.1

-0.09

1.00

mmol/l

0.39

123

Other localized connective tissue disorders

587

1.27

1.11

11.1

7.2

0.75

1.32

mmol/l

0.56

472

Abrasion of teeth

1128

7852

1.06

1.11

6.7

6.8

1.12

1.17

mmol/l

0.15

905

6148

Follow-up care involving plastic surgery

131

1115

1.19

1.11

5.5

7.0

1.06

1.02

mmol/l

0.04

112

872

Allergic colitis

398

1.32

1.11

19.3

10.0

0.99

0.31

mmol/l

0.80

306

Benign neoplasm: Tonsil

331

1.37

1.11

4.0

7.4

0.01

1.67

mmol/l

2.03

265

Other benign neoplasms of uterus

180

2055

0.86

1.11

4.5

5.3

1.18

1.41

mmol/l

0.33

140

1614

Sweet's syndrome

2.13

1.10

8.3

5.7

1.80

1.16

mmol/l

—

Malignant neoplasm of other and ill-defined digestive organs

255

1.43

1.10

3.6

5.9

1.53

1.33

mmol/l

0.10

197

Unspecified abortion

154

1328

1.17

1.10

6.4

7.0

0.86

1.17

mmol/l

0.42

118

1051

Benign leiomyoma with endometriosis

539

4989

1.09

1.10

6.1

6.0

1.06

1.49

mmol/l

2.16

425

3929

Scissor bite

451

1.30

1.09

10.3

11.5

0.80

0.43

mmol/l

0.41

353

Livedoid vasculitis

131

1.63

1.08

9.2

11.1

0.29

1.33

mmol/l

0.47

108

Benign neoplasm: Skin of lip

394

1.33

1.08

5.3

6.2

1.16

1.53

mmol/l

0.31

316

Malignant neoplasm of gallbladder

164

1.55

1.07

4.6

6.9

1.46

1.65

mmol/l

0.11

135

Toxoplasmosis

155

1.55

1.07

6.1

7.8

0.63

1.44

mmol/l

0.58

117

Striae atrophicae

264

1.40

1.06

8.0

8.6

0.35

1.27

mmol/l

0.95

208

Contracture of muscle

123

1.63

1.06

3.4

6.7

0.25

1.24

mmol/l

0.78

Tic and related disorders

204

1.45

1.05

8.4

6.6

0.88

0.76

mmol/l

0.09

165

Inflammation of lacrimal passages (chronic)

548

1.27

1.05

5.6

7.5

1.24

1.37

mmol/l

0.09

425

Febrile neutrophilic dermatosis [Sweet]

1.99

1.04

8.3

5.5

1.80

1.16

mmol/l

—

Primary open-angle glaucoma, strict

1312

12500

1.05

1.03

6.0

6.3

1.10

1.17

mmol/l

0.31

975

9781

Carcinoma in situ of middle ear and respiratory system

157

1.54

1.03

8.3

6.4

3.46

1.54

mmol/l

1.42

122

Lymphangioma, anys site

215

1.44

1.02

4.7

10.0

-0.03

0.87

mmol/l

0.67

168

Adhesive middle ear disease

459

1.29

1.02

5.2

8.0

1.21

1.16

mmol/l

0.04

362

Other disorders of amniotic fluid and membranes

260

2868

0.89

1.02

5.9

7.2

0.68

0.66

mmol/l

0.04

180

2145

Abnormalities of forces of labour

233

2608

0.89

1.02

7.9

7.0

0.54

1.01

mmol/l

1.58

194

2045

Crowding of teeth, including avohilmo

204

1486

1.14

1.02

9.6

8.5

0.71

0.39

mmol/l

0.66

152

1110

Dislocations, sprains and strains involving multiple body regions

2.10

1.02

9.7

22.0

0.21

1.36

mmol/l

—

Puerperal sepsis

442

4075

1.09

1.02

7.3

7.0

1.14

mmol/l

0.00

362

3252

Open bite

122

1040

1.18

1.01

11.0

8.5

0.97

0.75

mmol/l

0.22

795

Carcinoma in situ of skin of ear and external auricular canal

525

1.28

1.01

6.3

6.8

0.04

1.10

mmol/l

1.76

404

Benign lipomatous neoplasm of other sites/unspecified

387

3553

1.10

1.01

6.8

7.1

0.87

1.22

mmol/l

1.14

316

2762

Female infertility

1011

5907

1.06

1.01

6.5

7.3

0.70

0.92

mmol/l

1.12

769

4645

Amoebiasis

149

1.53

1.00

12.8

11.7

-0.70

1.68

mmol/l

0.76

128

Calculus of urinary tract in diseases classified elsewhere

2.50

1.00

10.5

8.0

2.28

0.47

mmol/l

—

Benign neoplasm: Connective and other soft tissue of thorax

125

1.59

0.99

5.5

5.1

1.15

1.36

mmol/l

0.13

Chronic myringitis

150

1.54

0.99

3.1

13.0

1.91

1.09

mmol/l

0.32

122

Optic neuritis

132

1137

1.17

0.99

5.2

8.5

0.97

1.04

mmol/l

0.09

885

Disorders of porphyrin and bilirubin metabolism

294

1.36

0.99

8.1

10.5

0.87

1.05

mmol/l

0.10

233

Malignant neoplasm of eye and adnexa

278

1.38

0.98

4.9

8.3

0.98

1.24

mmol/l

0.16

231

Cutaneous autosensitization

2.39

0.97

15.0

8.9

1.05

0.80

mmol/l

—

Other benign neoplasm of uterus: Cervix uteri

142

1.53

0.96

5.4

5.1

1.57

1.74

mmol/l

0.05

115

Crystalline deposits in vitreous body

332

1.34

0.96

4.7

6.7

1.45

1.53

mmol/l

0.06

267

Chronic mastoiditis

117

1004

1.19

0.96

7.2

7.5

1.52

1.25

mmol/l

0.37

779

Autism

373

1.30

0.96

6.0

9.6

1.38

0.56

mmol/l

0.60

296

Pemphigus

219

1.42

0.95

9.0

5.2

-0.60

1.23

mmol/l

0.63

177

Special screening examination for infectious and parasitic diseases

770

5418

1.07

0.95

8.7

7.6

-0.31

0.69

mmol/l

8.19

658

4250

Carcinoma in situ of cervix uteri, endocervix

235

1.39

0.95

7.2

8.6

-0.05

1.01

mmol/l

0.70

178

Respiratory and cardiovascular disorders specific to the perinatal period

341

1.30

0.94

16.8

-0.55

-0.14

mmol/l

0.37

265

Foreign body entering into or through eye or natural orifice

314

2867

1.11

0.93

7.3

8.3

0.74

1.02

mmol/l

0.56

248

2240

Other conjunctival vascular disorders and cysts

785

1.21

0.93

5.5

8.2

0.71

1.34

mmol/l

0.87

631

Normotensive glaucoma

382

3525

1.10

0.92

6.2

6.5

0.99

1.23

mmol/l

0.68

283

2760

Benign neoplasm: Parathyroid gland

316

1.34

0.92

3.3

5.8

0.77

1.70

mmol/l

1.08

250

Seminoma of testis, excluding all cancers (controls excluding all cancers)

272

1.36

0.91

12.8

10.3

0.52

1.30

mmol/l

0.68

214

Other combined immunodeficiencies

1.97

0.91

3.4

4.8

1.72

1.26

mmol/l

—

Open bite that required surgery (Lefort1 or BSSRO)

160

1.47

0.91

2.5

10.8

2.59

1.12

mmol/l

0.69

123

Endometriosis ASRM stages 3,4

810

7662

1.06

0.91

6.1

6.2

1.24

1.12

mmol/l

0.49

621

6024

Complications associated with artificial fertilization

271

1.35

0.91

4.6

9.2

0.13

0.46

mmol/l

0.13

198

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

317

1.33

0.89

6.1

6.7

1.70

1.17

mmol/l

0.52

256

Ankylosing spondylitis, strict definition

146

1280

1.15

0.89

8.2

9.5

1.13

0.96

mmol/l

0.23

115

1012

Squamous cell neoplasms and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

2.11

0.89

8.3

6.2

-0.02

2.21

mmol/l

—

Malignant neoplasm of other and unspecified male genital organs

2.16

0.89

37.7

8.1

-0.83

2.17

mmol/l

—

Colorectal squamous cell carcinoma, excluding all cancers (controls excluding all cancers)

2.11

0.89

8.3

6.2

-0.02

2.21

mmol/l

—

Other maternal disorders predominantly related to pregnancy

2026

12293

1.04

0.88

6.4

7.1

1.00

1.04

mmol/l

0.18

1536

9738

Benign neoplasm: Retina

154

1.48

0.88

5.4

5.9

0.38

1.09

mmol/l

0.32

123

Valgus deformity, not elsewhere classified

196

1.42

0.88

3.0

9.7

-0.66

1.50

mmol/l

1.64

153

Motor- or nonmotor-vehicle accident in traffic area

162

1.46

0.88

9.9

10.7

0.79

1.11

mmol/l

0.12

126

Other diseases of appendix

363

1.30

0.87

15.1

6.9

1.04

1.40

mmol/l

0.31

292

Acute myringitis

188

1.43

0.87

4.4

8.3

0.94

1.06

mmol/l

0.07

150

Glaucoma secondary to eye trauma

241

1.38

0.87

4.3

6.8

1.48

1.15

mmol/l

0.17

189

Oher contracture of tendon (sheath)

105

1.60

0.86

8.2

5.5

0.09

0.85

mmol/l

0.42

Rheumatic fever with heart involvement

172

1.46

0.86

14.5

6.2

1.47

1.45

mmol/l

0.01

132

Drowning and submersion while in natural water

164

1.48

0.86

3.2

11.0

-0.36

0.92

mmol/l

0.75

131

Cyst of Bartholin Gland

116

1003

1.17

0.86

4.3

7.1

0.66

1.15

mmol/l

1.26

784

Use of other anti-dementia drugs

1261

10527

1.05

0.85

3.5

5.6

1.40

1.17

mmol/l

1.18

917

7999

Use of memantine

1261

10527

1.05

0.85

3.5

5.6

1.40

1.17

mmol/l

1.18

917

7999

Toxic effect of contact with venomous animals

139

1221

1.15

0.84

7.3

8.4

0.91

1.10

mmol/l

0.22

111

962

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

276

1.34

0.84

5.2

6.2

1.22

1.53

mmol/l

0.28

218

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

139

1.50

0.84

4.9

5.8

-0.27

1.47

mmol/l

1.11

105

Occupant of special vehicle mainly used on industrial premises injured in transport accident

156

1.47

0.84

6.1

7.7

2.31

0.87

mmol/l

0.70

124

N06DA Anticholinesterases

1567

13159

0.96

0.84

3.7

5.9

1.28

1.17

mmol/l

0.53

1175

10116

Use of anticholinesterases

1567

13159

0.96

0.84

3.7

5.9

1.28

1.17

mmol/l

0.53

1175

10116

Malignant neoplasm of other and ill-defined sites

0.49

0.83

5.6

6.1

0.50

1.20

mmol/l

—

Embedded and impacted teeth

720

5783

1.06

0.83

7.1

7.8

0.79

0.61

mmol/l

0.55

531

4328

Carcinoma in situ of bronchus and lung

1.92

0.83

15.9

9.9

3.94

1.43

mmol/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

673

1.20

0.83

8.1

8.0

1.15

1.23

mmol/l

0.07

530

Other congenital malformations of urinary system

114

1.54

0.83

19.9

9.5

-0.90

0.69

mmol/l

0.97

Sclerosis of liver

2.53

0.83

13.8

5.6

-1.16

1.43

mmol/l

—

Sequelae of hyperalimentation

1.77

0.82

7.8

5.5

0.60

1.59

mmol/l

—

Disorders of sphingolipid metabolism and other lipid storage disorders

1.62

0.82

6.9

14.2

2.26

1.64

mmol/l

—

Cervical root disorders

208

1.39

0.82

4.9

7.0

1.11

1.24

mmol/l

0.08

175

Oral lichen ruber planus, hypothyreosis or thyroxin

475

1.25

0.82

7.1

6.4

0.92

1.62

mmol/l

0.99

386

Relapsing fevers

1.74

0.81

7.0

21.0

1.26

1.48

mmol/l

—

Loose body in joint

824

1.18

0.81

5.9

9.5

0.66

0.99

mmol/l

0.40

642

Psoriasis (vulgaris), strict definition

116

1010

1.16

0.81

8.7

9.5

0.81

1.15

mmol/l

0.40

816

Chronic diseases of tonsils and adenoids

3713

24073

0.97

0.81

7.1

7.9

1.03

0.94

mmol/l

0.65

2929

19008

Melanocytic naevi of lip

252

1.35

0.81

4.7

8.4

1.46

1.34

mmol/l

0.07

203

Melanocytic naevi of eyelid, including canthus

243

1.35

0.81

9.2

9.0

2.21

1.45

mmol/l

0.65

198

Nontoxic single thyroid nodule

227

2499

0.90

0.80

4.6

6.8

0.95

1.18

mmol/l

0.42

172

1939

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

269

1.33

0.80

4.5

6.3

1.70

1.30

mmol/l

0.29

210

Measles

278

1.32

0.80

5.7

10.5

1.21

1.23

mmol/l

0.01

216

Progressive external ophthalmoplegia

2.36

0.80

7.0

9.7

2.64

1.88

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

227

1.36

0.79

3.5

7.8

0.14

1.27

mmol/l

1.31

179

Myelodysplastic syndrome

307

1.31

0.79

4.8

5.5

0.99

1.38

mmol/l

0.16

241

Circumscribed brain atrophy

754

1.19

0.79

6.1

7.3

1.02

1.27

mmol/l

0.17

592

Unequal limb length (acquired)

157

1.43

0.78

6.5

8.8

0.39

1.15

mmol/l

0.78

120

Postpartum haemorrhage due to anatomy

168

1880

0.89

0.78

6.4

6.1

-0.21

0.47

mmol/l

1.21

114

1350

Other and unspecified papulosquamous disorders

184

1.41

0.78

7.9

6.2

0.14

1.24

mmol/l

0.59

142

Other noninflammatory disorders of vagina

265

2426

1.10

0.78

5.7

6.3

1.07

1.16

mmol/l

0.14

196

1937

Impacted cerumen

363

3906

0.92

0.78

5.9

6.9

0.80

1.10

mmol/l

0.91

294

3023

Benign neoplasm of thyroid gland

110

958

1.16

0.77

8.1

5.7

1.23

1.32

mmol/l

0.11

738

Endocrine disorders, other/unspecified

580

0.80

0.77

6.1

7.4

1.95

1.21

mmol/l

0.63

463

Eccrine sweat disorders

1.64

0.77

1.6

7.0

0.26

0.82

mmol/l

—

Medical treatment for female infertility

491

4593

1.07

0.76

5.9

6.7

0.54

0.70

mmol/l

0.43

350

3437

MS-disease / Multiple Sclerosis

225

2047

1.11

0.76

6.1

8.0

1.24

0.99

mmol/l

0.42

170

1586

Graves disease, strict definition

321

2968

1.09

0.76

5.6

7.5

0.99

1.05

mmol/l

0.10

251

2305

Other benign neoplasm of uterus: Other parts/unspecified

129

1457

0.87

0.75

4.0

4.9

1.05

1.67

mmol/l

1.05

104

1138

Other acute disseminated demyelination

237

1.34

0.75

6.7

7.2

1.25

1.22

mmol/l

0.02

184

Sequelae of transport accidents

143

1.45

0.74

13.3

10.8

3.42

0.97

mmol/l

1.77

111

Palatinal maxillary operation

100

1.52

0.74

11.7

16.2

-0.57

-0.11

mmol/l

—

Distal bite

694

0.82

0.74

8.6

10.5

0.76

0.54

mmol/l

0.22

539

Deformity of finger(s)

204

1.37

0.73

5.4

7.1

0.38

1.25

mmol/l

0.74

158

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

203

1.35

0.72

6.4

7.3

-0.18

1.10

mmol/l

1.47

154

Complications following abortion and ectopic and molar pregnancy

121

1068

1.15

0.72

7.3

7.1

1.30

1.29

mmol/l

0.01

100

865

Foreign body in genitourinary tract

248

1.32

0.72

4.2

9.3

1.83

1.19

mmol/l

0.45

200

Other and unspecified disease of Bartholin gland

103

900

1.16

0.71

6.8

6.9

0.85

1.22

mmol/l

0.48

716

Polyglandular dysfunction, other/unspecified

1.99

0.71

10.6

7.2

6.54

2.32

mmol/l

—

Uterine polyps

344

3200

1.08

0.71

6.3

6.7

1.47

1.14

mmol/l

0.94

275

2607

Other acquired deformities of ankle and foot

231

1.33

0.71

4.2

7.3

1.31

1.34

mmol/l

0.01

185

Other and unspecified neuropathies

136

1.45

0.71

8.6

6.9

2.58

1.42

mmol/l

0.24

108

Complications predominantly related to the puerperium

780

7436

1.05

0.71

7.4

6.7

0.81

0.92

mmol/l

0.36

616

5756

Night blindness

1.94

0.69

10.0

11.1

-1.62

1.76

mmol/l

—

Migraine, unspecified, drug-induced

197

1.36

0.69

8.0

10.1

1.27

1.45

mmol/l

0.09

162

Nontoxic diffuse goitre

120

1063

1.14

0.69

6.1

1.29

1.18

mmol/l

0.12

103

835

Pregnancy, childbirth and the puerperium

1228

6674

0.96

0.69

5.4

5.9

1.07

1.21

mmol/l

0.52

947

5219

Tonsillectomy and adenotomy

2038

14611

0.97

0.68

6.7

8.1

0.85

mmol/l

0.02

1561

11283

Alzheimer’s disease (Early onset), excluding more controls

116

1236

0.88

0.68

6.1

5.9

1.09

0.93

mmol/l

0.17

936

Benign neoplasm: Vagina

331

1.26

0.68

5.7

1.90

1.57

mmol/l

0.25

262

Other forms of systemic lupus erythematosus

224

1.33

0.68

14.7

5.7

0.72

1.34

mmol/l

0.42

181

Undefined dementia

457

4459

0.94

0.67

3.7

5.1

1.83

1.19

mmol/l

2.65

332

3306

Subacute thyroiditis

125

1112

1.14

0.67

6.9

6.6

0.98

1.18

mmol/l

0.25

103

872

Hereditary corneal dystrophies

129

1152

1.14

0.67

7.6

6.9

0.66

1.13

mmol/l

0.81

112

910

Onycholysis

172

1.37

0.67

6.0

9.9

1.89

1.28

mmol/l

0.62

138

Anisometropia and aniseikonia

988

0.86

0.66

10.2

7.5

0.25

1.14

mmol/l

1.14

780

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

803

1.16

0.66

5.4

6.0

1.68

1.32

mmol/l

0.31

604

Bus occupant injured in other and unspecified transport accidents

181

1.36

0.66

7.0

6.7

-0.90

1.46

mmol/l

3.64

144

Juvenile dermatomyositis

1.81

0.66

5.0

6.8

0.74

0.77

mmol/l

—

Traumatic amputation of hip and thigh

1.72

0.65

8.6

5.9

1.25

1.03

mmol/l

—

Injury of nerves at ankle and foot level

190

1.35

0.65

9.2

7.6

2.75

0.96

mmol/l

0.90

147

Monocytic leukaemia

113

1.49

0.65

6.1

5.6

1.81

1.71

mmol/l

0.03

Chronic myeloproliferative disease

500

1.21

0.64

6.9

7.9

0.31

1.33

mmol/l

0.72

390

All dysplastic lesions of the vagina

693

1.17

0.64

5.8

7.2

0.79

1.38

mmol/l

0.86

551

Exposure to high-pressure jet

0.00

0.63

0.0

5.0

—

-0.06

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

389

1.23

0.63

6.6

6.4

1.12

1.54

mmol/l

0.58

304

Actinomycosis

105

1.48

0.63

8.3

7.4

2.52

1.45

mmol/l

0.42

Felty syndrome

192

1.35

0.63

10.0

6.1

0.59

1.26

mmol/l

0.43

153

Chorioretinal inflammation

102

902

1.14

0.62

10.1

8.1

0.90

1.20

mmol/l

0.36

702

Cholesteatoma of middle ear

225

2076

1.09

0.62

7.5

7.4

1.14

1.12

mmol/l

0.03

174

1611

Dermatitis due to ingested food

569

1.18

0.62

22.3

10.6

0.02

-0.00

mmol/l

0.02

434

Benign mammary dysplasia

553

5255

1.06

0.62

6.5

6.2

1.22

1.32

mmol/l

0.24

437

4185

Carcinoma in situ of penis

1.60

0.62

6.8

19.6

-0.26

1.24

mmol/l

—

LSIL lesion of the cervix uteri, vagina or vulva

379

3561

1.07

0.61

6.2

6.6

1.13

0.93

mmol/l

0.53

291

2721

Benign neoplasm: Rectum/anal canal icd-9

291

1.26

0.60

5.3

5.2

1.75

1.86

mmol/l

0.09

222

Other endocrine disorders

153

1333

1.11

0.60

7.9

9.7

0.64

0.82

mmol/l

0.22

122

1046

Benign neoplasm: Endocrine gland, other/unspecified

115

1.45

0.60

3.6

6.3

-0.03

1.43

mmol/l

1.03

Other benign neoplasm of uterus: Corpus uteri

247

1.29

0.60

6.0

6.2

1.66

1.50

mmol/l

0.10

204

Allergic contact dermatitis due to drugs in contact with skin

698

1.16

0.60

6.9

7.3

0.98

1.32

mmol/l

0.36

549

Choroidal haemorrhage and rupture

124

1.44

0.60

4.2

6.0

0.51

1.09

mmol/l

—

Impacted maxillary molar

107

950

1.13

0.59

6.3

8.0

-0.41

0.51

mmol/l

1.34

686

Other congenital malformations of face and neck

754

1.15

0.59

8.3

8.9

1.22

0.92

mmol/l

0.25

600

Ovarian hyperstimulation (induction)

273

1.26

0.59

4.8

7.4

0.04

0.79

mmol/l

0.32

186

Vascular dementia (multiple infarctions)

456

1.20

0.59

5.8

5.7

1.22

1.30

mmol/l

0.04

327

Hand

150

1.37

0.58

4.9

10.6

1.16

1.25

mmol/l

0.03

119

Benign neoplasm: Vulva

559

1.18

0.58

4.6

5.9

1.67

1.27

mmol/l

0.45

442

Benign neoplasm: Short bones of upper limb

439

1.20

0.58

4.2

7.9

0.82

1.28

mmol/l

0.58

354

Postpartum hemorraghe, parous women as controls

584

5366

0.95

0.58

6.5

0.13

0.80

mmol/l

4.40

426

4046

Separation of retinal layers (serosa)

166

1521

1.10

0.56

9.0

8.3

0.81

1.18

mmol/l

0.72

137

1211

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

143

1.37

0.55

13.6

6.2

2.39

1.49

mmol/l

0.43

117

Female infertility, cervigal, vaginal, other or unspecified origin

892

5746

1.04

0.55

6.4

7.4

0.64

0.91

mmol/l

1.34

683

4526

Reduction defects of upper limb

1.50

0.55

10.7

7.6

-0.33

1.85

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

503

4785

1.05

0.55

8.6

7.3

0.57

0.82

mmol/l

0.66

385

3659

Noise effects on inner ear

181

1667

1.10

0.55

7.7

8.6

1.22

0.89

mmol/l

0.47

135

1297

Postdysenteric arthropathy

282

0.77

0.54

5.5

10.6

-0.00

1.01

mmol/l

0.92

229

Cleft lip and palate

143

1.36

0.54

7.3

12.5

2.02

1.01

mmol/l

0.53

110

Disorders of glossopharyngeal nerve

1.47

0.54

28.7

9.4

1.79

1.85

mmol/l

—

Melanoma in situ

146

1332

1.11

0.54

6.1

6.5

0.83

1.31

mmol/l

0.85

122

1020

Galactorrhea

214

1.28

0.54

5.1

6.8

1.88

1.25

mmol/l

0.44

165

Filariasis

1.58

0.54

11.7

6.8

1.38

2.21

mmol/l

—

Melanoma in situ of upper limb, including shoulder

188

1.31

0.54

4.9

5.6

2.60

1.63

mmol/l

0.41

148

Acquired keratosis [keratoderma] palmaris et plantaris

144

1.36

0.54

22.2

7.3

1.92

1.31

mmol/l

0.47

116

Keratoconus

734

1.14

0.53

9.2

8.1

1.96

1.10

mmol/l

1.35

599

Other diseases caused by chlamydiae

269

1.25

0.53

10.8

7.0

1.68

1.40

mmol/l

0.11

209

Postpartum hemorraghe, all women as controls

584

6080

0.95

0.52

6.5

6.8

0.13

0.79

mmol/l

4.33

426

4574

Otorrhoea

1.49

0.52

23.3

7.3

-2.23

1.36

mmol/l

1.10

Infectious mononucleosis

204

1889

1.08

0.52

8.2

8.3

0.93

0.62

mmol/l

0.51

149

1416

L02BB Anti-androgens

442

4208

1.06

0.51

5.0

6.9

0.61

0.97

mmol/l

0.89

314

3181

Subclinical iodine-deficiency hypothyroidism

1.61

0.51

5.9

6.8

-0.01

1.69

mmol/l

—

Other protozoal intestinal diseases

367

0.81

0.51

5.9

9.2

0.59

1.24

mmol/l

0.49

301

Exfoliative dermatitis

382

1.20

0.50

9.2

7.3

1.13

1.17

mmol/l

0.02

292

Carcinoma in situ of skin, other sites/unspecified

457

1.18

0.50

4.9

6.7

1.72

1.40

mmol/l

0.40

358

Inflammatory disease of cervix uteri

201

2163

0.92

0.50

5.7

6.2

1.50

1.22

mmol/l

0.52

158

1695

Benign neoplasm: Short bones of lower limb

291

1.22

0.48

5.8

10.3

0.97

1.07

mmol/l

0.06

239

Granuloma annulare

411

1.18

0.48

8.3

7.3

1.78

1.26

mmol/l

0.53

334

Carcinoma in situ of middle ear and respiratory system

183

1.30

0.48

8.3

7.1

3.46

0.87

mmol/l

2.18

146

Pityriasis rosea

182

1.29

0.48

5.7

10.0

-0.29

1.33

mmol/l

0.79

141

Wide developmental disorders

551

1.15

0.47

5.5

10.7

0.91

0.29

mmol/l

0.49

439

Benign neoplasm: Lip

763

1.13

0.45

5.4

6.9

1.38

1.36

mmol/l

0.01

599

Other benign neoplasm of uterus: Cervix uteri

166

1.29

0.45

5.4

5.5

1.58

1.54

mmol/l

0.01

133

Seminoma of testis

303

1.21

0.45

12.8

11.0

0.52

0.81

mmol/l

0.19

244

Dental caries 3 and operation codes, only avohilmo

1565

8058

0.97

0.45

7.7

8.0

1.14

1.12

mmol/l

0.06

1240

6284

Carcinoma in situ of penis

1.47

0.45

6.8

19.6

-0.26

0.97

mmol/l

—

Melanoma in situ of ear and external auricular canal

1.66

0.44

13.0

4.9

-0.36

2.20

mmol/l

—

Exposure to excessive heat of man-made origin

267

1.23

0.44

9.2

6.9

0.97

1.27

mmol/l

0.20

209

Benign neoplasm: Connective and other soft tissue of thorax

149

1.31

0.44

5.5

6.4

1.15

1.18

mmol/l

0.02

118

Other disorders of carbohydrate metabolism

113

1.36

0.44

4.6

10.3

0.35

1.40

mmol/l

—

Other recurrent vertebral subluxation

1.64

0.44

8.0

6.0

1.60

0.95

mmol/l

—

Carcinoma in situ of breast, other/unspecified

456

0.84

0.44

4.7

6.1

2.03

1.67

mmol/l

0.33

370

Antepartum haemorrhage, not elsewhere classified

192

1792

1.08

0.43

9.4

7.0

0.95

0.70

mmol/l

0.46

150

1344

Parapsoriasis

587

1.14

0.42

9.1

8.0

1.02

1.15

mmol/l

0.09

470

Complications following myocardial infarction

241

1.22

0.42

10.6

6.0

0.33

1.32

mmol/l

0.59

184

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

1.53

0.42

2.0

28.0

-0.92

1.11

mmol/l

—

Spontaneous abortion

1527

10630

0.98

0.41

6.0

6.8

1.06

1.05

mmol/l

0.03

1170

8386

Mandibular hypoplasia

141

1.30

0.41

10.9

6.9

0.76

1.44

mmol/l

0.29

107

Otosclerosis

278

2933

0.94

0.41

7.6

7.4

0.94

1.13

mmol/l

0.37

222

2292

Malignant melanoma of skin

491

4718

1.05

0.41

6.4

6.9

0.80

1.09

mmol/l

0.86

396

3627

Benign neoplasm: Tonsil

381

1.17

0.41

4.0

7.6

0.01

1.30

mmol/l

1.41

314

Neuroendocrine tumor and carcinoma of stomach

160

1.29

0.41

4.9

6.8

-0.27

0.99

mmol/l

0.73

127

Carcinoid syndrome

335

1.19

0.41

5.8

9.5

0.91

1.43

mmol/l

0.30

270

Endometriosis of rectovaginal septum and vagina

273

2586

1.06

0.40

6.2

1.56

1.17

mmol/l

1.13

204

2059

Use of entacapone

298

1.20

0.40

5.1

6.4

2.27

1.42

mmol/l

0.55

242

Other congenital malformations of male genital organs

160

1.27

0.40

11.0

14.5

-0.29

0.46

mmol/l

0.47

136

Benign neoplasm of male genital organs

704

1.12

0.40

7.7

7.9

1.28

1.03

mmol/l

0.23

533

Overjet

440

0.85

0.40

12.7

10.3

0.39

0.44

mmol/l

0.02

342

Use of rivastigmine

629

6066

1.04

0.40

3.5

5.5

1.17

1.20

mmol/l

0.05

474

4603

Autism spe

381

1.16

0.40

4.9

9.7

1.17

0.60

mmol/l

0.35

298

Adenocarcinoma of pancreas

114

1050

1.10

0.39

6.6

7.3

0.95

1.27

mmol/l

0.44

820

Melanoma in situ of trunk

492

0.86

0.38

7.8

7.3

0.09

1.27

mmol/l

1.43

383

Medicines for HER+ breast cancer

1466

13972

1.02

0.38

5.2

6.4

1.20

1.27

mmol/l

0.30

1205

11213

Donors of organs and tissues

308

1.18

0.38

10.7

7.9

0.53

0.83

mmol/l

0.28

237

Other specific arthropathies, wide

648

1.12

0.38

6.8

9.6

0.35

1.18

mmol/l

0.77

507

Use of amantadine

507

1.14

0.37

4.8

6.8

0.32

1.55

mmol/l

1.22

405

FESS (DNB20)

435

4522

0.96

0.36

6.0

8.1

1.26

0.98

mmol/l

1.03

322

3530

Dementia in Alzheimer disease

776

6826

0.97

0.36

3.4

5.6

1.38

1.12

mmol/l

1.13

570

5211

conjunctival degenerations and deposits

747

1.11

0.36

8.8

7.2

1.49

1.26

mmol/l

0.33

593

Syndactyly

1.43

0.36

67.0

8.4

-0.43

1.07

mmol/l

—

Abnormal findings on diagnostic imaging of breast

396

1.15

0.35

7.2

6.4

2.41

1.50

mmol/l

0.87

325

General hospital and personal-use devices associated with adverse incidents

1.37

0.35

5.0

19.0

0.73

1.46

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

135

1448

0.93

0.35

10.4

7.0

0.28

0.81

mmol/l

0.94

104

1092

Other and unspecified degenerative diseases of nervous system

865

1.10

0.34

3.9

7.7

1.36

1.34

mmol/l

0.02

663

Pervasive developmental disorders excl. Autism + Asperger

199

1.21

0.34

5.0

16.1

-0.04

0.61

mmol/l

0.33

160

Leiomyoma of uterus

2650

14842

1.02

0.34

6.2

6.4

1.08

1.27

mmol/l

1.73

2131

11760

Melanoma of uvea

323

1.16

0.33

7.9

7.8

1.46

1.62

mmol/l

0.09

250

Anomalies of dental arch relationship, including avohilmo

608

5294

1.03

0.33

7.6

7.8

1.13

0.81

mmol/l

1.57

481

4068

Alzheimer’s disease, wide definition

1114

9521

0.98

0.32

3.8

5.6

1.16

1.18

mmol/l

0.06

840

7237

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

196

2070

0.94

0.32

9.7

6.9

0.69

0.90

mmol/l

0.31

157

1597

Benign neoplasm: Female genital organ, unspecified

0.69

0.32

10.9

4.8

4.83

1.61

mmol/l

—

Deep endometriosis

306

2932

1.05

0.32

5.9

6.1

1.49

1.13

mmol/l

1.05

223

2273

Retained placenta and membranes, without haemorrhage

349

3630

0.96

0.31

5.5

6.6

1.13

1.09

mmol/l

0.07

273

2858

Congenital malformations of larynx

1.37

0.31

41.4

13.0

0.53

1.05

mmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

793

1.09

0.31

7.7

7.5

1.59

1.37

mmol/l

0.21

623

Benign neoplasm: Parathyroid gland

363

1.15

0.31

3.3

6.8

0.77

1.39

mmol/l

0.62

291

Other puerperal infections

137

1460

0.94

0.31

7.1

6.9

-0.09

0.61

mmol/l

2.06

110

1075

Impacted teeth

415

4002

0.96

0.30

7.0

7.9

0.62

0.52

mmol/l

0.19

308

2938

Malignant melanoma

649

6316

1.03

0.30

6.5

6.9

0.88

1.10

mmol/l

0.75

522

4878

Ankyloglossia

258

1.17

0.30

10.3

12.8

-1.31

0.14

mmol/l

0.72

202

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

130

1.26

0.30

4.9

6.6

2.05

1.31

mmol/l

—

101

Tic and related disorders

250

1.17

0.30

8.4

9.8

0.88

0.78

mmol/l

0.07

190

Perioral dermatitis

488

1.11

0.29

10.1

9.4

1.14

1.12

mmol/l

0.01

388

Benign neoplasm: Rectum/anal canal icd-9

318

1.15

0.28

5.3

5.5

1.75

1.55

mmol/l

0.16

245

Malignant neoplasm of breast, HER-positive

1332

13370

0.98

0.28

5.3

6.3

1.24

1.28

mmol/l

0.18

1102

10755

Deep bite that required surgery

280

1.15

0.28

3.4

10.7

0.35

1.16

mmol/l

0.49

221

Defect, injury or illness of neck

131

1.24

0.28

12.8

7.6

0.75

1.43

mmol/l

0.50

102

Tic disorders

233

1.17

0.28

9.0

9.6

0.60

0.81

mmol/l

0.16

180

Melanoma in situ of other and unspecified parts of face

426

0.88

0.28

8.9

7.0

1.05

1.42

mmol/l

0.22

344

Melanoma in situ

146

1542

0.94

0.27

6.1

7.4

0.83

1.13

mmol/l

0.45

122

1196

Congenital malformations of ovaries, fallopian tubes and broad ligaments

137

1292

1.06

0.27

7.5

6.9

0.99

0.97

mmol/l

0.02

112

994

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

160

1517

1.06

0.27

4.4

6.8

1.50

1.16

mmol/l

0.70

125

1211

Calcaneal spur

376

1.13

0.27

10.8

6.7

1.32

1.25

mmol/l

0.05

303

Other deformity of hallux (acquired)

253

1.16

0.27

3.7

6.3

0.73

1.25

mmol/l

0.36

198

Synovial hypertrophy, not elsewhere classified

253

1.16

0.27

6.8

10.7

0.20

1.05

mmol/l

0.41

196

Disorder of carbohydrate metabolism, other/unspecified

1.33

0.27

2.2

12.7

0.98

1.38

mmol/l

—

Other specified disorders of external ear

155

1472

1.06

0.26

5.7

8.3

0.85

1.14

mmol/l

0.42

123

1137

Presbyopia

214

2049

1.05

0.26

8.1

0.67

1.13

mmol/l

1.18

174

1626

Human immunodeficiency virus [HIV] disease

601

0.91

0.25

14.7

10.8

-0.07

1.09

mmol/l

1.16

481

Diseases caused by chlamydiae

226

1.16

0.25

12.7

7.7

0.73

1.37

mmol/l

0.32

172

Benign neoplasm: Uterine tubes and ligaments

189

1.18

0.25

4.7

5.3

2.39

1.95

mmol/l

0.12

152

Benign neoplasm: Vagina

369

1.12

0.25

5.7

5.8

1.90

1.60

mmol/l

0.22

296

Persons encountering health services in circumstances related to reproduction

2411

16138

1.01

0.25

8.7

8.6

0.83

1.03

mmol/l

1.83

1928

12824

Unspecified lump in breast

557

5431

1.03

0.24

7.2

6.3

0.81

1.22

mmol/l

1.84

461

4311

Benign neoplasm: Skin of lip

466

1.11

0.24

5.3

6.6

1.16

1.31

mmol/l

0.11

377

Visual disturbances in diseases classified elsewhere

0.00

0.24

0.0

7.0

—

2.50

—

Crushing injury of forearm

1.31

0.23

29.8

7.8

0.60

0.18

mmol/l

—

Malignant neoplasm of lip

285

1.14

0.23

9.5

6.1

0.26

1.25

mmol/l

2.09

217

Benign neoplasm: Female genital organ, unspecified

0.75

0.23

10.9

4.4

4.83

2.19

mmol/l

—

Mental and behavioural disorders due to cocaine

1.31

0.23

9.6

22.4

-1.00

1.67

mmol/l

—

Maternal care for known or suspected fetal abnormality and damage

322

2959

0.97

0.23

6.6

7.4

0.10

0.62

mmol/l

1.42

243

2210

Benign neoplasm: Prostate

283

0.87

0.22

4.9

7.5

0.44

1.09

mmol/l

0.31

215

Adult-onset Still disease

107

1.24

0.22

8.7

5.7

2.46

1.62

mmol/l

—

Villonodular synovitis (pigmented)

220

1.15

0.22

5.5

11.3

1.22

1.48

mmol/l

0.08

172

Benign neoplasm of breast

421

4100

1.03

0.22

6.8

6.3

1.26

1.19

mmol/l

0.15

353

3242

Acrodermatitis chronica atrophicans

1.28

0.21

9.2

7.0

0.50

1.70

mmol/l

—

Other and unspecified parapsoriasis

176

0.84

0.21

25.7

5.7

1.39

1.11

mmol/l

0.11

139

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

500

1.09

0.21

4.9

6.5

1.43

1.51

mmol/l

0.06

395

Dementia due to Parkinson's disease

929

1.06

0.20

4.5

6.7

1.85

1.22

mmol/l

1.18

707

Contact with nonpowered hand tool

161

1545

1.05

0.20

8.7

8.8

0.90

1.00

mmol/l

0.13

131

1216

L02BG Aromatase inhibitors

1129

11456

0.98

0.20

5.2

6.4

1.27

mmol/l

0.01

927

9218

Benign neoplasm of other and unspecified female genital organs

143

1369

1.05

0.20

5.7

6.1

2.10

1.30

mmol/l

1.64

113

1079

Personal history of allergy to analgesic agent

137

1.18

0.19

5.4

6.9

1.48

1.25

mmol/l

0.09

108

Periodontosis

1.25

0.19

13.3

7.6

-2.26

1.92

mmol/l

—

Follicular adenocarcinoma of thyroid gland

206

0.86

0.19

2.4

6.4

2.00

1.27

mmol/l

0.51

166

Asymptomatic human immunodeficiency virus [HIV] infection status

176

1.15

0.18

7.8

14.8

0.12

1.02

mmol/l

0.30

138

Other and unspecified disorders of pigmentation

195

1.14

0.18

4.1

8.9

-0.35

1.23

mmol/l

1.23

151

Transient global amnesia

385

3761

1.03

0.18

5.3

6.8

1.12

1.17

mmol/l

0.09

309

2957

Other abnormal products of conception

852

5585

1.02

0.18

5.9

7.2

0.75

0.83

mmol/l

0.25

636

4245

Colorectal neuroendocrine tumor and carcinoma

436

1.09

0.18

6.6

6.8

1.12

1.19

mmol/l

0.07

347

Localized scleroderma [morphea]

407

1.09

0.17

11.2

7.7

0.50

1.46

mmol/l

0.75

326

Abnormality of red blood cells

167

1.15

0.17

6.2

8.2

0.88

1.15

mmol/l

0.09

137

Maternal care for known or suspected abnormality of pelvic organs

658

4458

1.02

0.17

6.0

7.2

0.23

0.79

mmol/l

3.08

480

3406

Benign neoplasm: Eye, unspecified

141

0.84

0.17

9.0

4.4

0.61

0.92

mmol/l

—

109

Melanocytic naevi of eyelid, including canthus

292

1.11

0.17

9.2

8.5

2.21

1.35

mmol/l

0.79

236

Single delivery by caesarean section

493

2792

1.02

0.17

6.5

8.2

-0.08

0.70

mmol/l

3.33

357

2141

Maternal care for other known or suspected fetal problems

522

3416

0.98

0.17

6.2

7.3

-0.03

0.62

mmol/l

3.46

379

2535

Lordosis

1.12

0.16

7.5

4.9

1.60

1.55

mmol/l

—

Ethmoidectomy

464

4731

0.98

0.16

6.2

8.1

1.24

1.00

mmol/l

0.86

345

3700

Alzheimer’s disease (Late onset)

1041

8807

1.01

0.16

3.5

5.5

1.18

1.19

mmol/l

0.02

779

6687

Benign neoplasm of male genital organs

820

0.95

0.16

7.7

9.2

1.28

0.98

mmol/l

0.29

629

Sudden idiopathic hearing loss

418

4099

1.02

0.15

8.2

7.3

1.29

1.09

mmol/l

0.44

332

3189

Use of interferon beta-1a

517

1.07

0.15

6.8

9.7

0.97

0.99

mmol/l

0.02

396

Benign neoplasm: Bone and articular cartilage, unspecified

188

1.13

0.15

5.6

9.8

1.59

1.55

mmol/l

0.02

143

Multiple gestation

200

2059

0.97

0.15

7.3

7.1

0.54

0.76

mmol/l

0.30

153

1574

Melanoma in situ of trunk

460

0.93

0.15

7.8

6.3

0.09

1.44

mmol/l

1.71

351

Obstructed labour due to maternal pelvic abnormality

507

4984

1.02

0.14

7.1

6.9

1.06

1.20

mmol/l

0.35

400

3986

Erosion and ectropion of cervix uteri

960

0.95

0.14

5.4

6.4

0.60

1.39

mmol/l

0.74

766

Cicatricial alopecia [scarring hair loss]

247

1.10

0.14

6.6

9.4

0.00

1.40

mmol/l

1.45

202

Unspecified dementia

455

4175

0.98

0.14

3.7

5.4

1.80

1.12

mmol/l

2.87

330

3126

Triptan medication for migraine, min. 3 purchases

1994

15603

1.01

0.14

6.8

7.5

0.86

0.96

mmol/l

0.66

1546

12165

LSIL lesion of the cervix uteri

270

2638

1.02

0.13

5.8

6.6

1.08

0.87

mmol/l

0.46

202

2003

Other and unspecified localized connective tissue disorders

106

0.84

0.13

4.3

4.7

1.26

1.41

mmol/l

—

Foreign body on external eye

576

5846

0.98

0.13

6.9

8.7

0.97

0.96

mmol/l

0.04

455

4603

Retinoschisis and retinal cysts

894

1.05

0.13

4.8

8.0

0.48

1.27

mmol/l

1.51

700

Twin gestation

193

1982

0.97

0.13

7.5

7.0

0.53

0.74

mmol/l

0.26

148

1511

Hydatidiform mole

316

1.08

0.13

1.9

8.4

2.20

1.27

mmol/l

1.19

247

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

226

1.10

0.13

10.2

16.7

-1.41

-0.04

mmol/l

0.94

181

Monocytic leukaemia

143

1.14

0.12

6.1

5.7

1.81

1.19

mmol/l

0.19

116

Other noninflammatory disorders of cervix uteri

167

1716

0.97

0.12

5.3

6.5

0.78

1.32

mmol/l

0.81

133

1388

L02BX Other hormone antagonists and related agents

233

2380

0.98

0.12

4.9

7.3

0.78

0.96

mmol/l

0.27

175

1815

Dyshidrosis [pompholyx]

394

0.94

0.11

5.1

6.2

0.09

0.80

mmol/l

0.25

301

Contact with lifting and transmission devices, not elsewhere classified

612

1.05

0.11

8.5

10.2

1.39

1.03

mmol/l

0.44

479

Melanoma in situ of ear and external auricular canal

1.19

0.10

13.0

9.5

-0.36

2.36

mmol/l

—

Hair colour and hair shaft abnormalities

154

1.12

0.10

4.6

7.8

2.12

0.97

mmol/l

0.66

130

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

196

2004

0.98

0.10

9.7

6.6

0.69

0.87

mmol/l

0.25

157

1544

Postpartum haemorrhage due to retained placenta

269

2642

1.02

0.10

7.0

6.5

-0.28

0.80

mmol/l

5.01

191

1993

Helminthiases

526

1.05

0.10

8.7

7.8

0.62

1.15

mmol/l

0.48

426

Other fusion of spine

1.07

0.09

7.8

5.8

0.28

1.86

mmol/l

—

Habitual aborter

320

1.07

0.09

3.9

7.6

-0.03

0.34

mmol/l

0.21

239

Maternal care for known or suspected malpresentation of fetus

385

2912

0.98

0.09

6.1

7.2

0.45

0.58

mmol/l

0.25

278

2158

Unspecified urinary incontinence

323

3181

1.02

0.09

8.2

6.6

1.01

1.24

mmol/l

0.45

265

2476

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

135

1384

0.97

0.09

10.4

6.7

0.28

0.74

mmol/l

0.76

104

1035

Rubella [German measles]

131

1278

1.03

0.09

14.1

9.6

1.23

0.73

mmol/l

0.92

105

1037

Use of cabergoline

341

1.06

0.09

3.6

8.4

0.50

1.03

mmol/l

0.42

264

Unspecified human immunodeficiency virus [HIV] disease

302

1.07

0.09

14.5

10.3

-0.86

1.04

mmol/l

1.21

247

Noninfective disorders of pinna

1.06

0.09

5.3

6.6

0.22

0.44

mmol/l

—

Use of trihexyphenidyl

1.12

0.08

5.3

5.1

3.74

2.34

mmol/l

—

Enteritis due to Yersinia enterocolitica

146

1.10

0.08

3.8

7.9

2.22

1.03

mmol/l

1.43

112

Universal erythroderma, KELA reimbursement

499

1.05

0.08

10.0

7.6

1.40

0.97

mmol/l

0.27

402

Mandibular retrognathia AND surgery (BSSRO)

623

0.96

0.08

3.1

10.2

1.33

1.10

mmol/l

0.16

490

Venous complications and haemorrhoids in the puerperium

273

1.07

0.08

5.3

7.2

1.53

1.49

mmol/l

0.01

223

Other and unspecified disorders of vitreous body

1912

18920

1.01

0.08

6.6

7.2

1.14

1.12

mmol/l

0.08

1580

15059

Small cell lung cancer

895

1.03

0.08

5.4

6.1

1.68

1.26

mmol/l

0.38

688

Small cell lung cancer, helper endpoint

895

1.03

0.08

5.4

6.1

1.68

1.26

mmol/l

0.38

688

Oesophagitis, drug-induced

1.06

0.07

19.9

5.2

-0.05

1.03

mmol/l

—

Unattended death

286

0.94

0.07

4.9

6.7

1.91

1.34

mmol/l

0.37

222

Congenital malformations of anterior segment of eye

235

1.07

0.07

8.8

10.1

2.02

1.07

mmol/l

0.71

186

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

235

0.93

0.07

3.3

11.0

1.59

0.73

mmol/l

0.66

186

Benign neoplasm: Skin, unspecified

139

1363

1.02

0.07

6.9

7.7

0.88

1.13

mmol/l

0.44

113

1074

Malignant neoplasm, without specification of site

119

1165

1.02

0.07

5.9

6.4

1.19

1.36

mmol/l

0.19

881

Melanoma of uvea

354

1.05

0.07

7.9

9.4

1.46

1.35

mmol/l

0.06

285

Other obstetric trauma

105

1074

0.98

0.06

8.3

6.4

0.55

0.78

mmol/l

0.28

801

Use of dimethyl fumarate

152

0.92

0.06

12.9

7.4

2.47

0.91

mmol/l

—

112

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1608

12577

1.00

0.06

6.5

6.8

1.00

1.05

mmol/l

0.22

1241

9804

Melanoma in situ of other and unspecified parts of face

395

0.96

0.06

8.9

5.4

1.05

1.65

mmol/l

0.41

298

Congenital malformations of breast

296

1.05

0.06

5.5

6.4

1.12

1.31

mmol/l

0.07

227

Human immunodeficiency virus [HIV] disease resulting in other conditions

536

0.97

0.05

15.2

11.4

-0.31

1.13

mmol/l

1.51

430

Peripheral retinal degeneration

109

1070

1.02

0.05

5.3

7.4

1.38

1.24

mmol/l

0.19

837

Use of galantamine

292

2892

1.01

0.05

3.1

5.5

1.36

1.29

mmol/l

0.11

213

2177

Maternal care for cervical incompetence

112

1101

1.02

0.05

6.6

6.5

1.10

1.16

mmol/l

0.05

865

Mesial bite

181

0.94

0.05

6.3

11.7

0.81

0.85

mmol/l

0.04

147

Burn and corrosion confined to eye and adnexa

706

0.98

0.05

6.1

9.2

1.70

1.02

mmol/l

0.82

567

Vertigo of central origin

524

0.97

0.04

4.2

6.4

1.68

1.26

mmol/l

0.34

411

Melanoma in situ of upper limb, including shoulder

229

1.05

0.04

4.9

6.1

2.60

1.15

mmol/l

0.69

184

Gestational diabetes (for exclusion)

909

6461

1.00

0.04

6.6

7.1

0.46

0.73

mmol/l

1.21

662

4860

Hypertrophy of (infrapatellar) fat pad

271

0.96

0.04

3.8

10.3

2.24

1.37

mmol/l

0.98

219

Premenstrual syndrome

220

1.05

0.03

6.4

10.0

1.52

1.10

mmol/l

0.21

171

Mumps

834

0.98

0.03

8.1

8.5

0.47

1.13

mmol/l

1.09

660

Use of fingolimod

159

0.94

0.03

3.1

6.8

0.25

0.56

mmol/l

—

120

Other and unspecified spinal muscular atrophies

280

1.04

0.03

9.0

8.6

3.07

1.20

mmol/l

1.58

221

Contraceptive management

1563

11015

1.00

0.03

7.8

8.6

0.81

1.03

mmol/l

1.68

1227

8750

Oral lichen ruber planus, including avohilmo

203

2013

1.01

0.03

6.4

7.6

0.71

1.27

mmol/l

2.04

158

1611

Other benign neoplasms of uterus

180

1784

1.01

0.03

4.5

5.2

1.18

1.67

mmol/l

0.91

140

1416

Other disorders of breast

385

3870

0.99

0.03

6.4

6.6

1.10

mmol/l

0.00

320

3040

Deep bite

321

2792

1.01

0.02

7.0

8.8

1.00

0.78

mmol/l

0.61

255

2162

Pollen allergy

506

4987

1.00

0.02

7.2

8.1

0.59

0.72

mmol/l

0.42

410

3813

Mandibular retrognathia

169

1673

1.01

0.02

6.2

9.1

1.37

0.96

mmol/l

0.80

122

1323

Asymmetry of jaw

312

1.03

0.02

5.3

10.6

0.89

1.00

mmol/l

0.05

251

Bilateral sagittal split ramus osteotomy operation

831

1.01

0.01

3.1

9.3

1.24

1.09

mmol/l

0.13

642

Other obstructed labour

206

2071

0.99

0.01

6.5

6.8

1.05

0.99

mmol/l

0.07

163

1624

Other endophthalmitis

167

0.95

0.01

5.0

5.7

-0.96

1.53

mmol/l

0.87

129

Infections of breast associated with childbirth

712

1.01

0.01

8.8

7.6

0.66

1.05

mmol/l

0.42

538

Benign neoplasm: Vulva

643

1.01

0.01

4.6

6.3

1.67

1.32

mmol/l

0.37

517

Benign neoplasm: Bone and articular cartilage, unspecified

216

0.97

0.00

5.6

10.7

1.59

1.52

mmol/l

0.04

174

LSIL lesion of the vagina

344

1.02

0.00

5.1

7.2

0.78

1.51

mmol/l

0.58

275

Corneal degeneration

474

1.01

0.00

8.9

6.8

1.79

1.30

mmol/l

0.39

385

Benign neoplasm of thyroid gland

110

1106

0.99

0.00

8.1

6.7

1.23

1.29

mmol/l

0.08

877

Maternal care for known or suspected disproportion

914

1.00

0.00

4.4

6.8

0.62

0.96

mmol/l

0.41

681

LeFortI or BSSRO operation

102

1016

1.00

0.00

3.0

9.0

1.29

1.06

mmol/l

0.25

788

Bullous keratopathy

288

1.01

0.00

4.7

5.1

1.03

1.67

mmol/l

0.32

227

Foreign body granuloma of skin and subcutaneous tissue

114

0.96

0.00

7.5

4.4

1.90

1.47

mmol/l

—

Internuclear ophthalmoplegia

1.01

0.00

13.1

6.6

1.55

1.25

mmol/l

—

Benign neoplasm: Prostate

246

1.02

0.00

4.9

6.9

0.44

1.23

mmol/l

0.39

183

Contact with venomous snakes and lizards

301

1.00

0.00

2.8

9.7

1.03

1.23

mmol/l

0.13

248

Carcinoma in situ of breast, other/unspecified

391

1.00

0.00

4.7

5.3

2.03

1.56

mmol/l

0.45

313

Benign neoplasm: Eye, unspecified

123

0.97

0.00

9.0

4.2

0.61

1.38

mmol/l

—

Benign neoplasm: Uterine tubes and ligaments

218

1.01

0.00

4.7

6.4

2.39

1.67

mmol/l

0.21

178

Feeding problems of newborn

0.92

0.00

14.7

19.7

1.65

0.63

mmol/l

—

Toxic effect of noxious substances eaten as seafood

0.00

0.0

3.7

—

1.65

—

Other congenital infectious and parasitic diseases

0.00

0.0

11.4

—

2.80

—

Intrauterine hypoxia

0.00

0.0

9.0

—

0.39

—

Allergic contact dermatitis

446

4460

1.00

0.00

7.0

6.9

0.91

0.99

mmol/l

0.14

345

3446

Neuropathic heredofamilial amyloidosis

0.00

0.0

7.3

—

0.67

—

Anthrax

0.00

0.0

9.1

—

2.94

—

Other protozoal diseases, not elsewhere classified/unspecified

0.00

0.0

15.8

—

2.38

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Base excess in Arterial blood by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS